data_2ldm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ldm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.237 0.397 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -104.19 128.77 51.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.218 1.007 . . . . 0.0 110.159 -169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.8 mp0 -144.45 -172.87 3.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.021 1.728 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.61 144.07 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 66.95 7.07 5.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.802 2.441 . . . . 0.0 114.101 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.3 tp10 -120.24 170.22 9.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 109.668 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.6 144.38 51.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.782 2.033 . . . . 0.0 113.058 -170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.7 164.24 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 127.189 2.196 . . . . 0.0 108.543 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.07 127.69 42.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.18 47.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -68.8 104.89 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -66.82 154.37 41.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m -58.04 -20.29 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 112.424 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.39 -49.63 76.83 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.2 p -171.72 -68.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.15 -162.83 1.58 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.906 1.282 . . . . 0.0 110.808 -169.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -58.55 138.76 56.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -144.28 157.5 56.44 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 128.577 2.751 . . . . 0.0 104.71 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.53 146.96 75.84 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.302 1.335 . . . . 0.0 110.432 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.96 162.11 41.72 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.243 1.817 . . . . 0.0 108.622 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.64 129.72 42.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.57 1.548 . . . . 0.0 107.118 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.53 138.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.942 1.247 . . . . 0.0 107.97 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 p -118.03 -30.52 5.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.291 0.636 . . . . 0.0 110.572 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.2 164.3 37.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.468 1.031 . . . . 0.0 110.248 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.3 t -143.61 147.75 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -133.77 130.26 37.77 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -60.1 -22.97 63.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.149 0.979 . . . . 0.0 112.36 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -54.5 -30.47 53.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.842 0.857 . . . . 0.0 112.342 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.36 26.15 0.75 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.308 0.956 . . . . 0.0 113.024 172.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.2 p -129.4 165.74 20.95 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.807 1.303 . . . . 0.0 110.839 -171.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.48 145.91 37.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.411 2.284 . . . . 0.0 107.382 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.4 m -124.88 131.94 53.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 169.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.66 149.9 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -114.19 119.95 38.82 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.392 1.477 . . . . 0.0 107.021 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.91 140.76 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -63.0 -21.13 65.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.852 0.861 . . . . 0.0 112.986 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.87 -19.9 63.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.797 0.839 . . . . 0.0 112.178 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.86 46.72 1.16 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.83 1.205 . . . . 0.0 110.725 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.3 t -133.96 138.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.5 140.67 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.03 159.73 41.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.335 0.654 . . . . 0.0 110.64 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.1 m -107.76 136.41 47.55 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.55 -179.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.248 2.219 . . . . 0.0 108.379 -169.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.9 168.93 8.9 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.218 -0.926 . . . . 0.0 110.682 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -53.39 -40.21 64.86 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.361 0.664 . . . . 0.0 110.864 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.1 pt -63.61 -5.9 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -115.9 -7.58 11.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 112.636 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.8 t -142.65 139.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 120.076 1.307 . . . . 0.0 111.651 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -148.16 174.3 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 110.055 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.34 167.91 1.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.758 0.823 . . . . 0.0 110.875 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.15 -18.15 65.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.391 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.18 116.85 6.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -61.63 -31.02 71.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -69.28 -55.9 9.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -152.14 165.16 35.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.662 0.744 . . . . 0.0 112.988 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.74 156.15 38.18 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.192 1.397 . . . . 0.0 110.468 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.98 23.53 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.938 0.895 . . . . 0.0 111.256 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.9 -62.89 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 120.707 -1.246 . . . . 0.0 109.686 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.57 -27.91 72.88 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -141.28 165.99 26.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.35 22.74 7.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.642 1.11 . . . . 0.0 113.427 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -77.62 -21.26 52.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.362 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -79.15 175.65 55.01 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.308 0.949 . . . . 0.0 112.987 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.6 m -150.54 171.21 17.44 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.183 2.193 . . . . 0.0 107.949 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -60.15 120.21 9.32 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.66 -164.13 1.58 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.371 1.868 . . . . 0.0 107.655 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -148.18 -176.89 5.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 66.2 m -129.54 169.11 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.149 1.38 . . . . 0.0 111.031 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -127.89 17.65 6.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -168.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -138.71 134.78 34.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 C-N-CA 125.795 1.638 . . . . 0.0 109.629 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 46.32 38.31 5.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 128.5 2.72 . . . . 0.0 115.43 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -110.06 -173.05 2.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 108.12 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -49.23 138.8 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.687 0.795 . . . . 0.0 109.273 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 62.41 25.79 15.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.194 1.798 . . . . 0.0 113.18 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -135.57 167.27 21.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.887 1.275 . . . . 0.0 108.551 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -69.7 156.05 39.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.846 1.258 . . . . 0.0 113.364 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.88 162.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.826 2.45 . . . . 0.0 107.045 169.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 mt -96.07 127.68 42.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.71 44.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.625 0.77 . . . . 0.0 109.406 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -68.84 107.89 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.966 0.507 . . . . 0.0 110.0 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.23 163.91 23.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.341 1.056 . . . . 0.0 109.548 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -57.33 -18.08 15.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.294 1.038 . . . . 0.0 113.201 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -11.68 49.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.41 1.484 . . . . 0.0 113.487 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.5 m 92.54 17.83 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.5 2.72 . . . . 0.0 114.988 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.56 8.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.007 0.821 . . . . 0.0 110.762 169.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -70.76 141.56 51.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.62 160.74 43.55 Favored Pre-proline 0 C--O 1.241 0.634 0 C-N-CA 128.337 2.655 . . . . 0.0 105.529 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.69 147.52 69.82 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.401 1.4 . . . . 0.0 111.039 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.41 161.07 43.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.177 1.791 . . . . 0.0 108.459 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -91.83 131.29 37.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.513 1.525 . . . . 0.0 107.814 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.6 134.16 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.7 p -112.02 -31.52 6.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.445 0.698 . . . . 0.0 110.201 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 164.14 38.09 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.49 1.041 . . . . 0.0 110.418 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.65 142.92 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -130.99 119.24 21.78 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -61.31 -20.63 63.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.499 0.72 . . . . 0.0 112.74 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -52.7 -31.69 38.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.201 1.001 . . . . 0.0 112.42 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.54 25.3 0.51 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.373 0.987 . . . . 0.0 112.885 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.1 p -131.35 169.05 16.53 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.073 1.437 . . . . 0.0 110.606 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -141.82 156.04 45.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.982 2.113 . . . . 0.0 108.104 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -134.2 132.32 39.6 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.03 155.78 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -119.46 123.39 43.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -82.57 151.06 26.57 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.63 -27.1 68.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.673 0.789 . . . . 0.0 112.648 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.05 -23.03 67.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.644 0.777 . . . . 0.0 112.074 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.23 -14.21 8.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.491 1.519 . . . . 0.0 113.108 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.28 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.351 1.075 . . . . 0.0 108.801 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.47 139.06 52.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -153.67 155.38 35.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 110.984 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 m -98.31 138.13 36.01 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.89 171.91 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.093 1.757 . . . . 0.0 108.777 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.3 167.75 10.22 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.35 -0.844 . . . . 0.0 110.403 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -55.08 -37.71 67.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.524 0.73 . . . . 0.0 111.341 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.9 pt -62.79 -10.82 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -109.52 -9.34 14.91 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.234 0.924 . . . . 0.0 112.735 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.05 141.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.733 1.152 . . . . 0.0 111.348 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -146.95 175.2 10.85 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.019 0.928 . . . . 0.0 110.18 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.69 168.09 1.83 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.388 1.075 . . . . 0.0 111.325 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -68.33 -14.79 63.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.818 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.0 m -62.17 120.48 10.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.222 0.919 . . . . 0.0 108.526 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -61.32 -35.75 78.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.2 -42.54 20.64 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -148.86 162.91 38.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.755 0.707 . . . . 0.0 111.961 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -76.73 167.37 21.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 110.214 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.6 mm -129.16 -19.1 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.464 1.505 . . . . 0.0 111.466 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.08 -35.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.412 1.46 . . . . 0.0 112.244 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.86 -30.37 63.01 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -149.77 150.81 32.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.46 64.59 3.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.051 1.341 . . . . 0.0 110.54 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -171.52 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.721 2.008 . . . . 0.0 109.565 -169.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 57.97 -168.11 5.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.09 1.805 . . . . 0.0 116.806 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.6 m -151.09 155.66 39.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.069 2.548 . . . . 0.0 107.045 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -66.08 122.02 16.46 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.03 -163.21 1.58 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.814 1.646 . . . . 0.0 108.472 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -144.9 -179.51 6.65 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 110.9 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 13.8 p -149.38 -178.61 6.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.769 2.028 . . . . 0.0 109.493 -174.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -130.21 6.13 4.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.1 35.87 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.101 1.36 . . . . 0.0 111.812 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 109.979 178.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--O 1.236 0.35 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.46 129.86 55.9 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.33 1.052 . . . . 0.0 110.929 -167.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.0 mp0 -142.84 -174.43 4.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.675 1.99 . . . . 0.0 108.48 -177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.88 143.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 60.06 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 112.959 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.469 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.5 tp10 -128.34 170.1 13.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.435 1.094 . . . . 0.0 108.263 171.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -77.28 155.59 31.96 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.758 -0.589 . . . . 0.0 112.102 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.45 167.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.551 1.94 . . . . 0.0 108.613 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.4 125.62 43.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.04 138.91 48.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 m -68.82 142.05 54.97 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.355 0.598 . . . . 0.0 110.901 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -119.03 154.93 32.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.765 1.626 . . . . 0.0 108.061 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -58.45 -19.8 39.69 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.64 1.176 . . . . 0.0 113.248 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.24 -47.63 80.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.151 0.981 . . . . 0.0 112.699 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.3 p -168.68 -68.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.896 0.478 . . . . 0.0 112.156 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -158.0 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.234 1.813 . . . . 0.0 109.303 -169.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -46.19 139.23 4.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.608 2.363 . . . . 0.0 115.66 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -145.77 157.51 51.09 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.5 3.12 . . . . 0.0 105.314 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.83 146.22 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.772 1.648 . . . . 0.0 110.869 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.64 162.68 41.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.912 1.685 . . . . 0.0 108.878 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -95.66 135.65 37.07 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.36 137.08 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 p -114.21 -30.88 6.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.279 0.632 . . . . 0.0 110.165 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.81 40.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.499 1.045 . . . . 0.0 110.303 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.36 140.55 41.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -131.06 118.49 20.63 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -59.05 -23.31 61.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.214 1.006 . . . . 0.0 112.475 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.26 -30.43 60.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.741 0.816 . . . . 0.0 112.491 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.17 23.75 0.82 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.567 1.079 . . . . 0.0 112.71 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.7 p -130.89 171.84 12.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.757 1.278 . . . . 0.0 110.382 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.27 154.19 42.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.657 1.983 . . . . 0.0 107.476 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -131.98 131.1 42.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.65 153.94 26.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.17 125.29 49.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.358 1.463 . . . . 0.0 107.332 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.11 151.3 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.45 -23.04 66.22 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.12 -25.0 65.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.971 0.508 . . . . 0.0 111.987 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.0 5.23 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.096 1.332 . . . . 0.0 113.188 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 146.93 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.397 1.098 . . . . 0.0 109.416 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.69 145.16 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -148.67 154.39 39.6 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.195 0.598 . . . . 0.0 110.864 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -107.57 130.74 54.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.29 175.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.335 1.454 . . . . 0.0 109.183 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.88 168.14 10.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.337 -0.852 . . . . 0.0 110.798 -171.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.08 -39.85 66.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.046 0.538 . . . . 0.0 111.232 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.87 -8.18 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -113.21 -6.3 13.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.09 139.3 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.145 1.339 . . . . 0.0 111.341 -172.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -147.57 177.29 9.38 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.736 0.815 . . . . 0.0 110.25 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.64 167.23 3.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.135 0.974 . . . . 0.0 110.933 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -69.49 -17.68 63.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.078 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.9 m -63.16 124.44 21.17 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.11 -34.24 71.79 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.81 -68.96 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -149.24 167.78 25.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.093 0.957 . . . . 0.0 110.69 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.5 159.09 33.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 110.843 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -136.6 15.66 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.196 0.998 . . . . 0.0 111.401 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.06 -44.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 120.447 -1.408 . . . . 0.0 111.791 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.91 75.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.124 0.875 . . . . 0.0 110.941 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.97 165.48 31.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.067 2.547 . . . . 0.0 104.435 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.91 16.04 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.458 1.481 . . . . 0.0 114.031 -169.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -79.82 -18.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.899 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.69 179.8 43.48 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 119.153 0.888 . . . . 0.0 112.962 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.8 m -146.71 163.64 35.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.782 1.633 . . . . 0.0 108.698 -169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -64.5 113.71 3.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.16 -166.13 1.76 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.735 1.614 . . . . 0.0 108.67 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -148.23 -173.4 4.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.984 1.314 . . . . 0.0 109.821 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 24.3 p -151.12 176.85 10.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.101 1.761 . . . . 0.0 109.681 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -121.82 -1.61 9.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -71.81 119.04 15.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.433 1.493 . . . . 0.0 107.141 179.342 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -103.03 124.95 49.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.237 1.015 . . . . 0.0 109.819 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.4 mp0 -144.57 -173.28 4.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.528 1.531 . . . . 0.0 108.908 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.5 141.95 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 58.4 25.03 12.39 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.866 1.667 . . . . 0.0 113.438 -175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.0 tp10 -134.75 162.82 31.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.429 1.092 . . . . 0.0 108.395 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -65.44 150.09 48.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.628 2.371 . . . . 0.0 113.777 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.71 168.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 128.198 2.599 . . . . 0.0 107.961 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.25 127.17 46.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.36 138.45 41.63 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.739 0.816 . . . . 0.0 109.371 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 m -69.11 121.01 15.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 110.712 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -93.45 155.46 17.34 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.745 1.218 . . . . 0.0 108.652 174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -58.64 -20.89 51.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.749 1.22 . . . . 0.0 112.911 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.23 -46.35 83.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.328 1.051 . . . . 0.0 112.634 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -168.57 -68.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.189 0.45 . . . . 0.0 112.146 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.27 -157.79 0.74 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.187 1.795 . . . . 0.0 108.948 -170.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -46.25 138.85 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.615 1.966 . . . . 0.0 115.643 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -145.16 156.82 54.34 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 129.793 3.237 . . . . 0.0 103.988 168.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.57 145.57 52.8 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.449 1.433 . . . . 0.0 110.616 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.11 168.36 27.53 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.797 2.439 . . . . 0.0 107.152 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -110.45 147.92 33.1 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.982 1.265 . . . . 0.0 109.742 169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.35 140.78 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -115.67 -33.24 5.25 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.767 0.827 . . . . 0.0 109.179 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 163.89 38.58 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.166 0.986 . . . . 0.0 110.494 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.7 146.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -134.74 125.25 26.6 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.66 -23.75 63.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.673 0.789 . . . . 0.0 112.11 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.65 -27.65 58.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.552 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.5 21.6 2.2 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.563 1.077 . . . . 0.0 112.212 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 p -125.36 169.11 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.364 1.082 . . . . 0.0 110.02 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.72 153.5 41.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.444 1.898 . . . . 0.0 107.603 -168.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.8 m -132.16 136.16 46.87 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.55 158.59 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -123.89 126.94 47.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.98 154.69 26.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.16 -26.3 68.74 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.143 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.36 -18.85 5.74 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.831 1.205 . . . . 0.0 112.858 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.55 143.47 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 109.619 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.83 144.98 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -150.38 154.4 37.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.03 0.532 . . . . 0.0 110.635 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.44 129.18 55.27 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.91 179.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.536 1.534 . . . . 0.0 109.271 -169.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.95 167.23 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.095 -1.003 . . . . 0.0 110.529 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -54.36 -38.55 66.22 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.539 0.736 . . . . 0.0 110.882 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -63.26 -8.78 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -111.24 -8.03 14.4 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.005 0.922 . . . . 0.0 112.595 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.01 141.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 120.182 1.355 . . . . 0.0 110.992 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -150.12 173.43 13.9 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.421 0.688 . . . . 0.0 110.106 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.05 165.78 0.62 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.238 1.415 . . . . 0.0 111.039 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -67.27 -16.08 64.07 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.703 -0.623 . . . . 0.0 111.911 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 m -62.78 116.16 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.79 -32.98 72.3 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.46 -65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.723 0.809 . . . . 0.0 112.693 -169.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -152.75 162.67 40.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.268 1.427 . . . . 0.0 108.609 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -73.7 166.67 22.87 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.549 0.214 . . . . 0.0 111.027 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.34 -22.42 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.103 0.961 . . . . 0.0 110.954 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.81 -45.32 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 119.645 1.111 . . . . 0.0 110.906 -172.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.7 97.58 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -159.27 154.42 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.923 2.089 . . . . 0.0 105.42 169.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.19 58.37 2.03 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.983 0.913 . . . . 0.0 112.219 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -74.4 -44.73 50.7 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.435 -0.791 . . . . 0.0 110.717 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -94.82 -168.22 36.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.559 1.076 . . . . 0.0 111.731 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.4 t -147.73 177.55 9.21 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.324 1.45 . . . . 0.0 108.168 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -57.28 120.34 7.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.478 0.711 . . . . 0.0 110.469 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.91 -165.16 1.44 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.438 1.895 . . . . 0.0 107.416 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -147.85 -174.0 4.44 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.815 1.246 . . . . 0.0 109.663 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.8 t -145.76 174.12 11.5 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.042 1.337 . . . . 0.0 109.739 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 14.5 m -128.93 4.63 5.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.566 1.547 . . . . 0.0 111.523 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.93 42.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.508 1.123 . . . . 0.0 110.796 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 C--O 1.236 0.36 0 C-N-CA 124.838 1.255 . . . . 0.0 109.474 172.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.93 137.38 53.52 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.196 0.998 . . . . 0.0 109.898 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 6.0 mp0 -144.36 -173.98 4.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 109.186 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -53.36 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 61.68 22.33 12.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.495 1.918 . . . . 0.0 113.095 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -127.87 169.28 14.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.18 0.992 . . . . 0.0 108.904 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -68.04 146.96 53.02 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.353 1.461 . . . . 0.0 112.864 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.64 166.34 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.69 1.996 . . . . 0.0 108.085 169.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.53 124.06 47.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.47 140.45 41.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.173 0.989 . . . . 0.0 109.209 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -69.25 111.82 5.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.541 0.736 . . . . 0.0 109.871 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -82.41 152.73 26.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 m -58.46 -20.06 42.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.67 1.188 . . . . 0.0 112.841 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.15 -48.28 76.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.395 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 p -169.82 -67.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.498 0.59 . . . . 0.0 112.367 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.23 -158.12 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.033 1.333 . . . . 0.0 110.208 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -54.25 141.26 30.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.75 1.22 . . . . 0.0 113.254 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -140.75 159.3 63.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 129.174 2.99 . . . . 0.0 105.593 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.77 143.09 72.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.296 1.331 . . . . 0.0 110.262 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.52 165.39 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.99 1.716 . . . . 0.0 108.591 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.05 130.41 47.06 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.6 137.77 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 p -114.12 -30.86 6.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.454 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.49 163.35 39.73 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.174 0.99 . . . . 0.0 110.521 168.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.91 140.88 37.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -132.58 122.87 25.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -58.53 -25.03 62.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.078 0.951 . . . . 0.0 112.488 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -56.74 -28.74 61.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.95 0.9 . . . . 0.0 112.491 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 128.14 22.86 1.34 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.488 1.042 . . . . 0.0 112.677 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 p -127.53 168.51 14.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.633 1.216 . . . . 0.0 110.036 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.54 153.95 43.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.282 1.833 . . . . 0.0 107.465 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -132.04 134.37 45.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.44 158.36 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -122.01 128.99 52.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.641 1.576 . . . . 0.0 107.019 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -87.8 151.62 22.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -61.89 -25.94 67.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.53 -27.2 69.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.674 0.79 . . . . 0.0 112.309 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.07 -14.45 7.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.072 1.32 . . . . 0.0 113.178 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.44 143.96 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.521 1.16 . . . . 0.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.1 143.7 38.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.27 155.68 39.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.278 0.631 . . . . 0.0 110.893 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 m -108.38 130.26 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.61 -179.27 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.408 1.483 . . . . 0.0 109.474 -169.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -103.38 169.37 8.58 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.191 -0.943 . . . . 0.0 110.775 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.14 -37.38 66.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.838 -0.539 . . . . 0.0 111.25 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.68 -5.48 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.025 -1.047 . . . . 0.0 113.551 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -118.41 -10.23 10.2 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.358 1.063 . . . . 0.0 112.287 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.5 t -143.11 141.54 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.904 1.229 . . . . 0.0 111.331 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -147.89 179.15 7.94 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.88 0.872 . . . . 0.0 109.23 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.9 165.6 0.9 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.659 1.184 . . . . 0.0 110.989 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.82 -29.75 70.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.563 169.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.34 115.81 5.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.61 -23.33 67.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.98 -63.74 1.0 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.66 0.664 . . . . 0.0 112.385 -170.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -153.66 164.29 38.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.035 1.334 . . . . 0.0 109.339 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -75.42 157.57 33.93 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.396 1.079 . . . . 0.0 110.747 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.38 21.99 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.932 0.893 . . . . 0.0 111.722 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.74 -48.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.518 -1.364 . . . . 0.0 111.847 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.76 -34.17 88.02 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -146.07 160.92 41.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.7 67.89 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.825 1.193 . . . . 0.0 110.393 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -123.27 -22.06 5.21 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.24 -179.97 51.72 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.232 0.907 . . . . 0.0 113.671 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.4 m -150.81 166.14 31.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.258 2.623 . . . . 0.0 106.994 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -56.15 128.78 37.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.954 0.797 . . . . 0.0 111.725 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.71 -176.47 5.56 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.023 1.729 . . . . 0.0 108.581 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -155.74 179.11 9.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.613 1.565 . . . . 0.0 109.343 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 74.3 m -129.91 152.34 49.49 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.736 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 p -78.44 -31.47 48.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.523 1.129 . . . . 0.0 112.001 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -67.01 119.21 11.6 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 0.0 108.247 169.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 50.33 36.17 12.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.766 1.626 . . . . 0.0 114.102 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 -173.8 4.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.097 0.959 . . . . 0.0 110.521 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.1 143.51 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 60.3 22.58 12.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.235 1.814 . . . . 0.0 113.07 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -130.12 169.28 15.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.365 1.066 . . . . 0.0 108.47 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.92 150.62 48.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.646 1.978 . . . . 0.0 112.719 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.91 163.01 3.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.843 2.457 . . . . 0.0 107.909 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.59 124.4 40.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.652 -2.722 . . . . 0.0 103.652 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.58 137.89 49.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.1 m -68.77 144.78 54.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -123.51 154.92 38.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.975 1.71 . . . . 0.0 108.141 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.9 m -58.13 -20.5 40.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.673 1.189 . . . . 0.0 112.981 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.02 -48.04 79.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.115 0.966 . . . . 0.0 112.627 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.8 p -169.49 -67.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.128 0.571 . . . . 0.0 112.131 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.52 -157.59 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.042 1.737 . . . . 0.0 109.529 -169.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -47.09 140.71 4.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.0 2.12 . . . . 0.0 115.757 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -145.97 157.95 49.6 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 129.306 3.042 . . . . 0.0 105.399 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 144.46 56.8 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.177 1.918 . . . . 0.0 110.743 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.89 165.05 37.3 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.729 1.612 . . . . 0.0 109.247 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -98.98 130.87 45.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.774 1.63 . . . . 0.0 107.611 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.96 137.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.7 p -114.6 -32.61 5.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.321 0.648 . . . . 0.0 110.522 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.32 163.3 39.74 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.415 1.086 . . . . 0.0 110.27 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -138.0 142.47 35.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -129.54 118.89 22.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -61.58 -20.02 62.84 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.427 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.34 -31.62 54.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.915 0.886 . . . . 0.0 112.285 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.94 24.95 0.7 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.564 1.078 . . . . 0.0 112.697 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.3 p -130.83 169.05 16.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.371 1.585 . . . . 0.0 110.424 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -140.53 152.95 45.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.491 1.916 . . . . 0.0 107.636 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -130.8 131.56 44.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.22 155.14 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -118.52 127.8 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.747 1.619 . . . . 0.0 107.05 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -83.19 150.26 26.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -64.42 -24.24 67.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.47 -23.99 65.56 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.08 0.552 . . . . 0.0 112.345 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 131.47 -16.51 5.13 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.716 1.15 . . . . 0.0 113.607 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.59 147.21 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.413 1.107 . . . . 0.0 109.39 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -132.98 144.83 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.86 158.01 43.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.116 0.566 . . . . 0.0 110.739 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -111.8 130.82 55.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.49 176.7 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.192 1.397 . . . . 0.0 109.192 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.89 167.43 10.52 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.043 -1.036 . . . . 0.0 110.474 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.42 -39.6 67.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 0.0 111.135 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.81 -11.88 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -108.34 -5.24 16.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.855 0.862 . . . . 0.0 112.485 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.18 140.58 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.211 1.369 . . . . 0.0 111.858 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -148.37 177.83 9.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.32 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 168.68 1.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 110.51 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -68.43 -17.46 64.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.623 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 124.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.827 0.851 . . . . 0.0 109.191 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -60.17 -32.72 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.43 -61.62 2.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.852 1.261 . . . . 0.0 114.329 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -153.17 167.25 29.92 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.36 1.064 . . . . 0.0 110.535 -169.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -73.77 169.5 17.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.799 0.84 . . . . 0.0 109.302 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.5 mt -131.41 -13.81 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 111.323 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.01 -40.5 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.103 1.32 . . . . 0.0 111.854 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.29 -29.89 75.88 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -151.15 148.44 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.286 2.234 . . . . 0.0 105.313 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.4 -167.45 1.6 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.961 0.904 . . . . 0.0 110.325 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 77.73 -3.06 2.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.443 2.297 . . . . 0.0 114.503 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.35 179.25 53.49 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 119.123 0.874 . . . . 0.0 111.828 169.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.0 m -147.42 155.4 41.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.959 1.703 . . . . 0.0 108.397 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -66.61 131.07 45.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.22 -158.3 0.85 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.37 1.868 . . . . 0.0 107.063 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -144.17 -179.31 6.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.202 1.001 . . . . 0.0 109.87 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 44.9 m -142.07 155.7 45.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.048 1.339 . . . . 0.0 110.194 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 m -80.88 -24.32 38.41 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.72 122.32 17.39 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.211 0.605 . . . . 0.0 109.596 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 125.944 1.698 . . . . 0.0 107.561 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 56.9 35.34 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.954 1.702 . . . . 0.0 112.904 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -82.92 -173.77 4.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.441 1.096 . . . . 0.0 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.0 mt -50.6 142.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 60.62 21.89 11.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.309 1.844 . . . . 0.0 113.35 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -128.34 170.06 13.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.21 1.004 . . . . 0.0 109.136 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -70.46 149.43 47.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.63 1.172 . . . . 0.0 111.359 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.39 166.08 4.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 126.937 2.095 . . . . 0.0 108.324 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -100.73 124.3 46.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.26 138.9 48.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.0 m -69.28 144.87 53.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.474 0.654 . . . . 0.0 110.9 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -121.41 155.54 34.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.782 1.633 . . . . 0.0 107.991 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -58.24 -20.54 42.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.838 1.255 . . . . 0.0 112.994 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.65 -47.5 79.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.057 0.943 . . . . 0.0 112.48 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.4 p -169.13 -67.99 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.924 0.49 . . . . 0.0 112.238 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.21 -158.19 0.78 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.479 1.911 . . . . 0.0 109.047 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -43.96 137.99 3.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.944 2.498 . . . . 0.0 116.048 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -145.86 157.44 50.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.345 3.058 . . . . 0.0 104.943 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 145.14 48.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.912 1.741 . . . . 0.0 110.77 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.13 165.31 36.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.717 1.607 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -98.5 133.1 43.33 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.149 1.38 . . . . 0.0 107.73 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 136.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -113.73 -32.26 6.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.34 0.656 . . . . 0.0 110.306 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.01 38.1 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.604 1.093 . . . . 0.0 110.502 169.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -138.88 140.8 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -129.42 122.81 30.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.22 -21.2 61.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.772 0.829 . . . . 0.0 112.439 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.28 -29.72 61.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.25 23.93 1.09 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.68 1.133 . . . . 0.0 112.608 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 171.48 12.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.627 1.214 . . . . 0.0 110.609 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.99 154.3 43.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.863 2.065 . . . . 0.0 107.764 -169.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -132.23 132.19 42.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.81 154.82 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.88 125.63 50.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.476 1.51 . . . . 0.0 107.423 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.99 150.53 28.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -64.32 -23.64 67.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.08 -27.92 69.43 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.451 0.7 . . . . 0.0 112.068 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.54 -18.74 5.14 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.943 1.259 . . . . 0.0 113.066 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.36 146.3 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.199 1.0 . . . . 0.0 109.588 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.3 144.71 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.51 154.38 40.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.226 0.61 . . . . 0.0 110.276 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -107.46 131.87 53.82 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 169.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.09 175.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.421 1.488 . . . . 0.0 109.375 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -99.32 168.5 9.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.139 -0.975 . . . . 0.0 110.419 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -53.17 -42.38 66.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.728 0.411 . . . . 0.0 111.023 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.6 pt -60.97 -12.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -105.79 -6.31 19.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.548 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 t -141.76 139.4 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.723 1.601 . . . . 0.0 112.686 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -150.3 176.66 10.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.75 169.27 1.92 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -65.69 -16.29 63.61 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.857 -0.527 . . . . 0.0 111.071 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -62.14 119.17 8.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.203 1.401 . . . . 0.0 108.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -59.54 -30.79 68.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.64 -70.3 0.25 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -150.83 173.34 14.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.764 0.792 . . . . 0.0 111.731 -169.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -72.92 154.23 40.64 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.767 1.627 . . . . 0.0 110.888 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.8 mt -139.22 22.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-N 118.872 0.76 . . . . 0.0 111.852 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 -51.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 120.216 -1.553 . . . . 0.0 112.457 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -37.73 94.74 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.592 1.087 . . . . 0.0 111.654 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -152.26 76.1 1.15 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.9 134.09 56.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -150.23 -45.43 0.13 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.938 1.695 . . . . 0.0 110.756 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -90.25 -163.57 39.19 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 122.287 0.937 . . . . 0.0 112.873 -170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.0 m -146.77 146.53 30.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 106.583 -170.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -61.02 132.85 55.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 111.408 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.64 -152.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.695 1.998 . . . . 0.0 106.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -146.11 -175.86 4.93 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.175 0.99 . . . . 0.0 110.486 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 28.5 t -150.82 179.76 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.783 2.033 . . . . 0.0 108.143 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -124.59 0.15 8.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.15 1.38 . . . . 0.0 111.821 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -70.1 114.58 8.4 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 126.742 2.017 . . . . 0.0 106.714 179.134 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 51.31 39.82 24.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.412 2.285 . . . . 0.0 113.65 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -83.05 -174.17 5.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.317 1.047 . . . . 0.0 111.849 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.0 mt -53.49 143.86 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.237 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 64.63 -0.24 0.99 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.815 2.446 . . . . 0.0 114.04 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.75 172.04 8.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.755 1.162 . . . . 0.0 109.396 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -69.53 149.02 48.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.711 1.204 . . . . 0.0 110.884 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.94 171.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 127.278 2.231 . . . . 0.0 108.847 169.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.34 128.96 54.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 168.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.24 143.74 44.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 m -69.21 103.07 1.83 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -68.22 156.29 37.92 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -58.57 -19.47 38.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.402 1.081 . . . . 0.0 112.212 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.31 -51.57 69.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.124 0.97 . . . . 0.0 112.906 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 p -169.55 -74.66 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.48 -157.25 0.75 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.676 1.59 . . . . 0.0 109.808 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.63 135.9 46.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.725 1.61 . . . . 0.0 114.691 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.62 162.09 46.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 129.589 3.156 . . . . 0.0 105.375 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.67 146.0 77.59 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 121.724 1.616 . . . . 0.0 110.712 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.93 31.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.457 1.903 . . . . 0.0 109.03 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -102.2 134.26 45.75 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.6 1.56 . . . . 0.0 107.27 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.67 139.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.421 1.009 . . . . 0.0 108.324 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -116.05 -32.27 5.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.927 -0.559 . . . . 0.0 109.794 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.62 162.58 41.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.478 1.035 . . . . 0.0 110.165 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.5 t -137.42 138.26 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -130.49 117.84 20.22 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.28 -20.52 59.41 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.672 0.789 . . . . 0.0 112.763 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.57 -30.75 55.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.842 0.857 . . . . 0.0 112.285 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.26 23.11 0.85 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 124.675 1.131 . . . . 0.0 112.801 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -130.97 171.12 13.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.647 1.223 . . . . 0.0 110.166 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.2 156.26 43.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.795 2.038 . . . . 0.0 107.605 -169.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -134.99 133.53 39.57 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.23 155.64 23.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.98 129.59 55.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.697 1.599 . . . . 0.0 107.051 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -92.64 146.32 23.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -61.67 -21.07 64.11 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -169.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.04 -19.65 65.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.261 0.625 . . . . 0.0 112.288 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.45 46.24 1.34 Allowed Glycine 0 C--N 1.342 0.884 0 C-N-CA 124.184 0.897 . . . . 0.0 110.983 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.81 140.09 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.7 141.66 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.5 153.98 36.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.236 0.614 . . . . 0.0 110.655 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 m -100.05 135.94 40.71 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.3 176.93 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.978 1.711 . . . . 0.0 109.125 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.54 166.84 11.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.096 -1.003 . . . . 0.0 110.715 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -54.81 -38.48 67.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.824 0.849 . . . . 0.0 111.233 171.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.5 pt -61.73 -13.95 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.85 -7.66 19.25 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.253 0.933 . . . . 0.0 112.685 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.76 140.2 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 120.275 1.398 . . . . 0.0 111.173 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -149.07 175.42 11.35 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.259 1.024 . . . . 0.0 109.8 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.0 167.1 1.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.287 1.035 . . . . 0.0 110.931 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.4 -23.7 67.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.103 169.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.2 m -63.15 102.89 0.42 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.89 -24.78 66.23 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.72 -54.19 42.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.209 1.004 . . . . 0.0 112.516 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -154.91 157.63 38.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.45 1.1 . . . . 0.0 110.912 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -73.73 153.69 39.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 109.253 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.93 21.75 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 124.031 0.932 . . . . 0.0 111.557 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.38 -41.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 120.67 -1.269 . . . . 0.0 110.975 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -21.13 79.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.602 0.637 . . . . 0.0 111.95 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -142.67 152.13 42.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.964 2.105 . . . . 0.0 106.045 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.47 2.05 35.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -108.23 2.64 22.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.341 0.973 . . . . 0.0 113.471 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.24 175.25 36.34 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.859 0.754 . . . . 0.0 112.921 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 m -148.22 159.5 43.91 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.646 1.578 . . . . 0.0 109.274 -169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -59.11 141.58 53.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.105 0.562 . . . . 0.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.79 179.14 8.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 108.278 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -171.38 -152.4 0.08 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.728 1.611 . . . . 0.0 108.161 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 34.0 m 58.78 42.1 20.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.013 1.325 . . . . 0.0 110.817 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m -85.69 170.59 12.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.231 2.212 . . . . 0.0 110.878 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -63.68 146.84 53.05 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.831 -0.543 . . . . 0.0 110.061 170.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 107.474 173.636 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -116.84 136.68 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.362 1.065 . . . . 0.0 109.179 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.493 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.6 mp0 -144.35 -173.48 4.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.518 1.927 . . . . 0.0 108.63 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.91 142.67 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 61.59 21.78 12.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.115 1.766 . . . . 0.0 113.411 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.493 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.2 tp10 -128.12 170.29 13.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.538 1.135 . . . . 0.0 108.372 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.08 146.11 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.576 1.55 . . . . 0.0 112.3 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.42 173.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 127.735 2.414 . . . . 0.0 108.534 172.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.1 mt -107.36 129.23 54.94 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 141.15 42.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.99 0.916 . . . . 0.0 109.463 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.2 m -70.24 102.83 2.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.317 1.047 . . . . 0.0 110.525 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -68.21 154.44 41.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -59.56 -17.98 37.1 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.361 1.064 . . . . 0.0 113.049 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.13 -50.13 73.75 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.441 0.697 . . . . 0.0 111.911 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -171.96 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.28 0.632 . . . . 0.0 111.947 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.36 -160.51 1.18 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 111.385 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.79 134.97 36.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.919 2.088 . . . . 0.0 115.936 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -140.61 159.48 62.75 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 129.173 2.989 . . . . 0.0 105.342 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.82 144.97 79.37 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.718 1.612 . . . . 0.0 110.536 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.83 165.14 36.33 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.774 1.63 . . . . 0.0 109.084 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -98.69 131.11 45.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.133 1.373 . . . . 0.0 107.366 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.11 138.35 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 p -114.7 -31.3 6.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.513 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.98 163.06 40.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.581 1.082 . . . . 0.0 110.257 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -134.98 142.3 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -133.4 112.23 11.42 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.71 -19.97 53.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.716 0.806 . . . . 0.0 112.833 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.71 -31.64 38.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.079 0.952 . . . . 0.0 112.454 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.83 18.96 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.527 1.061 . . . . 0.0 113.052 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.7 p -129.8 170.13 14.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.923 1.361 . . . . 0.0 110.164 -170.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.66 154.81 41.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.904 1.682 . . . . 0.0 107.396 -169.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -131.69 134.83 46.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.4 m -142.32 158.85 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.23 125.23 44.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.274 1.43 . . . . 0.0 107.184 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.58 151.18 26.5 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -64.81 -24.34 67.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.71 -26.5 68.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.6 0.76 . . . . 0.0 112.247 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.32 -13.95 6.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.976 1.274 . . . . 0.0 113.306 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.47 143.05 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.445 1.122 . . . . 0.0 109.141 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.69 144.1 38.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.38 153.31 33.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.289 0.635 . . . . 0.0 110.673 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -108.58 128.55 54.93 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.02 -178.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.133 1.373 . . . . 0.0 109.227 -168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.76 169.28 8.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.003 -1.06 . . . . 0.0 110.845 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.0 -37.21 68.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.074 0.55 . . . . 0.0 111.043 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.97 -5.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 120.882 -1.136 . . . . 0.0 113.509 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -118.94 -12.83 9.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.381 1.073 . . . . 0.0 112.145 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.41 138.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.255 1.389 . . . . 0.0 110.588 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -147.37 176.69 9.82 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.71 0.804 . . . . 0.0 109.47 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.58 168.1 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.074 0.949 . . . . 0.0 110.714 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -28.04 69.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.247 170.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -64.39 116.52 6.16 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.698 0.799 . . . . 0.0 109.168 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -65.85 -24.73 66.94 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -84.14 -36.49 22.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -146.86 165.0 31.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 110.624 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.08 169.19 14.17 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.3 mm -129.18 -13.75 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 124.819 1.248 . . . . 0.0 111.393 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.66 -36.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.54 1.518 . . . . 0.0 112.971 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.05 -30.24 77.2 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.605 1.093 . . . . 0.0 110.642 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -151.2 153.86 35.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.396 2.678 . . . . 0.0 104.28 169.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.65 12.23 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.98 1.264 . . . . 0.0 114.327 -169.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.44 -6.28 59.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.168 0.894 . . . . 0.0 112.266 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.4 -177.91 41.73 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 121.962 0.757 . . . . 0.0 114.04 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -148.21 165.88 29.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.326 1.451 . . . . 0.0 109.53 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -72.28 135.32 45.95 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.511 -0.743 . . . . 0.0 110.571 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -152.15 -171.27 3.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.246 1.818 . . . . 0.0 107.465 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -154.76 -178.73 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.577 1.551 . . . . 0.0 108.762 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 77.6 p -143.2 175.91 9.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.359 1.064 . . . . 0.0 109.931 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 p -116.44 -0.6 12.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.615 1.166 . . . . 0.0 113.232 -169.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -80.98 44.58 0.77 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.592 1.087 . . . . 0.0 110.529 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 48.8 mt . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.726 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 72.18 83.26 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.296 2.638 . . . . 0.0 113.06 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -139.23 -173.65 3.65 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.73 1.612 . . . . 0.0 109.512 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.1 mt -48.96 141.94 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.476 1.11 . . . . 0.0 109.467 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.49 22.25 11.93 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.091 1.756 . . . . 0.0 113.29 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -127.62 170.27 12.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.235 1.014 . . . . 0.0 108.805 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -74.03 149.65 41.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.778 1.231 . . . . 0.0 111.516 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.45 168.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.787 2.035 . . . . 0.0 108.059 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -101.69 130.92 48.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.61 140.2 44.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.997 0.919 . . . . 0.0 109.014 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.1 m -69.73 102.59 1.94 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.815 0.846 . . . . 0.0 110.711 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.91 153.39 41.88 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -58.19 -20.48 41.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.048 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.21 -48.03 77.24 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.09 0.956 . . . . 0.0 112.396 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.8 p -169.59 -72.75 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.586 0.354 . . . . 0.0 111.615 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 -156.14 0.69 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.135 1.374 . . . . 0.0 110.012 -173.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -49.31 139.71 11.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.914 1.686 . . . . 0.0 115.047 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -146.33 156.51 49.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 130.12 3.368 . . . . 0.0 104.246 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.3 147.13 71.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.521 1.481 . . . . 0.0 110.968 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.34 164.69 36.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.182 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -95.24 132.63 40.01 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.526 1.53 . . . . 0.0 107.691 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.26 135.72 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.7 p -112.66 -33.57 6.08 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.849 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.19 164.67 36.87 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 110.723 168.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.58 142.31 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -131.39 119.21 21.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -61.24 -19.76 62.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.409 0.684 . . . . 0.0 112.556 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.6 -30.76 44.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 112.296 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.79 20.54 0.76 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.556 1.074 . . . . 0.0 112.967 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -129.3 169.82 14.38 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.72 1.26 . . . . 0.0 110.394 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -143.44 155.82 44.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.954 2.102 . . . . 0.0 107.728 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -133.0 131.81 41.16 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -140.04 157.32 25.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -122.09 122.83 40.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -78.24 150.24 33.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -64.18 -25.34 68.03 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.08 -26.83 68.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.629 0.772 . . . . 0.0 112.265 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.4 -16.83 5.93 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.102 1.334 . . . . 0.0 113.033 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.14 143.4 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.255 1.027 . . . . 0.0 109.356 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.67 144.41 38.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -152.05 155.9 38.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.269 0.628 . . . . 0.0 110.474 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -109.96 129.79 55.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.37 179.58 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.405 1.482 . . . . 0.0 109.677 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.32 168.51 9.29 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.08 0.952 . . . . 0.0 110.758 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -55.43 -36.83 66.92 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.795 -0.566 . . . . 0.0 111.321 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.8 pt -64.23 -5.06 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -118.05 -11.04 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.315 1.046 . . . . 0.0 112.484 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.91 141.07 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 120.263 1.392 . . . . 0.0 110.991 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -150.47 172.33 15.62 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.305 1.042 . . . . 0.0 109.703 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 166.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.778 1.231 . . . . 0.0 111.59 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -68.1 -8.58 39.35 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.56 -0.713 . . . . 0.0 111.541 169.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -67.97 117.28 9.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.71 -44.27 90.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 112.121 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.62 -67.02 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -151.23 163.36 39.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.741 1.216 . . . . 0.0 109.353 -170.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -84.54 164.18 18.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.075 0.55 . . . . 0.0 111.882 -170.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.7 15.01 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.759 0.824 . . . . 0.0 112.183 -173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.05 158.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 120.397 -1.44 . . . . 0.0 107.413 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.53 3.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.708 1.147 . . . . 0.0 111.992 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -143.72 65.86 1.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.926 2.09 . . . . 0.0 106.259 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.47 132.09 52.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.383 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.89 -2.33 0.93 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.149 0.979 . . . . 0.0 113.035 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.38 -159.29 9.13 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.42 1.009 . . . . 0.0 112.794 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.8 m -139.4 164.69 29.18 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.06 1.744 . . . . 0.0 109.84 -169.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -60.7 145.3 49.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.2 -165.39 1.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.161 2.584 . . . . 0.0 107.1 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.94 169.94 17.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.269 1.028 . . . . 0.0 109.658 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 36.7 m -135.23 179.98 5.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.97 1.308 . . . . 0.0 111.056 -170.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.8 m -134.65 6.17 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.726 0.81 . . . . 0.0 113.039 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -75.88 24.82 0.12 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.408 1.483 . . . . 0.0 112.933 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.235 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 109.625 -178.454 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 72.22 80.96 0.14 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.033 2.533 . . . . 0.0 113.279 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.57 -174.77 3.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.091 1.356 . . . . 0.0 109.523 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.0 mt -53.2 143.58 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.58 17.1 10.15 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.952 1.701 . . . . 0.0 113.258 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -123.27 173.24 8.06 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -84.37 156.45 21.84 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.408 -0.807 . . . . 0.0 111.302 -169.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.97 167.51 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.305 1.842 . . . . 0.0 109.05 170.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.97 127.35 41.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.36 144.14 38.07 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.455 0.702 . . . . 0.0 109.644 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -68.83 108.44 3.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.396 0.679 . . . . 0.0 109.883 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -73.29 162.56 29.22 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.987 0.915 . . . . 0.0 109.726 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 m -58.0 -19.64 32.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.568 1.147 . . . . 0.0 112.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.43 -23.15 56.65 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 113.334 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.2 m 110.7 8.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 130.151 3.38 . . . . 0.0 114.898 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -153.64 -176.93 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.555 1.07 . . . . 0.0 111.229 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.89 140.07 53.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -142.02 158.34 62.04 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 128.341 2.656 . . . . 0.0 106.074 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.23 145.61 73.04 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.612 1.541 . . . . 0.0 111.206 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.31 156.89 37.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.171 1.789 . . . . 0.0 109.044 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.54 133.51 34.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.907 1.283 . . . . 0.0 108.391 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.46 133.77 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 p -111.55 -32.56 6.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.031 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 164.4 38.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.721 1.146 . . . . 0.0 110.676 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.13 141.42 33.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -129.57 128.0 41.84 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.73 -24.49 61.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.805 0.842 . . . . 0.0 112.47 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.29 -27.59 55.92 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 112.732 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.07 19.07 2.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.636 1.112 . . . . 0.0 112.705 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.2 p -123.54 168.98 11.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.502 1.151 . . . . 0.0 110.116 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.05 153.36 42.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 106.965 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -133.26 135.7 45.08 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.94 159.69 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -123.96 120.63 33.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -77.03 150.04 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -64.89 -23.55 67.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -63.39 -24.44 67.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.392 0.677 . . . . 0.0 112.435 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.98 -14.56 7.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.02 1.295 . . . . 0.0 113.009 173.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.48 143.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.288 1.044 . . . . 0.0 108.992 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.76 143.61 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -151.18 155.47 38.94 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.056 0.543 . . . . 0.0 110.699 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -108.97 131.48 55.01 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.01 178.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.748 1.619 . . . . 0.0 108.902 -169.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.69 165.7 12.58 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.018 -1.051 . . . . 0.0 110.496 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.54 -37.07 64.97 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.856 0.862 . . . . 0.0 111.016 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.36 -11.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.005 -1.059 . . . . 0.0 113.547 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -106.6 -8.99 16.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 112.636 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.59 139.54 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.437 1.017 . . . . 0.0 110.99 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -152.12 175.03 13.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.944 0.498 . . . . 0.0 110.682 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.17 165.35 0.52 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.331 1.453 . . . . 0.0 111.728 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -64.25 -16.7 62.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.843 -0.536 . . . . 0.0 111.844 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 m -62.14 116.25 4.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.41 1.084 . . . . 0.0 108.983 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.26 -28.3 67.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.37 -76.76 0.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.153 0.581 . . . . 0.0 111.812 -171.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.18 165.36 29.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 0.0 109.537 -170.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.92 163.58 25.14 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.176 0.512 . . . . 0.0 112.329 -171.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 mt -129.7 28.29 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 124.958 1.303 . . . . 0.0 108.606 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.32 160.46 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.45 1.9 . . . . 0.0 106.207 175.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.66 -62.43 3.53 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.867 1.222 . . . . 0.0 111.716 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -142.0 72.22 1.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.28 130.47 46.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.47 -21.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -171.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.76 -171.17 47.44 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 121.955 0.753 . . . . 0.0 111.832 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.3 m -146.24 159.9 42.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.643 1.977 . . . . 0.0 108.03 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -56.38 127.93 33.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.767 0.427 . . . . 0.0 111.113 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.1 -164.52 1.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.44 1.896 . . . . 0.0 107.4 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -145.23 -180.0 7.01 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 109.748 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 t -142.15 175.34 9.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.355 1.462 . . . . 0.0 108.889 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.2 m -133.0 -10.16 3.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -79.73 111.08 15.68 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 170.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 110.301 -178.402 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 55.14 36.27 26.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.656 1.583 . . . . 0.0 114.155 169.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -82.24 -173.35 4.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.578 0.751 . . . . 0.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.94 142.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 61.87 21.49 12.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.384 1.873 . . . . 0.0 113.337 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.19 170.19 13.28 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.354 1.062 . . . . 0.0 109.192 171.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.19 149.07 50.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.006 2.122 . . . . 0.0 112.534 -174.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.31 164.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 127.932 2.493 . . . . 0.0 108.525 171.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.48 130.21 42.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 168.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.66 145.12 38.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.517 0.727 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -69.02 116.09 9.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.906 0.482 . . . . 0.0 109.714 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -79.62 164.25 23.96 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.224 1.01 . . . . 0.0 110.597 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.9 m -57.23 -24.3 53.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.841 0.856 . . . . 0.0 112.33 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.77 -4.07 18.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.092 1.357 . . . . 0.0 113.459 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.4 m 75.28 156.86 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.633 2.773 . . . . 0.0 111.593 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.65 176.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.079 2.551 . . . . 0.0 115.425 -169.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -71.12 148.53 47.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -144.48 162.32 39.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 129.337 3.055 . . . . 0.0 106.01 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.33 145.89 61.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.892 1.728 . . . . 0.0 110.721 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.58 33.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.536 1.935 . . . . 0.0 108.748 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -101.58 133.78 45.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 107.414 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.79 136.67 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 p -114.02 -32.9 5.9 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.278 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.21 35.28 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.263 0.938 . . . . 0.0 110.63 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.3 t -141.65 140.56 30.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -130.63 123.66 29.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -60.08 -22.97 63.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.722 0.809 . . . . 0.0 112.568 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.27 -28.62 59.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.877 . . . . 0.0 112.278 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.51 22.32 1.2 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.769 1.176 . . . . 0.0 112.782 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.6 p -127.12 169.42 13.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.786 1.293 . . . . 0.0 110.271 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -142.45 156.41 45.18 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.905 2.082 . . . . 0.0 108.022 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -133.92 134.83 43.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.56 157.57 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.85 131.33 53.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.442 1.497 . . . . 0.0 107.186 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.67 148.57 23.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.41 -24.28 66.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -169.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.56 -30.47 71.5 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.298 0.639 . . . . 0.0 112.386 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.23 -15.31 4.23 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.46 1.029 . . . . 0.0 113.545 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.58 143.88 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 109.348 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.0 145.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.46 157.43 42.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.153 0.581 . . . . 0.0 110.719 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -108.74 131.92 54.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.15 178.6 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.307 1.443 . . . . 0.0 109.518 -169.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.71 167.11 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.141 -0.974 . . . . 0.0 110.502 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.28 -39.21 66.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.498 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.7 pt -61.51 -13.38 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -104.25 -8.69 19.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.112 -0.946 . . . . 0.0 112.637 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.8 140.5 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.818 1.19 . . . . 0.0 111.863 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -150.13 177.86 9.51 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 110.34 171.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.49 167.97 2.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.026 0.93 . . . . 0.0 111.096 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -69.29 -17.27 63.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.37 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -63.01 122.98 17.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.73 -37.86 77.1 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.354 0.662 . . . . 0.0 112.158 -173.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.6 -69.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -149.7 168.8 22.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.877 0.871 . . . . 0.0 111.204 -169.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.5 155.06 34.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.653 1.581 . . . . 0.0 110.83 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.32 21.27 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 123.987 0.915 . . . . 0.0 112.067 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.98 -46.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.192 -1.567 . . . . 0.0 112.078 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.83 -32.49 82.99 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -145.84 162.9 36.63 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.28 56.24 1.04 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.39 1.45 . . . . 0.0 112.044 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.94 -19.14 9.29 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.95 -177.17 51.44 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 122.277 0.931 . . . . 0.0 112.676 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.7 m -148.67 165.17 32.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.246 2.218 . . . . 0.0 107.388 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -61.33 120.68 10.91 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.394 -0.816 . . . . 0.0 110.154 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -155.01 -170.91 3.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.185 2.194 . . . . 0.0 107.327 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -150.19 171.63 16.61 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.903 0.881 . . . . 0.0 110.179 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.7 m -138.1 178.09 7.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.567 1.547 . . . . 0.0 110.212 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.5 m -127.92 8.77 6.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.88 31.73 0.37 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.404 1.081 . . . . 0.0 111.732 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.789 1.236 . . . . 0.0 110.589 -179.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -107.55 127.83 53.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.47 1.108 . . . . 0.0 109.784 -169.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.44 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.7 mp0 -144.39 -173.79 4.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.664 1.586 . . . . 0.0 109.257 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.4 mt -51.51 143.71 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.68 22.11 12.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.27 1.828 . . . . 0.0 113.422 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -130.13 169.57 15.16 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.345 1.058 . . . . 0.0 108.83 171.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.4 146.3 53.34 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.779 2.032 . . . . 0.0 112.689 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.29 171.88 5.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 0.0 107.915 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.7 mt -109.82 124.4 51.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 138.97 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.145 0.978 . . . . 0.0 108.649 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.9 m -69.09 134.87 49.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -109.73 156.95 19.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.282 1.433 . . . . 0.0 108.442 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -58.64 -19.78 41.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.503 1.121 . . . . 0.0 112.863 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.57 -50.19 70.74 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.103 0.961 . . . . 0.0 112.461 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -170.68 -67.5 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.94 0.496 . . . . 0.0 111.845 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -155.26 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.732 1.613 . . . . 0.0 109.675 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -51.81 139.08 22.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.897 2.079 . . . . 0.0 115.78 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -142.87 157.34 61.49 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 128.914 2.885 . . . . 0.0 105.582 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.73 145.73 64.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 120.985 1.124 . . . . 0.0 111.092 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.04 164.52 37.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.449 1.5 . . . . 0.0 109.356 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -97.63 132.16 43.54 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.381 1.473 . . . . 0.0 107.789 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.62 138.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 p -115.07 -32.34 5.75 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.249 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 164.86 36.63 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.572 1.078 . . . . 0.0 110.465 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.59 141.65 32.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.27 113.97 13.24 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.7 -19.67 59.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.322 0.649 . . . . 0.0 112.517 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.22 -30.47 38.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.064 0.946 . . . . 0.0 112.421 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.57 22.56 0.61 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.399 1.0 . . . . 0.0 112.743 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.4 p -131.85 169.64 15.97 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.059 1.429 . . . . 0.0 110.589 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -144.37 153.0 41.5 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.496 1.918 . . . . 0.0 107.215 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -130.8 134.07 46.53 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 170.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.12 155.26 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -118.48 125.93 50.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.668 1.587 . . . . 0.0 107.003 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.76 151.69 27.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -65.83 -22.76 66.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.67 -27.49 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.141 0.577 . . . . 0.0 112.196 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.7 -17.74 5.21 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.882 1.23 . . . . 0.0 113.09 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.13 146.07 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.232 1.013 . . . . 0.0 109.478 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.03 144.65 36.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.16 154.3 38.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.188 0.595 . . . . 0.0 110.851 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -108.37 130.23 55.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.79 175.84 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.377 1.471 . . . . 0.0 108.758 -169.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -97.53 168.39 10.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.008 -1.058 . . . . 0.0 110.543 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.53 -39.03 67.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.432 0.693 . . . . 0.0 111.086 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.79 -6.61 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -114.3 -7.67 12.93 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 112.622 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.5 140.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 120.283 1.401 . . . . 0.0 111.71 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -149.42 174.24 12.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.088 0.955 . . . . 0.0 109.958 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.21 168.75 0.67 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.453 1.101 . . . . 0.0 111.265 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -63.13 -20.6 65.52 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.551 -0.718 . . . . 0.0 110.743 169.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.8 m -62.38 123.73 19.03 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.161 0.984 . . . . 0.0 110.561 170.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -60.68 -40.36 91.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.823 0.849 . . . . 0.0 112.128 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.96 -67.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -150.61 168.04 25.5 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.028 0.931 . . . . 0.0 111.049 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.23 156.72 38.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.204 1.402 . . . . 0.0 110.782 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -139.75 24.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.958 0.903 . . . . 0.0 111.44 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.44 -60.66 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 120.603 -1.311 . . . . 0.0 109.93 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.33 -34.38 85.08 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -136.39 163.28 30.83 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.972 2.109 . . . . 0.0 105.779 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.73 18.11 9.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 114.137 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -79.57 -18.11 52.44 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.467 -0.777 . . . . 0.0 112.714 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.75 175.79 51.5 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 119.465 1.03 . . . . 0.0 113.114 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.8 m -149.98 163.77 37.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 107.761 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -61.45 132.04 52.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.477 -0.764 . . . . 0.0 111.279 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.21 -172.46 3.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.551 1.94 . . . . 0.0 108.355 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -146.42 168.72 20.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.538 1.135 . . . . 0.0 110.189 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 15.5 m -135.5 161.96 34.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.894 1.278 . . . . 0.0 109.171 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 p -106.39 -25.98 11.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -73.81 129.12 37.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 109.295 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.871 175.113 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 72.79 71.49 0.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.212 1.805 . . . . 0.0 113.65 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -121.95 -174.29 2.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.742 1.617 . . . . 0.0 109.616 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.51 142.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 60.81 24.14 14.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.723 1.609 . . . . 0.0 113.185 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.27 169.78 13.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.676 1.191 . . . . 0.0 108.137 170.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.74 155.12 40.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.853 0.861 . . . . 0.0 112.603 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.32 164.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.275 2.23 . . . . 0.0 107.902 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.56 128.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.15 141.03 46.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 108.84 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.0 m -69.62 117.53 11.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.21 0.604 . . . . 0.0 109.684 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -84.21 162.56 20.14 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.722 1.209 . . . . 0.0 109.403 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -55.65 -20.12 12.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.071 1.348 . . . . 0.0 112.987 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.35 -51.88 18.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.356 1.463 . . . . 0.0 112.048 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m 161.66 -46.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.74 2.816 . . . . 0.0 111.252 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.38 -168.0 2.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.056 0.844 . . . . 0.0 113.027 -169.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -54.31 141.77 28.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.083 2.153 . . . . 0.0 116.367 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -149.7 160.26 34.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 130.085 3.354 . . . . 0.0 105.168 168.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.16 147.3 66.44 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.489 1.459 . . . . 0.0 110.937 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.43 162.96 40.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.642 1.977 . . . . 0.0 108.952 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -91.47 133.66 35.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.174 1.39 . . . . 0.0 107.578 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.97 134.46 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -111.39 -31.94 6.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.698 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.57 160.74 43.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.592 1.087 . . . . 0.0 110.446 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.3 140.1 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 170.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -132.33 111.95 11.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -62.19 -16.35 52.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.728 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -53.47 -31.46 45.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.732 0.813 . . . . 0.0 112.071 169.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.19 18.18 0.75 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.837 1.208 . . . . 0.0 112.722 174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.1 p -129.41 172.16 11.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.735 1.267 . . . . 0.0 110.256 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -145.98 154.79 42.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.692 1.997 . . . . 0.0 107.178 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -133.0 133.65 43.41 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.87 157.78 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -122.98 124.67 43.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.225 1.41 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -80.09 149.64 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -65.54 -25.37 67.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.32 -25.65 66.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.318 0.647 . . . . 0.0 112.153 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.99 3.94 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.449 1.023 . . . . 0.0 113.766 171.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.61 144.99 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.204 1.002 . . . . 0.0 109.437 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.91 143.95 39.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -149.41 155.03 39.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.826 0.451 . . . . 0.0 110.826 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 128.84 55.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 m -147.44 178.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.133 1.373 . . . . 0.0 109.183 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.3 169.06 10.03 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.229 -0.919 . . . . 0.0 110.837 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -55.55 -38.58 69.49 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.043 0.537 . . . . 0.0 111.042 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.37 -6.32 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.979 -1.076 . . . . 0.0 113.532 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -115.48 -8.5 12.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 112.453 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.5 139.63 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 120.377 1.444 . . . . 0.0 110.932 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.02 172.7 14.32 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.992 0.917 . . . . 0.0 110.012 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 166.39 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 111.18 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -67.11 -11.44 57.2 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.406 -0.809 . . . . 0.0 111.118 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 121.29 13.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 109.299 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.65 -44.5 90.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.547 0.739 . . . . 0.0 110.848 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -57.39 -61.29 2.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.263 1.425 . . . . 0.0 113.578 -169.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -154.87 164.77 38.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.217 1.407 . . . . 0.0 108.373 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.19 171.34 13.15 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.97 -69.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.644 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.33 -19.98 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 121.085 1.766 . . . . 0.0 114.356 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.02 19.56 29.91 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.404 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -152.84 -41.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.907 1.354 . . . . 0.0 113.381 -170.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 60.01 8.86 1.57 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.077 2.551 . . . . 0.0 116.651 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -108.09 -23.67 11.88 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.069 1.304 . . . . 0.0 111.12 173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.81 171.72 25.92 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 122.124 0.847 . . . . 0.0 113.055 174.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.5 m -146.38 159.67 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.876 1.671 . . . . 0.0 109.015 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.95 130.42 45.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.07 -168.54 3.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.317 1.847 . . . . 0.0 107.415 170.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -146.13 167.28 23.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.968 0.907 . . . . 0.0 109.875 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 20.4 m -136.8 -178.05 5.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.67 1.188 . . . . 0.0 111.047 -170.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 10.7 m -132.64 6.87 4.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -76.41 28.53 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.617 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.536 0.424 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -176.612 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -109.46 126.53 53.59 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.623 1.169 . . . . 0.0 109.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.4 mp0 -140.15 -174.03 3.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.686 1.594 . . . . 0.0 108.564 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -47.94 140.97 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.174 0.99 . . . . 0.0 108.504 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 59.5 25.66 14.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.5 1.92 . . . . 0.0 112.926 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -136.04 162.4 33.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.247 1.019 . . . . 0.0 108.976 172.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -65.41 146.21 55.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.588 2.355 . . . . 0.0 113.903 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.84 171.99 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 127.558 2.343 . . . . 0.0 108.487 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.49 124.06 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.68 141.61 47.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.895 0.878 . . . . 0.0 109.069 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 m -69.05 103.77 1.95 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -69.42 155.15 40.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.2 m -58.22 -20.79 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 112.383 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -58.74 -48.91 79.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.296 1.038 . . . . 0.0 113.07 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 p -168.83 -71.61 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -161.62 1.38 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.388 1.875 . . . . 0.0 109.348 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -51.57 136.15 26.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.9 161.61 42.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 129.377 3.071 . . . . 0.0 104.654 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.18 147.22 59.69 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.955 1.77 . . . . 0.0 111.007 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.7 169.22 25.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.858 2.463 . . . . 0.0 107.132 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.07 146.35 41.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.55 1.068 . . . . 0.0 109.735 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.5 142.45 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.021 0.928 . . . . 0.0 108.555 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 p -119.11 -28.64 5.43 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.809 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.93 158.99 43.92 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 119.523 1.056 . . . . 0.0 110.087 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.5 143.05 38.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -134.08 116.74 15.81 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.35 -19.75 62.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.341 0.656 . . . . 0.0 112.409 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.84 -30.51 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.889 0.876 . . . . 0.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.96 23.54 0.77 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.537 1.065 . . . . 0.0 112.691 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.4 p -131.66 169.34 16.3 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.442 1.621 . . . . 0.0 110.46 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.41 150.99 37.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.387 1.875 . . . . 0.0 108.053 -169.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 m -130.59 134.41 46.97 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.05 156.84 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -119.98 127.04 52.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.28 146.4 26.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -60.91 -25.86 67.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -169.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.33 -29.34 70.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.979 0.512 . . . . 0.0 112.195 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.02 -19.07 3.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.47 1.033 . . . . 0.0 113.148 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.45 141.31 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.319 1.047 . . . . 0.0 109.643 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.92 142.3 43.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.01 157.85 39.69 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.895 0.478 . . . . 0.0 110.793 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 84.7 m -106.64 136.66 46.04 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.28 179.97 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.707 2.003 . . . . 0.0 108.375 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.06 168.13 10.46 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.51 -39.05 67.21 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.808 0.843 . . . . 0.0 111.272 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.48 -9.79 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -110.44 -7.24 14.79 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.05 0.94 . . . . 0.0 112.677 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 t -141.95 142.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.873 1.215 . . . . 0.0 111.081 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -148.61 179.03 8.13 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.034 0.934 . . . . 0.0 109.543 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.26 166.62 0.8 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.692 1.197 . . . . 0.0 110.833 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.29 -28.58 69.82 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.492 169.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -64.1 118.37 8.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.746 0.819 . . . . 0.0 109.154 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.21 -24.47 67.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.67 -62.42 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -154.39 167.07 31.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.92 1.288 . . . . 0.0 109.864 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.13 165.96 24.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.806 0.842 . . . . 0.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.6 mt -129.11 -14.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 117.788 -1.101 . . . . 0.0 111.867 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.01 -28.88 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 121.413 1.915 . . . . 0.0 114.018 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.15 -44.64 97.88 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -159.06 121.44 3.54 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.9 104.62 5.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -169.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -137.27 -30.67 0.84 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -171.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -91.95 -174.56 42.52 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.953 0.797 . . . . 0.0 114.168 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 80.4 p -153.31 170.99 19.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.659 1.984 . . . . 0.0 108.152 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -58.04 124.7 20.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.381 0.992 . . . . 0.0 111.526 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -158.53 -172.22 3.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.941 1.696 . . . . 0.0 109.001 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -155.19 -177.77 6.77 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.129 1.771 . . . . 0.0 109.254 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 90.0 p -144.43 -179.07 6.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.229 1.011 . . . . 0.0 110.094 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 m -110.67 4.2 19.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.849 0.86 . . . . 0.0 112.674 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.84 40.62 0.47 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.509 1.123 . . . . 0.0 110.76 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 127.388 2.275 . . . . 0.0 112.764 -169.498 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 119.284 -0.389 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 55.56 37.86 29.43 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.274 1.829 . . . . 0.0 112.521 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.69 -174.4 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.407 1.083 . . . . 0.0 109.921 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.9 143.12 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 61.84 19.01 10.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.127 1.771 . . . . 0.0 113.401 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -125.16 171.56 10.22 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -83.42 159.24 21.83 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.42 167.71 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 126.641 1.977 . . . . 0.0 108.12 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.3 mt -94.97 133.57 38.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.72 142.92 34.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.802 0.841 . . . . 0.0 109.392 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -69.54 109.65 4.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.744 0.818 . . . . 0.0 109.549 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -79.25 159.51 27.26 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -57.86 -19.64 30.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.359 1.463 . . . . 0.0 113.05 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -49.62 -57.45 7.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.902 1.281 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 m 171.27 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 112.375 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.19 -167.62 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.871 0.76 . . . . 0.0 113.012 -169.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -64.9 141.78 58.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.584 1.154 . . . . 0.0 114.07 -169.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.45 157.83 51.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 128.776 2.83 . . . . 0.0 105.138 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.87 149.3 72.29 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.571 1.514 . . . . 0.0 111.046 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.03 158.46 40.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.886 2.074 . . . . 0.0 108.627 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.5 135.33 33.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.03 134.47 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -111.86 -30.33 7.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.423 0.689 . . . . 0.0 110.448 172.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.31 161.73 42.18 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.624 1.102 . . . . 0.0 110.612 169.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.42 141.29 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -127.86 132.87 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.68 -26.01 63.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.947 0.899 . . . . 0.0 112.174 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.94 -24.9 62.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.923 0.889 . . . . 0.0 112.743 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.95 19.13 4.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.75 1.166 . . . . 0.0 112.628 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -120.76 167.93 11.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.297 1.049 . . . . 0.0 110.253 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -140.8 152.79 45.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.815 2.046 . . . . 0.0 107.543 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.4 m -130.47 130.9 44.82 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 169.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.87 153.0 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -120.21 119.7 33.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.312 1.445 . . . . 0.0 107.299 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.43 146.88 38.32 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -64.86 -21.13 66.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 112.935 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.86 -18.63 64.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.812 0.845 . . . . 0.0 112.382 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.41 47.83 1.49 Allowed Glycine 0 C--N 1.342 0.877 0 C-N-CA 124.324 0.964 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.9 t -134.63 142.73 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -132.51 144.71 36.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -150.1 158.46 44.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 110.406 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -109.78 130.36 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.2 -178.54 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.401 1.48 . . . . 0.0 109.832 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -105.69 169.54 8.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.796 1.238 . . . . 0.0 111.051 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -55.17 -38.07 67.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.215 0.606 . . . . 0.0 111.195 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.52 -5.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -117.85 -10.45 10.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.424 1.09 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.46 139.61 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.92 1.236 . . . . 0.0 111.216 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -149.94 169.69 20.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.604 0.762 . . . . 0.0 109.936 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.91 165.33 0.65 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.262 1.025 . . . . 0.0 111.588 172.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.93 -13.34 59.56 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.618 -0.676 . . . . 0.0 111.233 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.7 m -63.04 116.16 5.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.531 1.132 . . . . 0.0 109.332 169.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -58.29 -46.06 86.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.787 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.95 -52.14 46.61 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -151.31 160.84 43.58 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.985 0.914 . . . . 0.0 110.422 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -76.1 171.15 14.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.692 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.9 mm -119.57 -16.67 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.446 1.099 . . . . 0.0 111.049 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.88 -168.05 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 120.167 1.349 . . . . 0.0 108.808 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.63 -37.57 2.93 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.448 -1.408 . . . . 0.0 112.777 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -148.02 -46.17 0.16 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.925 0.89 . . . . 0.0 110.145 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.27 25.22 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.25 0.547 . . . . 0.0 112.16 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.34 169.85 9.92 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.841 1.257 . . . . 0.0 109.095 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -161.44 -144.95 4.15 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.954 1.74 . . . . 0.0 109.088 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 t -139.4 149.16 43.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.179 0.992 . . . . 0.0 108.933 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -68.53 140.64 55.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.873 0.469 . . . . 0.0 110.423 -170.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.27 -165.28 2.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.169 1.787 . . . . 0.0 107.316 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -145.6 165.95 27.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.011 0.925 . . . . 0.0 109.729 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 27.8 m -133.84 -173.84 3.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.626 1.17 . . . . 0.0 110.408 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.1 m -132.79 6.47 4.0 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -75.8 22.56 0.14 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.279 1.432 . . . . 0.0 113.208 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--O 1.238 0.474 0 C-N-CA 123.93 0.892 . . . . 0.0 109.456 -178.804 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 57.03 55.0 6.4 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.286 1.834 . . . . 0.0 115.124 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.01 -173.75 4.89 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.534 0.683 . . . . 0.0 111.992 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.76 143.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 62.11 17.93 9.58 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.158 1.783 . . . . 0.0 113.291 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.66 173.72 6.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.233 1.013 . . . . 0.0 108.421 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -76.32 158.84 31.11 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.808 -0.557 . . . . 0.0 111.307 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.93 175.16 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.861 2.064 . . . . 0.0 108.226 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.5 mt -115.29 123.54 49.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.74 46.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.295 1.038 . . . . 0.0 108.934 -172.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.3 m -69.52 116.07 9.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -81.83 159.11 23.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.422 0.689 . . . . 0.0 109.314 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m -57.73 -20.82 37.21 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.887 1.275 . . . . 0.0 112.637 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.06 -49.76 75.79 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.178 0.591 . . . . 0.0 111.752 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.94 -65.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.084 0.554 . . . . 0.0 112.111 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 -160.86 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 110.909 -170.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -52.64 139.11 26.83 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -146.02 158.79 48.04 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.499 3.12 . . . . 0.0 105.175 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.88 148.37 64.17 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.627 1.551 . . . . 0.0 110.717 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.08 167.52 30.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.5 135.56 41.74 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.351 1.461 . . . . 0.0 108.083 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 138.94 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -117.44 -32.83 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.211 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.63 162.08 41.72 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.887 1.222 . . . . 0.0 110.315 168.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.7 134.21 45.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -129.4 115.42 17.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -169.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.43 -21.42 59.97 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.733 0.813 . . . . 0.0 112.466 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.36 -29.89 36.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 112.725 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.6 17.02 1.41 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.813 1.197 . . . . 0.0 112.756 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.1 p -127.19 169.03 13.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.861 1.33 . . . . 0.0 109.645 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.75 149.41 31.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 m -132.22 136.18 46.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.85 161.68 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -122.29 124.74 44.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -80.86 150.67 29.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.24 -23.61 66.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.152 0.581 . . . . 0.0 112.092 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.83 -15.18 5.96 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.234 1.397 . . . . 0.0 113.262 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.78 145.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 118.466 1.133 . . . . 0.0 109.266 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.21 144.21 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -149.75 156.44 41.86 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.913 0.485 . . . . 0.0 111.02 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -114.37 130.8 56.7 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.86 179.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.987 1.715 . . . . 0.0 108.346 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -85.89 164.73 17.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.793 -1.192 . . . . 0.0 110.054 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -54.44 -40.55 68.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.719 0.808 . . . . 0.0 110.827 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.2 pt -60.39 -16.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -97.55 -4.5 37.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.204 0.911 . . . . 0.0 112.684 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.1 146.91 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.758 1.163 . . . . 0.0 111.481 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -151.53 173.37 14.69 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.37 1.068 . . . . 0.0 108.68 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.28 169.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.879 1.272 . . . . 0.0 110.943 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -68.8 2.26 2.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.096 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 m -63.21 142.41 58.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.831 -1.168 . . . . 0.0 109.838 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -66.47 -55.59 14.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.855 0.462 . . . . 0.0 110.647 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.58 -66.94 0.56 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -146.44 -178.94 6.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 0.0 111.209 -169.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -73.17 171.26 13.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.444 1.498 . . . . 0.0 111.714 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -131.72 -19.73 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 125.455 1.502 . . . . 0.0 111.156 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.59 -38.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.803 -1.185 . . . . 0.0 111.996 -170.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.06 -49.14 42.73 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -161.24 117.12 2.16 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.31 128.2 35.39 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.467 0.576 . . . . 0.0 112.412 -169.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -146.9 -19.85 0.41 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.962 1.305 . . . . 0.0 113.149 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.65 165.6 36.6 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 119.745 1.157 . . . . 0.0 112.754 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 72.0 p -147.43 -17.39 0.38 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -152.53 146.43 25.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.814 1.188 . . . . 0.0 108.684 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.85 152.38 36.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.791 0.837 . . . . 0.0 111.18 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -78.27 172.95 12.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.776 0.831 . . . . 0.0 110.794 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 4.0 p -149.66 8.2 0.67 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.526 1.13 . . . . 0.0 112.455 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 m -141.21 -178.71 5.72 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.087 0.955 . . . . 0.0 110.387 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 24.5 m80 58.88 27.97 16.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.58 1.552 . . . . 0.0 113.511 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.545 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.11 24.07 5.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -88.74 -173.02 3.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.151 0.98 . . . . 0.0 110.039 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.2 mt -50.81 141.18 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.326 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.77 25.18 15.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.277 1.831 . . . . 0.0 113.206 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.89 168.96 18.56 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.187 0.995 . . . . 0.0 110.067 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.23 145.6 55.71 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.849 2.059 . . . . 0.0 113.638 -171.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.63 160.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 128.113 2.565 . . . . 0.0 107.88 169.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.5 mt -97.49 122.83 41.0 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 143.19 42.65 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.566 0.746 . . . . 0.0 109.049 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.9 m -68.66 105.73 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -68.87 157.62 36.2 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 m -58.94 -16.35 17.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.403 1.081 . . . . 0.0 112.544 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.18 -57.48 9.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.795 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.6 p 170.02 -38.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.404 1.882 . . . . 0.0 113.991 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -173.46 3.95 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.38 0.991 . . . . 0.0 112.807 -169.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.35 141.08 58.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 113.329 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.6 161.39 49.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 128.732 2.813 . . . . 0.0 104.737 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.72 146.68 61.16 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 120.22 1.114 . . . . 0.0 110.186 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.76 165.86 34.69 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.809 2.044 . . . . 0.0 108.453 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -102.36 132.4 48.37 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.648 1.179 . . . . 0.0 107.878 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.74 139.8 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -114.45 -33.69 5.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.72 160.27 43.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.596 1.089 . . . . 0.0 110.344 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.6 t -133.0 145.56 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -131.96 120.22 22.18 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -59.48 -23.4 62.72 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.001 0.921 . . . . 0.0 112.804 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.69 -30.46 61.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.921 0.889 . . . . 0.0 112.386 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.91 24.67 0.79 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.465 1.031 . . . . 0.0 112.952 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.1 p -130.86 170.36 14.51 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.748 1.274 . . . . 0.0 110.331 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -142.39 156.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.824 2.049 . . . . 0.0 108.246 -169.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.2 m -135.22 132.67 38.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.86 156.78 32.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -119.12 120.39 36.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -79.21 145.5 33.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -63.48 -24.98 68.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.21 -26.47 68.38 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.636 0.774 . . . . 0.0 112.125 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.46 -14.92 5.55 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.943 1.258 . . . . 0.0 113.327 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.89 143.9 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.574 1.187 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.29 139.28 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -155.72 155.89 33.92 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.969 0.507 . . . . 0.0 111.684 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -95.31 139.37 31.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.31 172.65 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.935 1.694 . . . . 0.0 108.684 -169.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -97.47 167.97 10.66 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.573 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -56.01 -36.79 68.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.29 0.636 . . . . 0.0 111.06 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 pt -64.17 -7.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.049 -1.032 . . . . 0.0 113.524 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -113.47 -9.2 13.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.316 1.046 . . . . 0.0 112.432 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.9 t -142.27 142.21 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.954 1.252 . . . . 0.0 111.644 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -147.09 172.2 14.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.188 1.395 . . . . 0.0 108.856 170.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 169.9 0.24 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.084 1.354 . . . . 0.0 110.842 169.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -65.8 -2.67 3.95 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.43 -0.794 . . . . 0.0 111.397 169.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.5 m -62.27 125.78 25.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.055 1.742 . . . . 0.0 108.997 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.25 -39.31 68.54 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.676 -0.64 . . . . 0.0 111.922 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.57 -60.95 1.96 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.813 0.278 . . . . 0.0 111.504 -169.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -152.64 172.75 16.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.766 1.626 . . . . 0.0 108.321 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -77.29 176.39 8.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.394 0.678 . . . . 0.0 112.373 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.7 mm -123.62 -62.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.615 1.566 . . . . 0.0 110.096 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.0 -32.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.482 1.037 . . . . 0.0 113.063 -169.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.87 -48.88 58.55 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -160.62 136.1 8.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.29 116.71 26.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.808 0.731 . . . . 0.0 112.596 -169.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -144.42 -18.47 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.306 169.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.96 161.81 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 120.113 1.324 . . . . 0.0 113.093 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 44.0 m -147.18 -21.33 0.4 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.89 139.92 31.0 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.631 1.559 . . . . 0.0 109.282 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.86 154.66 41.66 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.816 0.846 . . . . 0.0 110.845 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.73 165.7 21.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.414 0.686 . . . . 0.0 112.15 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 m -147.21 6.94 0.88 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.262 1.025 . . . . 0.0 113.279 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.2 m -135.68 174.89 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.536 1.062 . . . . 0.0 112.28 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 86.5 t60 55.06 -97.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.797 2.039 . . . . 0.0 111.114 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 126.754 2.021 . . . . 0.0 111.977 -169.372 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -120.76 134.94 55.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.065 1.746 . . . . 0.0 108.253 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -139.17 -174.43 3.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.091 1.357 . . . . 0.0 109.871 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.17 142.43 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.72 24.73 13.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.011 1.725 . . . . 0.0 112.864 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.39 168.18 18.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.232 1.013 . . . . 0.0 108.749 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -73.25 147.99 44.08 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.311 1.845 . . . . 0.0 113.893 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.27 165.68 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 127.448 2.299 . . . . 0.0 108.101 171.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -96.26 131.13 43.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.75 141.44 43.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -69.49 113.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.227 0.611 . . . . 0.0 109.706 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -77.8 157.92 29.75 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.985 0.914 . . . . 0.0 109.32 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 m -58.07 -20.39 39.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.175 0.99 . . . . 0.0 112.748 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.06 -49.53 76.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.054 0.542 . . . . 0.0 112.086 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.89 -66.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -161.79 1.41 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.736 1.215 . . . . 0.0 111.069 -170.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -53.73 141.09 27.61 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -147.23 158.3 44.51 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 129.564 3.145 . . . . 0.0 105.072 168.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 145.01 66.17 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.471 1.447 . . . . 0.0 110.607 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.49 166.0 32.45 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.511 1.925 . . . . 0.0 108.499 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -103.97 133.72 48.45 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.64 138.84 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -114.76 -32.01 5.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.306 0.642 . . . . 0.0 109.77 169.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.4 41.14 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.608 1.094 . . . . 0.0 110.385 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.2 t -136.43 139.31 45.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -132.04 110.36 10.67 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -61.61 -17.34 54.81 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.22 -31.82 45.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.942 0.897 . . . . 0.0 112.137 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.73 20.27 0.54 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.653 1.12 . . . . 0.0 112.928 173.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.3 p -131.65 171.57 13.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.122 1.461 . . . . 0.0 110.075 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 155.89 43.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.354 1.862 . . . . 0.0 107.759 -169.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -133.23 132.88 42.0 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.52 155.69 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.01 126.59 50.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.85 1.66 . . . . 0.0 107.356 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -82.93 154.71 24.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -60.58 -30.54 69.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.48 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -25.85 68.57 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.639 0.776 . . . . 0.0 112.364 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.07 -14.96 7.4 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.997 1.284 . . . . 0.0 113.116 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.55 144.43 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.494 1.147 . . . . 0.0 109.247 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.3 t -131.63 143.26 40.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.95 156.7 42.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.216 0.606 . . . . 0.0 110.84 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -109.35 129.15 55.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 169.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.24 177.91 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.197 1.399 . . . . 0.0 109.428 -169.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.66 169.15 9.47 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.245 -0.909 . . . . 0.0 110.677 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -54.64 -38.46 66.88 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.517 0.727 . . . . 0.0 111.325 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.0 pt -63.98 -7.89 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -113.67 -6.98 13.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.172 0.989 . . . . 0.0 112.576 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.6 t -142.11 140.47 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.054 1.297 . . . . 0.0 110.872 -175.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -145.94 174.3 11.38 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.822 0.849 . . . . 0.0 109.841 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.12 166.94 1.89 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -81.52 47.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 168.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.0 m -127.1 139.75 52.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 172.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -63.07 -41.77 99.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.001 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.82 -68.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -168.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -150.59 178.85 8.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.73 1.212 . . . . 0.0 111.022 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -75.89 159.1 31.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.11 1.764 . . . . 0.0 111.76 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -139.75 34.14 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.515 1.126 . . . . 0.0 110.976 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.0 p -154.16 -49.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 120.479 -1.388 . . . . 0.0 110.874 169.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.33 -32.03 71.84 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -146.1 165.78 28.08 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.75 51.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.136 1.335 . . . . 0.0 112.632 -168.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -120.05 -5.49 10.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.03 162.79 38.85 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 122.18 0.878 . . . . 0.0 115.01 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 t -164.27 171.46 14.87 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 127.272 2.229 . . . . 0.0 106.73 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 52.65 76.28 0.2 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.192 1.397 . . . . 0.0 109.124 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.0 25.92 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -158.45 161.79 37.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.768 1.167 . . . . 0.0 109.953 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 3.2 m -142.86 147.96 36.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.608 0.763 . . . . 0.0 109.994 -169.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.9 m -82.45 -7.52 59.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.986 0.914 . . . . 0.0 113.265 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.57 27.0 0.05 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.703 2.001 . . . . 0.0 114.267 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.235 0.323 0 O-C-N 121.043 -1.036 . . . . 0.0 109.825 178.06 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -53.3 111.47 0.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.38 2.272 . . . . 0.0 110.431 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.503 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 36.2 mt-30 -145.24 -175.35 4.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.356 2.262 . . . . 0.0 107.542 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.69 142.85 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.5 22.59 12.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.547 1.539 . . . . 0.0 113.307 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.2 tp10 -131.29 169.81 15.47 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -81.3 158.59 24.71 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.658 -0.651 . . . . 0.0 111.164 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.16 169.57 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 126.659 1.983 . . . . 0.0 107.969 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.39 122.72 44.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.2 139.26 46.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.533 1.133 . . . . 0.0 108.58 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.8 m -68.96 135.12 50.46 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.806 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -112.18 154.79 24.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.926 1.691 . . . . 0.0 108.148 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.8 m -58.38 -20.71 46.23 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.647 1.179 . . . . 0.0 113.009 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.84 -47.92 79.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.251 1.02 . . . . 0.0 112.791 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.6 p -168.11 -68.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.886 0.475 . . . . 0.0 111.907 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -156.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.351 1.861 . . . . 0.0 109.253 -169.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -46.56 138.08 6.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.504 2.322 . . . . 0.0 115.854 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -145.49 157.08 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.202 3.001 . . . . 0.0 105.313 169.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.02 145.73 56.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.48 1.454 . . . . 0.0 110.75 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.77 155.7 37.68 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.575 1.55 . . . . 0.0 109.176 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.08 134.89 35.37 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.6 133.16 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.069 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -110.41 -31.46 7.27 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.276 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.12 163.91 38.39 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.52 1.054 . . . . 0.0 110.714 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.32 140.9 39.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -131.21 115.48 16.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -172.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.21 -21.02 61.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.584 0.753 . . . . 0.0 112.624 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.86 -31.39 39.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.083 0.953 . . . . 0.0 112.449 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.23 23.37 0.68 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.447 1.022 . . . . 0.0 112.697 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 p -131.75 169.88 15.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.988 1.394 . . . . 0.0 110.48 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -143.16 152.62 41.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.5 1.92 . . . . 0.0 107.504 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -130.69 131.57 44.9 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 m -138.95 155.44 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -120.73 122.39 40.3 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.195 1.398 . . . . 0.0 107.453 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -77.93 148.34 34.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.6 -21.92 66.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.197 0.599 . . . . 0.0 112.525 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.77 -26.85 68.92 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.691 0.796 . . . . 0.0 112.305 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.2 5.91 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.052 1.311 . . . . 0.0 112.83 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.03 144.85 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.345 1.073 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.11 144.41 38.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.2 155.21 40.27 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.128 0.571 . . . . 0.0 110.658 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.8 129.28 55.38 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.56 176.56 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.245 1.418 . . . . 0.0 109.087 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.3 168.43 9.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 -170.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -55.35 -37.13 67.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.561 0.744 . . . . 0.0 110.957 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.0 pt -64.88 -7.09 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -115.37 -7.52 12.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.188 0.995 . . . . 0.0 112.511 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.08 141.04 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 119.758 1.163 . . . . 0.0 110.847 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -150.17 176.96 10.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.702 0.801 . . . . 0.0 109.968 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.52 168.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.635 1.174 . . . . 0.0 111.054 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -62.67 -21.6 65.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.055 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -62.45 120.51 11.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.926 0.891 . . . . 0.0 110.596 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.5 -40.59 79.02 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.154 0.982 . . . . 0.0 111.942 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.44 -64.52 0.84 Allowed 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -150.16 166.37 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.57 0.7 . . . . 0.0 112.628 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.84 153.25 36.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.271 1.829 . . . . 0.0 111.393 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -138.98 23.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.555 0.742 . . . . 0.0 112.08 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.72 -51.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 112.943 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.49 60.83 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.415 1.007 . . . . 0.0 111.93 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -150.99 60.21 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.27 126.06 24.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.01 17.85 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.548 1.139 . . . . 0.0 112.962 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -147.5 -169.33 14.73 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.237 0.926 . . . . 0.0 112.773 -170.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -146.59 170.9 15.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.887 1.275 . . . . 0.0 110.751 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -57.84 135.61 56.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.534 0.734 . . . . 0.0 111.598 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.72 -170.84 2.7 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.716 2.006 . . . . 0.0 108.23 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -151.43 173.67 14.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.851 1.261 . . . . 0.0 110.115 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 35.2 p -152.1 167.91 26.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.234 1.014 . . . . 0.0 109.821 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.4 m -79.61 -1.11 36.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.685 1.194 . . . . 0.0 113.409 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -72.97 89.68 1.44 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.979 0.912 . . . . 0.0 109.597 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.235 0.297 0 C-N-CA 126.145 1.778 . . . . 0.0 108.535 -178.218 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 110.824 -0.065 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -141.03 51.75 1.6 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.722 1.209 . . . . 0.0 109.557 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.44 119.53 20.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -104.19 128.77 51.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.218 1.007 . . . . 0.0 110.159 -169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.8 mp0 -144.45 -172.87 3.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.021 1.728 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.61 144.07 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 66.95 7.07 5.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.802 2.441 . . . . 0.0 114.101 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.423 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.3 tp10 -120.24 170.22 9.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 109.668 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.6 144.38 51.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.782 2.033 . . . . 0.0 113.058 -170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.7 164.24 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 127.189 2.196 . . . . 0.0 108.543 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.07 127.69 42.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.18 47.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -68.8 104.89 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -66.82 154.37 41.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m -58.04 -20.29 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 112.424 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.39 -49.63 76.83 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.2 p -171.72 -68.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.15 -162.83 1.58 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.906 1.282 . . . . 0.0 110.808 -169.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -58.55 138.76 56.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -144.28 157.5 56.44 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 128.577 2.751 . . . . 0.0 104.71 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.53 146.96 75.84 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.302 1.335 . . . . 0.0 110.432 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.96 162.11 41.72 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.243 1.817 . . . . 0.0 108.622 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.64 129.72 42.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.57 1.548 . . . . 0.0 107.118 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.53 138.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.942 1.247 . . . . 0.0 107.97 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 p -118.03 -30.52 5.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.291 0.636 . . . . 0.0 110.572 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.2 164.3 37.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.468 1.031 . . . . 0.0 110.248 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.3 t -143.61 147.75 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -133.77 130.26 37.77 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -60.1 -22.97 63.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.149 0.979 . . . . 0.0 112.36 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -54.5 -30.47 53.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.842 0.857 . . . . 0.0 112.342 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.36 26.15 0.75 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.308 0.956 . . . . 0.0 113.024 172.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.2 p -129.4 165.74 20.95 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.807 1.303 . . . . 0.0 110.839 -171.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.48 145.91 37.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.411 2.284 . . . . 0.0 107.382 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.4 m -124.88 131.94 53.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 169.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.66 149.9 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -114.19 119.95 38.82 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.392 1.477 . . . . 0.0 107.021 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.91 140.76 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -63.0 -21.13 65.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.852 0.861 . . . . 0.0 112.986 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.87 -19.9 63.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.797 0.839 . . . . 0.0 112.178 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.86 46.72 1.16 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.83 1.205 . . . . 0.0 110.725 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.3 t -133.96 138.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.5 140.67 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.03 159.73 41.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.335 0.654 . . . . 0.0 110.64 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.1 m -107.76 136.41 47.55 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.55 -179.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.248 2.219 . . . . 0.0 108.379 -169.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.9 168.93 8.9 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.218 -0.926 . . . . 0.0 110.682 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -53.39 -40.21 64.86 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.361 0.664 . . . . 0.0 110.864 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.1 pt -63.61 -5.9 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -115.9 -7.58 11.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 112.636 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.8 t -142.65 139.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 120.076 1.307 . . . . 0.0 111.651 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -148.16 174.3 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 110.055 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.34 167.91 1.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.758 0.823 . . . . 0.0 110.875 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.15 -18.15 65.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.391 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.18 116.85 6.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -61.63 -31.02 71.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -69.28 -55.9 9.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -152.14 165.16 35.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.662 0.744 . . . . 0.0 112.988 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.74 156.15 38.18 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.192 1.397 . . . . 0.0 110.468 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.98 23.53 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.938 0.895 . . . . 0.0 111.256 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.9 -62.89 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 120.707 -1.246 . . . . 0.0 109.686 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.57 -27.91 72.88 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -141.28 165.99 26.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.35 22.74 7.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.642 1.11 . . . . 0.0 113.427 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -77.62 -21.26 52.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.362 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -79.15 175.65 55.01 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.308 0.949 . . . . 0.0 112.987 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.6 m -150.54 171.21 17.44 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.183 2.193 . . . . 0.0 107.949 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -60.15 120.21 9.32 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.66 -164.13 1.58 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.371 1.868 . . . . 0.0 107.655 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -148.18 -176.89 5.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 66.2 m -129.54 169.11 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.149 1.38 . . . . 0.0 111.031 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -127.89 17.65 6.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -168.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -138.71 134.78 34.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -162.71 169.56 19.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.795 1.638 . . . . 0.0 109.629 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.5 m -64.08 -27.99 69.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.384 1.074 . . . . 0.0 113.591 -174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -87.14 2.34 50.16 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.31 142.95 41.58 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 170.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 63.43 39.46 9.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.811 1.644 . . . . 0.0 113.526 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -106.42 2.38 26.38 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 111.743 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 46.32 38.31 5.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 128.5 2.72 . . . . 0.0 115.43 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -110.06 -173.05 2.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 108.12 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -49.23 138.8 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.687 0.795 . . . . 0.0 109.273 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 62.41 25.79 15.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.194 1.798 . . . . 0.0 113.18 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -135.57 167.27 21.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.887 1.275 . . . . 0.0 108.551 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -69.7 156.05 39.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.846 1.258 . . . . 0.0 113.364 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.88 162.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.826 2.45 . . . . 0.0 107.045 169.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 mt -96.07 127.68 42.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.71 44.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.625 0.77 . . . . 0.0 109.406 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -68.84 107.89 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.966 0.507 . . . . 0.0 110.0 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.23 163.91 23.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.341 1.056 . . . . 0.0 109.548 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -57.33 -18.08 15.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.294 1.038 . . . . 0.0 113.201 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -11.68 49.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.41 1.484 . . . . 0.0 113.487 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.5 m 92.54 17.83 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.5 2.72 . . . . 0.0 114.988 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.56 8.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.007 0.821 . . . . 0.0 110.762 169.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -70.76 141.56 51.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.62 160.74 43.55 Favored Pre-proline 0 C--O 1.241 0.634 0 C-N-CA 128.337 2.655 . . . . 0.0 105.529 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.69 147.52 69.82 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.401 1.4 . . . . 0.0 111.039 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.41 161.07 43.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.177 1.791 . . . . 0.0 108.459 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -91.83 131.29 37.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.513 1.525 . . . . 0.0 107.814 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.6 134.16 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.7 p -112.02 -31.52 6.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.445 0.698 . . . . 0.0 110.201 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 164.14 38.09 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.49 1.041 . . . . 0.0 110.418 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.65 142.92 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -130.99 119.24 21.78 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -61.31 -20.63 63.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.499 0.72 . . . . 0.0 112.74 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -52.7 -31.69 38.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.201 1.001 . . . . 0.0 112.42 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.54 25.3 0.51 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.373 0.987 . . . . 0.0 112.885 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.1 p -131.35 169.05 16.53 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.073 1.437 . . . . 0.0 110.606 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -141.82 156.04 45.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.982 2.113 . . . . 0.0 108.104 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -134.2 132.32 39.6 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.03 155.78 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -119.46 123.39 43.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -82.57 151.06 26.57 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.63 -27.1 68.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.673 0.789 . . . . 0.0 112.648 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.05 -23.03 67.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.644 0.777 . . . . 0.0 112.074 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.23 -14.21 8.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.491 1.519 . . . . 0.0 113.108 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.28 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.351 1.075 . . . . 0.0 108.801 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.47 139.06 52.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -153.67 155.38 35.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 110.984 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 m -98.31 138.13 36.01 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.89 171.91 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.093 1.757 . . . . 0.0 108.777 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.3 167.75 10.22 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.35 -0.844 . . . . 0.0 110.403 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -55.08 -37.71 67.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.524 0.73 . . . . 0.0 111.341 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.9 pt -62.79 -10.82 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -109.52 -9.34 14.91 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.234 0.924 . . . . 0.0 112.735 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.05 141.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.733 1.152 . . . . 0.0 111.348 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -146.95 175.2 10.85 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.019 0.928 . . . . 0.0 110.18 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.69 168.09 1.83 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.388 1.075 . . . . 0.0 111.325 173.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -68.33 -14.79 63.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.818 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.0 m -62.17 120.48 10.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.222 0.919 . . . . 0.0 108.526 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -61.32 -35.75 78.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.2 -42.54 20.64 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -148.86 162.91 38.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.755 0.707 . . . . 0.0 111.961 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -76.73 167.37 21.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 110.214 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.6 mm -129.16 -19.1 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.464 1.505 . . . . 0.0 111.466 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.08 -35.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.412 1.46 . . . . 0.0 112.244 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.86 -30.37 63.01 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -149.77 150.81 32.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.46 64.59 3.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.051 1.341 . . . . 0.0 110.54 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -171.52 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.721 2.008 . . . . 0.0 109.565 -169.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 57.97 -168.11 5.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.09 1.805 . . . . 0.0 116.806 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.6 m -151.09 155.66 39.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.069 2.548 . . . . 0.0 107.045 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -66.08 122.02 16.46 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.03 -163.21 1.58 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.814 1.646 . . . . 0.0 108.472 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -144.9 -179.51 6.65 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 110.9 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 13.8 p -149.38 -178.61 6.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.769 2.028 . . . . 0.0 109.493 -174.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -130.21 6.13 4.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.1 35.87 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.101 1.36 . . . . 0.0 111.812 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.25 152.6 40.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 109.979 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.7 m -68.07 -15.28 63.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.235 1.014 . . . . 0.0 113.214 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -136.55 26.6 3.11 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.132 1.373 . . . . 0.0 111.739 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -57.81 -46.11 85.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -169.685 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 m -137.19 23.84 3.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.812 0.845 . . . . 0.0 111.748 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -125.18 125.93 44.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 169.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.46 129.86 55.9 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.33 1.052 . . . . 0.0 110.929 -167.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.469 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.0 mp0 -142.84 -174.43 4.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.675 1.99 . . . . 0.0 108.48 -177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.88 143.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 60.06 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 112.959 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.469 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.5 tp10 -128.34 170.1 13.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.435 1.094 . . . . 0.0 108.263 171.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -77.28 155.59 31.96 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.758 -0.589 . . . . 0.0 112.102 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.45 167.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.551 1.94 . . . . 0.0 108.613 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.4 125.62 43.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.04 138.91 48.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 m -68.82 142.05 54.97 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.355 0.598 . . . . 0.0 110.901 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -119.03 154.93 32.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.765 1.626 . . . . 0.0 108.061 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -58.45 -19.8 39.69 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.64 1.176 . . . . 0.0 113.248 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.24 -47.63 80.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.151 0.981 . . . . 0.0 112.699 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.3 p -168.68 -68.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.896 0.478 . . . . 0.0 112.156 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -158.0 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.234 1.813 . . . . 0.0 109.303 -169.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -46.19 139.23 4.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.608 2.363 . . . . 0.0 115.66 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -145.77 157.51 51.09 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.5 3.12 . . . . 0.0 105.314 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.83 146.22 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.772 1.648 . . . . 0.0 110.869 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.64 162.68 41.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.912 1.685 . . . . 0.0 108.878 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -95.66 135.65 37.07 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.36 137.08 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 p -114.21 -30.88 6.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.279 0.632 . . . . 0.0 110.165 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.81 40.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.499 1.045 . . . . 0.0 110.303 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.36 140.55 41.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -131.06 118.49 20.63 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -59.05 -23.31 61.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.214 1.006 . . . . 0.0 112.475 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.26 -30.43 60.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.741 0.816 . . . . 0.0 112.491 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.17 23.75 0.82 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.567 1.079 . . . . 0.0 112.71 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.7 p -130.89 171.84 12.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.757 1.278 . . . . 0.0 110.382 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.27 154.19 42.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.657 1.983 . . . . 0.0 107.476 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -131.98 131.1 42.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.65 153.94 26.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.17 125.29 49.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.358 1.463 . . . . 0.0 107.332 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.11 151.3 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.45 -23.04 66.22 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.12 -25.0 65.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.971 0.508 . . . . 0.0 111.987 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.0 5.23 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.096 1.332 . . . . 0.0 113.188 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 146.93 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.397 1.098 . . . . 0.0 109.416 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.69 145.16 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -148.67 154.39 39.6 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.195 0.598 . . . . 0.0 110.864 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -107.57 130.74 54.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.29 175.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.335 1.454 . . . . 0.0 109.183 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.88 168.14 10.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.337 -0.852 . . . . 0.0 110.798 -171.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.08 -39.85 66.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.046 0.538 . . . . 0.0 111.232 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.87 -8.18 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -113.21 -6.3 13.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.09 139.3 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.145 1.339 . . . . 0.0 111.341 -172.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -147.57 177.29 9.38 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.736 0.815 . . . . 0.0 110.25 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.64 167.23 3.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.135 0.974 . . . . 0.0 110.933 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -69.49 -17.68 63.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.078 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.9 m -63.16 124.44 21.17 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.11 -34.24 71.79 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.81 -68.96 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -149.24 167.78 25.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.093 0.957 . . . . 0.0 110.69 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.5 159.09 33.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 110.843 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -136.6 15.66 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.196 0.998 . . . . 0.0 111.401 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.06 -44.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 120.447 -1.408 . . . . 0.0 111.791 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.91 75.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.124 0.875 . . . . 0.0 110.941 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.97 165.48 31.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.067 2.547 . . . . 0.0 104.435 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.91 16.04 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.458 1.481 . . . . 0.0 114.031 -169.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -79.82 -18.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.899 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.69 179.8 43.48 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 119.153 0.888 . . . . 0.0 112.962 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.8 m -146.71 163.64 35.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.782 1.633 . . . . 0.0 108.698 -169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -64.5 113.71 3.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.16 -166.13 1.76 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.735 1.614 . . . . 0.0 108.67 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -148.23 -173.4 4.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.984 1.314 . . . . 0.0 109.821 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 24.3 p -151.12 176.85 10.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.101 1.761 . . . . 0.0 109.681 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -121.82 -1.61 9.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -71.81 119.04 15.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.74 151.53 41.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.433 1.493 . . . . 0.0 107.141 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -65.69 -30.91 71.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.654 0.781 . . . . 0.0 111.588 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -62.15 -23.23 66.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.941 0.897 . . . . 0.0 112.654 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -68.48 -20.6 64.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.761 0.71 . . . . 0.0 112.083 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -178.485 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.294 0.092 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.8 m 58.52 48.7 11.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.536 1.134 . . . . 0.0 111.075 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -127.85 109.07 11.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -103.03 124.95 49.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.237 1.015 . . . . 0.0 109.819 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.4 mp0 -144.57 -173.28 4.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.528 1.531 . . . . 0.0 108.908 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.5 141.95 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 58.4 25.03 12.39 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.866 1.667 . . . . 0.0 113.438 -175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.0 tp10 -134.75 162.82 31.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.429 1.092 . . . . 0.0 108.395 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -65.44 150.09 48.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.628 2.371 . . . . 0.0 113.777 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.71 168.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 128.198 2.599 . . . . 0.0 107.961 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.25 127.17 46.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.36 138.45 41.63 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.739 0.816 . . . . 0.0 109.371 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 m -69.11 121.01 15.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 110.712 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -93.45 155.46 17.34 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.745 1.218 . . . . 0.0 108.652 174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -58.64 -20.89 51.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.749 1.22 . . . . 0.0 112.911 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.23 -46.35 83.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.328 1.051 . . . . 0.0 112.634 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -168.57 -68.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.189 0.45 . . . . 0.0 112.146 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.27 -157.79 0.74 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.187 1.795 . . . . 0.0 108.948 -170.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -46.25 138.85 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.615 1.966 . . . . 0.0 115.643 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -145.16 156.82 54.34 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 129.793 3.237 . . . . 0.0 103.988 168.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.57 145.57 52.8 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.449 1.433 . . . . 0.0 110.616 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.11 168.36 27.53 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.797 2.439 . . . . 0.0 107.152 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -110.45 147.92 33.1 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.982 1.265 . . . . 0.0 109.742 169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.35 140.78 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -115.67 -33.24 5.25 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.767 0.827 . . . . 0.0 109.179 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 163.89 38.58 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.166 0.986 . . . . 0.0 110.494 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.7 146.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -134.74 125.25 26.6 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.66 -23.75 63.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.673 0.789 . . . . 0.0 112.11 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.65 -27.65 58.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.552 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.5 21.6 2.2 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.563 1.077 . . . . 0.0 112.212 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 p -125.36 169.11 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.364 1.082 . . . . 0.0 110.02 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.72 153.5 41.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.444 1.898 . . . . 0.0 107.603 -168.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.8 m -132.16 136.16 46.87 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.55 158.59 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -123.89 126.94 47.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.98 154.69 26.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.16 -26.3 68.74 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.143 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.36 -18.85 5.74 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.831 1.205 . . . . 0.0 112.858 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.55 143.47 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 109.619 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.83 144.98 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -150.38 154.4 37.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.03 0.532 . . . . 0.0 110.635 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.44 129.18 55.27 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.91 179.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.536 1.534 . . . . 0.0 109.271 -169.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.95 167.23 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.095 -1.003 . . . . 0.0 110.529 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -54.36 -38.55 66.22 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.539 0.736 . . . . 0.0 110.882 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -63.26 -8.78 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -111.24 -8.03 14.4 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.005 0.922 . . . . 0.0 112.595 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.01 141.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 120.182 1.355 . . . . 0.0 110.992 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -150.12 173.43 13.9 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.421 0.688 . . . . 0.0 110.106 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.05 165.78 0.62 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.238 1.415 . . . . 0.0 111.039 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -67.27 -16.08 64.07 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.703 -0.623 . . . . 0.0 111.911 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 m -62.78 116.16 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.79 -32.98 72.3 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.46 -65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.723 0.809 . . . . 0.0 112.693 -169.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -152.75 162.67 40.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.268 1.427 . . . . 0.0 108.609 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -73.7 166.67 22.87 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.549 0.214 . . . . 0.0 111.027 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.34 -22.42 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.103 0.961 . . . . 0.0 110.954 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.81 -45.32 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 119.645 1.111 . . . . 0.0 110.906 -172.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.7 97.58 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -159.27 154.42 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.923 2.089 . . . . 0.0 105.42 169.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.19 58.37 2.03 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.983 0.913 . . . . 0.0 112.219 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -74.4 -44.73 50.7 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.435 -0.791 . . . . 0.0 110.717 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -94.82 -168.22 36.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.559 1.076 . . . . 0.0 111.731 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.4 t -147.73 177.55 9.21 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.324 1.45 . . . . 0.0 108.168 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -57.28 120.34 7.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.478 0.711 . . . . 0.0 110.469 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.91 -165.16 1.44 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.438 1.895 . . . . 0.0 107.416 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -147.85 -174.0 4.44 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.815 1.246 . . . . 0.0 109.663 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.8 t -145.76 174.12 11.5 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.042 1.337 . . . . 0.0 109.739 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 14.5 m -128.93 4.63 5.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.566 1.547 . . . . 0.0 111.523 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.93 42.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.508 1.123 . . . . 0.0 110.796 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.9 157.95 26.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.838 1.255 . . . . 0.0 109.474 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.3 m -66.32 -31.92 73.0 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 0.0 111.762 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.98 -11.83 60.03 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.92 0.888 . . . . 0.0 112.707 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -140.53 35.27 1.84 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.487 1.115 . . . . 0.0 110.37 -169.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -176.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.329 0.109 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -76.35 75.85 3.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.028 1.331 . . . . 0.0 110.907 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.67 134.83 47.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.93 137.38 53.52 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.196 0.998 . . . . 0.0 109.898 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 6.0 mp0 -144.36 -173.98 4.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 109.186 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -53.36 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 61.68 22.33 12.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.495 1.918 . . . . 0.0 113.095 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -127.87 169.28 14.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.18 0.992 . . . . 0.0 108.904 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -68.04 146.96 53.02 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.353 1.461 . . . . 0.0 112.864 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.64 166.34 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.69 1.996 . . . . 0.0 108.085 169.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.53 124.06 47.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.47 140.45 41.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.173 0.989 . . . . 0.0 109.209 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -69.25 111.82 5.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.541 0.736 . . . . 0.0 109.871 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -82.41 152.73 26.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 m -58.46 -20.06 42.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.67 1.188 . . . . 0.0 112.841 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.15 -48.28 76.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.395 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 p -169.82 -67.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.498 0.59 . . . . 0.0 112.367 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.23 -158.12 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.033 1.333 . . . . 0.0 110.208 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -54.25 141.26 30.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.75 1.22 . . . . 0.0 113.254 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -140.75 159.3 63.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 129.174 2.99 . . . . 0.0 105.593 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.77 143.09 72.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.296 1.331 . . . . 0.0 110.262 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.52 165.39 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.99 1.716 . . . . 0.0 108.591 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.05 130.41 47.06 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.6 137.77 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 p -114.12 -30.86 6.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.454 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.49 163.35 39.73 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.174 0.99 . . . . 0.0 110.521 168.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.91 140.88 37.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -132.58 122.87 25.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -58.53 -25.03 62.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.078 0.951 . . . . 0.0 112.488 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -56.74 -28.74 61.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.95 0.9 . . . . 0.0 112.491 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 128.14 22.86 1.34 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.488 1.042 . . . . 0.0 112.677 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 p -127.53 168.51 14.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.633 1.216 . . . . 0.0 110.036 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.54 153.95 43.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.282 1.833 . . . . 0.0 107.465 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -132.04 134.37 45.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.44 158.36 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -122.01 128.99 52.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.641 1.576 . . . . 0.0 107.019 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -87.8 151.62 22.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -61.89 -25.94 67.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.53 -27.2 69.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.674 0.79 . . . . 0.0 112.309 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.07 -14.45 7.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.072 1.32 . . . . 0.0 113.178 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.44 143.96 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.521 1.16 . . . . 0.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.1 143.7 38.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.27 155.68 39.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.278 0.631 . . . . 0.0 110.893 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 m -108.38 130.26 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.61 -179.27 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.408 1.483 . . . . 0.0 109.474 -169.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -103.38 169.37 8.58 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.191 -0.943 . . . . 0.0 110.775 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.14 -37.38 66.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.838 -0.539 . . . . 0.0 111.25 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.68 -5.48 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.025 -1.047 . . . . 0.0 113.551 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -118.41 -10.23 10.2 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.358 1.063 . . . . 0.0 112.287 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.5 t -143.11 141.54 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.904 1.229 . . . . 0.0 111.331 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -147.89 179.15 7.94 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.88 0.872 . . . . 0.0 109.23 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.9 165.6 0.9 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.659 1.184 . . . . 0.0 110.989 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.82 -29.75 70.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.563 169.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.34 115.81 5.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.61 -23.33 67.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.98 -63.74 1.0 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.66 0.664 . . . . 0.0 112.385 -170.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -153.66 164.29 38.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.035 1.334 . . . . 0.0 109.339 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -75.42 157.57 33.93 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.396 1.079 . . . . 0.0 110.747 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.38 21.99 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.932 0.893 . . . . 0.0 111.722 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.74 -48.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.518 -1.364 . . . . 0.0 111.847 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.76 -34.17 88.02 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -146.07 160.92 41.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.7 67.89 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.825 1.193 . . . . 0.0 110.393 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -123.27 -22.06 5.21 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.24 -179.97 51.72 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.232 0.907 . . . . 0.0 113.671 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.4 m -150.81 166.14 31.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.258 2.623 . . . . 0.0 106.994 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -56.15 128.78 37.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.954 0.797 . . . . 0.0 111.725 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.71 -176.47 5.56 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.023 1.729 . . . . 0.0 108.581 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -155.74 179.11 9.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.613 1.565 . . . . 0.0 109.343 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 74.3 m -129.91 152.34 49.49 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.736 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 p -78.44 -31.47 48.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.523 1.129 . . . . 0.0 112.001 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -67.01 119.21 11.6 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 4.3 pp -160.9 -177.77 6.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 0.0 108.247 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.4 m -74.02 -26.88 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.33 1.052 . . . . 0.0 113.432 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -87.01 14.05 8.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.92 0.888 . . . . 0.0 111.639 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -61.81 150.67 36.48 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.15 -0.969 . . . . 0.0 109.605 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 169.204 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.45 0.167 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m -58.21 139.7 54.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.238 1.015 . . . . 0.0 110.941 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -137.52 0.7 2.29 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 50.33 36.17 12.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.766 1.626 . . . . 0.0 114.102 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 -173.8 4.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.097 0.959 . . . . 0.0 110.521 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.1 143.51 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 60.3 22.58 12.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.235 1.814 . . . . 0.0 113.07 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -130.12 169.28 15.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.365 1.066 . . . . 0.0 108.47 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.92 150.62 48.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.646 1.978 . . . . 0.0 112.719 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.91 163.01 3.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.843 2.457 . . . . 0.0 107.909 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.59 124.4 40.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.652 -2.722 . . . . 0.0 103.652 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.58 137.89 49.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.1 m -68.77 144.78 54.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -123.51 154.92 38.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.975 1.71 . . . . 0.0 108.141 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.9 m -58.13 -20.5 40.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.673 1.189 . . . . 0.0 112.981 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.02 -48.04 79.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.115 0.966 . . . . 0.0 112.627 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.8 p -169.49 -67.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.128 0.571 . . . . 0.0 112.131 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.52 -157.59 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.042 1.737 . . . . 0.0 109.529 -169.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -47.09 140.71 4.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.0 2.12 . . . . 0.0 115.757 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -145.97 157.95 49.6 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 129.306 3.042 . . . . 0.0 105.399 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 144.46 56.8 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.177 1.918 . . . . 0.0 110.743 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.89 165.05 37.3 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.729 1.612 . . . . 0.0 109.247 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -98.98 130.87 45.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.774 1.63 . . . . 0.0 107.611 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.96 137.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.7 p -114.6 -32.61 5.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.321 0.648 . . . . 0.0 110.522 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.32 163.3 39.74 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.415 1.086 . . . . 0.0 110.27 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -138.0 142.47 35.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -129.54 118.89 22.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -61.58 -20.02 62.84 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.427 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.34 -31.62 54.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.915 0.886 . . . . 0.0 112.285 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.94 24.95 0.7 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.564 1.078 . . . . 0.0 112.697 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.3 p -130.83 169.05 16.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.371 1.585 . . . . 0.0 110.424 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -140.53 152.95 45.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.491 1.916 . . . . 0.0 107.636 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -130.8 131.56 44.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.22 155.14 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -118.52 127.8 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.747 1.619 . . . . 0.0 107.05 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -83.19 150.26 26.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -64.42 -24.24 67.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.47 -23.99 65.56 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.08 0.552 . . . . 0.0 112.345 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 131.47 -16.51 5.13 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.716 1.15 . . . . 0.0 113.607 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.59 147.21 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.413 1.107 . . . . 0.0 109.39 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -132.98 144.83 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.86 158.01 43.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.116 0.566 . . . . 0.0 110.739 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -111.8 130.82 55.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.49 176.7 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.192 1.397 . . . . 0.0 109.192 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.89 167.43 10.52 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.043 -1.036 . . . . 0.0 110.474 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.42 -39.6 67.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 0.0 111.135 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.81 -11.88 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -108.34 -5.24 16.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.855 0.862 . . . . 0.0 112.485 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.18 140.58 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.211 1.369 . . . . 0.0 111.858 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -148.37 177.83 9.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.32 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 168.68 1.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 110.51 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -68.43 -17.46 64.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.623 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 124.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.827 0.851 . . . . 0.0 109.191 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -60.17 -32.72 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.43 -61.62 2.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.852 1.261 . . . . 0.0 114.329 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -153.17 167.25 29.92 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.36 1.064 . . . . 0.0 110.535 -169.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -73.77 169.5 17.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.799 0.84 . . . . 0.0 109.302 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.5 mt -131.41 -13.81 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 111.323 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.01 -40.5 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.103 1.32 . . . . 0.0 111.854 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.29 -29.89 75.88 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -151.15 148.44 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.286 2.234 . . . . 0.0 105.313 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.4 -167.45 1.6 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.961 0.904 . . . . 0.0 110.325 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 77.73 -3.06 2.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.443 2.297 . . . . 0.0 114.503 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.35 179.25 53.49 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 119.123 0.874 . . . . 0.0 111.828 169.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.0 m -147.42 155.4 41.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.959 1.703 . . . . 0.0 108.397 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -66.61 131.07 45.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.22 -158.3 0.85 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.37 1.868 . . . . 0.0 107.063 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -144.17 -179.31 6.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.202 1.001 . . . . 0.0 109.87 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 44.9 m -142.07 155.7 45.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.048 1.339 . . . . 0.0 110.194 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 m -80.88 -24.32 38.41 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.72 122.32 17.39 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.211 0.605 . . . . 0.0 109.596 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.5 mt -146.74 151.29 36.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.944 1.698 . . . . 0.0 107.561 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.8 m -66.73 -12.28 57.96 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.125 1.37 . . . . 0.0 113.856 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -122.37 17.92 10.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.706 1.202 . . . . 0.0 112.966 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -129.44 17.63 5.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.072 1.349 . . . . 0.0 110.583 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.467 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -141.11 46.66 1.73 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.732 1.213 . . . . 0.0 109.072 -172.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.17 -5.77 2.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.566 1.147 . . . . 0.0 112.409 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 56.9 35.34 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.954 1.702 . . . . 0.0 112.904 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -82.92 -173.77 4.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.441 1.096 . . . . 0.0 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.0 mt -50.6 142.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 60.62 21.89 11.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.309 1.844 . . . . 0.0 113.35 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -128.34 170.06 13.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.21 1.004 . . . . 0.0 109.136 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -70.46 149.43 47.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.63 1.172 . . . . 0.0 111.359 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.39 166.08 4.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 126.937 2.095 . . . . 0.0 108.324 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -100.73 124.3 46.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.26 138.9 48.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.0 m -69.28 144.87 53.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.474 0.654 . . . . 0.0 110.9 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -121.41 155.54 34.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.782 1.633 . . . . 0.0 107.991 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -58.24 -20.54 42.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.838 1.255 . . . . 0.0 112.994 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.65 -47.5 79.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.057 0.943 . . . . 0.0 112.48 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.4 p -169.13 -67.99 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.924 0.49 . . . . 0.0 112.238 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.21 -158.19 0.78 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.479 1.911 . . . . 0.0 109.047 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -43.96 137.99 3.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.944 2.498 . . . . 0.0 116.048 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -145.86 157.44 50.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.345 3.058 . . . . 0.0 104.943 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 145.14 48.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.912 1.741 . . . . 0.0 110.77 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.13 165.31 36.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.717 1.607 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -98.5 133.1 43.33 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.149 1.38 . . . . 0.0 107.73 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 136.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -113.73 -32.26 6.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.34 0.656 . . . . 0.0 110.306 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.01 38.1 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.604 1.093 . . . . 0.0 110.502 169.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -138.88 140.8 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -129.42 122.81 30.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.22 -21.2 61.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.772 0.829 . . . . 0.0 112.439 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.28 -29.72 61.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.25 23.93 1.09 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.68 1.133 . . . . 0.0 112.608 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 171.48 12.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.627 1.214 . . . . 0.0 110.609 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.99 154.3 43.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.863 2.065 . . . . 0.0 107.764 -169.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -132.23 132.19 42.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.81 154.82 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.88 125.63 50.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.476 1.51 . . . . 0.0 107.423 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.99 150.53 28.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -64.32 -23.64 67.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.08 -27.92 69.43 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.451 0.7 . . . . 0.0 112.068 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.54 -18.74 5.14 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.943 1.259 . . . . 0.0 113.066 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.36 146.3 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.199 1.0 . . . . 0.0 109.588 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.3 144.71 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.51 154.38 40.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.226 0.61 . . . . 0.0 110.276 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -107.46 131.87 53.82 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 169.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.09 175.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.421 1.488 . . . . 0.0 109.375 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -99.32 168.5 9.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.139 -0.975 . . . . 0.0 110.419 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -53.17 -42.38 66.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.728 0.411 . . . . 0.0 111.023 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.6 pt -60.97 -12.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -105.79 -6.31 19.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.548 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 t -141.76 139.4 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.723 1.601 . . . . 0.0 112.686 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -150.3 176.66 10.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.75 169.27 1.92 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -65.69 -16.29 63.61 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.857 -0.527 . . . . 0.0 111.071 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -62.14 119.17 8.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.203 1.401 . . . . 0.0 108.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -59.54 -30.79 68.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.64 -70.3 0.25 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -150.83 173.34 14.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.764 0.792 . . . . 0.0 111.731 -169.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -72.92 154.23 40.64 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.767 1.627 . . . . 0.0 110.888 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.8 mt -139.22 22.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-N 118.872 0.76 . . . . 0.0 111.852 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 -51.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 120.216 -1.553 . . . . 0.0 112.457 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -37.73 94.74 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.592 1.087 . . . . 0.0 111.654 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -152.26 76.1 1.15 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.9 134.09 56.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -150.23 -45.43 0.13 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.938 1.695 . . . . 0.0 110.756 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -90.25 -163.57 39.19 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 122.287 0.937 . . . . 0.0 112.873 -170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.0 m -146.77 146.53 30.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 106.583 -170.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -61.02 132.85 55.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 111.408 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.64 -152.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.695 1.998 . . . . 0.0 106.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -146.11 -175.86 4.93 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.175 0.99 . . . . 0.0 110.486 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 28.5 t -150.82 179.76 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.783 2.033 . . . . 0.0 108.143 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -124.59 0.15 8.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.15 1.38 . . . . 0.0 111.821 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -70.1 114.58 8.4 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.05 157.17 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.742 2.017 . . . . 0.0 106.714 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.6 m -65.9 -28.41 68.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.662 0.785 . . . . 0.0 112.488 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -26.24 61.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.596 0.758 . . . . 0.0 111.658 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -64.14 149.67 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.462 0.574 . . . . 0.0 109.824 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.379 0 N-CA-C 107.796 -2.121 . . . . 0.0 107.796 169.56 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -143.41 155.45 44.4 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 109.359 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -142.39 -3.4 1.05 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.553 1.141 . . . . 0.0 111.77 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 51.31 39.82 24.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.412 2.285 . . . . 0.0 113.65 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -83.05 -174.17 5.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.317 1.047 . . . . 0.0 111.849 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.0 mt -53.49 143.86 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.237 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 64.63 -0.24 0.99 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.815 2.446 . . . . 0.0 114.04 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.75 172.04 8.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.755 1.162 . . . . 0.0 109.396 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -69.53 149.02 48.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.711 1.204 . . . . 0.0 110.884 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.94 171.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 127.278 2.231 . . . . 0.0 108.847 169.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.34 128.96 54.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 168.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.24 143.74 44.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 m -69.21 103.07 1.83 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -68.22 156.29 37.92 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -58.57 -19.47 38.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.402 1.081 . . . . 0.0 112.212 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.31 -51.57 69.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.124 0.97 . . . . 0.0 112.906 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 p -169.55 -74.66 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.48 -157.25 0.75 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.676 1.59 . . . . 0.0 109.808 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.63 135.9 46.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.725 1.61 . . . . 0.0 114.691 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.62 162.09 46.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 129.589 3.156 . . . . 0.0 105.375 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.67 146.0 77.59 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 121.724 1.616 . . . . 0.0 110.712 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.93 31.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.457 1.903 . . . . 0.0 109.03 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -102.2 134.26 45.75 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.6 1.56 . . . . 0.0 107.27 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.67 139.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.421 1.009 . . . . 0.0 108.324 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -116.05 -32.27 5.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.927 -0.559 . . . . 0.0 109.794 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.62 162.58 41.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.478 1.035 . . . . 0.0 110.165 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.5 t -137.42 138.26 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -130.49 117.84 20.22 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.28 -20.52 59.41 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.672 0.789 . . . . 0.0 112.763 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.57 -30.75 55.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.842 0.857 . . . . 0.0 112.285 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.26 23.11 0.85 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 124.675 1.131 . . . . 0.0 112.801 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -130.97 171.12 13.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.647 1.223 . . . . 0.0 110.166 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.2 156.26 43.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.795 2.038 . . . . 0.0 107.605 -169.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -134.99 133.53 39.57 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.23 155.64 23.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.98 129.59 55.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.697 1.599 . . . . 0.0 107.051 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -92.64 146.32 23.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -61.67 -21.07 64.11 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -169.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.04 -19.65 65.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.261 0.625 . . . . 0.0 112.288 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.45 46.24 1.34 Allowed Glycine 0 C--N 1.342 0.884 0 C-N-CA 124.184 0.897 . . . . 0.0 110.983 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.81 140.09 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.7 141.66 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.5 153.98 36.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.236 0.614 . . . . 0.0 110.655 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 m -100.05 135.94 40.71 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.3 176.93 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.978 1.711 . . . . 0.0 109.125 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.54 166.84 11.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.096 -1.003 . . . . 0.0 110.715 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -54.81 -38.48 67.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.824 0.849 . . . . 0.0 111.233 171.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.5 pt -61.73 -13.95 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.85 -7.66 19.25 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.253 0.933 . . . . 0.0 112.685 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.76 140.2 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 120.275 1.398 . . . . 0.0 111.173 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -149.07 175.42 11.35 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.259 1.024 . . . . 0.0 109.8 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.0 167.1 1.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.287 1.035 . . . . 0.0 110.931 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.4 -23.7 67.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.103 169.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.2 m -63.15 102.89 0.42 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.89 -24.78 66.23 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.72 -54.19 42.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.209 1.004 . . . . 0.0 112.516 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -154.91 157.63 38.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.45 1.1 . . . . 0.0 110.912 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -73.73 153.69 39.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 109.253 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.93 21.75 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 124.031 0.932 . . . . 0.0 111.557 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.38 -41.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 120.67 -1.269 . . . . 0.0 110.975 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -21.13 79.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.602 0.637 . . . . 0.0 111.95 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -142.67 152.13 42.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.964 2.105 . . . . 0.0 106.045 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.47 2.05 35.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -108.23 2.64 22.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.341 0.973 . . . . 0.0 113.471 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.24 175.25 36.34 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.859 0.754 . . . . 0.0 112.921 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 m -148.22 159.5 43.91 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.646 1.578 . . . . 0.0 109.274 -169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -59.11 141.58 53.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.105 0.562 . . . . 0.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.79 179.14 8.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 108.278 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -171.38 -152.4 0.08 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.728 1.611 . . . . 0.0 108.161 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 34.0 m 58.78 42.1 20.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.013 1.325 . . . . 0.0 110.817 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m -85.69 170.59 12.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.231 2.212 . . . . 0.0 110.878 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -63.68 146.84 53.05 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.831 -0.543 . . . . 0.0 110.061 170.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 89.3 mt -142.58 152.27 42.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 107.474 173.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 5.1 p -66.03 -33.84 76.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -64.81 -21.21 66.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.96 0.904 . . . . 0.0 111.951 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -29.87 70.12 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.887 0.767 . . . . 0.0 111.349 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -177.829 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.0 m -144.75 26.64 1.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.478 1.111 . . . . 0.0 112.007 -170.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.09 131.61 35.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -116.84 136.68 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.362 1.065 . . . . 0.0 109.179 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.493 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.6 mp0 -144.35 -173.48 4.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.518 1.927 . . . . 0.0 108.63 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.91 142.67 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 61.59 21.78 12.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.115 1.766 . . . . 0.0 113.411 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.493 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.2 tp10 -128.12 170.29 13.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.538 1.135 . . . . 0.0 108.372 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.08 146.11 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.576 1.55 . . . . 0.0 112.3 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.42 173.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 127.735 2.414 . . . . 0.0 108.534 172.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.1 mt -107.36 129.23 54.94 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 141.15 42.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.99 0.916 . . . . 0.0 109.463 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.2 m -70.24 102.83 2.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.317 1.047 . . . . 0.0 110.525 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -68.21 154.44 41.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -59.56 -17.98 37.1 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.361 1.064 . . . . 0.0 113.049 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.13 -50.13 73.75 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.441 0.697 . . . . 0.0 111.911 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -171.96 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.28 0.632 . . . . 0.0 111.947 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.36 -160.51 1.18 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 111.385 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.79 134.97 36.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.919 2.088 . . . . 0.0 115.936 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -140.61 159.48 62.75 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 129.173 2.989 . . . . 0.0 105.342 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.82 144.97 79.37 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.718 1.612 . . . . 0.0 110.536 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.83 165.14 36.33 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.774 1.63 . . . . 0.0 109.084 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -98.69 131.11 45.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.133 1.373 . . . . 0.0 107.366 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.11 138.35 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 p -114.7 -31.3 6.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.513 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.98 163.06 40.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.581 1.082 . . . . 0.0 110.257 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -134.98 142.3 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -133.4 112.23 11.42 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.71 -19.97 53.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.716 0.806 . . . . 0.0 112.833 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.71 -31.64 38.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.079 0.952 . . . . 0.0 112.454 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.83 18.96 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.527 1.061 . . . . 0.0 113.052 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.7 p -129.8 170.13 14.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.923 1.361 . . . . 0.0 110.164 -170.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.66 154.81 41.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.904 1.682 . . . . 0.0 107.396 -169.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -131.69 134.83 46.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.4 m -142.32 158.85 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.23 125.23 44.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.274 1.43 . . . . 0.0 107.184 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.58 151.18 26.5 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -64.81 -24.34 67.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.71 -26.5 68.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.6 0.76 . . . . 0.0 112.247 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.32 -13.95 6.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.976 1.274 . . . . 0.0 113.306 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.47 143.05 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.445 1.122 . . . . 0.0 109.141 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.69 144.1 38.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.38 153.31 33.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.289 0.635 . . . . 0.0 110.673 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -108.58 128.55 54.93 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.02 -178.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.133 1.373 . . . . 0.0 109.227 -168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.76 169.28 8.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.003 -1.06 . . . . 0.0 110.845 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.0 -37.21 68.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.074 0.55 . . . . 0.0 111.043 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.97 -5.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 120.882 -1.136 . . . . 0.0 113.509 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -118.94 -12.83 9.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.381 1.073 . . . . 0.0 112.145 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.41 138.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.255 1.389 . . . . 0.0 110.588 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -147.37 176.69 9.82 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.71 0.804 . . . . 0.0 109.47 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.58 168.1 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.074 0.949 . . . . 0.0 110.714 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -28.04 69.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.247 170.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -64.39 116.52 6.16 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.698 0.799 . . . . 0.0 109.168 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -65.85 -24.73 66.94 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -84.14 -36.49 22.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -146.86 165.0 31.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 110.624 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.08 169.19 14.17 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.3 mm -129.18 -13.75 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 124.819 1.248 . . . . 0.0 111.393 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.66 -36.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.54 1.518 . . . . 0.0 112.971 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.05 -30.24 77.2 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.605 1.093 . . . . 0.0 110.642 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -151.2 153.86 35.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.396 2.678 . . . . 0.0 104.28 169.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.65 12.23 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.98 1.264 . . . . 0.0 114.327 -169.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.44 -6.28 59.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.168 0.894 . . . . 0.0 112.266 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.4 -177.91 41.73 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 121.962 0.757 . . . . 0.0 114.04 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -148.21 165.88 29.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.326 1.451 . . . . 0.0 109.53 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -72.28 135.32 45.95 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.511 -0.743 . . . . 0.0 110.571 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -152.15 -171.27 3.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.246 1.818 . . . . 0.0 107.465 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -154.76 -178.73 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.577 1.551 . . . . 0.0 108.762 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 77.6 p -143.2 175.91 9.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.359 1.064 . . . . 0.0 109.931 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 p -116.44 -0.6 12.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.615 1.166 . . . . 0.0 113.232 -169.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -80.98 44.58 0.77 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.592 1.087 . . . . 0.0 110.529 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.31 144.83 48.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.7 m -62.92 -27.69 69.55 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.459 1.104 . . . . 0.0 113.276 -172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -63.89 -25.33 68.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.745 -0.597 . . . . 0.0 112.347 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -68.96 -15.88 63.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.363 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.108 -174.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.32 0.105 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.4 m -63.63 151.47 41.61 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.817 0.847 . . . . 0.0 110.728 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -137.62 -15.72 1.38 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.603 1.561 . . . . 0.0 111.508 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 72.18 83.26 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.296 2.638 . . . . 0.0 113.06 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -139.23 -173.65 3.65 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.73 1.612 . . . . 0.0 109.512 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.1 mt -48.96 141.94 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.476 1.11 . . . . 0.0 109.467 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.49 22.25 11.93 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.091 1.756 . . . . 0.0 113.29 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -127.62 170.27 12.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.235 1.014 . . . . 0.0 108.805 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -74.03 149.65 41.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.778 1.231 . . . . 0.0 111.516 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.45 168.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.787 2.035 . . . . 0.0 108.059 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -101.69 130.92 48.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.61 140.2 44.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.997 0.919 . . . . 0.0 109.014 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.1 m -69.73 102.59 1.94 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.815 0.846 . . . . 0.0 110.711 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.91 153.39 41.88 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -58.19 -20.48 41.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.048 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.21 -48.03 77.24 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.09 0.956 . . . . 0.0 112.396 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.8 p -169.59 -72.75 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.586 0.354 . . . . 0.0 111.615 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 -156.14 0.69 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.135 1.374 . . . . 0.0 110.012 -173.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -49.31 139.71 11.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.914 1.686 . . . . 0.0 115.047 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -146.33 156.51 49.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 130.12 3.368 . . . . 0.0 104.246 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.3 147.13 71.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.521 1.481 . . . . 0.0 110.968 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.34 164.69 36.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.182 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -95.24 132.63 40.01 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.526 1.53 . . . . 0.0 107.691 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.26 135.72 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.7 p -112.66 -33.57 6.08 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.849 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.19 164.67 36.87 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 110.723 168.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.58 142.31 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -131.39 119.21 21.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -61.24 -19.76 62.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.409 0.684 . . . . 0.0 112.556 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.6 -30.76 44.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 112.296 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.79 20.54 0.76 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.556 1.074 . . . . 0.0 112.967 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -129.3 169.82 14.38 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.72 1.26 . . . . 0.0 110.394 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -143.44 155.82 44.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.954 2.102 . . . . 0.0 107.728 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -133.0 131.81 41.16 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -140.04 157.32 25.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -122.09 122.83 40.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -78.24 150.24 33.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -64.18 -25.34 68.03 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.08 -26.83 68.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.629 0.772 . . . . 0.0 112.265 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.4 -16.83 5.93 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.102 1.334 . . . . 0.0 113.033 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.14 143.4 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.255 1.027 . . . . 0.0 109.356 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.67 144.41 38.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -152.05 155.9 38.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.269 0.628 . . . . 0.0 110.474 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -109.96 129.79 55.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.37 179.58 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.405 1.482 . . . . 0.0 109.677 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.32 168.51 9.29 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.08 0.952 . . . . 0.0 110.758 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -55.43 -36.83 66.92 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.795 -0.566 . . . . 0.0 111.321 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.8 pt -64.23 -5.06 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -118.05 -11.04 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.315 1.046 . . . . 0.0 112.484 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.91 141.07 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 120.263 1.392 . . . . 0.0 110.991 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -150.47 172.33 15.62 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.305 1.042 . . . . 0.0 109.703 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 166.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.778 1.231 . . . . 0.0 111.59 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -68.1 -8.58 39.35 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.56 -0.713 . . . . 0.0 111.541 169.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -67.97 117.28 9.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.71 -44.27 90.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 112.121 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.62 -67.02 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -151.23 163.36 39.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.741 1.216 . . . . 0.0 109.353 -170.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -84.54 164.18 18.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.075 0.55 . . . . 0.0 111.882 -170.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.7 15.01 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.759 0.824 . . . . 0.0 112.183 -173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.05 158.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 120.397 -1.44 . . . . 0.0 107.413 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.53 3.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.708 1.147 . . . . 0.0 111.992 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -143.72 65.86 1.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.926 2.09 . . . . 0.0 106.259 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.47 132.09 52.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.383 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.89 -2.33 0.93 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.149 0.979 . . . . 0.0 113.035 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.38 -159.29 9.13 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.42 1.009 . . . . 0.0 112.794 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.8 m -139.4 164.69 29.18 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.06 1.744 . . . . 0.0 109.84 -169.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -60.7 145.3 49.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.2 -165.39 1.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.161 2.584 . . . . 0.0 107.1 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.94 169.94 17.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.269 1.028 . . . . 0.0 109.658 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 36.7 m -135.23 179.98 5.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.97 1.308 . . . . 0.0 111.056 -170.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.8 m -134.65 6.17 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.726 0.81 . . . . 0.0 113.039 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -75.88 24.82 0.12 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.408 1.483 . . . . 0.0 112.933 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.71 145.82 43.57 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 109.625 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.3 m -63.82 -31.34 72.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.431 0.692 . . . . 0.0 112.127 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -67.16 -22.28 65.77 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.711 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -68.44 -22.26 64.6 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.815 0.734 . . . . 0.0 111.995 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.999 -1.641 . . . . 0.0 108.999 -179.528 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.38 0.133 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 m -61.76 152.4 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.967 0.907 . . . . 0.0 110.848 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.18 -12.09 1.66 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.742 1.617 . . . . 0.0 111.552 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 72.22 80.96 0.14 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.033 2.533 . . . . 0.0 113.279 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.57 -174.77 3.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.091 1.356 . . . . 0.0 109.523 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.0 mt -53.2 143.58 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.58 17.1 10.15 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.952 1.701 . . . . 0.0 113.258 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -123.27 173.24 8.06 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -84.37 156.45 21.84 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.408 -0.807 . . . . 0.0 111.302 -169.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.97 167.51 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.305 1.842 . . . . 0.0 109.05 170.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.97 127.35 41.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.36 144.14 38.07 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.455 0.702 . . . . 0.0 109.644 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -68.83 108.44 3.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.396 0.679 . . . . 0.0 109.883 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -73.29 162.56 29.22 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.987 0.915 . . . . 0.0 109.726 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 m -58.0 -19.64 32.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.568 1.147 . . . . 0.0 112.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.43 -23.15 56.65 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 113.334 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.2 m 110.7 8.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 130.151 3.38 . . . . 0.0 114.898 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -153.64 -176.93 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.555 1.07 . . . . 0.0 111.229 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.89 140.07 53.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -142.02 158.34 62.04 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 128.341 2.656 . . . . 0.0 106.074 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.23 145.61 73.04 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.612 1.541 . . . . 0.0 111.206 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.31 156.89 37.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.171 1.789 . . . . 0.0 109.044 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.54 133.51 34.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.907 1.283 . . . . 0.0 108.391 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.46 133.77 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 p -111.55 -32.56 6.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.031 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 164.4 38.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.721 1.146 . . . . 0.0 110.676 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.13 141.42 33.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -129.57 128.0 41.84 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.73 -24.49 61.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.805 0.842 . . . . 0.0 112.47 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.29 -27.59 55.92 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 112.732 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.07 19.07 2.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.636 1.112 . . . . 0.0 112.705 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.2 p -123.54 168.98 11.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.502 1.151 . . . . 0.0 110.116 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.05 153.36 42.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 106.965 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -133.26 135.7 45.08 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.94 159.69 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -123.96 120.63 33.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -77.03 150.04 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -64.89 -23.55 67.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -63.39 -24.44 67.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.392 0.677 . . . . 0.0 112.435 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.98 -14.56 7.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.02 1.295 . . . . 0.0 113.009 173.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.48 143.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.288 1.044 . . . . 0.0 108.992 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.76 143.61 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -151.18 155.47 38.94 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.056 0.543 . . . . 0.0 110.699 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -108.97 131.48 55.01 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.01 178.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.748 1.619 . . . . 0.0 108.902 -169.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.69 165.7 12.58 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.018 -1.051 . . . . 0.0 110.496 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.54 -37.07 64.97 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.856 0.862 . . . . 0.0 111.016 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.36 -11.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.005 -1.059 . . . . 0.0 113.547 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -106.6 -8.99 16.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 112.636 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.59 139.54 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.437 1.017 . . . . 0.0 110.99 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -152.12 175.03 13.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.944 0.498 . . . . 0.0 110.682 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.17 165.35 0.52 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.331 1.453 . . . . 0.0 111.728 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -64.25 -16.7 62.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.843 -0.536 . . . . 0.0 111.844 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 m -62.14 116.25 4.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.41 1.084 . . . . 0.0 108.983 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.26 -28.3 67.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.37 -76.76 0.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.153 0.581 . . . . 0.0 111.812 -171.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.18 165.36 29.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 0.0 109.537 -170.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.92 163.58 25.14 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.176 0.512 . . . . 0.0 112.329 -171.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 mt -129.7 28.29 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 124.958 1.303 . . . . 0.0 108.606 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.32 160.46 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.45 1.9 . . . . 0.0 106.207 175.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.66 -62.43 3.53 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.867 1.222 . . . . 0.0 111.716 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -142.0 72.22 1.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.28 130.47 46.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.47 -21.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -171.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.76 -171.17 47.44 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 121.955 0.753 . . . . 0.0 111.832 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.3 m -146.24 159.9 42.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.643 1.977 . . . . 0.0 108.03 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -56.38 127.93 33.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.767 0.427 . . . . 0.0 111.113 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.1 -164.52 1.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.44 1.896 . . . . 0.0 107.4 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -145.23 -180.0 7.01 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 109.748 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 t -142.15 175.34 9.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.355 1.462 . . . . 0.0 108.889 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.2 m -133.0 -10.16 3.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -79.73 111.08 15.68 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 170.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 3.7 pp -153.75 -179.52 7.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 110.301 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 m -66.1 -23.93 66.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 113.518 -170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -78.29 65.91 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.095 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.09 -15.16 63.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.121 0.969 . . . . 0.0 112.092 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.684 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.538 0.208 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -34.56 75.51 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 61.71 -8.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.675 1.99 . . . . 0.0 115.354 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 55.14 36.27 26.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.656 1.583 . . . . 0.0 114.155 169.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -82.24 -173.35 4.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.578 0.751 . . . . 0.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.94 142.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 61.87 21.49 12.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.384 1.873 . . . . 0.0 113.337 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.19 170.19 13.28 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.354 1.062 . . . . 0.0 109.192 171.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.19 149.07 50.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.006 2.122 . . . . 0.0 112.534 -174.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.31 164.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 127.932 2.493 . . . . 0.0 108.525 171.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.48 130.21 42.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 168.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.66 145.12 38.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.517 0.727 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -69.02 116.09 9.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.906 0.482 . . . . 0.0 109.714 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -79.62 164.25 23.96 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.224 1.01 . . . . 0.0 110.597 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.9 m -57.23 -24.3 53.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.841 0.856 . . . . 0.0 112.33 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.77 -4.07 18.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.092 1.357 . . . . 0.0 113.459 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.4 m 75.28 156.86 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.633 2.773 . . . . 0.0 111.593 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.65 176.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.079 2.551 . . . . 0.0 115.425 -169.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -71.12 148.53 47.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -144.48 162.32 39.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 129.337 3.055 . . . . 0.0 106.01 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.33 145.89 61.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.892 1.728 . . . . 0.0 110.721 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.58 33.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.536 1.935 . . . . 0.0 108.748 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -101.58 133.78 45.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 107.414 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.79 136.67 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 p -114.02 -32.9 5.9 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.278 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.21 35.28 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.263 0.938 . . . . 0.0 110.63 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.3 t -141.65 140.56 30.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -130.63 123.66 29.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -60.08 -22.97 63.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.722 0.809 . . . . 0.0 112.568 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.27 -28.62 59.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.877 . . . . 0.0 112.278 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.51 22.32 1.2 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.769 1.176 . . . . 0.0 112.782 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.6 p -127.12 169.42 13.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.786 1.293 . . . . 0.0 110.271 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -142.45 156.41 45.18 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.905 2.082 . . . . 0.0 108.022 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -133.92 134.83 43.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.56 157.57 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.85 131.33 53.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.442 1.497 . . . . 0.0 107.186 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.67 148.57 23.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.41 -24.28 66.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -169.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.56 -30.47 71.5 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.298 0.639 . . . . 0.0 112.386 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.23 -15.31 4.23 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.46 1.029 . . . . 0.0 113.545 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.58 143.88 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 109.348 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.0 145.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.46 157.43 42.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.153 0.581 . . . . 0.0 110.719 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -108.74 131.92 54.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.15 178.6 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.307 1.443 . . . . 0.0 109.518 -169.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.71 167.11 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.141 -0.974 . . . . 0.0 110.502 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.28 -39.21 66.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.498 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.7 pt -61.51 -13.38 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -104.25 -8.69 19.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.112 -0.946 . . . . 0.0 112.637 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.8 140.5 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.818 1.19 . . . . 0.0 111.863 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -150.13 177.86 9.51 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 110.34 171.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.49 167.97 2.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.026 0.93 . . . . 0.0 111.096 176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -69.29 -17.27 63.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.37 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -63.01 122.98 17.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.73 -37.86 77.1 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.354 0.662 . . . . 0.0 112.158 -173.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.6 -69.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -149.7 168.8 22.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.877 0.871 . . . . 0.0 111.204 -169.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.5 155.06 34.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.653 1.581 . . . . 0.0 110.83 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.32 21.27 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 123.987 0.915 . . . . 0.0 112.067 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.98 -46.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.192 -1.567 . . . . 0.0 112.078 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.83 -32.49 82.99 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -145.84 162.9 36.63 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.28 56.24 1.04 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.39 1.45 . . . . 0.0 112.044 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.94 -19.14 9.29 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.95 -177.17 51.44 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 122.277 0.931 . . . . 0.0 112.676 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.7 m -148.67 165.17 32.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.246 2.218 . . . . 0.0 107.388 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -61.33 120.68 10.91 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.394 -0.816 . . . . 0.0 110.154 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -155.01 -170.91 3.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.185 2.194 . . . . 0.0 107.327 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -150.19 171.63 16.61 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.903 0.881 . . . . 0.0 110.179 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.7 m -138.1 178.09 7.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.567 1.547 . . . . 0.0 110.212 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.5 m -127.92 8.77 6.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.88 31.73 0.37 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.404 1.081 . . . . 0.0 111.732 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.84 168.06 8.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.789 1.236 . . . . 0.0 110.589 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.8 m -62.99 -28.85 70.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.391 1.076 . . . . 0.0 112.422 -177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -64.04 -30.07 71.17 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.756 -0.59 . . . . 0.0 111.357 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -79.3 -6.59 57.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.567 0.747 . . . . 0.0 112.092 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.542 -1.144 . . . . 0.0 110.251 177.187 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.423 0.154 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -142.41 37.55 1.52 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.72 1.208 . . . . 0.0 110.348 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.94 115.2 17.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -107.55 127.83 53.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.47 1.108 . . . . 0.0 109.784 -169.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.44 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.7 mp0 -144.39 -173.79 4.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.664 1.586 . . . . 0.0 109.257 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.4 mt -51.51 143.71 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.68 22.11 12.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.27 1.828 . . . . 0.0 113.422 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -130.13 169.57 15.16 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.345 1.058 . . . . 0.0 108.83 171.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.4 146.3 53.34 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.779 2.032 . . . . 0.0 112.689 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.29 171.88 5.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 0.0 107.915 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.7 mt -109.82 124.4 51.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 138.97 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.145 0.978 . . . . 0.0 108.649 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.9 m -69.09 134.87 49.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -109.73 156.95 19.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.282 1.433 . . . . 0.0 108.442 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -58.64 -19.78 41.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.503 1.121 . . . . 0.0 112.863 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.57 -50.19 70.74 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.103 0.961 . . . . 0.0 112.461 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -170.68 -67.5 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.94 0.496 . . . . 0.0 111.845 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -155.26 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.732 1.613 . . . . 0.0 109.675 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -51.81 139.08 22.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.897 2.079 . . . . 0.0 115.78 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -142.87 157.34 61.49 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 128.914 2.885 . . . . 0.0 105.582 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.73 145.73 64.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 120.985 1.124 . . . . 0.0 111.092 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.04 164.52 37.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.449 1.5 . . . . 0.0 109.356 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -97.63 132.16 43.54 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.381 1.473 . . . . 0.0 107.789 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.62 138.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 p -115.07 -32.34 5.75 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.249 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 164.86 36.63 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.572 1.078 . . . . 0.0 110.465 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.59 141.65 32.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.27 113.97 13.24 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.7 -19.67 59.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.322 0.649 . . . . 0.0 112.517 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.22 -30.47 38.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.064 0.946 . . . . 0.0 112.421 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.57 22.56 0.61 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.399 1.0 . . . . 0.0 112.743 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.4 p -131.85 169.64 15.97 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.059 1.429 . . . . 0.0 110.589 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -144.37 153.0 41.5 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.496 1.918 . . . . 0.0 107.215 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -130.8 134.07 46.53 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 170.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.12 155.26 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -118.48 125.93 50.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.668 1.587 . . . . 0.0 107.003 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.76 151.69 27.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -65.83 -22.76 66.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.67 -27.49 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.141 0.577 . . . . 0.0 112.196 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.7 -17.74 5.21 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.882 1.23 . . . . 0.0 113.09 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.13 146.07 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.232 1.013 . . . . 0.0 109.478 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.03 144.65 36.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.16 154.3 38.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.188 0.595 . . . . 0.0 110.851 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -108.37 130.23 55.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.79 175.84 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.377 1.471 . . . . 0.0 108.758 -169.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -97.53 168.39 10.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.008 -1.058 . . . . 0.0 110.543 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.53 -39.03 67.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.432 0.693 . . . . 0.0 111.086 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.79 -6.61 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -114.3 -7.67 12.93 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 112.622 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.5 140.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 120.283 1.401 . . . . 0.0 111.71 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -149.42 174.24 12.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.088 0.955 . . . . 0.0 109.958 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.21 168.75 0.67 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.453 1.101 . . . . 0.0 111.265 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -63.13 -20.6 65.52 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.551 -0.718 . . . . 0.0 110.743 169.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.8 m -62.38 123.73 19.03 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.161 0.984 . . . . 0.0 110.561 170.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -60.68 -40.36 91.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.823 0.849 . . . . 0.0 112.128 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.96 -67.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -150.61 168.04 25.5 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.028 0.931 . . . . 0.0 111.049 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.23 156.72 38.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.204 1.402 . . . . 0.0 110.782 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -139.75 24.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.958 0.903 . . . . 0.0 111.44 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.44 -60.66 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 120.603 -1.311 . . . . 0.0 109.93 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.33 -34.38 85.08 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -136.39 163.28 30.83 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.972 2.109 . . . . 0.0 105.779 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.73 18.11 9.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 114.137 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -79.57 -18.11 52.44 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.467 -0.777 . . . . 0.0 112.714 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.75 175.79 51.5 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 119.465 1.03 . . . . 0.0 113.114 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.8 m -149.98 163.77 37.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 107.761 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -61.45 132.04 52.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.477 -0.764 . . . . 0.0 111.279 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.21 -172.46 3.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.551 1.94 . . . . 0.0 108.355 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -146.42 168.72 20.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.538 1.135 . . . . 0.0 110.189 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 15.5 m -135.5 161.96 34.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.894 1.278 . . . . 0.0 109.171 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 p -106.39 -25.98 11.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -73.81 129.12 37.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 109.295 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.65 174.37 15.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.871 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . 0.44 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.0 m -66.26 -16.64 64.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 113.826 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -129.74 12.32 5.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.289 1.036 . . . . 0.0 113.075 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.73 144.73 56.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 173.914 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m 58.08 51.82 8.33 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.483 1.513 . . . . 0.0 112.373 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -98.02 13.13 31.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.822 1.249 . . . . 0.0 112.727 -170.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 72.79 71.49 0.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.212 1.805 . . . . 0.0 113.65 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -121.95 -174.29 2.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.742 1.617 . . . . 0.0 109.616 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.51 142.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 60.81 24.14 14.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.723 1.609 . . . . 0.0 113.185 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.27 169.78 13.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.676 1.191 . . . . 0.0 108.137 170.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.74 155.12 40.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.853 0.861 . . . . 0.0 112.603 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.32 164.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.275 2.23 . . . . 0.0 107.902 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.56 128.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.15 141.03 46.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 108.84 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.0 m -69.62 117.53 11.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.21 0.604 . . . . 0.0 109.684 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -84.21 162.56 20.14 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.722 1.209 . . . . 0.0 109.403 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -55.65 -20.12 12.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.071 1.348 . . . . 0.0 112.987 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.35 -51.88 18.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.356 1.463 . . . . 0.0 112.048 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m 161.66 -46.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.74 2.816 . . . . 0.0 111.252 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.38 -168.0 2.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.056 0.844 . . . . 0.0 113.027 -169.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -54.31 141.77 28.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.083 2.153 . . . . 0.0 116.367 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -149.7 160.26 34.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 130.085 3.354 . . . . 0.0 105.168 168.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.16 147.3 66.44 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.489 1.459 . . . . 0.0 110.937 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.43 162.96 40.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.642 1.977 . . . . 0.0 108.952 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -91.47 133.66 35.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.174 1.39 . . . . 0.0 107.578 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.97 134.46 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -111.39 -31.94 6.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.698 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.57 160.74 43.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.592 1.087 . . . . 0.0 110.446 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.3 140.1 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 170.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -132.33 111.95 11.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -62.19 -16.35 52.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.728 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -53.47 -31.46 45.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.732 0.813 . . . . 0.0 112.071 169.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.19 18.18 0.75 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.837 1.208 . . . . 0.0 112.722 174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.1 p -129.41 172.16 11.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.735 1.267 . . . . 0.0 110.256 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -145.98 154.79 42.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.692 1.997 . . . . 0.0 107.178 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -133.0 133.65 43.41 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.87 157.78 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -122.98 124.67 43.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.225 1.41 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -80.09 149.64 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -65.54 -25.37 67.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.32 -25.65 66.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.318 0.647 . . . . 0.0 112.153 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.99 3.94 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.449 1.023 . . . . 0.0 113.766 171.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.61 144.99 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.204 1.002 . . . . 0.0 109.437 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.91 143.95 39.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -149.41 155.03 39.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.826 0.451 . . . . 0.0 110.826 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 128.84 55.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 m -147.44 178.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.133 1.373 . . . . 0.0 109.183 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.3 169.06 10.03 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.229 -0.919 . . . . 0.0 110.837 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -55.55 -38.58 69.49 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.043 0.537 . . . . 0.0 111.042 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.37 -6.32 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.979 -1.076 . . . . 0.0 113.532 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -115.48 -8.5 12.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 112.453 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.5 139.63 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 120.377 1.444 . . . . 0.0 110.932 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.02 172.7 14.32 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.992 0.917 . . . . 0.0 110.012 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 166.39 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 111.18 172.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -67.11 -11.44 57.2 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.406 -0.809 . . . . 0.0 111.118 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 121.29 13.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 109.299 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.65 -44.5 90.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.547 0.739 . . . . 0.0 110.848 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -57.39 -61.29 2.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.263 1.425 . . . . 0.0 113.578 -169.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -154.87 164.77 38.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.217 1.407 . . . . 0.0 108.373 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.19 171.34 13.15 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.97 -69.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.644 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.33 -19.98 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 121.085 1.766 . . . . 0.0 114.356 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.02 19.56 29.91 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.404 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -152.84 -41.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.907 1.354 . . . . 0.0 113.381 -170.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 60.01 8.86 1.57 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.077 2.551 . . . . 0.0 116.651 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -108.09 -23.67 11.88 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.069 1.304 . . . . 0.0 111.12 173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.81 171.72 25.92 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 122.124 0.847 . . . . 0.0 113.055 174.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.5 m -146.38 159.67 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.876 1.671 . . . . 0.0 109.015 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.95 130.42 45.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.07 -168.54 3.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.317 1.847 . . . . 0.0 107.415 170.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -146.13 167.28 23.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.968 0.907 . . . . 0.0 109.875 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 20.4 m -136.8 -178.05 5.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.67 1.188 . . . . 0.0 111.047 -170.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 10.7 m -132.64 6.87 4.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -76.41 28.53 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.617 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 77.5 mt -62.32 149.54 41.85 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . 0.413 ' SG ' ' HM1' ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 15.2 m 77.3 -26.79 0.18 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.72 2.808 . . . . 0.0 112.115 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -63.13 -46.31 87.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -82.8 147.77 28.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.398 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -178.735 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -138.6 18.11 2.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.167 0.987 . . . . 0.0 111.234 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.14 109.86 7.55 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -109.46 126.53 53.59 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.623 1.169 . . . . 0.0 109.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.4 mp0 -140.15 -174.03 3.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.686 1.594 . . . . 0.0 108.564 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -47.94 140.97 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.174 0.99 . . . . 0.0 108.504 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 59.5 25.66 14.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.5 1.92 . . . . 0.0 112.926 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.419 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -136.04 162.4 33.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.247 1.019 . . . . 0.0 108.976 172.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -65.41 146.21 55.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.588 2.355 . . . . 0.0 113.903 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.84 171.99 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 127.558 2.343 . . . . 0.0 108.487 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.49 124.06 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.68 141.61 47.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.895 0.878 . . . . 0.0 109.069 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 m -69.05 103.77 1.95 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -69.42 155.15 40.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.2 m -58.22 -20.79 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 112.383 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -58.74 -48.91 79.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.296 1.038 . . . . 0.0 113.07 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 p -168.83 -71.61 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -161.62 1.38 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.388 1.875 . . . . 0.0 109.348 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -51.57 136.15 26.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.9 161.61 42.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 129.377 3.071 . . . . 0.0 104.654 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.18 147.22 59.69 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.955 1.77 . . . . 0.0 111.007 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.7 169.22 25.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.858 2.463 . . . . 0.0 107.132 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.07 146.35 41.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.55 1.068 . . . . 0.0 109.735 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.5 142.45 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.021 0.928 . . . . 0.0 108.555 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 p -119.11 -28.64 5.43 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.809 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.93 158.99 43.92 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 119.523 1.056 . . . . 0.0 110.087 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.5 143.05 38.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -134.08 116.74 15.81 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.35 -19.75 62.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.341 0.656 . . . . 0.0 112.409 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.84 -30.51 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.889 0.876 . . . . 0.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.96 23.54 0.77 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.537 1.065 . . . . 0.0 112.691 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.4 p -131.66 169.34 16.3 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.442 1.621 . . . . 0.0 110.46 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.41 150.99 37.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.387 1.875 . . . . 0.0 108.053 -169.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 m -130.59 134.41 46.97 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.05 156.84 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -119.98 127.04 52.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.28 146.4 26.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -60.91 -25.86 67.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -169.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.33 -29.34 70.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.979 0.512 . . . . 0.0 112.195 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.02 -19.07 3.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.47 1.033 . . . . 0.0 113.148 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.45 141.31 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.319 1.047 . . . . 0.0 109.643 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.92 142.3 43.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.01 157.85 39.69 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.895 0.478 . . . . 0.0 110.793 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 84.7 m -106.64 136.66 46.04 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.28 179.97 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.707 2.003 . . . . 0.0 108.375 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.06 168.13 10.46 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.51 -39.05 67.21 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.808 0.843 . . . . 0.0 111.272 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.48 -9.79 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -110.44 -7.24 14.79 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.05 0.94 . . . . 0.0 112.677 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 t -141.95 142.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.873 1.215 . . . . 0.0 111.081 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -148.61 179.03 8.13 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.034 0.934 . . . . 0.0 109.543 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.26 166.62 0.8 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.692 1.197 . . . . 0.0 110.833 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.29 -28.58 69.82 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.492 169.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -64.1 118.37 8.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.746 0.819 . . . . 0.0 109.154 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.21 -24.47 67.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.67 -62.42 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -154.39 167.07 31.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.92 1.288 . . . . 0.0 109.864 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.13 165.96 24.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.806 0.842 . . . . 0.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.6 mt -129.11 -14.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 117.788 -1.101 . . . . 0.0 111.867 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.01 -28.88 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 121.413 1.915 . . . . 0.0 114.018 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.15 -44.64 97.88 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -159.06 121.44 3.54 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.9 104.62 5.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -169.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -137.27 -30.67 0.84 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -171.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -91.95 -174.56 42.52 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.953 0.797 . . . . 0.0 114.168 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 80.4 p -153.31 170.99 19.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.659 1.984 . . . . 0.0 108.152 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -58.04 124.7 20.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.381 0.992 . . . . 0.0 111.526 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -158.53 -172.22 3.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.941 1.696 . . . . 0.0 109.001 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -155.19 -177.77 6.77 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.129 1.771 . . . . 0.0 109.254 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 90.0 p -144.43 -179.07 6.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.229 1.011 . . . . 0.0 110.094 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 m -110.67 4.2 19.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.849 0.86 . . . . 0.0 112.674 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.84 40.62 0.47 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.509 1.123 . . . . 0.0 110.76 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.7 38.98 0.16 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.388 2.275 . . . . 0.0 112.764 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . 0.401 HM1B ' SG ' ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.2 m -118.87 27.34 8.94 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 109.066 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.74 -52.46 0.43 Allowed 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.854 1.261 . . . . 0.0 111.187 -170.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -69.21 -28.81 66.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.646 0.657 . . . . 0.0 110.286 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 172.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.462 0.172 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -59.81 149.7 30.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.534 1.133 . . . . 0.0 111.119 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -137.69 -7.53 1.67 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.302 1.441 . . . . 0.0 112.0 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 55.56 37.86 29.43 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.274 1.829 . . . . 0.0 112.521 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.69 -174.4 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.407 1.083 . . . . 0.0 109.921 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.9 143.12 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 61.84 19.01 10.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.127 1.771 . . . . 0.0 113.401 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -125.16 171.56 10.22 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -83.42 159.24 21.83 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.42 167.71 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 126.641 1.977 . . . . 0.0 108.12 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.3 mt -94.97 133.57 38.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.72 142.92 34.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.802 0.841 . . . . 0.0 109.392 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -69.54 109.65 4.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.744 0.818 . . . . 0.0 109.549 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -79.25 159.51 27.26 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -57.86 -19.64 30.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.359 1.463 . . . . 0.0 113.05 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -49.62 -57.45 7.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.902 1.281 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 m 171.27 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 112.375 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.19 -167.62 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.871 0.76 . . . . 0.0 113.012 -169.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -64.9 141.78 58.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.584 1.154 . . . . 0.0 114.07 -169.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.45 157.83 51.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 128.776 2.83 . . . . 0.0 105.138 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.87 149.3 72.29 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.571 1.514 . . . . 0.0 111.046 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.03 158.46 40.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.886 2.074 . . . . 0.0 108.627 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.5 135.33 33.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.03 134.47 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -111.86 -30.33 7.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.423 0.689 . . . . 0.0 110.448 172.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.31 161.73 42.18 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.624 1.102 . . . . 0.0 110.612 169.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.42 141.29 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -127.86 132.87 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.68 -26.01 63.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.947 0.899 . . . . 0.0 112.174 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.94 -24.9 62.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.923 0.889 . . . . 0.0 112.743 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.95 19.13 4.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.75 1.166 . . . . 0.0 112.628 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -120.76 167.93 11.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.297 1.049 . . . . 0.0 110.253 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -140.8 152.79 45.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.815 2.046 . . . . 0.0 107.543 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.4 m -130.47 130.9 44.82 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 169.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.87 153.0 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -120.21 119.7 33.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.312 1.445 . . . . 0.0 107.299 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.43 146.88 38.32 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -64.86 -21.13 66.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 112.935 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.86 -18.63 64.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.812 0.845 . . . . 0.0 112.382 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.41 47.83 1.49 Allowed Glycine 0 C--N 1.342 0.877 0 C-N-CA 124.324 0.964 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.9 t -134.63 142.73 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -132.51 144.71 36.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -150.1 158.46 44.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 110.406 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -109.78 130.36 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.2 -178.54 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.401 1.48 . . . . 0.0 109.832 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -105.69 169.54 8.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.796 1.238 . . . . 0.0 111.051 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -55.17 -38.07 67.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.215 0.606 . . . . 0.0 111.195 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.52 -5.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -117.85 -10.45 10.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.424 1.09 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.46 139.61 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.92 1.236 . . . . 0.0 111.216 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -149.94 169.69 20.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.604 0.762 . . . . 0.0 109.936 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.91 165.33 0.65 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.262 1.025 . . . . 0.0 111.588 172.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.93 -13.34 59.56 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.618 -0.676 . . . . 0.0 111.233 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.7 m -63.04 116.16 5.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.531 1.132 . . . . 0.0 109.332 169.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -58.29 -46.06 86.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.787 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.95 -52.14 46.61 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -151.31 160.84 43.58 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.985 0.914 . . . . 0.0 110.422 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -76.1 171.15 14.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.692 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.9 mm -119.57 -16.67 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.446 1.099 . . . . 0.0 111.049 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.88 -168.05 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 120.167 1.349 . . . . 0.0 108.808 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.63 -37.57 2.93 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.448 -1.408 . . . . 0.0 112.777 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -148.02 -46.17 0.16 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.925 0.89 . . . . 0.0 110.145 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.27 25.22 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.25 0.547 . . . . 0.0 112.16 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.34 169.85 9.92 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.841 1.257 . . . . 0.0 109.095 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -161.44 -144.95 4.15 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.954 1.74 . . . . 0.0 109.088 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 t -139.4 149.16 43.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.179 0.992 . . . . 0.0 108.933 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -68.53 140.64 55.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.873 0.469 . . . . 0.0 110.423 -170.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.27 -165.28 2.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.169 1.787 . . . . 0.0 107.316 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -145.6 165.95 27.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.011 0.925 . . . . 0.0 109.729 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 27.8 m -133.84 -173.84 3.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.626 1.17 . . . . 0.0 110.408 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.1 m -132.79 6.47 4.0 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -75.8 22.56 0.14 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.279 1.432 . . . . 0.0 113.208 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.77 145.74 39.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.93 0.892 . . . . 0.0 109.456 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 5.7 p -65.58 -27.91 68.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.938 0.895 . . . . 0.0 112.311 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -79.63 -4.67 52.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.491 1.117 . . . . 0.0 112.929 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -133.15 172.94 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.586 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.365 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.36 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.5 m -142.08 152.96 43.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.696 1.199 . . . . 0.0 109.366 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.45 -1.34 6.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.576 0.75 . . . . 0.0 112.365 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 57.03 55.0 6.4 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.286 1.834 . . . . 0.0 115.124 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.01 -173.75 4.89 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.534 0.683 . . . . 0.0 111.992 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.76 143.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 62.11 17.93 9.58 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.158 1.783 . . . . 0.0 113.291 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.66 173.72 6.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.233 1.013 . . . . 0.0 108.421 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -76.32 158.84 31.11 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.808 -0.557 . . . . 0.0 111.307 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.93 175.16 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.861 2.064 . . . . 0.0 108.226 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.5 mt -115.29 123.54 49.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.74 46.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.295 1.038 . . . . 0.0 108.934 -172.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.3 m -69.52 116.07 9.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -81.83 159.11 23.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.422 0.689 . . . . 0.0 109.314 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m -57.73 -20.82 37.21 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.887 1.275 . . . . 0.0 112.637 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.06 -49.76 75.79 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.178 0.591 . . . . 0.0 111.752 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.94 -65.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.084 0.554 . . . . 0.0 112.111 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 -160.86 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 110.909 -170.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -52.64 139.11 26.83 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -146.02 158.79 48.04 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.499 3.12 . . . . 0.0 105.175 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.88 148.37 64.17 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.627 1.551 . . . . 0.0 110.717 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.08 167.52 30.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.5 135.56 41.74 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.351 1.461 . . . . 0.0 108.083 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 138.94 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -117.44 -32.83 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.211 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.63 162.08 41.72 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.887 1.222 . . . . 0.0 110.315 168.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.7 134.21 45.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -129.4 115.42 17.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -169.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.43 -21.42 59.97 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.733 0.813 . . . . 0.0 112.466 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.36 -29.89 36.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 112.725 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.6 17.02 1.41 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.813 1.197 . . . . 0.0 112.756 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.1 p -127.19 169.03 13.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.861 1.33 . . . . 0.0 109.645 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.75 149.41 31.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 m -132.22 136.18 46.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.85 161.68 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -122.29 124.74 44.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -80.86 150.67 29.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.24 -23.61 66.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.152 0.581 . . . . 0.0 112.092 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.83 -15.18 5.96 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.234 1.397 . . . . 0.0 113.262 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.78 145.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 118.466 1.133 . . . . 0.0 109.266 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.21 144.21 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -149.75 156.44 41.86 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.913 0.485 . . . . 0.0 111.02 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -114.37 130.8 56.7 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.86 179.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.987 1.715 . . . . 0.0 108.346 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -85.89 164.73 17.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.793 -1.192 . . . . 0.0 110.054 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -54.44 -40.55 68.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.719 0.808 . . . . 0.0 110.827 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.2 pt -60.39 -16.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -97.55 -4.5 37.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.204 0.911 . . . . 0.0 112.684 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.1 146.91 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.758 1.163 . . . . 0.0 111.481 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -151.53 173.37 14.69 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.37 1.068 . . . . 0.0 108.68 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.28 169.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.879 1.272 . . . . 0.0 110.943 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -68.8 2.26 2.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.096 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 m -63.21 142.41 58.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.831 -1.168 . . . . 0.0 109.838 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -66.47 -55.59 14.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.855 0.462 . . . . 0.0 110.647 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.58 -66.94 0.56 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -146.44 -178.94 6.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 0.0 111.209 -169.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -73.17 171.26 13.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.444 1.498 . . . . 0.0 111.714 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -131.72 -19.73 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 125.455 1.502 . . . . 0.0 111.156 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.59 -38.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.803 -1.185 . . . . 0.0 111.996 -170.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.06 -49.14 42.73 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -161.24 117.12 2.16 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.31 128.2 35.39 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.467 0.576 . . . . 0.0 112.412 -169.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -146.9 -19.85 0.41 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.962 1.305 . . . . 0.0 113.149 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.65 165.6 36.6 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 119.745 1.157 . . . . 0.0 112.754 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 72.0 p -147.43 -17.39 0.38 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -152.53 146.43 25.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.814 1.188 . . . . 0.0 108.684 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.85 152.38 36.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.791 0.837 . . . . 0.0 111.18 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -78.27 172.95 12.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.776 0.831 . . . . 0.0 110.794 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 4.0 p -149.66 8.2 0.67 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.526 1.13 . . . . 0.0 112.455 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 m -141.21 -178.71 5.72 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.087 0.955 . . . . 0.0 110.387 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 24.5 m80 58.88 27.97 16.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.58 1.552 . . . . 0.0 113.511 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 70.7 mt -71.12 158.5 36.35 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . 0.411 ' SG ' ' HM1' ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 16.9 m 72.07 -28.05 0.18 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.483 2.713 . . . . 0.0 113.65 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.34 -23.96 66.12 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.035 -1.041 . . . . 0.0 111.571 170.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.34 -17.74 64.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.499 -0.763 . . . . 0.0 112.826 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.486 -1.175 . . . . 0.0 110.587 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m -134.4 33.09 3.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.453 0.701 . . . . 0.0 111.441 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 61.86 -40.85 0.14 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.837 3.255 . . . . 0.0 119.287 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.11 24.07 5.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -88.74 -173.02 3.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.151 0.98 . . . . 0.0 110.039 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.2 mt -50.81 141.18 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.326 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.77 25.18 15.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.277 1.831 . . . . 0.0 113.206 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.89 168.96 18.56 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.187 0.995 . . . . 0.0 110.067 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.23 145.6 55.71 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.849 2.059 . . . . 0.0 113.638 -171.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.63 160.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 128.113 2.565 . . . . 0.0 107.88 169.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.5 mt -97.49 122.83 41.0 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 143.19 42.65 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.566 0.746 . . . . 0.0 109.049 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.9 m -68.66 105.73 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -68.87 157.62 36.2 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 m -58.94 -16.35 17.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.403 1.081 . . . . 0.0 112.544 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.18 -57.48 9.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.795 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.6 p 170.02 -38.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.404 1.882 . . . . 0.0 113.991 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -173.46 3.95 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.38 0.991 . . . . 0.0 112.807 -169.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.35 141.08 58.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 113.329 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.6 161.39 49.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 128.732 2.813 . . . . 0.0 104.737 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.72 146.68 61.16 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 120.22 1.114 . . . . 0.0 110.186 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.76 165.86 34.69 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.809 2.044 . . . . 0.0 108.453 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -102.36 132.4 48.37 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.648 1.179 . . . . 0.0 107.878 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.74 139.8 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -114.45 -33.69 5.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.72 160.27 43.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.596 1.089 . . . . 0.0 110.344 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.6 t -133.0 145.56 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -131.96 120.22 22.18 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -59.48 -23.4 62.72 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.001 0.921 . . . . 0.0 112.804 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.69 -30.46 61.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.921 0.889 . . . . 0.0 112.386 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.91 24.67 0.79 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.465 1.031 . . . . 0.0 112.952 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.1 p -130.86 170.36 14.51 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.748 1.274 . . . . 0.0 110.331 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -142.39 156.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.824 2.049 . . . . 0.0 108.246 -169.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.2 m -135.22 132.67 38.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.86 156.78 32.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -119.12 120.39 36.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -79.21 145.5 33.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -63.48 -24.98 68.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.21 -26.47 68.38 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.636 0.774 . . . . 0.0 112.125 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.46 -14.92 5.55 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.943 1.258 . . . . 0.0 113.327 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.89 143.9 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.574 1.187 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.29 139.28 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -155.72 155.89 33.92 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.969 0.507 . . . . 0.0 111.684 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -95.31 139.37 31.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.31 172.65 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.935 1.694 . . . . 0.0 108.684 -169.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -97.47 167.97 10.66 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.573 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -56.01 -36.79 68.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.29 0.636 . . . . 0.0 111.06 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 pt -64.17 -7.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.049 -1.032 . . . . 0.0 113.524 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -113.47 -9.2 13.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.316 1.046 . . . . 0.0 112.432 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.9 t -142.27 142.21 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.954 1.252 . . . . 0.0 111.644 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -147.09 172.2 14.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.188 1.395 . . . . 0.0 108.856 170.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 169.9 0.24 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.084 1.354 . . . . 0.0 110.842 169.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -65.8 -2.67 3.95 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.43 -0.794 . . . . 0.0 111.397 169.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.5 m -62.27 125.78 25.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.055 1.742 . . . . 0.0 108.997 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.25 -39.31 68.54 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.676 -0.64 . . . . 0.0 111.922 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.57 -60.95 1.96 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.813 0.278 . . . . 0.0 111.504 -169.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -152.64 172.75 16.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.766 1.626 . . . . 0.0 108.321 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -77.29 176.39 8.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.394 0.678 . . . . 0.0 112.373 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.7 mm -123.62 -62.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.615 1.566 . . . . 0.0 110.096 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.0 -32.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.482 1.037 . . . . 0.0 113.063 -169.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.87 -48.88 58.55 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -160.62 136.1 8.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.29 116.71 26.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.808 0.731 . . . . 0.0 112.596 -169.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -144.42 -18.47 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.306 169.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.96 161.81 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 120.113 1.324 . . . . 0.0 113.093 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 44.0 m -147.18 -21.33 0.4 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.89 139.92 31.0 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.631 1.559 . . . . 0.0 109.282 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.86 154.66 41.66 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.816 0.846 . . . . 0.0 110.845 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.73 165.7 21.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.414 0.686 . . . . 0.0 112.15 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 m -147.21 6.94 0.88 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.262 1.025 . . . . 0.0 113.279 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.2 m -135.68 174.89 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.536 1.062 . . . . 0.0 112.28 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 86.5 t60 55.06 -97.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.797 2.039 . . . . 0.0 111.114 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.5 mt 58.28 173.35 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.754 2.021 . . . . 0.0 111.977 -169.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 15.2 m 61.52 8.76 2.37 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.838 2.055 . . . . 0.0 114.151 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -144.0 13.21 1.65 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.305 1.442 . . . . 0.0 112.305 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -63.59 142.15 58.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 173.497 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.29 0.091 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 m -75.73 78.24 2.68 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.373 1.469 . . . . 0.0 110.967 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -148.57 137.48 21.59 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -120.76 134.94 55.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.065 1.746 . . . . 0.0 108.253 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -139.17 -174.43 3.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.091 1.357 . . . . 0.0 109.871 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.17 142.43 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.72 24.73 13.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.011 1.725 . . . . 0.0 112.864 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.39 168.18 18.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.232 1.013 . . . . 0.0 108.749 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -73.25 147.99 44.08 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.311 1.845 . . . . 0.0 113.893 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.27 165.68 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 127.448 2.299 . . . . 0.0 108.101 171.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -96.26 131.13 43.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.75 141.44 43.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -69.49 113.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.227 0.611 . . . . 0.0 109.706 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -77.8 157.92 29.75 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.985 0.914 . . . . 0.0 109.32 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 m -58.07 -20.39 39.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.175 0.99 . . . . 0.0 112.748 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.06 -49.53 76.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.054 0.542 . . . . 0.0 112.086 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.89 -66.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -161.79 1.41 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.736 1.215 . . . . 0.0 111.069 -170.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -53.73 141.09 27.61 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -147.23 158.3 44.51 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 129.564 3.145 . . . . 0.0 105.072 168.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 145.01 66.17 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.471 1.447 . . . . 0.0 110.607 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.49 166.0 32.45 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.511 1.925 . . . . 0.0 108.499 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -103.97 133.72 48.45 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.64 138.84 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -114.76 -32.01 5.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.306 0.642 . . . . 0.0 109.77 169.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.4 41.14 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.608 1.094 . . . . 0.0 110.385 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.2 t -136.43 139.31 45.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -132.04 110.36 10.67 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -61.61 -17.34 54.81 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.22 -31.82 45.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.942 0.897 . . . . 0.0 112.137 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.73 20.27 0.54 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.653 1.12 . . . . 0.0 112.928 173.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.3 p -131.65 171.57 13.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.122 1.461 . . . . 0.0 110.075 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 155.89 43.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.354 1.862 . . . . 0.0 107.759 -169.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -133.23 132.88 42.0 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.52 155.69 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.01 126.59 50.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.85 1.66 . . . . 0.0 107.356 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -82.93 154.71 24.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -60.58 -30.54 69.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.48 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -25.85 68.57 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.639 0.776 . . . . 0.0 112.364 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.07 -14.96 7.4 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.997 1.284 . . . . 0.0 113.116 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.55 144.43 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.494 1.147 . . . . 0.0 109.247 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.3 t -131.63 143.26 40.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.95 156.7 42.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.216 0.606 . . . . 0.0 110.84 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -109.35 129.15 55.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 169.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.24 177.91 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.197 1.399 . . . . 0.0 109.428 -169.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.66 169.15 9.47 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.245 -0.909 . . . . 0.0 110.677 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -54.64 -38.46 66.88 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.517 0.727 . . . . 0.0 111.325 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.0 pt -63.98 -7.89 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -113.67 -6.98 13.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.172 0.989 . . . . 0.0 112.576 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.6 t -142.11 140.47 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.054 1.297 . . . . 0.0 110.872 -175.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -145.94 174.3 11.38 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.822 0.849 . . . . 0.0 109.841 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.12 166.94 1.89 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -81.52 47.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 168.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.0 m -127.1 139.75 52.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 172.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -63.07 -41.77 99.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.001 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.82 -68.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -168.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -150.59 178.85 8.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.73 1.212 . . . . 0.0 111.022 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -75.89 159.1 31.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.11 1.764 . . . . 0.0 111.76 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -139.75 34.14 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.515 1.126 . . . . 0.0 110.976 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.0 p -154.16 -49.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 120.479 -1.388 . . . . 0.0 110.874 169.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.33 -32.03 71.84 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -146.1 165.78 28.08 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.75 51.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.136 1.335 . . . . 0.0 112.632 -168.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -120.05 -5.49 10.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.03 162.79 38.85 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 122.18 0.878 . . . . 0.0 115.01 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 t -164.27 171.46 14.87 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 127.272 2.229 . . . . 0.0 106.73 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 52.65 76.28 0.2 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.192 1.397 . . . . 0.0 109.124 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.0 25.92 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -158.45 161.79 37.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.768 1.167 . . . . 0.0 109.953 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 3.2 m -142.86 147.96 36.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.608 0.763 . . . . 0.0 109.994 -169.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.9 m -82.45 -7.52 59.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.986 0.914 . . . . 0.0 113.265 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.57 27.0 0.05 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.703 2.001 . . . . 0.0 114.267 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.82 146.54 49.3 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.043 -1.036 . . . . 0.0 109.825 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.0 m -67.42 -31.65 72.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.292 0.637 . . . . 0.0 111.577 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.48 -12.27 56.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.959 0.904 . . . . 0.0 112.674 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -66.37 146.74 54.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.152 0.887 . . . . 0.0 108.86 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 172.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m -139.22 32.53 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.255 1.022 . . . . 0.0 110.761 -169.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.64 64.69 0.77 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -53.3 111.47 0.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.38 2.272 . . . . 0.0 110.431 -173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.503 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 36.2 mt-30 -145.24 -175.35 4.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.356 2.262 . . . . 0.0 107.542 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.69 142.85 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.5 22.59 12.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.547 1.539 . . . . 0.0 113.307 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.2 tp10 -131.29 169.81 15.47 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -81.3 158.59 24.71 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.658 -0.651 . . . . 0.0 111.164 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.16 169.57 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 126.659 1.983 . . . . 0.0 107.969 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.39 122.72 44.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.2 139.26 46.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.533 1.133 . . . . 0.0 108.58 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.8 m -68.96 135.12 50.46 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.806 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -112.18 154.79 24.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.926 1.691 . . . . 0.0 108.148 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.8 m -58.38 -20.71 46.23 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.647 1.179 . . . . 0.0 113.009 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.84 -47.92 79.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.251 1.02 . . . . 0.0 112.791 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.6 p -168.11 -68.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.886 0.475 . . . . 0.0 111.907 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -156.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.351 1.861 . . . . 0.0 109.253 -169.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -46.56 138.08 6.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.504 2.322 . . . . 0.0 115.854 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -145.49 157.08 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.202 3.001 . . . . 0.0 105.313 169.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.02 145.73 56.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.48 1.454 . . . . 0.0 110.75 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.77 155.7 37.68 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.575 1.55 . . . . 0.0 109.176 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.08 134.89 35.37 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.6 133.16 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.069 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -110.41 -31.46 7.27 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.276 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.12 163.91 38.39 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.52 1.054 . . . . 0.0 110.714 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.32 140.9 39.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -131.21 115.48 16.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -172.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.21 -21.02 61.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.584 0.753 . . . . 0.0 112.624 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.86 -31.39 39.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.083 0.953 . . . . 0.0 112.449 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.23 23.37 0.68 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.447 1.022 . . . . 0.0 112.697 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 p -131.75 169.88 15.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.988 1.394 . . . . 0.0 110.48 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -143.16 152.62 41.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.5 1.92 . . . . 0.0 107.504 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -130.69 131.57 44.9 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 m -138.95 155.44 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -120.73 122.39 40.3 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.195 1.398 . . . . 0.0 107.453 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -77.93 148.34 34.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.6 -21.92 66.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.197 0.599 . . . . 0.0 112.525 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.77 -26.85 68.92 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.691 0.796 . . . . 0.0 112.305 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.2 5.91 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.052 1.311 . . . . 0.0 112.83 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.03 144.85 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.345 1.073 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.11 144.41 38.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.2 155.21 40.27 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.128 0.571 . . . . 0.0 110.658 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.8 129.28 55.38 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.56 176.56 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.245 1.418 . . . . 0.0 109.087 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.3 168.43 9.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 -170.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -55.35 -37.13 67.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.561 0.744 . . . . 0.0 110.957 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.0 pt -64.88 -7.09 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -115.37 -7.52 12.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.188 0.995 . . . . 0.0 112.511 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.08 141.04 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 119.758 1.163 . . . . 0.0 110.847 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -150.17 176.96 10.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.702 0.801 . . . . 0.0 109.968 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.52 168.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.635 1.174 . . . . 0.0 111.054 175.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -62.67 -21.6 65.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.055 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -62.45 120.51 11.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.926 0.891 . . . . 0.0 110.596 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.5 -40.59 79.02 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.154 0.982 . . . . 0.0 111.942 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.44 -64.52 0.84 Allowed 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -150.16 166.37 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.57 0.7 . . . . 0.0 112.628 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.84 153.25 36.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.271 1.829 . . . . 0.0 111.393 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -138.98 23.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.555 0.742 . . . . 0.0 112.08 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.72 -51.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 112.943 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.49 60.83 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.415 1.007 . . . . 0.0 111.93 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -150.99 60.21 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.27 126.06 24.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.01 17.85 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.548 1.139 . . . . 0.0 112.962 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -147.5 -169.33 14.73 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.237 0.926 . . . . 0.0 112.773 -170.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -146.59 170.9 15.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.887 1.275 . . . . 0.0 110.751 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -57.84 135.61 56.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.534 0.734 . . . . 0.0 111.598 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.72 -170.84 2.7 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.716 2.006 . . . . 0.0 108.23 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -151.43 173.67 14.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.851 1.261 . . . . 0.0 110.115 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 35.2 p -152.1 167.91 26.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.234 1.014 . . . . 0.0 109.821 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.4 m -79.61 -1.11 36.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.685 1.194 . . . . 0.0 113.409 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -72.97 89.68 1.44 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.979 0.912 . . . . 0.0 109.597 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.93 169.53 17.54 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.145 1.778 . . . . 0.0 108.535 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.0 m -62.79 -30.7 71.66 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.828 1.251 . . . . 0.0 113.757 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -81.52 60.79 4.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.723 0.809 . . . . 0.0 109.113 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -57.83 154.15 12.6 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 109.406 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 169.801 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.237 0.397 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -104.19 128.77 51.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.218 1.007 . . . . 0.0 110.159 -169.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.8 mp0 -144.45 -172.87 3.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.021 1.728 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.61 144.07 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 66.95 7.07 5.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.802 2.441 . . . . 0.0 114.101 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.3 tp10 -120.24 170.22 9.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 109.668 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.6 144.38 51.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.782 2.033 . . . . 0.0 113.058 -170.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.7 164.24 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 127.189 2.196 . . . . 0.0 108.543 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.07 127.69 42.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.18 47.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -68.8 104.89 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -66.82 154.37 41.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m -58.04 -20.29 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 112.424 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.39 -49.63 76.83 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.2 p -171.72 -68.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.15 -162.83 1.58 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.906 1.282 . . . . 0.0 110.808 -169.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -58.55 138.76 56.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -144.28 157.5 56.44 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 128.577 2.751 . . . . 0.0 104.71 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.53 146.96 75.84 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.302 1.335 . . . . 0.0 110.432 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.96 162.11 41.72 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.243 1.817 . . . . 0.0 108.622 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.64 129.72 42.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.57 1.548 . . . . 0.0 107.118 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.53 138.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.942 1.247 . . . . 0.0 107.97 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 p -118.03 -30.52 5.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.291 0.636 . . . . 0.0 110.572 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.2 164.3 37.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.468 1.031 . . . . 0.0 110.248 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.3 t -143.61 147.75 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -133.77 130.26 37.77 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -60.1 -22.97 63.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.149 0.979 . . . . 0.0 112.36 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -54.5 -30.47 53.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.842 0.857 . . . . 0.0 112.342 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.36 26.15 0.75 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.308 0.956 . . . . 0.0 113.024 172.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.2 p -129.4 165.74 20.95 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.807 1.303 . . . . 0.0 110.839 -171.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.48 145.91 37.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.411 2.284 . . . . 0.0 107.382 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.4 m -124.88 131.94 53.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 169.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.66 149.9 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -114.19 119.95 38.82 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.392 1.477 . . . . 0.0 107.021 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.91 140.76 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -63.0 -21.13 65.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.852 0.861 . . . . 0.0 112.986 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.87 -19.9 63.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.797 0.839 . . . . 0.0 112.178 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.86 46.72 1.16 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.83 1.205 . . . . 0.0 110.725 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.3 t -133.96 138.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.5 140.67 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.03 159.73 41.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.335 0.654 . . . . 0.0 110.64 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.1 m -107.76 136.41 47.55 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.55 -179.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.248 2.219 . . . . 0.0 108.379 -169.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.9 168.93 8.9 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.218 -0.926 . . . . 0.0 110.682 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -53.39 -40.21 64.86 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.361 0.664 . . . . 0.0 110.864 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.1 pt -63.61 -5.9 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -115.9 -7.58 11.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 112.636 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.8 t -142.65 139.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 120.076 1.307 . . . . 0.0 111.651 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -148.16 174.3 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 110.055 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.34 167.91 1.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.758 0.823 . . . . 0.0 110.875 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.15 -18.15 65.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.391 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.18 116.85 6.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -61.63 -31.02 71.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -69.28 -55.9 9.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -152.14 165.16 35.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.662 0.744 . . . . 0.0 112.988 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.74 156.15 38.18 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.192 1.397 . . . . 0.0 110.468 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.98 23.53 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.938 0.895 . . . . 0.0 111.256 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.9 -62.89 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 120.707 -1.246 . . . . 0.0 109.686 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.57 -27.91 72.88 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -141.28 165.99 26.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.35 22.74 7.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.642 1.11 . . . . 0.0 113.427 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -77.62 -21.26 52.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.362 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -79.15 175.65 55.01 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.308 0.949 . . . . 0.0 112.987 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.6 m -150.54 171.21 17.44 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.183 2.193 . . . . 0.0 107.949 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -60.15 120.21 9.32 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.66 -164.13 1.58 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.371 1.868 . . . . 0.0 107.655 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -148.18 -176.89 5.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 66.2 m -129.54 169.11 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.149 1.38 . . . . 0.0 111.031 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -127.89 17.65 6.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -168.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -138.71 134.78 34.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 C-N-CA 125.795 1.638 . . . . 0.0 109.629 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 8.5 m-85 46.32 38.31 5.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 128.5 2.72 . . . . 0.0 115.43 170.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -110.06 -173.05 2.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 108.12 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -49.23 138.8 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.687 0.795 . . . . 0.0 109.273 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 62.41 25.79 15.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.194 1.798 . . . . 0.0 113.18 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -135.57 167.27 21.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.887 1.275 . . . . 0.0 108.551 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -69.7 156.05 39.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.846 1.258 . . . . 0.0 113.364 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.88 162.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.826 2.45 . . . . 0.0 107.045 169.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 mt -96.07 127.68 42.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.71 44.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.625 0.77 . . . . 0.0 109.406 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -68.84 107.89 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.966 0.507 . . . . 0.0 110.0 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.23 163.91 23.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.341 1.056 . . . . 0.0 109.548 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -57.33 -18.08 15.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.294 1.038 . . . . 0.0 113.201 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -11.68 49.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.41 1.484 . . . . 0.0 113.487 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.5 m 92.54 17.83 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.5 2.72 . . . . 0.0 114.988 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.56 8.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.007 0.821 . . . . 0.0 110.762 169.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -70.76 141.56 51.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.62 160.74 43.55 Favored Pre-proline 0 C--O 1.241 0.634 0 C-N-CA 128.337 2.655 . . . . 0.0 105.529 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.69 147.52 69.82 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.401 1.4 . . . . 0.0 111.039 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.41 161.07 43.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.177 1.791 . . . . 0.0 108.459 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -91.83 131.29 37.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.513 1.525 . . . . 0.0 107.814 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.6 134.16 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.7 p -112.02 -31.52 6.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.445 0.698 . . . . 0.0 110.201 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 164.14 38.09 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.49 1.041 . . . . 0.0 110.418 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.65 142.92 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -130.99 119.24 21.78 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -61.31 -20.63 63.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.499 0.72 . . . . 0.0 112.74 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -52.7 -31.69 38.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.201 1.001 . . . . 0.0 112.42 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.54 25.3 0.51 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.373 0.987 . . . . 0.0 112.885 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.1 p -131.35 169.05 16.53 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.073 1.437 . . . . 0.0 110.606 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -141.82 156.04 45.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.982 2.113 . . . . 0.0 108.104 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -134.2 132.32 39.6 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.03 155.78 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -119.46 123.39 43.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -82.57 151.06 26.57 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.63 -27.1 68.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.673 0.789 . . . . 0.0 112.648 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.05 -23.03 67.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.644 0.777 . . . . 0.0 112.074 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.23 -14.21 8.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.491 1.519 . . . . 0.0 113.108 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.28 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.351 1.075 . . . . 0.0 108.801 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.47 139.06 52.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -153.67 155.38 35.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 110.984 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 m -98.31 138.13 36.01 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.89 171.91 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.093 1.757 . . . . 0.0 108.777 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.3 167.75 10.22 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.35 -0.844 . . . . 0.0 110.403 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -55.08 -37.71 67.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.524 0.73 . . . . 0.0 111.341 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.9 pt -62.79 -10.82 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -109.52 -9.34 14.91 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.234 0.924 . . . . 0.0 112.735 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.05 141.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.733 1.152 . . . . 0.0 111.348 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -146.95 175.2 10.85 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.019 0.928 . . . . 0.0 110.18 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.69 168.09 1.83 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.388 1.075 . . . . 0.0 111.325 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -68.33 -14.79 63.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.818 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.0 m -62.17 120.48 10.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.222 0.919 . . . . 0.0 108.526 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -61.32 -35.75 78.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.2 -42.54 20.64 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -148.86 162.91 38.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.755 0.707 . . . . 0.0 111.961 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -76.73 167.37 21.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 110.214 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.6 mm -129.16 -19.1 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.464 1.505 . . . . 0.0 111.466 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.08 -35.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.412 1.46 . . . . 0.0 112.244 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.86 -30.37 63.01 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -149.77 150.81 32.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.46 64.59 3.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.051 1.341 . . . . 0.0 110.54 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -171.52 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.721 2.008 . . . . 0.0 109.565 -169.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 57.97 -168.11 5.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.09 1.805 . . . . 0.0 116.806 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.6 m -151.09 155.66 39.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.069 2.548 . . . . 0.0 107.045 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -66.08 122.02 16.46 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.03 -163.21 1.58 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.814 1.646 . . . . 0.0 108.472 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -144.9 -179.51 6.65 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 110.9 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 13.8 p -149.38 -178.61 6.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.769 2.028 . . . . 0.0 109.493 -174.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -130.21 6.13 4.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.1 35.87 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.101 1.36 . . . . 0.0 111.812 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 109.979 178.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--O 1.236 0.35 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.46 129.86 55.9 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.33 1.052 . . . . 0.0 110.929 -167.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.485 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.0 mp0 -142.84 -174.43 4.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.675 1.99 . . . . 0.0 108.48 -177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.88 143.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 60.06 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 112.959 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.5 tp10 -128.34 170.1 13.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.435 1.094 . . . . 0.0 108.263 171.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -77.28 155.59 31.96 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.758 -0.589 . . . . 0.0 112.102 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.45 167.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.551 1.94 . . . . 0.0 108.613 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.4 125.62 43.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.04 138.91 48.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 m -68.82 142.05 54.97 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.355 0.598 . . . . 0.0 110.901 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -119.03 154.93 32.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.765 1.626 . . . . 0.0 108.061 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -58.45 -19.8 39.69 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.64 1.176 . . . . 0.0 113.248 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.24 -47.63 80.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.151 0.981 . . . . 0.0 112.699 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.3 p -168.68 -68.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.896 0.478 . . . . 0.0 112.156 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -158.0 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.234 1.813 . . . . 0.0 109.303 -169.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -46.19 139.23 4.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.608 2.363 . . . . 0.0 115.66 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -145.77 157.51 51.09 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.5 3.12 . . . . 0.0 105.314 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.83 146.22 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.772 1.648 . . . . 0.0 110.869 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.64 162.68 41.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.912 1.685 . . . . 0.0 108.878 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -95.66 135.65 37.07 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.36 137.08 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 p -114.21 -30.88 6.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.279 0.632 . . . . 0.0 110.165 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.81 40.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.499 1.045 . . . . 0.0 110.303 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.36 140.55 41.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -131.06 118.49 20.63 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -59.05 -23.31 61.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.214 1.006 . . . . 0.0 112.475 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.26 -30.43 60.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.741 0.816 . . . . 0.0 112.491 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.17 23.75 0.82 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.567 1.079 . . . . 0.0 112.71 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.7 p -130.89 171.84 12.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.757 1.278 . . . . 0.0 110.382 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.27 154.19 42.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.657 1.983 . . . . 0.0 107.476 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -131.98 131.1 42.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.65 153.94 26.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.17 125.29 49.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.358 1.463 . . . . 0.0 107.332 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.11 151.3 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.45 -23.04 66.22 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.12 -25.0 65.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.971 0.508 . . . . 0.0 111.987 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.0 5.23 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.096 1.332 . . . . 0.0 113.188 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 146.93 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.397 1.098 . . . . 0.0 109.416 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.69 145.16 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -148.67 154.39 39.6 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.195 0.598 . . . . 0.0 110.864 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -107.57 130.74 54.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.29 175.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.335 1.454 . . . . 0.0 109.183 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.88 168.14 10.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.337 -0.852 . . . . 0.0 110.798 -171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.08 -39.85 66.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.046 0.538 . . . . 0.0 111.232 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.87 -8.18 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -113.21 -6.3 13.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.09 139.3 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.145 1.339 . . . . 0.0 111.341 -172.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -147.57 177.29 9.38 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.736 0.815 . . . . 0.0 110.25 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.64 167.23 3.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.135 0.974 . . . . 0.0 110.933 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -69.49 -17.68 63.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.078 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.9 m -63.16 124.44 21.17 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.11 -34.24 71.79 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.81 -68.96 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -149.24 167.78 25.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.093 0.957 . . . . 0.0 110.69 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.5 159.09 33.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 110.843 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -136.6 15.66 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.196 0.998 . . . . 0.0 111.401 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.06 -44.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 120.447 -1.408 . . . . 0.0 111.791 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.91 75.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.124 0.875 . . . . 0.0 110.941 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.97 165.48 31.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.067 2.547 . . . . 0.0 104.435 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.91 16.04 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.458 1.481 . . . . 0.0 114.031 -169.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -79.82 -18.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.899 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.69 179.8 43.48 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 119.153 0.888 . . . . 0.0 112.962 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.8 m -146.71 163.64 35.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.782 1.633 . . . . 0.0 108.698 -169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -64.5 113.71 3.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.16 -166.13 1.76 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.735 1.614 . . . . 0.0 108.67 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -148.23 -173.4 4.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.984 1.314 . . . . 0.0 109.821 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 24.3 p -151.12 176.85 10.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.101 1.761 . . . . 0.0 109.681 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -121.82 -1.61 9.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -71.81 119.04 15.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.433 1.493 . . . . 0.0 107.141 179.342 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -103.03 124.95 49.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.237 1.015 . . . . 0.0 109.819 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.408 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.4 mp0 -144.57 -173.28 4.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.528 1.531 . . . . 0.0 108.908 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.5 141.95 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 58.4 25.03 12.39 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.866 1.667 . . . . 0.0 113.438 -175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.0 tp10 -134.75 162.82 31.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.429 1.092 . . . . 0.0 108.395 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -65.44 150.09 48.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.628 2.371 . . . . 0.0 113.777 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.71 168.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 128.198 2.599 . . . . 0.0 107.961 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.25 127.17 46.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.36 138.45 41.63 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.739 0.816 . . . . 0.0 109.371 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 m -69.11 121.01 15.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 110.712 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -93.45 155.46 17.34 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.745 1.218 . . . . 0.0 108.652 174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -58.64 -20.89 51.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.749 1.22 . . . . 0.0 112.911 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.23 -46.35 83.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.328 1.051 . . . . 0.0 112.634 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -168.57 -68.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.189 0.45 . . . . 0.0 112.146 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.27 -157.79 0.74 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.187 1.795 . . . . 0.0 108.948 -170.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -46.25 138.85 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.615 1.966 . . . . 0.0 115.643 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -145.16 156.82 54.34 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 129.793 3.237 . . . . 0.0 103.988 168.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.57 145.57 52.8 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.449 1.433 . . . . 0.0 110.616 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.11 168.36 27.53 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.797 2.439 . . . . 0.0 107.152 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -110.45 147.92 33.1 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.982 1.265 . . . . 0.0 109.742 169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.35 140.78 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -115.67 -33.24 5.25 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.767 0.827 . . . . 0.0 109.179 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 163.89 38.58 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.166 0.986 . . . . 0.0 110.494 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.7 146.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -134.74 125.25 26.6 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.66 -23.75 63.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.673 0.789 . . . . 0.0 112.11 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.65 -27.65 58.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.552 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.5 21.6 2.2 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.563 1.077 . . . . 0.0 112.212 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 p -125.36 169.11 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.364 1.082 . . . . 0.0 110.02 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.72 153.5 41.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.444 1.898 . . . . 0.0 107.603 -168.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.8 m -132.16 136.16 46.87 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.55 158.59 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -123.89 126.94 47.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.98 154.69 26.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.16 -26.3 68.74 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.143 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.36 -18.85 5.74 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.831 1.205 . . . . 0.0 112.858 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.55 143.47 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 109.619 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.83 144.98 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -150.38 154.4 37.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.03 0.532 . . . . 0.0 110.635 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.44 129.18 55.27 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.91 179.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.536 1.534 . . . . 0.0 109.271 -169.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.95 167.23 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.095 -1.003 . . . . 0.0 110.529 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -54.36 -38.55 66.22 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.539 0.736 . . . . 0.0 110.882 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -63.26 -8.78 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -111.24 -8.03 14.4 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.005 0.922 . . . . 0.0 112.595 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.01 141.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 120.182 1.355 . . . . 0.0 110.992 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -150.12 173.43 13.9 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.421 0.688 . . . . 0.0 110.106 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.05 165.78 0.62 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.238 1.415 . . . . 0.0 111.039 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -67.27 -16.08 64.07 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.703 -0.623 . . . . 0.0 111.911 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 m -62.78 116.16 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.79 -32.98 72.3 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.46 -65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.723 0.809 . . . . 0.0 112.693 -169.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -152.75 162.67 40.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.268 1.427 . . . . 0.0 108.609 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -73.7 166.67 22.87 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.549 0.214 . . . . 0.0 111.027 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.34 -22.42 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.103 0.961 . . . . 0.0 110.954 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.81 -45.32 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 119.645 1.111 . . . . 0.0 110.906 -172.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.7 97.58 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -159.27 154.42 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.923 2.089 . . . . 0.0 105.42 169.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.19 58.37 2.03 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.983 0.913 . . . . 0.0 112.219 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -74.4 -44.73 50.7 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.435 -0.791 . . . . 0.0 110.717 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -94.82 -168.22 36.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.559 1.076 . . . . 0.0 111.731 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.4 t -147.73 177.55 9.21 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.324 1.45 . . . . 0.0 108.168 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -57.28 120.34 7.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.478 0.711 . . . . 0.0 110.469 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.91 -165.16 1.44 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.438 1.895 . . . . 0.0 107.416 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -147.85 -174.0 4.44 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.815 1.246 . . . . 0.0 109.663 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.8 t -145.76 174.12 11.5 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.042 1.337 . . . . 0.0 109.739 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 14.5 m -128.93 4.63 5.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.566 1.547 . . . . 0.0 111.523 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.93 42.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.508 1.123 . . . . 0.0 110.796 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 C--O 1.236 0.36 0 C-N-CA 124.838 1.255 . . . . 0.0 109.474 172.365 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.93 137.38 53.52 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.196 0.998 . . . . 0.0 109.898 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 6.0 mp0 -144.36 -173.98 4.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 109.186 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -53.36 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 61.68 22.33 12.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.495 1.918 . . . . 0.0 113.095 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -127.87 169.28 14.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.18 0.992 . . . . 0.0 108.904 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -68.04 146.96 53.02 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.353 1.461 . . . . 0.0 112.864 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.64 166.34 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.69 1.996 . . . . 0.0 108.085 169.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.53 124.06 47.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.47 140.45 41.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.173 0.989 . . . . 0.0 109.209 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -69.25 111.82 5.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.541 0.736 . . . . 0.0 109.871 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -82.41 152.73 26.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 m -58.46 -20.06 42.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.67 1.188 . . . . 0.0 112.841 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.15 -48.28 76.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.395 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 p -169.82 -67.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.498 0.59 . . . . 0.0 112.367 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.23 -158.12 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.033 1.333 . . . . 0.0 110.208 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -54.25 141.26 30.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.75 1.22 . . . . 0.0 113.254 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -140.75 159.3 63.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 129.174 2.99 . . . . 0.0 105.593 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.77 143.09 72.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.296 1.331 . . . . 0.0 110.262 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.52 165.39 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.99 1.716 . . . . 0.0 108.591 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.05 130.41 47.06 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.6 137.77 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 p -114.12 -30.86 6.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.454 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.49 163.35 39.73 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.174 0.99 . . . . 0.0 110.521 168.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.91 140.88 37.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -132.58 122.87 25.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -58.53 -25.03 62.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.078 0.951 . . . . 0.0 112.488 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -56.74 -28.74 61.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.95 0.9 . . . . 0.0 112.491 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 128.14 22.86 1.34 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.488 1.042 . . . . 0.0 112.677 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 p -127.53 168.51 14.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.633 1.216 . . . . 0.0 110.036 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.54 153.95 43.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.282 1.833 . . . . 0.0 107.465 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -132.04 134.37 45.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.44 158.36 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -122.01 128.99 52.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.641 1.576 . . . . 0.0 107.019 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -87.8 151.62 22.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -61.89 -25.94 67.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.53 -27.2 69.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.674 0.79 . . . . 0.0 112.309 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.07 -14.45 7.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.072 1.32 . . . . 0.0 113.178 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.44 143.96 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.521 1.16 . . . . 0.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.1 143.7 38.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.27 155.68 39.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.278 0.631 . . . . 0.0 110.893 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 m -108.38 130.26 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.61 -179.27 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.408 1.483 . . . . 0.0 109.474 -169.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -103.38 169.37 8.58 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.191 -0.943 . . . . 0.0 110.775 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.14 -37.38 66.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.838 -0.539 . . . . 0.0 111.25 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.68 -5.48 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.025 -1.047 . . . . 0.0 113.551 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -118.41 -10.23 10.2 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.358 1.063 . . . . 0.0 112.287 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.5 t -143.11 141.54 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.904 1.229 . . . . 0.0 111.331 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -147.89 179.15 7.94 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.88 0.872 . . . . 0.0 109.23 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.9 165.6 0.9 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.659 1.184 . . . . 0.0 110.989 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.82 -29.75 70.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.563 169.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.34 115.81 5.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.61 -23.33 67.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.98 -63.74 1.0 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.66 0.664 . . . . 0.0 112.385 -170.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -153.66 164.29 38.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.035 1.334 . . . . 0.0 109.339 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -75.42 157.57 33.93 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.396 1.079 . . . . 0.0 110.747 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.38 21.99 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.932 0.893 . . . . 0.0 111.722 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.74 -48.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.518 -1.364 . . . . 0.0 111.847 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.76 -34.17 88.02 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -146.07 160.92 41.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.7 67.89 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.825 1.193 . . . . 0.0 110.393 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -123.27 -22.06 5.21 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.24 -179.97 51.72 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.232 0.907 . . . . 0.0 113.671 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.4 m -150.81 166.14 31.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.258 2.623 . . . . 0.0 106.994 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -56.15 128.78 37.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.954 0.797 . . . . 0.0 111.725 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.71 -176.47 5.56 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.023 1.729 . . . . 0.0 108.581 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -155.74 179.11 9.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.613 1.565 . . . . 0.0 109.343 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 74.3 m -129.91 152.34 49.49 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.736 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 p -78.44 -31.47 48.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.523 1.129 . . . . 0.0 112.001 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -67.01 119.21 11.6 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 0.0 108.247 169.936 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 50.33 36.17 12.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.766 1.626 . . . . 0.0 114.102 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 -173.8 4.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.097 0.959 . . . . 0.0 110.521 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.1 143.51 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 60.3 22.58 12.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.235 1.814 . . . . 0.0 113.07 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -130.12 169.28 15.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.365 1.066 . . . . 0.0 108.47 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.92 150.62 48.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.646 1.978 . . . . 0.0 112.719 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.91 163.01 3.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.843 2.457 . . . . 0.0 107.909 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.59 124.4 40.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.652 -2.722 . . . . 0.0 103.652 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.58 137.89 49.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.1 m -68.77 144.78 54.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -123.51 154.92 38.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.975 1.71 . . . . 0.0 108.141 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.9 m -58.13 -20.5 40.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.673 1.189 . . . . 0.0 112.981 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.02 -48.04 79.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.115 0.966 . . . . 0.0 112.627 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.8 p -169.49 -67.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.128 0.571 . . . . 0.0 112.131 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.52 -157.59 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.042 1.737 . . . . 0.0 109.529 -169.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -47.09 140.71 4.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.0 2.12 . . . . 0.0 115.757 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -145.97 157.95 49.6 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 129.306 3.042 . . . . 0.0 105.399 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 144.46 56.8 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.177 1.918 . . . . 0.0 110.743 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.89 165.05 37.3 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.729 1.612 . . . . 0.0 109.247 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -98.98 130.87 45.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.774 1.63 . . . . 0.0 107.611 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.96 137.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.7 p -114.6 -32.61 5.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.321 0.648 . . . . 0.0 110.522 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.32 163.3 39.74 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.415 1.086 . . . . 0.0 110.27 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -138.0 142.47 35.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -129.54 118.89 22.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -61.58 -20.02 62.84 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.427 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.34 -31.62 54.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.915 0.886 . . . . 0.0 112.285 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.94 24.95 0.7 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.564 1.078 . . . . 0.0 112.697 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.3 p -130.83 169.05 16.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.371 1.585 . . . . 0.0 110.424 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -140.53 152.95 45.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.491 1.916 . . . . 0.0 107.636 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -130.8 131.56 44.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.22 155.14 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -118.52 127.8 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.747 1.619 . . . . 0.0 107.05 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -83.19 150.26 26.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -64.42 -24.24 67.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.47 -23.99 65.56 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.08 0.552 . . . . 0.0 112.345 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 131.47 -16.51 5.13 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.716 1.15 . . . . 0.0 113.607 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.59 147.21 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.413 1.107 . . . . 0.0 109.39 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -132.98 144.83 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.86 158.01 43.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.116 0.566 . . . . 0.0 110.739 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -111.8 130.82 55.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.49 176.7 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.192 1.397 . . . . 0.0 109.192 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.89 167.43 10.52 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.043 -1.036 . . . . 0.0 110.474 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.42 -39.6 67.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 0.0 111.135 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.81 -11.88 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -108.34 -5.24 16.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.855 0.862 . . . . 0.0 112.485 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.18 140.58 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.211 1.369 . . . . 0.0 111.858 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -148.37 177.83 9.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.32 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 168.68 1.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 110.51 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -68.43 -17.46 64.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.623 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 124.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.827 0.851 . . . . 0.0 109.191 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -60.17 -32.72 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.43 -61.62 2.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.852 1.261 . . . . 0.0 114.329 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -153.17 167.25 29.92 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.36 1.064 . . . . 0.0 110.535 -169.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -73.77 169.5 17.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.799 0.84 . . . . 0.0 109.302 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.5 mt -131.41 -13.81 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 111.323 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.01 -40.5 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.103 1.32 . . . . 0.0 111.854 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.29 -29.89 75.88 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -151.15 148.44 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.286 2.234 . . . . 0.0 105.313 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.4 -167.45 1.6 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.961 0.904 . . . . 0.0 110.325 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 77.73 -3.06 2.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.443 2.297 . . . . 0.0 114.503 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.35 179.25 53.49 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 119.123 0.874 . . . . 0.0 111.828 169.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.0 m -147.42 155.4 41.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.959 1.703 . . . . 0.0 108.397 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -66.61 131.07 45.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.22 -158.3 0.85 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.37 1.868 . . . . 0.0 107.063 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -144.17 -179.31 6.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.202 1.001 . . . . 0.0 109.87 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 44.9 m -142.07 155.7 45.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.048 1.339 . . . . 0.0 110.194 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 m -80.88 -24.32 38.41 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.72 122.32 17.39 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.211 0.605 . . . . 0.0 109.596 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 125.944 1.698 . . . . 0.0 107.561 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 56.9 35.34 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.954 1.702 . . . . 0.0 112.904 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -82.92 -173.77 4.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.441 1.096 . . . . 0.0 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.0 mt -50.6 142.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 60.62 21.89 11.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.309 1.844 . . . . 0.0 113.35 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -128.34 170.06 13.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.21 1.004 . . . . 0.0 109.136 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -70.46 149.43 47.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.63 1.172 . . . . 0.0 111.359 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.39 166.08 4.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 126.937 2.095 . . . . 0.0 108.324 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -100.73 124.3 46.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.26 138.9 48.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.0 m -69.28 144.87 53.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.474 0.654 . . . . 0.0 110.9 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -121.41 155.54 34.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.782 1.633 . . . . 0.0 107.991 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -58.24 -20.54 42.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.838 1.255 . . . . 0.0 112.994 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.65 -47.5 79.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.057 0.943 . . . . 0.0 112.48 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.4 p -169.13 -67.99 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.924 0.49 . . . . 0.0 112.238 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.21 -158.19 0.78 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.479 1.911 . . . . 0.0 109.047 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -43.96 137.99 3.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.944 2.498 . . . . 0.0 116.048 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -145.86 157.44 50.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.345 3.058 . . . . 0.0 104.943 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 145.14 48.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.912 1.741 . . . . 0.0 110.77 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.13 165.31 36.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.717 1.607 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -98.5 133.1 43.33 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.149 1.38 . . . . 0.0 107.73 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 136.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -113.73 -32.26 6.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.34 0.656 . . . . 0.0 110.306 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.01 38.1 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.604 1.093 . . . . 0.0 110.502 169.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -138.88 140.8 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -129.42 122.81 30.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.22 -21.2 61.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.772 0.829 . . . . 0.0 112.439 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.28 -29.72 61.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.25 23.93 1.09 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.68 1.133 . . . . 0.0 112.608 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 171.48 12.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.627 1.214 . . . . 0.0 110.609 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.99 154.3 43.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.863 2.065 . . . . 0.0 107.764 -169.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -132.23 132.19 42.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.81 154.82 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.88 125.63 50.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.476 1.51 . . . . 0.0 107.423 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.99 150.53 28.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -64.32 -23.64 67.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.08 -27.92 69.43 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.451 0.7 . . . . 0.0 112.068 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.54 -18.74 5.14 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.943 1.259 . . . . 0.0 113.066 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.36 146.3 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.199 1.0 . . . . 0.0 109.588 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.3 144.71 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.51 154.38 40.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.226 0.61 . . . . 0.0 110.276 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -107.46 131.87 53.82 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 169.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.09 175.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.421 1.488 . . . . 0.0 109.375 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -99.32 168.5 9.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.139 -0.975 . . . . 0.0 110.419 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -53.17 -42.38 66.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.728 0.411 . . . . 0.0 111.023 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.6 pt -60.97 -12.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -105.79 -6.31 19.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.548 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 t -141.76 139.4 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.723 1.601 . . . . 0.0 112.686 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -150.3 176.66 10.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.75 169.27 1.92 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -65.69 -16.29 63.61 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.857 -0.527 . . . . 0.0 111.071 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -62.14 119.17 8.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.203 1.401 . . . . 0.0 108.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -59.54 -30.79 68.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.64 -70.3 0.25 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -150.83 173.34 14.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.764 0.792 . . . . 0.0 111.731 -169.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -72.92 154.23 40.64 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.767 1.627 . . . . 0.0 110.888 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.8 mt -139.22 22.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-N 118.872 0.76 . . . . 0.0 111.852 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 -51.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 120.216 -1.553 . . . . 0.0 112.457 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -37.73 94.74 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.592 1.087 . . . . 0.0 111.654 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -152.26 76.1 1.15 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.9 134.09 56.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -150.23 -45.43 0.13 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.938 1.695 . . . . 0.0 110.756 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -90.25 -163.57 39.19 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 122.287 0.937 . . . . 0.0 112.873 -170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.0 m -146.77 146.53 30.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 106.583 -170.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -61.02 132.85 55.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 111.408 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.64 -152.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.695 1.998 . . . . 0.0 106.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -146.11 -175.86 4.93 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.175 0.99 . . . . 0.0 110.486 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 28.5 t -150.82 179.76 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.783 2.033 . . . . 0.0 108.143 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -124.59 0.15 8.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.15 1.38 . . . . 0.0 111.821 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -70.1 114.58 8.4 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 126.742 2.017 . . . . 0.0 106.714 179.134 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 51.31 39.82 24.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.412 2.285 . . . . 0.0 113.65 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -83.05 -174.17 5.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.317 1.047 . . . . 0.0 111.849 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.0 mt -53.49 143.86 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.237 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 64.63 -0.24 0.99 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.815 2.446 . . . . 0.0 114.04 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.75 172.04 8.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.755 1.162 . . . . 0.0 109.396 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -69.53 149.02 48.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.711 1.204 . . . . 0.0 110.884 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.94 171.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 127.278 2.231 . . . . 0.0 108.847 169.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.34 128.96 54.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 168.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.24 143.74 44.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 m -69.21 103.07 1.83 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -68.22 156.29 37.92 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -58.57 -19.47 38.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.402 1.081 . . . . 0.0 112.212 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.31 -51.57 69.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.124 0.97 . . . . 0.0 112.906 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 p -169.55 -74.66 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.48 -157.25 0.75 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.676 1.59 . . . . 0.0 109.808 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.63 135.9 46.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.725 1.61 . . . . 0.0 114.691 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.62 162.09 46.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 129.589 3.156 . . . . 0.0 105.375 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.67 146.0 77.59 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 121.724 1.616 . . . . 0.0 110.712 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.93 31.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.457 1.903 . . . . 0.0 109.03 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -102.2 134.26 45.75 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.6 1.56 . . . . 0.0 107.27 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.67 139.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.421 1.009 . . . . 0.0 108.324 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -116.05 -32.27 5.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.927 -0.559 . . . . 0.0 109.794 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.62 162.58 41.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.478 1.035 . . . . 0.0 110.165 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.5 t -137.42 138.26 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -130.49 117.84 20.22 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.28 -20.52 59.41 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.672 0.789 . . . . 0.0 112.763 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.57 -30.75 55.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.842 0.857 . . . . 0.0 112.285 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.26 23.11 0.85 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 124.675 1.131 . . . . 0.0 112.801 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -130.97 171.12 13.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.647 1.223 . . . . 0.0 110.166 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.2 156.26 43.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.795 2.038 . . . . 0.0 107.605 -169.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -134.99 133.53 39.57 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.23 155.64 23.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.98 129.59 55.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.697 1.599 . . . . 0.0 107.051 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -92.64 146.32 23.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -61.67 -21.07 64.11 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -169.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.04 -19.65 65.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.261 0.625 . . . . 0.0 112.288 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.45 46.24 1.34 Allowed Glycine 0 C--N 1.342 0.884 0 C-N-CA 124.184 0.897 . . . . 0.0 110.983 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.81 140.09 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.7 141.66 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.5 153.98 36.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.236 0.614 . . . . 0.0 110.655 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 m -100.05 135.94 40.71 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.3 176.93 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.978 1.711 . . . . 0.0 109.125 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.54 166.84 11.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.096 -1.003 . . . . 0.0 110.715 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -54.81 -38.48 67.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.824 0.849 . . . . 0.0 111.233 171.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.5 pt -61.73 -13.95 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.85 -7.66 19.25 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.253 0.933 . . . . 0.0 112.685 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.76 140.2 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 120.275 1.398 . . . . 0.0 111.173 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -149.07 175.42 11.35 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.259 1.024 . . . . 0.0 109.8 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.0 167.1 1.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.287 1.035 . . . . 0.0 110.931 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.4 -23.7 67.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.103 169.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.2 m -63.15 102.89 0.42 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.89 -24.78 66.23 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.72 -54.19 42.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.209 1.004 . . . . 0.0 112.516 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -154.91 157.63 38.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.45 1.1 . . . . 0.0 110.912 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -73.73 153.69 39.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 109.253 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.93 21.75 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 124.031 0.932 . . . . 0.0 111.557 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.38 -41.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 120.67 -1.269 . . . . 0.0 110.975 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -21.13 79.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.602 0.637 . . . . 0.0 111.95 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -142.67 152.13 42.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.964 2.105 . . . . 0.0 106.045 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.47 2.05 35.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -108.23 2.64 22.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.341 0.973 . . . . 0.0 113.471 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.24 175.25 36.34 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.859 0.754 . . . . 0.0 112.921 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 m -148.22 159.5 43.91 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.646 1.578 . . . . 0.0 109.274 -169.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -59.11 141.58 53.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.105 0.562 . . . . 0.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.79 179.14 8.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 108.278 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -171.38 -152.4 0.08 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.728 1.611 . . . . 0.0 108.161 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 34.0 m 58.78 42.1 20.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.013 1.325 . . . . 0.0 110.817 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m -85.69 170.59 12.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.231 2.212 . . . . 0.0 110.878 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -63.68 146.84 53.05 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.831 -0.543 . . . . 0.0 110.061 170.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 107.474 173.636 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -116.84 136.68 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.362 1.065 . . . . 0.0 109.179 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.6 mp0 -144.35 -173.48 4.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.518 1.927 . . . . 0.0 108.63 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.91 142.67 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 61.59 21.78 12.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.115 1.766 . . . . 0.0 113.411 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.2 tp10 -128.12 170.29 13.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.538 1.135 . . . . 0.0 108.372 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.08 146.11 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.576 1.55 . . . . 0.0 112.3 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.42 173.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 127.735 2.414 . . . . 0.0 108.534 172.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.1 mt -107.36 129.23 54.94 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 141.15 42.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.99 0.916 . . . . 0.0 109.463 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.2 m -70.24 102.83 2.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.317 1.047 . . . . 0.0 110.525 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -68.21 154.44 41.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -59.56 -17.98 37.1 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.361 1.064 . . . . 0.0 113.049 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.13 -50.13 73.75 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.441 0.697 . . . . 0.0 111.911 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -171.96 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.28 0.632 . . . . 0.0 111.947 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.36 -160.51 1.18 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 111.385 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.79 134.97 36.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.919 2.088 . . . . 0.0 115.936 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -140.61 159.48 62.75 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 129.173 2.989 . . . . 0.0 105.342 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.82 144.97 79.37 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.718 1.612 . . . . 0.0 110.536 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.83 165.14 36.33 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.774 1.63 . . . . 0.0 109.084 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -98.69 131.11 45.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.133 1.373 . . . . 0.0 107.366 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.11 138.35 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 p -114.7 -31.3 6.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.513 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.98 163.06 40.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.581 1.082 . . . . 0.0 110.257 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -134.98 142.3 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -133.4 112.23 11.42 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.71 -19.97 53.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.716 0.806 . . . . 0.0 112.833 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.71 -31.64 38.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.079 0.952 . . . . 0.0 112.454 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.83 18.96 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.527 1.061 . . . . 0.0 113.052 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.7 p -129.8 170.13 14.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.923 1.361 . . . . 0.0 110.164 -170.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.66 154.81 41.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.904 1.682 . . . . 0.0 107.396 -169.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -131.69 134.83 46.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.4 m -142.32 158.85 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.23 125.23 44.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.274 1.43 . . . . 0.0 107.184 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.58 151.18 26.5 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -64.81 -24.34 67.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.71 -26.5 68.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.6 0.76 . . . . 0.0 112.247 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.32 -13.95 6.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.976 1.274 . . . . 0.0 113.306 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.47 143.05 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.445 1.122 . . . . 0.0 109.141 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.69 144.1 38.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.38 153.31 33.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.289 0.635 . . . . 0.0 110.673 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -108.58 128.55 54.93 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.02 -178.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.133 1.373 . . . . 0.0 109.227 -168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.76 169.28 8.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.003 -1.06 . . . . 0.0 110.845 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.0 -37.21 68.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.074 0.55 . . . . 0.0 111.043 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.97 -5.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 120.882 -1.136 . . . . 0.0 113.509 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -118.94 -12.83 9.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.381 1.073 . . . . 0.0 112.145 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.41 138.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.255 1.389 . . . . 0.0 110.588 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -147.37 176.69 9.82 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.71 0.804 . . . . 0.0 109.47 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.58 168.1 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.074 0.949 . . . . 0.0 110.714 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -28.04 69.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.247 170.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -64.39 116.52 6.16 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.698 0.799 . . . . 0.0 109.168 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -65.85 -24.73 66.94 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -84.14 -36.49 22.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -146.86 165.0 31.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 110.624 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.08 169.19 14.17 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.3 mm -129.18 -13.75 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 124.819 1.248 . . . . 0.0 111.393 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.66 -36.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.54 1.518 . . . . 0.0 112.971 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.05 -30.24 77.2 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.605 1.093 . . . . 0.0 110.642 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -151.2 153.86 35.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.396 2.678 . . . . 0.0 104.28 169.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.65 12.23 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.98 1.264 . . . . 0.0 114.327 -169.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.44 -6.28 59.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.168 0.894 . . . . 0.0 112.266 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.4 -177.91 41.73 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 121.962 0.757 . . . . 0.0 114.04 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -148.21 165.88 29.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.326 1.451 . . . . 0.0 109.53 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -72.28 135.32 45.95 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.511 -0.743 . . . . 0.0 110.571 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -152.15 -171.27 3.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.246 1.818 . . . . 0.0 107.465 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -154.76 -178.73 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.577 1.551 . . . . 0.0 108.762 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 77.6 p -143.2 175.91 9.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.359 1.064 . . . . 0.0 109.931 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 p -116.44 -0.6 12.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.615 1.166 . . . . 0.0 113.232 -169.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -80.98 44.58 0.77 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.592 1.087 . . . . 0.0 110.529 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 48.8 mt . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.726 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 72.18 83.26 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.296 2.638 . . . . 0.0 113.06 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -139.23 -173.65 3.65 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.73 1.612 . . . . 0.0 109.512 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.1 mt -48.96 141.94 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.476 1.11 . . . . 0.0 109.467 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.49 22.25 11.93 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.091 1.756 . . . . 0.0 113.29 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -127.62 170.27 12.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.235 1.014 . . . . 0.0 108.805 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -74.03 149.65 41.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.778 1.231 . . . . 0.0 111.516 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.45 168.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.787 2.035 . . . . 0.0 108.059 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -101.69 130.92 48.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.61 140.2 44.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.997 0.919 . . . . 0.0 109.014 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.1 m -69.73 102.59 1.94 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.815 0.846 . . . . 0.0 110.711 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.91 153.39 41.88 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -58.19 -20.48 41.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.048 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.21 -48.03 77.24 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.09 0.956 . . . . 0.0 112.396 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.8 p -169.59 -72.75 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.586 0.354 . . . . 0.0 111.615 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 -156.14 0.69 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.135 1.374 . . . . 0.0 110.012 -173.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -49.31 139.71 11.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.914 1.686 . . . . 0.0 115.047 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -146.33 156.51 49.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 130.12 3.368 . . . . 0.0 104.246 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.3 147.13 71.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.521 1.481 . . . . 0.0 110.968 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.34 164.69 36.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.182 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -95.24 132.63 40.01 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.526 1.53 . . . . 0.0 107.691 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.26 135.72 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.7 p -112.66 -33.57 6.08 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.849 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.19 164.67 36.87 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 110.723 168.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.58 142.31 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -131.39 119.21 21.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -61.24 -19.76 62.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.409 0.684 . . . . 0.0 112.556 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.6 -30.76 44.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 112.296 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.79 20.54 0.76 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.556 1.074 . . . . 0.0 112.967 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -129.3 169.82 14.38 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.72 1.26 . . . . 0.0 110.394 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -143.44 155.82 44.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.954 2.102 . . . . 0.0 107.728 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -133.0 131.81 41.16 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -140.04 157.32 25.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -122.09 122.83 40.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -78.24 150.24 33.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -64.18 -25.34 68.03 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.08 -26.83 68.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.629 0.772 . . . . 0.0 112.265 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.4 -16.83 5.93 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.102 1.334 . . . . 0.0 113.033 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.14 143.4 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.255 1.027 . . . . 0.0 109.356 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.67 144.41 38.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -152.05 155.9 38.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.269 0.628 . . . . 0.0 110.474 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -109.96 129.79 55.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.37 179.58 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.405 1.482 . . . . 0.0 109.677 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.32 168.51 9.29 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.08 0.952 . . . . 0.0 110.758 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -55.43 -36.83 66.92 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.795 -0.566 . . . . 0.0 111.321 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.8 pt -64.23 -5.06 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -118.05 -11.04 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.315 1.046 . . . . 0.0 112.484 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.91 141.07 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 120.263 1.392 . . . . 0.0 110.991 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -150.47 172.33 15.62 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.305 1.042 . . . . 0.0 109.703 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 166.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.778 1.231 . . . . 0.0 111.59 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -68.1 -8.58 39.35 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.56 -0.713 . . . . 0.0 111.541 169.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -67.97 117.28 9.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.71 -44.27 90.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 112.121 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.62 -67.02 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -151.23 163.36 39.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.741 1.216 . . . . 0.0 109.353 -170.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -84.54 164.18 18.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.075 0.55 . . . . 0.0 111.882 -170.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.7 15.01 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.759 0.824 . . . . 0.0 112.183 -173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.05 158.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 120.397 -1.44 . . . . 0.0 107.413 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.53 3.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.708 1.147 . . . . 0.0 111.992 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -143.72 65.86 1.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.926 2.09 . . . . 0.0 106.259 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.47 132.09 52.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.383 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.89 -2.33 0.93 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.149 0.979 . . . . 0.0 113.035 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.38 -159.29 9.13 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.42 1.009 . . . . 0.0 112.794 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.8 m -139.4 164.69 29.18 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.06 1.744 . . . . 0.0 109.84 -169.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -60.7 145.3 49.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.2 -165.39 1.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.161 2.584 . . . . 0.0 107.1 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.94 169.94 17.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.269 1.028 . . . . 0.0 109.658 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 36.7 m -135.23 179.98 5.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.97 1.308 . . . . 0.0 111.056 -170.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.8 m -134.65 6.17 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.726 0.81 . . . . 0.0 113.039 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -75.88 24.82 0.12 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.408 1.483 . . . . 0.0 112.933 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.235 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 109.625 -178.454 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 72.22 80.96 0.14 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.033 2.533 . . . . 0.0 113.279 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.57 -174.77 3.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.091 1.356 . . . . 0.0 109.523 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.0 mt -53.2 143.58 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.58 17.1 10.15 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.952 1.701 . . . . 0.0 113.258 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -123.27 173.24 8.06 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -84.37 156.45 21.84 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.408 -0.807 . . . . 0.0 111.302 -169.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.97 167.51 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.305 1.842 . . . . 0.0 109.05 170.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.97 127.35 41.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.36 144.14 38.07 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.455 0.702 . . . . 0.0 109.644 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -68.83 108.44 3.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.396 0.679 . . . . 0.0 109.883 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -73.29 162.56 29.22 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.987 0.915 . . . . 0.0 109.726 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 m -58.0 -19.64 32.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.568 1.147 . . . . 0.0 112.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.43 -23.15 56.65 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 113.334 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.2 m 110.7 8.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 130.151 3.38 . . . . 0.0 114.898 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -153.64 -176.93 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.555 1.07 . . . . 0.0 111.229 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.89 140.07 53.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -142.02 158.34 62.04 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 128.341 2.656 . . . . 0.0 106.074 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.23 145.61 73.04 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.612 1.541 . . . . 0.0 111.206 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.31 156.89 37.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.171 1.789 . . . . 0.0 109.044 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.54 133.51 34.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.907 1.283 . . . . 0.0 108.391 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.46 133.77 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 p -111.55 -32.56 6.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.031 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 164.4 38.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.721 1.146 . . . . 0.0 110.676 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.13 141.42 33.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -129.57 128.0 41.84 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.73 -24.49 61.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.805 0.842 . . . . 0.0 112.47 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.29 -27.59 55.92 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 112.732 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.07 19.07 2.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.636 1.112 . . . . 0.0 112.705 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.2 p -123.54 168.98 11.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.502 1.151 . . . . 0.0 110.116 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.05 153.36 42.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 106.965 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -133.26 135.7 45.08 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.94 159.69 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -123.96 120.63 33.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -77.03 150.04 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -64.89 -23.55 67.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -63.39 -24.44 67.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.392 0.677 . . . . 0.0 112.435 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.98 -14.56 7.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.02 1.295 . . . . 0.0 113.009 173.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.48 143.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.288 1.044 . . . . 0.0 108.992 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.76 143.61 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -151.18 155.47 38.94 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.056 0.543 . . . . 0.0 110.699 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -108.97 131.48 55.01 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.01 178.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.748 1.619 . . . . 0.0 108.902 -169.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.69 165.7 12.58 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.018 -1.051 . . . . 0.0 110.496 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.54 -37.07 64.97 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.856 0.862 . . . . 0.0 111.016 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.36 -11.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.005 -1.059 . . . . 0.0 113.547 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -106.6 -8.99 16.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 112.636 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.59 139.54 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.437 1.017 . . . . 0.0 110.99 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -152.12 175.03 13.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.944 0.498 . . . . 0.0 110.682 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.17 165.35 0.52 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.331 1.453 . . . . 0.0 111.728 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -64.25 -16.7 62.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.843 -0.536 . . . . 0.0 111.844 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 m -62.14 116.25 4.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.41 1.084 . . . . 0.0 108.983 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.26 -28.3 67.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.37 -76.76 0.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.153 0.581 . . . . 0.0 111.812 -171.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.18 165.36 29.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 0.0 109.537 -170.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.92 163.58 25.14 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.176 0.512 . . . . 0.0 112.329 -171.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 mt -129.7 28.29 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 124.958 1.303 . . . . 0.0 108.606 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.32 160.46 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.45 1.9 . . . . 0.0 106.207 175.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.66 -62.43 3.53 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.867 1.222 . . . . 0.0 111.716 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -142.0 72.22 1.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.28 130.47 46.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.47 -21.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -171.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.76 -171.17 47.44 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 121.955 0.753 . . . . 0.0 111.832 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.3 m -146.24 159.9 42.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.643 1.977 . . . . 0.0 108.03 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -56.38 127.93 33.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.767 0.427 . . . . 0.0 111.113 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.1 -164.52 1.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.44 1.896 . . . . 0.0 107.4 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -145.23 -180.0 7.01 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 109.748 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 t -142.15 175.34 9.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.355 1.462 . . . . 0.0 108.889 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.2 m -133.0 -10.16 3.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -79.73 111.08 15.68 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 170.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 110.301 -178.402 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 17.3 m-85 55.14 36.27 26.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.656 1.583 . . . . 0.0 114.155 169.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -82.24 -173.35 4.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.578 0.751 . . . . 0.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.94 142.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 61.87 21.49 12.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.384 1.873 . . . . 0.0 113.337 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.19 170.19 13.28 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.354 1.062 . . . . 0.0 109.192 171.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.19 149.07 50.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.006 2.122 . . . . 0.0 112.534 -174.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.31 164.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 127.932 2.493 . . . . 0.0 108.525 171.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.48 130.21 42.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 168.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.66 145.12 38.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.517 0.727 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -69.02 116.09 9.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.906 0.482 . . . . 0.0 109.714 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -79.62 164.25 23.96 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.224 1.01 . . . . 0.0 110.597 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.9 m -57.23 -24.3 53.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.841 0.856 . . . . 0.0 112.33 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.77 -4.07 18.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.092 1.357 . . . . 0.0 113.459 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.4 m 75.28 156.86 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.633 2.773 . . . . 0.0 111.593 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.65 176.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.079 2.551 . . . . 0.0 115.425 -169.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -71.12 148.53 47.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -144.48 162.32 39.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 129.337 3.055 . . . . 0.0 106.01 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.33 145.89 61.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.892 1.728 . . . . 0.0 110.721 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.58 33.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.536 1.935 . . . . 0.0 108.748 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -101.58 133.78 45.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 107.414 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.79 136.67 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 p -114.02 -32.9 5.9 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.278 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.21 35.28 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.263 0.938 . . . . 0.0 110.63 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.3 t -141.65 140.56 30.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -130.63 123.66 29.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -60.08 -22.97 63.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.722 0.809 . . . . 0.0 112.568 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.27 -28.62 59.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.877 . . . . 0.0 112.278 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.51 22.32 1.2 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.769 1.176 . . . . 0.0 112.782 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.6 p -127.12 169.42 13.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.786 1.293 . . . . 0.0 110.271 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -142.45 156.41 45.18 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.905 2.082 . . . . 0.0 108.022 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -133.92 134.83 43.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.56 157.57 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.85 131.33 53.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.442 1.497 . . . . 0.0 107.186 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.67 148.57 23.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.41 -24.28 66.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -169.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.56 -30.47 71.5 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.298 0.639 . . . . 0.0 112.386 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.23 -15.31 4.23 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.46 1.029 . . . . 0.0 113.545 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.58 143.88 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 109.348 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.0 145.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.46 157.43 42.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.153 0.581 . . . . 0.0 110.719 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -108.74 131.92 54.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.15 178.6 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.307 1.443 . . . . 0.0 109.518 -169.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.71 167.11 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.141 -0.974 . . . . 0.0 110.502 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.28 -39.21 66.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.498 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.7 pt -61.51 -13.38 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -104.25 -8.69 19.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.112 -0.946 . . . . 0.0 112.637 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.8 140.5 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.818 1.19 . . . . 0.0 111.863 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -150.13 177.86 9.51 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 110.34 171.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -60.49 167.97 2.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.026 0.93 . . . . 0.0 111.096 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -69.29 -17.27 63.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.37 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -63.01 122.98 17.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.73 -37.86 77.1 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.354 0.662 . . . . 0.0 112.158 -173.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.6 -69.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -149.7 168.8 22.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.877 0.871 . . . . 0.0 111.204 -169.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.5 155.06 34.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.653 1.581 . . . . 0.0 110.83 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.32 21.27 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 123.987 0.915 . . . . 0.0 112.067 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.98 -46.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.192 -1.567 . . . . 0.0 112.078 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.83 -32.49 82.99 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -145.84 162.9 36.63 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.28 56.24 1.04 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.39 1.45 . . . . 0.0 112.044 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.94 -19.14 9.29 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.95 -177.17 51.44 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 122.277 0.931 . . . . 0.0 112.676 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.7 m -148.67 165.17 32.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.246 2.218 . . . . 0.0 107.388 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -61.33 120.68 10.91 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.394 -0.816 . . . . 0.0 110.154 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -155.01 -170.91 3.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.185 2.194 . . . . 0.0 107.327 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -150.19 171.63 16.61 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.903 0.881 . . . . 0.0 110.179 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.7 m -138.1 178.09 7.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.567 1.547 . . . . 0.0 110.212 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.5 m -127.92 8.77 6.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.88 31.73 0.37 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.404 1.081 . . . . 0.0 111.732 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.789 1.236 . . . . 0.0 110.589 -179.909 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -107.55 127.83 53.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.47 1.108 . . . . 0.0 109.784 -169.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.7 mp0 -144.39 -173.79 4.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.664 1.586 . . . . 0.0 109.257 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.4 mt -51.51 143.71 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.68 22.11 12.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.27 1.828 . . . . 0.0 113.422 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -130.13 169.57 15.16 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.345 1.058 . . . . 0.0 108.83 171.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.4 146.3 53.34 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.779 2.032 . . . . 0.0 112.689 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.29 171.88 5.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 0.0 107.915 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.7 mt -109.82 124.4 51.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 138.97 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.145 0.978 . . . . 0.0 108.649 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.9 m -69.09 134.87 49.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -109.73 156.95 19.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.282 1.433 . . . . 0.0 108.442 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -58.64 -19.78 41.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.503 1.121 . . . . 0.0 112.863 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.57 -50.19 70.74 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.103 0.961 . . . . 0.0 112.461 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -170.68 -67.5 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.94 0.496 . . . . 0.0 111.845 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -155.26 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.732 1.613 . . . . 0.0 109.675 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -51.81 139.08 22.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.897 2.079 . . . . 0.0 115.78 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -142.87 157.34 61.49 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 128.914 2.885 . . . . 0.0 105.582 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.73 145.73 64.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 120.985 1.124 . . . . 0.0 111.092 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.04 164.52 37.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.449 1.5 . . . . 0.0 109.356 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -97.63 132.16 43.54 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.381 1.473 . . . . 0.0 107.789 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.62 138.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 p -115.07 -32.34 5.75 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.249 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 164.86 36.63 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.572 1.078 . . . . 0.0 110.465 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.59 141.65 32.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.27 113.97 13.24 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.7 -19.67 59.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.322 0.649 . . . . 0.0 112.517 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.22 -30.47 38.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.064 0.946 . . . . 0.0 112.421 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.57 22.56 0.61 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.399 1.0 . . . . 0.0 112.743 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.4 p -131.85 169.64 15.97 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.059 1.429 . . . . 0.0 110.589 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -144.37 153.0 41.5 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.496 1.918 . . . . 0.0 107.215 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -130.8 134.07 46.53 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 170.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.12 155.26 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -118.48 125.93 50.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.668 1.587 . . . . 0.0 107.003 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.76 151.69 27.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -65.83 -22.76 66.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.67 -27.49 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.141 0.577 . . . . 0.0 112.196 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.7 -17.74 5.21 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.882 1.23 . . . . 0.0 113.09 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.13 146.07 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.232 1.013 . . . . 0.0 109.478 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.03 144.65 36.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.16 154.3 38.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.188 0.595 . . . . 0.0 110.851 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -108.37 130.23 55.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.79 175.84 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.377 1.471 . . . . 0.0 108.758 -169.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -97.53 168.39 10.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.008 -1.058 . . . . 0.0 110.543 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.53 -39.03 67.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.432 0.693 . . . . 0.0 111.086 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.79 -6.61 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -114.3 -7.67 12.93 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 112.622 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.5 140.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 120.283 1.401 . . . . 0.0 111.71 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -149.42 174.24 12.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.088 0.955 . . . . 0.0 109.958 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.21 168.75 0.67 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.453 1.101 . . . . 0.0 111.265 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -63.13 -20.6 65.52 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.551 -0.718 . . . . 0.0 110.743 169.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.8 m -62.38 123.73 19.03 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.161 0.984 . . . . 0.0 110.561 170.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -60.68 -40.36 91.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.823 0.849 . . . . 0.0 112.128 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.96 -67.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -150.61 168.04 25.5 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.028 0.931 . . . . 0.0 111.049 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.23 156.72 38.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.204 1.402 . . . . 0.0 110.782 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -139.75 24.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.958 0.903 . . . . 0.0 111.44 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.44 -60.66 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 120.603 -1.311 . . . . 0.0 109.93 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.33 -34.38 85.08 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -136.39 163.28 30.83 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.972 2.109 . . . . 0.0 105.779 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.73 18.11 9.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 114.137 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -79.57 -18.11 52.44 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.467 -0.777 . . . . 0.0 112.714 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.75 175.79 51.5 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 119.465 1.03 . . . . 0.0 113.114 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.8 m -149.98 163.77 37.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 107.761 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -61.45 132.04 52.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.477 -0.764 . . . . 0.0 111.279 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.21 -172.46 3.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.551 1.94 . . . . 0.0 108.355 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -146.42 168.72 20.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.538 1.135 . . . . 0.0 110.189 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 15.5 m -135.5 161.96 34.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.894 1.278 . . . . 0.0 109.171 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 p -106.39 -25.98 11.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -73.81 129.12 37.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 109.295 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.871 175.113 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.429 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.9 m-85 72.79 71.49 0.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.212 1.805 . . . . 0.0 113.65 169.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -121.95 -174.29 2.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.742 1.617 . . . . 0.0 109.616 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.51 142.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 60.81 24.14 14.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.723 1.609 . . . . 0.0 113.185 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.27 169.78 13.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.676 1.191 . . . . 0.0 108.137 170.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.74 155.12 40.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.853 0.861 . . . . 0.0 112.603 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.32 164.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.275 2.23 . . . . 0.0 107.902 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.56 128.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.15 141.03 46.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 108.84 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.0 m -69.62 117.53 11.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.21 0.604 . . . . 0.0 109.684 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -84.21 162.56 20.14 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.722 1.209 . . . . 0.0 109.403 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -55.65 -20.12 12.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.071 1.348 . . . . 0.0 112.987 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.35 -51.88 18.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.356 1.463 . . . . 0.0 112.048 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m 161.66 -46.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.74 2.816 . . . . 0.0 111.252 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.38 -168.0 2.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.056 0.844 . . . . 0.0 113.027 -169.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -54.31 141.77 28.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.083 2.153 . . . . 0.0 116.367 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -149.7 160.26 34.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 130.085 3.354 . . . . 0.0 105.168 168.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.16 147.3 66.44 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.489 1.459 . . . . 0.0 110.937 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.43 162.96 40.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.642 1.977 . . . . 0.0 108.952 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -91.47 133.66 35.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.174 1.39 . . . . 0.0 107.578 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.97 134.46 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -111.39 -31.94 6.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.698 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.57 160.74 43.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.592 1.087 . . . . 0.0 110.446 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.3 140.1 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 170.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -132.33 111.95 11.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -62.19 -16.35 52.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.728 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -53.47 -31.46 45.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.732 0.813 . . . . 0.0 112.071 169.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.19 18.18 0.75 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.837 1.208 . . . . 0.0 112.722 174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.1 p -129.41 172.16 11.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.735 1.267 . . . . 0.0 110.256 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -145.98 154.79 42.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.692 1.997 . . . . 0.0 107.178 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -133.0 133.65 43.41 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.87 157.78 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -122.98 124.67 43.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.225 1.41 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -80.09 149.64 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -65.54 -25.37 67.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.32 -25.65 66.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.318 0.647 . . . . 0.0 112.153 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.99 3.94 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.449 1.023 . . . . 0.0 113.766 171.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.61 144.99 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.204 1.002 . . . . 0.0 109.437 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.91 143.95 39.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -149.41 155.03 39.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.826 0.451 . . . . 0.0 110.826 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 128.84 55.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 m -147.44 178.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.133 1.373 . . . . 0.0 109.183 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.3 169.06 10.03 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.229 -0.919 . . . . 0.0 110.837 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -55.55 -38.58 69.49 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.043 0.537 . . . . 0.0 111.042 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.37 -6.32 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.979 -1.076 . . . . 0.0 113.532 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -115.48 -8.5 12.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 112.453 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.5 139.63 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 120.377 1.444 . . . . 0.0 110.932 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.02 172.7 14.32 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.992 0.917 . . . . 0.0 110.012 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -54.65 166.39 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 111.18 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -67.11 -11.44 57.2 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.406 -0.809 . . . . 0.0 111.118 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 121.29 13.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 109.299 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.65 -44.5 90.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.547 0.739 . . . . 0.0 110.848 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -57.39 -61.29 2.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.263 1.425 . . . . 0.0 113.578 -169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -154.87 164.77 38.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.217 1.407 . . . . 0.0 108.373 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.19 171.34 13.15 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.97 -69.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.644 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.33 -19.98 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 121.085 1.766 . . . . 0.0 114.356 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.02 19.56 29.91 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.404 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -152.84 -41.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.907 1.354 . . . . 0.0 113.381 -170.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 60.01 8.86 1.57 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.077 2.551 . . . . 0.0 116.651 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -108.09 -23.67 11.88 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.069 1.304 . . . . 0.0 111.12 173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.81 171.72 25.92 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 122.124 0.847 . . . . 0.0 113.055 174.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.5 m -146.38 159.67 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.876 1.671 . . . . 0.0 109.015 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.95 130.42 45.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.07 -168.54 3.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.317 1.847 . . . . 0.0 107.415 170.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -146.13 167.28 23.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.968 0.907 . . . . 0.0 109.875 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 20.4 m -136.8 -178.05 5.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.67 1.188 . . . . 0.0 111.047 -170.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 10.7 m -132.64 6.87 4.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -76.41 28.53 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.617 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.536 0.424 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -176.612 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -109.46 126.53 53.59 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.623 1.169 . . . . 0.0 109.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.4 mp0 -140.15 -174.03 3.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.686 1.594 . . . . 0.0 108.564 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -47.94 140.97 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.174 0.99 . . . . 0.0 108.504 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 59.5 25.66 14.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.5 1.92 . . . . 0.0 112.926 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -136.04 162.4 33.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.247 1.019 . . . . 0.0 108.976 172.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -65.41 146.21 55.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.588 2.355 . . . . 0.0 113.903 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.84 171.99 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 127.558 2.343 . . . . 0.0 108.487 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.49 124.06 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.68 141.61 47.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.895 0.878 . . . . 0.0 109.069 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 m -69.05 103.77 1.95 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -69.42 155.15 40.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.2 m -58.22 -20.79 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 112.383 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -58.74 -48.91 79.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.296 1.038 . . . . 0.0 113.07 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 p -168.83 -71.61 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -161.62 1.38 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.388 1.875 . . . . 0.0 109.348 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -51.57 136.15 26.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.9 161.61 42.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 129.377 3.071 . . . . 0.0 104.654 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.18 147.22 59.69 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.955 1.77 . . . . 0.0 111.007 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.7 169.22 25.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.858 2.463 . . . . 0.0 107.132 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.07 146.35 41.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.55 1.068 . . . . 0.0 109.735 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.5 142.45 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.021 0.928 . . . . 0.0 108.555 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 p -119.11 -28.64 5.43 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.809 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.93 158.99 43.92 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 119.523 1.056 . . . . 0.0 110.087 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.5 143.05 38.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -134.08 116.74 15.81 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.35 -19.75 62.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.341 0.656 . . . . 0.0 112.409 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.84 -30.51 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.889 0.876 . . . . 0.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.96 23.54 0.77 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.537 1.065 . . . . 0.0 112.691 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.4 p -131.66 169.34 16.3 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.442 1.621 . . . . 0.0 110.46 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.41 150.99 37.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.387 1.875 . . . . 0.0 108.053 -169.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 m -130.59 134.41 46.97 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.05 156.84 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -119.98 127.04 52.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.28 146.4 26.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -60.91 -25.86 67.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -169.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.33 -29.34 70.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.979 0.512 . . . . 0.0 112.195 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.02 -19.07 3.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.47 1.033 . . . . 0.0 113.148 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.45 141.31 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.319 1.047 . . . . 0.0 109.643 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.92 142.3 43.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.01 157.85 39.69 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.895 0.478 . . . . 0.0 110.793 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 84.7 m -106.64 136.66 46.04 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.28 179.97 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.707 2.003 . . . . 0.0 108.375 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.06 168.13 10.46 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.51 -39.05 67.21 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.808 0.843 . . . . 0.0 111.272 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.48 -9.79 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -110.44 -7.24 14.79 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.05 0.94 . . . . 0.0 112.677 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 t -141.95 142.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.873 1.215 . . . . 0.0 111.081 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -148.61 179.03 8.13 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.034 0.934 . . . . 0.0 109.543 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.26 166.62 0.8 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.692 1.197 . . . . 0.0 110.833 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.29 -28.58 69.82 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.492 169.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -64.1 118.37 8.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.746 0.819 . . . . 0.0 109.154 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.21 -24.47 67.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.67 -62.42 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -154.39 167.07 31.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.92 1.288 . . . . 0.0 109.864 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.13 165.96 24.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.806 0.842 . . . . 0.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.6 mt -129.11 -14.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 117.788 -1.101 . . . . 0.0 111.867 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.01 -28.88 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 121.413 1.915 . . . . 0.0 114.018 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.15 -44.64 97.88 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -159.06 121.44 3.54 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.9 104.62 5.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -169.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -137.27 -30.67 0.84 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -171.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -91.95 -174.56 42.52 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.953 0.797 . . . . 0.0 114.168 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 80.4 p -153.31 170.99 19.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.659 1.984 . . . . 0.0 108.152 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -58.04 124.7 20.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.381 0.992 . . . . 0.0 111.526 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -158.53 -172.22 3.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.941 1.696 . . . . 0.0 109.001 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -155.19 -177.77 6.77 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.129 1.771 . . . . 0.0 109.254 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 90.0 p -144.43 -179.07 6.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.229 1.011 . . . . 0.0 110.094 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 m -110.67 4.2 19.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.849 0.86 . . . . 0.0 112.674 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.84 40.62 0.47 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.509 1.123 . . . . 0.0 110.76 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 127.388 2.275 . . . . 0.0 112.764 -169.498 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 119.284 -0.389 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 55.56 37.86 29.43 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.274 1.829 . . . . 0.0 112.521 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.69 -174.4 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.407 1.083 . . . . 0.0 109.921 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.9 143.12 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 61.84 19.01 10.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.127 1.771 . . . . 0.0 113.401 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -125.16 171.56 10.22 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -83.42 159.24 21.83 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.42 167.71 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 126.641 1.977 . . . . 0.0 108.12 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.3 mt -94.97 133.57 38.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.72 142.92 34.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.802 0.841 . . . . 0.0 109.392 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -69.54 109.65 4.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.744 0.818 . . . . 0.0 109.549 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -79.25 159.51 27.26 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -57.86 -19.64 30.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.359 1.463 . . . . 0.0 113.05 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -49.62 -57.45 7.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.902 1.281 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 m 171.27 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 112.375 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.19 -167.62 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.871 0.76 . . . . 0.0 113.012 -169.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -64.9 141.78 58.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.584 1.154 . . . . 0.0 114.07 -169.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.45 157.83 51.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 128.776 2.83 . . . . 0.0 105.138 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.87 149.3 72.29 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.571 1.514 . . . . 0.0 111.046 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.03 158.46 40.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.886 2.074 . . . . 0.0 108.627 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.5 135.33 33.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.03 134.47 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -111.86 -30.33 7.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.423 0.689 . . . . 0.0 110.448 172.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.31 161.73 42.18 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.624 1.102 . . . . 0.0 110.612 169.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.42 141.29 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -127.86 132.87 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.68 -26.01 63.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.947 0.899 . . . . 0.0 112.174 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.94 -24.9 62.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.923 0.889 . . . . 0.0 112.743 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.95 19.13 4.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.75 1.166 . . . . 0.0 112.628 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -120.76 167.93 11.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.297 1.049 . . . . 0.0 110.253 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -140.8 152.79 45.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.815 2.046 . . . . 0.0 107.543 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.4 m -130.47 130.9 44.82 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 169.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.87 153.0 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -120.21 119.7 33.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.312 1.445 . . . . 0.0 107.299 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.43 146.88 38.32 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -64.86 -21.13 66.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 112.935 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.86 -18.63 64.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.812 0.845 . . . . 0.0 112.382 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.41 47.83 1.49 Allowed Glycine 0 C--N 1.342 0.877 0 C-N-CA 124.324 0.964 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.9 t -134.63 142.73 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -132.51 144.71 36.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -150.1 158.46 44.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 110.406 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -109.78 130.36 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.2 -178.54 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.401 1.48 . . . . 0.0 109.832 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -105.69 169.54 8.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.796 1.238 . . . . 0.0 111.051 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -55.17 -38.07 67.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.215 0.606 . . . . 0.0 111.195 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.52 -5.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -117.85 -10.45 10.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.424 1.09 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.46 139.61 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.92 1.236 . . . . 0.0 111.216 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -149.94 169.69 20.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.604 0.762 . . . . 0.0 109.936 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.91 165.33 0.65 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.262 1.025 . . . . 0.0 111.588 172.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.93 -13.34 59.56 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.618 -0.676 . . . . 0.0 111.233 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.7 m -63.04 116.16 5.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.531 1.132 . . . . 0.0 109.332 169.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -58.29 -46.06 86.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.787 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.95 -52.14 46.61 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -151.31 160.84 43.58 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.985 0.914 . . . . 0.0 110.422 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -76.1 171.15 14.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.692 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.9 mm -119.57 -16.67 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.446 1.099 . . . . 0.0 111.049 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 144' ' ' GLY . 9.9 p -150.88 -168.05 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 120.167 1.349 . . . . 0.0 108.808 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' H ' HG22 ' A' ' 143' ' ' VAL . . . 84.63 -37.57 2.93 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.448 -1.408 . . . . 0.0 112.777 169.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -148.02 -46.17 0.16 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.925 0.89 . . . . 0.0 110.145 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.27 25.22 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.25 0.547 . . . . 0.0 112.16 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.34 169.85 9.92 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.841 1.257 . . . . 0.0 109.095 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -161.44 -144.95 4.15 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.954 1.74 . . . . 0.0 109.088 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 t -139.4 149.16 43.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.179 0.992 . . . . 0.0 108.933 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -68.53 140.64 55.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.873 0.469 . . . . 0.0 110.423 -170.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.27 -165.28 2.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.169 1.787 . . . . 0.0 107.316 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -145.6 165.95 27.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.011 0.925 . . . . 0.0 109.729 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 27.8 m -133.84 -173.84 3.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.626 1.17 . . . . 0.0 110.408 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.1 m -132.79 6.47 4.0 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -75.8 22.56 0.14 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.279 1.432 . . . . 0.0 113.208 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--O 1.238 0.474 0 C-N-CA 123.93 0.892 . . . . 0.0 109.456 -178.804 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 19.7 m-85 57.03 55.0 6.4 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.286 1.834 . . . . 0.0 115.124 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.01 -173.75 4.89 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.534 0.683 . . . . 0.0 111.992 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.76 143.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 62.11 17.93 9.58 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.158 1.783 . . . . 0.0 113.291 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.66 173.72 6.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.233 1.013 . . . . 0.0 108.421 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -76.32 158.84 31.11 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.808 -0.557 . . . . 0.0 111.307 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.93 175.16 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.861 2.064 . . . . 0.0 108.226 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.5 mt -115.29 123.54 49.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.74 46.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.295 1.038 . . . . 0.0 108.934 -172.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.3 m -69.52 116.07 9.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -81.83 159.11 23.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.422 0.689 . . . . 0.0 109.314 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m -57.73 -20.82 37.21 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.887 1.275 . . . . 0.0 112.637 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.06 -49.76 75.79 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.178 0.591 . . . . 0.0 111.752 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.94 -65.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.084 0.554 . . . . 0.0 112.111 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 -160.86 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 110.909 -170.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -52.64 139.11 26.83 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -146.02 158.79 48.04 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.499 3.12 . . . . 0.0 105.175 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.88 148.37 64.17 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.627 1.551 . . . . 0.0 110.717 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.08 167.52 30.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.5 135.56 41.74 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.351 1.461 . . . . 0.0 108.083 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 138.94 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -117.44 -32.83 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.211 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.63 162.08 41.72 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.887 1.222 . . . . 0.0 110.315 168.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.7 134.21 45.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -129.4 115.42 17.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -169.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.43 -21.42 59.97 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.733 0.813 . . . . 0.0 112.466 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.36 -29.89 36.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 112.725 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.6 17.02 1.41 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.813 1.197 . . . . 0.0 112.756 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.1 p -127.19 169.03 13.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.861 1.33 . . . . 0.0 109.645 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.75 149.41 31.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 m -132.22 136.18 46.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.85 161.68 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -122.29 124.74 44.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -80.86 150.67 29.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.24 -23.61 66.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.152 0.581 . . . . 0.0 112.092 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.83 -15.18 5.96 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.234 1.397 . . . . 0.0 113.262 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.78 145.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 118.466 1.133 . . . . 0.0 109.266 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.21 144.21 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -149.75 156.44 41.86 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.913 0.485 . . . . 0.0 111.02 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -114.37 130.8 56.7 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.86 179.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.987 1.715 . . . . 0.0 108.346 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -85.89 164.73 17.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.793 -1.192 . . . . 0.0 110.054 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -54.44 -40.55 68.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.719 0.808 . . . . 0.0 110.827 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.2 pt -60.39 -16.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -97.55 -4.5 37.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.204 0.911 . . . . 0.0 112.684 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.1 146.91 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.758 1.163 . . . . 0.0 111.481 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -151.53 173.37 14.69 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.37 1.068 . . . . 0.0 108.68 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.28 169.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.879 1.272 . . . . 0.0 110.943 173.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -68.8 2.26 2.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.096 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 m -63.21 142.41 58.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.831 -1.168 . . . . 0.0 109.838 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -66.47 -55.59 14.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.855 0.462 . . . . 0.0 110.647 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.58 -66.94 0.56 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -146.44 -178.94 6.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 0.0 111.209 -169.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -73.17 171.26 13.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.444 1.498 . . . . 0.0 111.714 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -131.72 -19.73 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 125.455 1.502 . . . . 0.0 111.156 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.59 -38.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.803 -1.185 . . . . 0.0 111.996 -170.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.06 -49.14 42.73 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -161.24 117.12 2.16 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.31 128.2 35.39 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.467 0.576 . . . . 0.0 112.412 -169.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -146.9 -19.85 0.41 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.962 1.305 . . . . 0.0 113.149 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.65 165.6 36.6 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 119.745 1.157 . . . . 0.0 112.754 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 72.0 p -147.43 -17.39 0.38 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -152.53 146.43 25.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.814 1.188 . . . . 0.0 108.684 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.85 152.38 36.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.791 0.837 . . . . 0.0 111.18 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -78.27 172.95 12.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.776 0.831 . . . . 0.0 110.794 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 4.0 p -149.66 8.2 0.67 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.526 1.13 . . . . 0.0 112.455 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 m -141.21 -178.71 5.72 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.087 0.955 . . . . 0.0 110.387 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 24.5 m80 58.88 27.97 16.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.58 1.552 . . . . 0.0 113.511 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.545 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.439 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.2 m-85 55.11 24.07 5.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -88.74 -173.02 3.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.151 0.98 . . . . 0.0 110.039 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.2 mt -50.81 141.18 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.326 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.77 25.18 15.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.277 1.831 . . . . 0.0 113.206 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.89 168.96 18.56 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.187 0.995 . . . . 0.0 110.067 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.23 145.6 55.71 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.849 2.059 . . . . 0.0 113.638 -171.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.63 160.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 128.113 2.565 . . . . 0.0 107.88 169.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.5 mt -97.49 122.83 41.0 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 143.19 42.65 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.566 0.746 . . . . 0.0 109.049 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.9 m -68.66 105.73 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -68.87 157.62 36.2 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 m -58.94 -16.35 17.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.403 1.081 . . . . 0.0 112.544 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.18 -57.48 9.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.795 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.6 p 170.02 -38.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.404 1.882 . . . . 0.0 113.991 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -173.46 3.95 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.38 0.991 . . . . 0.0 112.807 -169.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.35 141.08 58.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 113.329 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.6 161.39 49.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 128.732 2.813 . . . . 0.0 104.737 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.72 146.68 61.16 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 120.22 1.114 . . . . 0.0 110.186 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.76 165.86 34.69 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.809 2.044 . . . . 0.0 108.453 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -102.36 132.4 48.37 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.648 1.179 . . . . 0.0 107.878 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.74 139.8 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -114.45 -33.69 5.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.72 160.27 43.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.596 1.089 . . . . 0.0 110.344 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.6 t -133.0 145.56 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -131.96 120.22 22.18 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -59.48 -23.4 62.72 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.001 0.921 . . . . 0.0 112.804 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.69 -30.46 61.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.921 0.889 . . . . 0.0 112.386 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.91 24.67 0.79 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.465 1.031 . . . . 0.0 112.952 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.1 p -130.86 170.36 14.51 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.748 1.274 . . . . 0.0 110.331 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -142.39 156.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.824 2.049 . . . . 0.0 108.246 -169.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.2 m -135.22 132.67 38.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.86 156.78 32.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -119.12 120.39 36.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -79.21 145.5 33.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -63.48 -24.98 68.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.21 -26.47 68.38 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.636 0.774 . . . . 0.0 112.125 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.46 -14.92 5.55 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.943 1.258 . . . . 0.0 113.327 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.89 143.9 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.574 1.187 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.29 139.28 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -155.72 155.89 33.92 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.969 0.507 . . . . 0.0 111.684 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -95.31 139.37 31.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.31 172.65 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.935 1.694 . . . . 0.0 108.684 -169.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -97.47 167.97 10.66 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.573 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -56.01 -36.79 68.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.29 0.636 . . . . 0.0 111.06 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 pt -64.17 -7.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.049 -1.032 . . . . 0.0 113.524 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -113.47 -9.2 13.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.316 1.046 . . . . 0.0 112.432 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.9 t -142.27 142.21 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.954 1.252 . . . . 0.0 111.644 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -147.09 172.2 14.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.188 1.395 . . . . 0.0 108.856 170.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.26 169.9 0.24 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.084 1.354 . . . . 0.0 110.842 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -65.8 -2.67 3.95 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.43 -0.794 . . . . 0.0 111.397 169.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.5 m -62.27 125.78 25.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.055 1.742 . . . . 0.0 108.997 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.25 -39.31 68.54 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.676 -0.64 . . . . 0.0 111.922 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.57 -60.95 1.96 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.813 0.278 . . . . 0.0 111.504 -169.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -152.64 172.75 16.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.766 1.626 . . . . 0.0 108.321 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -77.29 176.39 8.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.394 0.678 . . . . 0.0 112.373 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.7 mm -123.62 -62.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.615 1.566 . . . . 0.0 110.096 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.0 -32.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.482 1.037 . . . . 0.0 113.063 -169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.87 -48.88 58.55 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -160.62 136.1 8.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.29 116.71 26.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.808 0.731 . . . . 0.0 112.596 -169.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -144.42 -18.47 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.306 169.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.96 161.81 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 120.113 1.324 . . . . 0.0 113.093 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 44.0 m -147.18 -21.33 0.4 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.89 139.92 31.0 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.631 1.559 . . . . 0.0 109.282 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.86 154.66 41.66 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.816 0.846 . . . . 0.0 110.845 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.73 165.7 21.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.414 0.686 . . . . 0.0 112.15 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 m -147.21 6.94 0.88 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.262 1.025 . . . . 0.0 113.279 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.2 m -135.68 174.89 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.536 1.062 . . . . 0.0 112.28 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 86.5 t60 55.06 -97.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.797 2.039 . . . . 0.0 111.114 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 126.754 2.021 . . . . 0.0 111.977 -169.372 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -120.76 134.94 55.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.065 1.746 . . . . 0.0 108.253 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.5 mp0 -139.17 -174.43 3.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.091 1.357 . . . . 0.0 109.871 -175.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.17 142.43 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.72 24.73 13.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.011 1.725 . . . . 0.0 112.864 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -132.39 168.18 18.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.232 1.013 . . . . 0.0 108.749 170.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -73.25 147.99 44.08 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.311 1.845 . . . . 0.0 113.893 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.27 165.68 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 127.448 2.299 . . . . 0.0 108.101 171.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -96.26 131.13 43.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.75 141.44 43.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -69.49 113.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.227 0.611 . . . . 0.0 109.706 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -77.8 157.92 29.75 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.985 0.914 . . . . 0.0 109.32 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 m -58.07 -20.39 39.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.175 0.99 . . . . 0.0 112.748 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.06 -49.53 76.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.054 0.542 . . . . 0.0 112.086 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.89 -66.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -161.79 1.41 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.736 1.215 . . . . 0.0 111.069 -170.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -53.73 141.09 27.61 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -147.23 158.3 44.51 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 129.564 3.145 . . . . 0.0 105.072 168.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 145.01 66.17 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.471 1.447 . . . . 0.0 110.607 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.49 166.0 32.45 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.511 1.925 . . . . 0.0 108.499 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -103.97 133.72 48.45 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.64 138.84 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -114.76 -32.01 5.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.306 0.642 . . . . 0.0 109.77 169.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.4 41.14 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.608 1.094 . . . . 0.0 110.385 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.2 t -136.43 139.31 45.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -132.04 110.36 10.67 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -61.61 -17.34 54.81 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.22 -31.82 45.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.942 0.897 . . . . 0.0 112.137 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.73 20.27 0.54 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.653 1.12 . . . . 0.0 112.928 173.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.3 p -131.65 171.57 13.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.122 1.461 . . . . 0.0 110.075 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 155.89 43.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.354 1.862 . . . . 0.0 107.759 -169.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -133.23 132.88 42.0 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.52 155.69 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.01 126.59 50.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.85 1.66 . . . . 0.0 107.356 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -82.93 154.71 24.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -60.58 -30.54 69.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.48 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -25.85 68.57 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.639 0.776 . . . . 0.0 112.364 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.07 -14.96 7.4 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.997 1.284 . . . . 0.0 113.116 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.55 144.43 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.494 1.147 . . . . 0.0 109.247 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.3 t -131.63 143.26 40.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.95 156.7 42.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.216 0.606 . . . . 0.0 110.84 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -109.35 129.15 55.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 169.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.24 177.91 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.197 1.399 . . . . 0.0 109.428 -169.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.66 169.15 9.47 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.245 -0.909 . . . . 0.0 110.677 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -54.64 -38.46 66.88 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.517 0.727 . . . . 0.0 111.325 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.0 pt -63.98 -7.89 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -113.67 -6.98 13.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.172 0.989 . . . . 0.0 112.576 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.6 t -142.11 140.47 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.054 1.297 . . . . 0.0 110.872 -175.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -145.94 174.3 11.38 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.822 0.849 . . . . 0.0 109.841 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 137' ' ' SER . . . -59.12 166.94 1.89 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -81.52 47.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 168.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 135' ' ' ALA . 41.0 m -127.1 139.75 52.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 172.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -63.07 -41.77 99.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.001 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.82 -68.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -168.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -150.59 178.85 8.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.73 1.212 . . . . 0.0 111.022 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -75.89 159.1 31.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.11 1.764 . . . . 0.0 111.76 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -139.75 34.14 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.515 1.126 . . . . 0.0 110.976 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.0 p -154.16 -49.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 120.479 -1.388 . . . . 0.0 110.874 169.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.33 -32.03 71.84 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -146.1 165.78 28.08 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.75 51.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.136 1.335 . . . . 0.0 112.632 -168.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -120.05 -5.49 10.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.03 162.79 38.85 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 122.18 0.878 . . . . 0.0 115.01 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 t -164.27 171.46 14.87 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 127.272 2.229 . . . . 0.0 106.73 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 52.65 76.28 0.2 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.192 1.397 . . . . 0.0 109.124 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.0 25.92 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -158.45 161.79 37.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.768 1.167 . . . . 0.0 109.953 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 3.2 m -142.86 147.96 36.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.608 0.763 . . . . 0.0 109.994 -169.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.9 m -82.45 -7.52 59.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.986 0.914 . . . . 0.0 113.265 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.57 27.0 0.05 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.703 2.001 . . . . 0.0 114.267 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.235 0.323 0 O-C-N 121.043 -1.036 . . . . 0.0 109.825 178.06 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 9.3 m-85 -53.3 111.47 0.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.38 2.272 . . . . 0.0 110.431 -173.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 36.2 mt-30 -145.24 -175.35 4.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.356 2.262 . . . . 0.0 107.542 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.69 142.85 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.5 22.59 12.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.547 1.539 . . . . 0.0 113.307 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.518 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.2 tp10 -131.29 169.81 15.47 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -81.3 158.59 24.71 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.658 -0.651 . . . . 0.0 111.164 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.16 169.57 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 126.659 1.983 . . . . 0.0 107.969 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.39 122.72 44.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.2 139.26 46.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.533 1.133 . . . . 0.0 108.58 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.8 m -68.96 135.12 50.46 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.806 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -112.18 154.79 24.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.926 1.691 . . . . 0.0 108.148 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.8 m -58.38 -20.71 46.23 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.647 1.179 . . . . 0.0 113.009 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.84 -47.92 79.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.251 1.02 . . . . 0.0 112.791 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.6 p -168.11 -68.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.886 0.475 . . . . 0.0 111.907 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -156.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.351 1.861 . . . . 0.0 109.253 -169.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -46.56 138.08 6.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.504 2.322 . . . . 0.0 115.854 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -145.49 157.08 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.202 3.001 . . . . 0.0 105.313 169.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.02 145.73 56.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.48 1.454 . . . . 0.0 110.75 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.77 155.7 37.68 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.575 1.55 . . . . 0.0 109.176 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.08 134.89 35.37 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.6 133.16 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.069 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -110.41 -31.46 7.27 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.276 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.12 163.91 38.39 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.52 1.054 . . . . 0.0 110.714 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.32 140.9 39.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -131.21 115.48 16.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -172.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.21 -21.02 61.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.584 0.753 . . . . 0.0 112.624 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.86 -31.39 39.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.083 0.953 . . . . 0.0 112.449 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.23 23.37 0.68 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.447 1.022 . . . . 0.0 112.697 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 p -131.75 169.88 15.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.988 1.394 . . . . 0.0 110.48 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -143.16 152.62 41.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.5 1.92 . . . . 0.0 107.504 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -130.69 131.57 44.9 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 m -138.95 155.44 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -120.73 122.39 40.3 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.195 1.398 . . . . 0.0 107.453 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -77.93 148.34 34.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.6 -21.92 66.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.197 0.599 . . . . 0.0 112.525 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.77 -26.85 68.92 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.691 0.796 . . . . 0.0 112.305 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.2 5.91 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.052 1.311 . . . . 0.0 112.83 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.03 144.85 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.345 1.073 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.11 144.41 38.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.2 155.21 40.27 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.128 0.571 . . . . 0.0 110.658 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.8 129.28 55.38 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.56 176.56 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.245 1.418 . . . . 0.0 109.087 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.3 168.43 9.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 -170.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -55.35 -37.13 67.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.561 0.744 . . . . 0.0 110.957 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.0 pt -64.88 -7.09 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -115.37 -7.52 12.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.188 0.995 . . . . 0.0 112.511 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.08 141.04 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 119.758 1.163 . . . . 0.0 110.847 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -150.17 176.96 10.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.702 0.801 . . . . 0.0 109.968 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.52 168.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.635 1.174 . . . . 0.0 111.054 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -62.67 -21.6 65.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.055 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -62.45 120.51 11.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.926 0.891 . . . . 0.0 110.596 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.5 -40.59 79.02 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.154 0.982 . . . . 0.0 111.942 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.44 -64.52 0.84 Allowed 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -150.16 166.37 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.57 0.7 . . . . 0.0 112.628 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.84 153.25 36.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.271 1.829 . . . . 0.0 111.393 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -138.98 23.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.555 0.742 . . . . 0.0 112.08 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.72 -51.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 112.943 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.49 60.83 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.415 1.007 . . . . 0.0 111.93 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -150.99 60.21 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.27 126.06 24.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.01 17.85 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.548 1.139 . . . . 0.0 112.962 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -147.5 -169.33 14.73 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.237 0.926 . . . . 0.0 112.773 -170.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -146.59 170.9 15.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.887 1.275 . . . . 0.0 110.751 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -57.84 135.61 56.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.534 0.734 . . . . 0.0 111.598 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.72 -170.84 2.7 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.716 2.006 . . . . 0.0 108.23 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -151.43 173.67 14.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.851 1.261 . . . . 0.0 110.115 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 35.2 p -152.1 167.91 26.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.234 1.014 . . . . 0.0 109.821 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.4 m -79.61 -1.11 36.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.685 1.194 . . . . 0.0 113.409 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -72.97 89.68 1.44 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.979 0.912 . . . . 0.0 109.597 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.235 0.297 0 C-N-CA 126.145 1.778 . . . . 0.0 108.535 -178.218 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 110.824 -0.065 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -141.03 51.75 1.6 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.722 1.209 . . . . 0.0 109.557 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.44 119.53 20.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -104.19 128.77 51.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.218 1.007 . . . . 0.0 110.159 -169.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.8 mp0 -144.45 -172.87 3.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.021 1.728 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.61 144.07 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 66.95 7.07 5.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.802 2.441 . . . . 0.0 114.101 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.3 tp10 -120.24 170.22 9.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 109.668 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.6 144.38 51.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.782 2.033 . . . . 0.0 113.058 -170.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.7 164.24 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 127.189 2.196 . . . . 0.0 108.543 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.07 127.69 42.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.18 47.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -68.8 104.89 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -66.82 154.37 41.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m -58.04 -20.29 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 112.424 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.39 -49.63 76.83 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.2 p -171.72 -68.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.15 -162.83 1.58 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.906 1.282 . . . . 0.0 110.808 -169.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -58.55 138.76 56.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -144.28 157.5 56.44 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 128.577 2.751 . . . . 0.0 104.71 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.53 146.96 75.84 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.302 1.335 . . . . 0.0 110.432 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.96 162.11 41.72 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.243 1.817 . . . . 0.0 108.622 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.64 129.72 42.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.57 1.548 . . . . 0.0 107.118 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.53 138.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.942 1.247 . . . . 0.0 107.97 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 p -118.03 -30.52 5.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.291 0.636 . . . . 0.0 110.572 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.2 164.3 37.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.468 1.031 . . . . 0.0 110.248 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.3 t -143.61 147.75 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -133.77 130.26 37.77 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -60.1 -22.97 63.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.149 0.979 . . . . 0.0 112.36 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -54.5 -30.47 53.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.842 0.857 . . . . 0.0 112.342 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.36 26.15 0.75 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.308 0.956 . . . . 0.0 113.024 172.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.2 p -129.4 165.74 20.95 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.807 1.303 . . . . 0.0 110.839 -171.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.48 145.91 37.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.411 2.284 . . . . 0.0 107.382 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.4 m -124.88 131.94 53.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 169.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.66 149.9 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -114.19 119.95 38.82 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.392 1.477 . . . . 0.0 107.021 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.91 140.76 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -63.0 -21.13 65.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.852 0.861 . . . . 0.0 112.986 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.87 -19.9 63.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.797 0.839 . . . . 0.0 112.178 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.86 46.72 1.16 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.83 1.205 . . . . 0.0 110.725 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.3 t -133.96 138.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.5 140.67 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.03 159.73 41.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.335 0.654 . . . . 0.0 110.64 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.1 m -107.76 136.41 47.55 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.55 -179.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.248 2.219 . . . . 0.0 108.379 -169.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.9 168.93 8.9 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.218 -0.926 . . . . 0.0 110.682 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -53.39 -40.21 64.86 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.361 0.664 . . . . 0.0 110.864 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.1 pt -63.61 -5.9 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -115.9 -7.58 11.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 112.636 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.8 t -142.65 139.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 120.076 1.307 . . . . 0.0 111.651 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -148.16 174.3 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 110.055 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.34 167.91 1.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.758 0.823 . . . . 0.0 110.875 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.15 -18.15 65.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.391 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.18 116.85 6.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -61.63 -31.02 71.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -69.28 -55.9 9.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -152.14 165.16 35.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.662 0.744 . . . . 0.0 112.988 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.74 156.15 38.18 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.192 1.397 . . . . 0.0 110.468 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.98 23.53 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.938 0.895 . . . . 0.0 111.256 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.9 -62.89 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 120.707 -1.246 . . . . 0.0 109.686 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.57 -27.91 72.88 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -141.28 165.99 26.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.35 22.74 7.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.642 1.11 . . . . 0.0 113.427 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -77.62 -21.26 52.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.362 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -79.15 175.65 55.01 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.308 0.949 . . . . 0.0 112.987 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.6 m -150.54 171.21 17.44 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.183 2.193 . . . . 0.0 107.949 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -60.15 120.21 9.32 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.66 -164.13 1.58 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.371 1.868 . . . . 0.0 107.655 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -148.18 -176.89 5.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 66.2 m -129.54 169.11 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.149 1.38 . . . . 0.0 111.031 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -127.89 17.65 6.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -168.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -138.71 134.78 34.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -162.71 169.56 19.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.795 1.638 . . . . 0.0 109.629 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.5 m -64.08 -27.99 69.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.384 1.074 . . . . 0.0 113.591 -174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -87.14 2.34 50.16 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.31 142.95 41.58 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 170.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 63.43 39.46 9.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.811 1.644 . . . . 0.0 113.526 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -106.42 2.38 26.38 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 111.743 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 8.5 m-85 46.32 38.31 5.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 128.5 2.72 . . . . 0.0 115.43 170.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -110.06 -173.05 2.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 108.12 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -49.23 138.8 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.687 0.795 . . . . 0.0 109.273 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 62.41 25.79 15.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.194 1.798 . . . . 0.0 113.18 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -135.57 167.27 21.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.887 1.275 . . . . 0.0 108.551 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -69.7 156.05 39.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.846 1.258 . . . . 0.0 113.364 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.88 162.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.826 2.45 . . . . 0.0 107.045 169.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 mt -96.07 127.68 42.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.71 44.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.625 0.77 . . . . 0.0 109.406 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -68.84 107.89 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.966 0.507 . . . . 0.0 110.0 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.23 163.91 23.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.341 1.056 . . . . 0.0 109.548 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -57.33 -18.08 15.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.294 1.038 . . . . 0.0 113.201 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -11.68 49.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.41 1.484 . . . . 0.0 113.487 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.5 m 92.54 17.83 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.5 2.72 . . . . 0.0 114.988 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.56 8.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.007 0.821 . . . . 0.0 110.762 169.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -70.76 141.56 51.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.62 160.74 43.55 Favored Pre-proline 0 C--O 1.241 0.634 0 C-N-CA 128.337 2.655 . . . . 0.0 105.529 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.69 147.52 69.82 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.401 1.4 . . . . 0.0 111.039 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.41 161.07 43.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.177 1.791 . . . . 0.0 108.459 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -91.83 131.29 37.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.513 1.525 . . . . 0.0 107.814 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.6 134.16 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.7 p -112.02 -31.52 6.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.445 0.698 . . . . 0.0 110.201 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 164.14 38.09 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.49 1.041 . . . . 0.0 110.418 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.65 142.92 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -130.99 119.24 21.78 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -61.31 -20.63 63.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.499 0.72 . . . . 0.0 112.74 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -52.7 -31.69 38.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.201 1.001 . . . . 0.0 112.42 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.54 25.3 0.51 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.373 0.987 . . . . 0.0 112.885 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.1 p -131.35 169.05 16.53 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.073 1.437 . . . . 0.0 110.606 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -141.82 156.04 45.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.982 2.113 . . . . 0.0 108.104 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -134.2 132.32 39.6 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.03 155.78 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -119.46 123.39 43.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -82.57 151.06 26.57 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.63 -27.1 68.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.673 0.789 . . . . 0.0 112.648 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.05 -23.03 67.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.644 0.777 . . . . 0.0 112.074 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.23 -14.21 8.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.491 1.519 . . . . 0.0 113.108 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.28 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.351 1.075 . . . . 0.0 108.801 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.47 139.06 52.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -153.67 155.38 35.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 110.984 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 m -98.31 138.13 36.01 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.89 171.91 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.093 1.757 . . . . 0.0 108.777 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.3 167.75 10.22 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.35 -0.844 . . . . 0.0 110.403 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -55.08 -37.71 67.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.524 0.73 . . . . 0.0 111.341 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.9 pt -62.79 -10.82 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -109.52 -9.34 14.91 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.234 0.924 . . . . 0.0 112.735 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.05 141.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.733 1.152 . . . . 0.0 111.348 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -146.95 175.2 10.85 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.019 0.928 . . . . 0.0 110.18 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.69 168.09 1.83 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.388 1.075 . . . . 0.0 111.325 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -68.33 -14.79 63.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.818 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.0 m -62.17 120.48 10.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.222 0.919 . . . . 0.0 108.526 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -61.32 -35.75 78.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.2 -42.54 20.64 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -148.86 162.91 38.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.755 0.707 . . . . 0.0 111.961 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -76.73 167.37 21.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 110.214 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.6 mm -129.16 -19.1 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.464 1.505 . . . . 0.0 111.466 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.08 -35.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.412 1.46 . . . . 0.0 112.244 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.86 -30.37 63.01 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -149.77 150.81 32.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.46 64.59 3.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.051 1.341 . . . . 0.0 110.54 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -171.52 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.721 2.008 . . . . 0.0 109.565 -169.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 57.97 -168.11 5.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.09 1.805 . . . . 0.0 116.806 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.6 m -151.09 155.66 39.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.069 2.548 . . . . 0.0 107.045 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -66.08 122.02 16.46 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.03 -163.21 1.58 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.814 1.646 . . . . 0.0 108.472 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -144.9 -179.51 6.65 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 110.9 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 13.8 p -149.38 -178.61 6.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.769 2.028 . . . . 0.0 109.493 -174.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -130.21 6.13 4.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.1 35.87 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.101 1.36 . . . . 0.0 111.812 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.25 152.6 40.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 109.979 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.7 m -68.07 -15.28 63.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.235 1.014 . . . . 0.0 113.214 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -136.55 26.6 3.11 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.132 1.373 . . . . 0.0 111.739 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -57.81 -46.11 85.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -169.685 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 m -137.19 23.84 3.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.812 0.845 . . . . 0.0 111.748 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -125.18 125.93 44.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 169.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.46 129.86 55.9 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.33 1.052 . . . . 0.0 110.929 -167.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.485 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.0 mp0 -142.84 -174.43 4.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.675 1.99 . . . . 0.0 108.48 -177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.88 143.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 60.06 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 112.959 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.5 tp10 -128.34 170.1 13.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.435 1.094 . . . . 0.0 108.263 171.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -77.28 155.59 31.96 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.758 -0.589 . . . . 0.0 112.102 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.45 167.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.551 1.94 . . . . 0.0 108.613 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.4 125.62 43.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.04 138.91 48.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 m -68.82 142.05 54.97 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.355 0.598 . . . . 0.0 110.901 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -119.03 154.93 32.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.765 1.626 . . . . 0.0 108.061 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -58.45 -19.8 39.69 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.64 1.176 . . . . 0.0 113.248 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.24 -47.63 80.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.151 0.981 . . . . 0.0 112.699 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.3 p -168.68 -68.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.896 0.478 . . . . 0.0 112.156 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -158.0 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.234 1.813 . . . . 0.0 109.303 -169.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -46.19 139.23 4.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.608 2.363 . . . . 0.0 115.66 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -145.77 157.51 51.09 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.5 3.12 . . . . 0.0 105.314 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.83 146.22 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.772 1.648 . . . . 0.0 110.869 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.64 162.68 41.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.912 1.685 . . . . 0.0 108.878 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -95.66 135.65 37.07 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.36 137.08 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 p -114.21 -30.88 6.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.279 0.632 . . . . 0.0 110.165 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.81 40.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.499 1.045 . . . . 0.0 110.303 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.36 140.55 41.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -131.06 118.49 20.63 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -59.05 -23.31 61.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.214 1.006 . . . . 0.0 112.475 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.26 -30.43 60.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.741 0.816 . . . . 0.0 112.491 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.17 23.75 0.82 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.567 1.079 . . . . 0.0 112.71 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.7 p -130.89 171.84 12.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.757 1.278 . . . . 0.0 110.382 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.27 154.19 42.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.657 1.983 . . . . 0.0 107.476 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -131.98 131.1 42.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.65 153.94 26.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.17 125.29 49.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.358 1.463 . . . . 0.0 107.332 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.11 151.3 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.45 -23.04 66.22 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.12 -25.0 65.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.971 0.508 . . . . 0.0 111.987 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.0 5.23 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.096 1.332 . . . . 0.0 113.188 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 146.93 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.397 1.098 . . . . 0.0 109.416 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.69 145.16 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -148.67 154.39 39.6 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.195 0.598 . . . . 0.0 110.864 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -107.57 130.74 54.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.29 175.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.335 1.454 . . . . 0.0 109.183 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.88 168.14 10.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.337 -0.852 . . . . 0.0 110.798 -171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.08 -39.85 66.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.046 0.538 . . . . 0.0 111.232 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.87 -8.18 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -113.21 -6.3 13.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.09 139.3 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.145 1.339 . . . . 0.0 111.341 -172.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -147.57 177.29 9.38 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.736 0.815 . . . . 0.0 110.25 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.64 167.23 3.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.135 0.974 . . . . 0.0 110.933 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -69.49 -17.68 63.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.078 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.9 m -63.16 124.44 21.17 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.11 -34.24 71.79 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.81 -68.96 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -149.24 167.78 25.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.093 0.957 . . . . 0.0 110.69 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.5 159.09 33.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 110.843 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -136.6 15.66 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.196 0.998 . . . . 0.0 111.401 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.06 -44.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 120.447 -1.408 . . . . 0.0 111.791 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.91 75.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.124 0.875 . . . . 0.0 110.941 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.97 165.48 31.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.067 2.547 . . . . 0.0 104.435 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.91 16.04 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.458 1.481 . . . . 0.0 114.031 -169.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -79.82 -18.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.899 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.69 179.8 43.48 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 119.153 0.888 . . . . 0.0 112.962 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.8 m -146.71 163.64 35.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.782 1.633 . . . . 0.0 108.698 -169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -64.5 113.71 3.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.16 -166.13 1.76 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.735 1.614 . . . . 0.0 108.67 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -148.23 -173.4 4.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.984 1.314 . . . . 0.0 109.821 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 24.3 p -151.12 176.85 10.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.101 1.761 . . . . 0.0 109.681 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -121.82 -1.61 9.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -71.81 119.04 15.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.74 151.53 41.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.433 1.493 . . . . 0.0 107.141 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' M2L . . . . . 0.437 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -65.69 -30.91 71.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.654 0.781 . . . . 0.0 111.588 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -62.15 -23.23 66.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.941 0.897 . . . . 0.0 112.654 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -68.48 -20.6 64.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.761 0.71 . . . . 0.0 112.083 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -178.485 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.294 0.092 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.8 m 58.52 48.7 11.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.536 1.134 . . . . 0.0 111.075 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -127.85 109.07 11.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -103.03 124.95 49.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.237 1.015 . . . . 0.0 109.819 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.408 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.4 mp0 -144.57 -173.28 4.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.528 1.531 . . . . 0.0 108.908 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.5 141.95 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 58.4 25.03 12.39 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.866 1.667 . . . . 0.0 113.438 -175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.0 tp10 -134.75 162.82 31.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.429 1.092 . . . . 0.0 108.395 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -65.44 150.09 48.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.628 2.371 . . . . 0.0 113.777 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.71 168.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 128.198 2.599 . . . . 0.0 107.961 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.25 127.17 46.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.36 138.45 41.63 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.739 0.816 . . . . 0.0 109.371 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 m -69.11 121.01 15.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 110.712 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -93.45 155.46 17.34 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.745 1.218 . . . . 0.0 108.652 174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -58.64 -20.89 51.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.749 1.22 . . . . 0.0 112.911 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.23 -46.35 83.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.328 1.051 . . . . 0.0 112.634 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -168.57 -68.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.189 0.45 . . . . 0.0 112.146 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.27 -157.79 0.74 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.187 1.795 . . . . 0.0 108.948 -170.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -46.25 138.85 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.615 1.966 . . . . 0.0 115.643 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -145.16 156.82 54.34 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 129.793 3.237 . . . . 0.0 103.988 168.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.57 145.57 52.8 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.449 1.433 . . . . 0.0 110.616 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.11 168.36 27.53 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.797 2.439 . . . . 0.0 107.152 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -110.45 147.92 33.1 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.982 1.265 . . . . 0.0 109.742 169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.35 140.78 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -115.67 -33.24 5.25 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.767 0.827 . . . . 0.0 109.179 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 163.89 38.58 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.166 0.986 . . . . 0.0 110.494 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.7 146.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -134.74 125.25 26.6 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.66 -23.75 63.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.673 0.789 . . . . 0.0 112.11 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.65 -27.65 58.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.552 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.5 21.6 2.2 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.563 1.077 . . . . 0.0 112.212 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 p -125.36 169.11 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.364 1.082 . . . . 0.0 110.02 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.72 153.5 41.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.444 1.898 . . . . 0.0 107.603 -168.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.8 m -132.16 136.16 46.87 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.55 158.59 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -123.89 126.94 47.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.98 154.69 26.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.16 -26.3 68.74 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.143 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.36 -18.85 5.74 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.831 1.205 . . . . 0.0 112.858 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.55 143.47 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 109.619 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.83 144.98 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -150.38 154.4 37.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.03 0.532 . . . . 0.0 110.635 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.44 129.18 55.27 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.91 179.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.536 1.534 . . . . 0.0 109.271 -169.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.95 167.23 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.095 -1.003 . . . . 0.0 110.529 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -54.36 -38.55 66.22 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.539 0.736 . . . . 0.0 110.882 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -63.26 -8.78 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -111.24 -8.03 14.4 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.005 0.922 . . . . 0.0 112.595 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.01 141.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 120.182 1.355 . . . . 0.0 110.992 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -150.12 173.43 13.9 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.421 0.688 . . . . 0.0 110.106 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.05 165.78 0.62 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.238 1.415 . . . . 0.0 111.039 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -67.27 -16.08 64.07 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.703 -0.623 . . . . 0.0 111.911 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 m -62.78 116.16 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.79 -32.98 72.3 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.46 -65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.723 0.809 . . . . 0.0 112.693 -169.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -152.75 162.67 40.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.268 1.427 . . . . 0.0 108.609 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -73.7 166.67 22.87 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.549 0.214 . . . . 0.0 111.027 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.34 -22.42 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.103 0.961 . . . . 0.0 110.954 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.81 -45.32 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 119.645 1.111 . . . . 0.0 110.906 -172.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.7 97.58 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -159.27 154.42 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.923 2.089 . . . . 0.0 105.42 169.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.19 58.37 2.03 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.983 0.913 . . . . 0.0 112.219 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -74.4 -44.73 50.7 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.435 -0.791 . . . . 0.0 110.717 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -94.82 -168.22 36.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.559 1.076 . . . . 0.0 111.731 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.4 t -147.73 177.55 9.21 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.324 1.45 . . . . 0.0 108.168 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -57.28 120.34 7.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.478 0.711 . . . . 0.0 110.469 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.91 -165.16 1.44 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.438 1.895 . . . . 0.0 107.416 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -147.85 -174.0 4.44 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.815 1.246 . . . . 0.0 109.663 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.8 t -145.76 174.12 11.5 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.042 1.337 . . . . 0.0 109.739 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 14.5 m -128.93 4.63 5.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.566 1.547 . . . . 0.0 111.523 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.93 42.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.508 1.123 . . . . 0.0 110.796 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.9 157.95 26.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.838 1.255 . . . . 0.0 109.474 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.3 m -66.32 -31.92 73.0 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 0.0 111.762 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.98 -11.83 60.03 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.92 0.888 . . . . 0.0 112.707 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -140.53 35.27 1.84 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.487 1.115 . . . . 0.0 110.37 -169.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -176.893 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.329 0.109 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -76.35 75.85 3.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.028 1.331 . . . . 0.0 110.907 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.67 134.83 47.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.93 137.38 53.52 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.196 0.998 . . . . 0.0 109.898 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 6.0 mp0 -144.36 -173.98 4.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 109.186 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -53.36 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 61.68 22.33 12.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.495 1.918 . . . . 0.0 113.095 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -127.87 169.28 14.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.18 0.992 . . . . 0.0 108.904 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -68.04 146.96 53.02 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.353 1.461 . . . . 0.0 112.864 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.64 166.34 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.69 1.996 . . . . 0.0 108.085 169.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.53 124.06 47.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.47 140.45 41.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.173 0.989 . . . . 0.0 109.209 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -69.25 111.82 5.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.541 0.736 . . . . 0.0 109.871 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -82.41 152.73 26.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 m -58.46 -20.06 42.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.67 1.188 . . . . 0.0 112.841 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.15 -48.28 76.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.395 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 p -169.82 -67.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.498 0.59 . . . . 0.0 112.367 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.23 -158.12 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.033 1.333 . . . . 0.0 110.208 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -54.25 141.26 30.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.75 1.22 . . . . 0.0 113.254 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -140.75 159.3 63.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 129.174 2.99 . . . . 0.0 105.593 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.77 143.09 72.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.296 1.331 . . . . 0.0 110.262 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.52 165.39 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.99 1.716 . . . . 0.0 108.591 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.05 130.41 47.06 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.6 137.77 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 p -114.12 -30.86 6.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.454 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.49 163.35 39.73 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.174 0.99 . . . . 0.0 110.521 168.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.91 140.88 37.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -132.58 122.87 25.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -58.53 -25.03 62.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.078 0.951 . . . . 0.0 112.488 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -56.74 -28.74 61.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.95 0.9 . . . . 0.0 112.491 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 128.14 22.86 1.34 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.488 1.042 . . . . 0.0 112.677 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 p -127.53 168.51 14.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.633 1.216 . . . . 0.0 110.036 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.54 153.95 43.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.282 1.833 . . . . 0.0 107.465 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -132.04 134.37 45.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.44 158.36 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -122.01 128.99 52.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.641 1.576 . . . . 0.0 107.019 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -87.8 151.62 22.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -61.89 -25.94 67.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.53 -27.2 69.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.674 0.79 . . . . 0.0 112.309 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.07 -14.45 7.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.072 1.32 . . . . 0.0 113.178 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.44 143.96 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.521 1.16 . . . . 0.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.1 143.7 38.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.27 155.68 39.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.278 0.631 . . . . 0.0 110.893 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 m -108.38 130.26 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.61 -179.27 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.408 1.483 . . . . 0.0 109.474 -169.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -103.38 169.37 8.58 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.191 -0.943 . . . . 0.0 110.775 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.14 -37.38 66.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.838 -0.539 . . . . 0.0 111.25 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.68 -5.48 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.025 -1.047 . . . . 0.0 113.551 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -118.41 -10.23 10.2 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.358 1.063 . . . . 0.0 112.287 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.5 t -143.11 141.54 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.904 1.229 . . . . 0.0 111.331 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -147.89 179.15 7.94 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.88 0.872 . . . . 0.0 109.23 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.9 165.6 0.9 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.659 1.184 . . . . 0.0 110.989 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.82 -29.75 70.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.563 169.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.34 115.81 5.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.61 -23.33 67.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -174.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.98 -63.74 1.0 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.66 0.664 . . . . 0.0 112.385 -170.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -153.66 164.29 38.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.035 1.334 . . . . 0.0 109.339 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -75.42 157.57 33.93 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.396 1.079 . . . . 0.0 110.747 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.38 21.99 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.932 0.893 . . . . 0.0 111.722 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.74 -48.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.518 -1.364 . . . . 0.0 111.847 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.76 -34.17 88.02 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -146.07 160.92 41.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.7 67.89 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.825 1.193 . . . . 0.0 110.393 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -123.27 -22.06 5.21 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.24 -179.97 51.72 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.232 0.907 . . . . 0.0 113.671 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.4 m -150.81 166.14 31.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.258 2.623 . . . . 0.0 106.994 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -56.15 128.78 37.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.954 0.797 . . . . 0.0 111.725 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.71 -176.47 5.56 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.023 1.729 . . . . 0.0 108.581 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -155.74 179.11 9.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.613 1.565 . . . . 0.0 109.343 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 74.3 m -129.91 152.34 49.49 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.736 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 p -78.44 -31.47 48.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.523 1.129 . . . . 0.0 112.001 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -67.01 119.21 11.6 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 4.3 pp -160.9 -177.77 6.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 0.0 108.247 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.4 m -74.02 -26.88 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.33 1.052 . . . . 0.0 113.432 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -87.01 14.05 8.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.92 0.888 . . . . 0.0 111.639 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -61.81 150.67 36.48 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.15 -0.969 . . . . 0.0 109.605 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 169.204 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.45 0.167 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m -58.21 139.7 54.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.238 1.015 . . . . 0.0 110.941 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -137.52 0.7 2.29 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 50.33 36.17 12.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.766 1.626 . . . . 0.0 114.102 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 -173.8 4.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.097 0.959 . . . . 0.0 110.521 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.1 143.51 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 60.3 22.58 12.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.235 1.814 . . . . 0.0 113.07 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -130.12 169.28 15.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.365 1.066 . . . . 0.0 108.47 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.92 150.62 48.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.646 1.978 . . . . 0.0 112.719 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.91 163.01 3.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.843 2.457 . . . . 0.0 107.909 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.59 124.4 40.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.652 -2.722 . . . . 0.0 103.652 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.58 137.89 49.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.1 m -68.77 144.78 54.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -123.51 154.92 38.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.975 1.71 . . . . 0.0 108.141 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.9 m -58.13 -20.5 40.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.673 1.189 . . . . 0.0 112.981 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.02 -48.04 79.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.115 0.966 . . . . 0.0 112.627 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.8 p -169.49 -67.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.128 0.571 . . . . 0.0 112.131 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.52 -157.59 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.042 1.737 . . . . 0.0 109.529 -169.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -47.09 140.71 4.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.0 2.12 . . . . 0.0 115.757 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -145.97 157.95 49.6 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 129.306 3.042 . . . . 0.0 105.399 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 144.46 56.8 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.177 1.918 . . . . 0.0 110.743 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.89 165.05 37.3 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.729 1.612 . . . . 0.0 109.247 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -98.98 130.87 45.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.774 1.63 . . . . 0.0 107.611 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.96 137.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.7 p -114.6 -32.61 5.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.321 0.648 . . . . 0.0 110.522 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.32 163.3 39.74 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.415 1.086 . . . . 0.0 110.27 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -138.0 142.47 35.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -129.54 118.89 22.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -61.58 -20.02 62.84 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.427 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.34 -31.62 54.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.915 0.886 . . . . 0.0 112.285 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.94 24.95 0.7 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.564 1.078 . . . . 0.0 112.697 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.3 p -130.83 169.05 16.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.371 1.585 . . . . 0.0 110.424 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -140.53 152.95 45.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.491 1.916 . . . . 0.0 107.636 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -130.8 131.56 44.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.22 155.14 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -118.52 127.8 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.747 1.619 . . . . 0.0 107.05 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -83.19 150.26 26.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -64.42 -24.24 67.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.47 -23.99 65.56 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.08 0.552 . . . . 0.0 112.345 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 131.47 -16.51 5.13 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.716 1.15 . . . . 0.0 113.607 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.59 147.21 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.413 1.107 . . . . 0.0 109.39 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -132.98 144.83 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.86 158.01 43.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.116 0.566 . . . . 0.0 110.739 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -111.8 130.82 55.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.49 176.7 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.192 1.397 . . . . 0.0 109.192 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.89 167.43 10.52 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.043 -1.036 . . . . 0.0 110.474 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.42 -39.6 67.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 0.0 111.135 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.81 -11.88 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -108.34 -5.24 16.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.855 0.862 . . . . 0.0 112.485 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.18 140.58 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.211 1.369 . . . . 0.0 111.858 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -148.37 177.83 9.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.32 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 168.68 1.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 110.51 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -68.43 -17.46 64.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.623 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 124.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.827 0.851 . . . . 0.0 109.191 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -60.17 -32.72 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.43 -61.62 2.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.852 1.261 . . . . 0.0 114.329 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -153.17 167.25 29.92 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.36 1.064 . . . . 0.0 110.535 -169.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -73.77 169.5 17.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.799 0.84 . . . . 0.0 109.302 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.5 mt -131.41 -13.81 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 111.323 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.01 -40.5 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.103 1.32 . . . . 0.0 111.854 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.29 -29.89 75.88 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -151.15 148.44 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.286 2.234 . . . . 0.0 105.313 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.4 -167.45 1.6 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.961 0.904 . . . . 0.0 110.325 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 77.73 -3.06 2.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.443 2.297 . . . . 0.0 114.503 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.35 179.25 53.49 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 119.123 0.874 . . . . 0.0 111.828 169.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.0 m -147.42 155.4 41.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.959 1.703 . . . . 0.0 108.397 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -66.61 131.07 45.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.22 -158.3 0.85 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.37 1.868 . . . . 0.0 107.063 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -144.17 -179.31 6.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.202 1.001 . . . . 0.0 109.87 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 44.9 m -142.07 155.7 45.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.048 1.339 . . . . 0.0 110.194 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 m -80.88 -24.32 38.41 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.72 122.32 17.39 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.211 0.605 . . . . 0.0 109.596 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.5 mt -146.74 151.29 36.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.944 1.698 . . . . 0.0 107.561 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' M2L . . . . . 0.422 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.8 m -66.73 -12.28 57.96 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.125 1.37 . . . . 0.0 113.856 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -122.37 17.92 10.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.706 1.202 . . . . 0.0 112.966 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -129.44 17.63 5.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.072 1.349 . . . . 0.0 110.583 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.467 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -141.11 46.66 1.73 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.732 1.213 . . . . 0.0 109.072 -172.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.17 -5.77 2.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.566 1.147 . . . . 0.0 112.409 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 56.9 35.34 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.954 1.702 . . . . 0.0 112.904 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -82.92 -173.77 4.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.441 1.096 . . . . 0.0 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.0 mt -50.6 142.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 60.62 21.89 11.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.309 1.844 . . . . 0.0 113.35 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -128.34 170.06 13.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.21 1.004 . . . . 0.0 109.136 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -70.46 149.43 47.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.63 1.172 . . . . 0.0 111.359 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.39 166.08 4.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 126.937 2.095 . . . . 0.0 108.324 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -100.73 124.3 46.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.26 138.9 48.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.0 m -69.28 144.87 53.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.474 0.654 . . . . 0.0 110.9 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -121.41 155.54 34.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.782 1.633 . . . . 0.0 107.991 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -58.24 -20.54 42.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.838 1.255 . . . . 0.0 112.994 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.65 -47.5 79.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.057 0.943 . . . . 0.0 112.48 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.4 p -169.13 -67.99 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.924 0.49 . . . . 0.0 112.238 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.21 -158.19 0.78 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.479 1.911 . . . . 0.0 109.047 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -43.96 137.99 3.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.944 2.498 . . . . 0.0 116.048 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -145.86 157.44 50.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.345 3.058 . . . . 0.0 104.943 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 145.14 48.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.912 1.741 . . . . 0.0 110.77 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.13 165.31 36.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.717 1.607 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -98.5 133.1 43.33 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.149 1.38 . . . . 0.0 107.73 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 136.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -113.73 -32.26 6.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.34 0.656 . . . . 0.0 110.306 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.01 38.1 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.604 1.093 . . . . 0.0 110.502 169.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -138.88 140.8 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -129.42 122.81 30.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.22 -21.2 61.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.772 0.829 . . . . 0.0 112.439 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.28 -29.72 61.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.25 23.93 1.09 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.68 1.133 . . . . 0.0 112.608 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 171.48 12.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.627 1.214 . . . . 0.0 110.609 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.99 154.3 43.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.863 2.065 . . . . 0.0 107.764 -169.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -132.23 132.19 42.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.81 154.82 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.88 125.63 50.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.476 1.51 . . . . 0.0 107.423 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.99 150.53 28.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -64.32 -23.64 67.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.08 -27.92 69.43 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.451 0.7 . . . . 0.0 112.068 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.54 -18.74 5.14 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.943 1.259 . . . . 0.0 113.066 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.36 146.3 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.199 1.0 . . . . 0.0 109.588 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.3 144.71 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.51 154.38 40.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.226 0.61 . . . . 0.0 110.276 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -107.46 131.87 53.82 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 169.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.09 175.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.421 1.488 . . . . 0.0 109.375 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -99.32 168.5 9.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.139 -0.975 . . . . 0.0 110.419 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -53.17 -42.38 66.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.728 0.411 . . . . 0.0 111.023 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.6 pt -60.97 -12.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -105.79 -6.31 19.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.548 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 t -141.76 139.4 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.723 1.601 . . . . 0.0 112.686 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -150.3 176.66 10.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.75 169.27 1.92 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -65.69 -16.29 63.61 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.857 -0.527 . . . . 0.0 111.071 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -62.14 119.17 8.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.203 1.401 . . . . 0.0 108.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -59.54 -30.79 68.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.64 -70.3 0.25 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -150.83 173.34 14.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.764 0.792 . . . . 0.0 111.731 -169.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -72.92 154.23 40.64 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.767 1.627 . . . . 0.0 110.888 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.8 mt -139.22 22.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-N 118.872 0.76 . . . . 0.0 111.852 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 -51.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 120.216 -1.553 . . . . 0.0 112.457 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -37.73 94.74 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.592 1.087 . . . . 0.0 111.654 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -152.26 76.1 1.15 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.9 134.09 56.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -150.23 -45.43 0.13 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.938 1.695 . . . . 0.0 110.756 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -90.25 -163.57 39.19 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 122.287 0.937 . . . . 0.0 112.873 -170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.0 m -146.77 146.53 30.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 106.583 -170.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -61.02 132.85 55.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 111.408 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.64 -152.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.695 1.998 . . . . 0.0 106.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -146.11 -175.86 4.93 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.175 0.99 . . . . 0.0 110.486 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 28.5 t -150.82 179.76 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.783 2.033 . . . . 0.0 108.143 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -124.59 0.15 8.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.15 1.38 . . . . 0.0 111.821 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -70.1 114.58 8.4 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.05 157.17 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.742 2.017 . . . . 0.0 106.714 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' M2L . . . . . 0.528 ' SG ' HM1B ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.6 m -65.9 -28.41 68.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.662 0.785 . . . . 0.0 112.488 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -26.24 61.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.596 0.758 . . . . 0.0 111.658 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -64.14 149.67 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.462 0.574 . . . . 0.0 109.824 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.379 0 N-CA-C 107.796 -2.121 . . . . 0.0 107.796 169.56 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -143.41 155.45 44.4 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 109.359 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -142.39 -3.4 1.05 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.553 1.141 . . . . 0.0 111.77 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 51.31 39.82 24.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.412 2.285 . . . . 0.0 113.65 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -83.05 -174.17 5.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.317 1.047 . . . . 0.0 111.849 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.0 mt -53.49 143.86 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.237 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 64.63 -0.24 0.99 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.815 2.446 . . . . 0.0 114.04 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.75 172.04 8.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.755 1.162 . . . . 0.0 109.396 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -69.53 149.02 48.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.711 1.204 . . . . 0.0 110.884 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.94 171.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 127.278 2.231 . . . . 0.0 108.847 169.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.34 128.96 54.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 168.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.24 143.74 44.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 m -69.21 103.07 1.83 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -68.22 156.29 37.92 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -58.57 -19.47 38.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.402 1.081 . . . . 0.0 112.212 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.31 -51.57 69.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.124 0.97 . . . . 0.0 112.906 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 p -169.55 -74.66 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.48 -157.25 0.75 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.676 1.59 . . . . 0.0 109.808 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.63 135.9 46.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.725 1.61 . . . . 0.0 114.691 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.62 162.09 46.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 129.589 3.156 . . . . 0.0 105.375 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.67 146.0 77.59 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 121.724 1.616 . . . . 0.0 110.712 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.93 31.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.457 1.903 . . . . 0.0 109.03 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -102.2 134.26 45.75 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.6 1.56 . . . . 0.0 107.27 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.67 139.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.421 1.009 . . . . 0.0 108.324 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -116.05 -32.27 5.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.927 -0.559 . . . . 0.0 109.794 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.62 162.58 41.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.478 1.035 . . . . 0.0 110.165 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.5 t -137.42 138.26 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -130.49 117.84 20.22 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.28 -20.52 59.41 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.672 0.789 . . . . 0.0 112.763 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.57 -30.75 55.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.842 0.857 . . . . 0.0 112.285 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.26 23.11 0.85 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 124.675 1.131 . . . . 0.0 112.801 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -130.97 171.12 13.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.647 1.223 . . . . 0.0 110.166 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.2 156.26 43.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.795 2.038 . . . . 0.0 107.605 -169.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -134.99 133.53 39.57 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.23 155.64 23.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.98 129.59 55.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.697 1.599 . . . . 0.0 107.051 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -92.64 146.32 23.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -61.67 -21.07 64.11 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -169.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.04 -19.65 65.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.261 0.625 . . . . 0.0 112.288 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.45 46.24 1.34 Allowed Glycine 0 C--N 1.342 0.884 0 C-N-CA 124.184 0.897 . . . . 0.0 110.983 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.81 140.09 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.7 141.66 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.5 153.98 36.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.236 0.614 . . . . 0.0 110.655 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 m -100.05 135.94 40.71 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.3 176.93 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.978 1.711 . . . . 0.0 109.125 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.54 166.84 11.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.096 -1.003 . . . . 0.0 110.715 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -54.81 -38.48 67.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.824 0.849 . . . . 0.0 111.233 171.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.5 pt -61.73 -13.95 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.85 -7.66 19.25 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.253 0.933 . . . . 0.0 112.685 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.76 140.2 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 120.275 1.398 . . . . 0.0 111.173 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -149.07 175.42 11.35 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.259 1.024 . . . . 0.0 109.8 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.0 167.1 1.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.287 1.035 . . . . 0.0 110.931 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.4 -23.7 67.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.103 169.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.2 m -63.15 102.89 0.42 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.89 -24.78 66.23 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.72 -54.19 42.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.209 1.004 . . . . 0.0 112.516 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -154.91 157.63 38.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.45 1.1 . . . . 0.0 110.912 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -73.73 153.69 39.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 109.253 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.93 21.75 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 124.031 0.932 . . . . 0.0 111.557 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.38 -41.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 120.67 -1.269 . . . . 0.0 110.975 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -21.13 79.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.602 0.637 . . . . 0.0 111.95 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -142.67 152.13 42.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.964 2.105 . . . . 0.0 106.045 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.47 2.05 35.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -108.23 2.64 22.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.341 0.973 . . . . 0.0 113.471 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.24 175.25 36.34 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.859 0.754 . . . . 0.0 112.921 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 m -148.22 159.5 43.91 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.646 1.578 . . . . 0.0 109.274 -169.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -59.11 141.58 53.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.105 0.562 . . . . 0.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.79 179.14 8.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 108.278 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -171.38 -152.4 0.08 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.728 1.611 . . . . 0.0 108.161 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 34.0 m 58.78 42.1 20.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.013 1.325 . . . . 0.0 110.817 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m -85.69 170.59 12.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.231 2.212 . . . . 0.0 110.878 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -63.68 146.84 53.05 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.831 -0.543 . . . . 0.0 110.061 170.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 89.3 mt -142.58 152.27 42.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 107.474 173.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 5.1 p -66.03 -33.84 76.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -64.81 -21.21 66.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.96 0.904 . . . . 0.0 111.951 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 373' ' ' LYS . 0.6 OUTLIER -61.27 -29.87 70.12 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.887 0.767 . . . . 0.0 111.349 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -177.829 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.0 m -144.75 26.64 1.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.478 1.111 . . . . 0.0 112.007 -170.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.09 131.61 35.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -116.84 136.68 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.362 1.065 . . . . 0.0 109.179 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.6 mp0 -144.35 -173.48 4.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.518 1.927 . . . . 0.0 108.63 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.91 142.67 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 61.59 21.78 12.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.115 1.766 . . . . 0.0 113.411 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.2 tp10 -128.12 170.29 13.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.538 1.135 . . . . 0.0 108.372 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.08 146.11 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.576 1.55 . . . . 0.0 112.3 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.42 173.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 127.735 2.414 . . . . 0.0 108.534 172.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.1 mt -107.36 129.23 54.94 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 141.15 42.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.99 0.916 . . . . 0.0 109.463 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.2 m -70.24 102.83 2.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.317 1.047 . . . . 0.0 110.525 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -68.21 154.44 41.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -59.56 -17.98 37.1 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.361 1.064 . . . . 0.0 113.049 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.13 -50.13 73.75 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.441 0.697 . . . . 0.0 111.911 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -171.96 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.28 0.632 . . . . 0.0 111.947 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.36 -160.51 1.18 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 111.385 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.79 134.97 36.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.919 2.088 . . . . 0.0 115.936 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -140.61 159.48 62.75 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 129.173 2.989 . . . . 0.0 105.342 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.82 144.97 79.37 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.718 1.612 . . . . 0.0 110.536 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.83 165.14 36.33 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.774 1.63 . . . . 0.0 109.084 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -98.69 131.11 45.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.133 1.373 . . . . 0.0 107.366 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.11 138.35 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 p -114.7 -31.3 6.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.513 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.98 163.06 40.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.581 1.082 . . . . 0.0 110.257 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -134.98 142.3 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -133.4 112.23 11.42 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.71 -19.97 53.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.716 0.806 . . . . 0.0 112.833 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.71 -31.64 38.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.079 0.952 . . . . 0.0 112.454 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.83 18.96 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.527 1.061 . . . . 0.0 113.052 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.7 p -129.8 170.13 14.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.923 1.361 . . . . 0.0 110.164 -170.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.66 154.81 41.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.904 1.682 . . . . 0.0 107.396 -169.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -131.69 134.83 46.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.4 m -142.32 158.85 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.23 125.23 44.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.274 1.43 . . . . 0.0 107.184 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.58 151.18 26.5 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -64.81 -24.34 67.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.71 -26.5 68.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.6 0.76 . . . . 0.0 112.247 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.32 -13.95 6.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.976 1.274 . . . . 0.0 113.306 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.47 143.05 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.445 1.122 . . . . 0.0 109.141 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.69 144.1 38.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.38 153.31 33.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.289 0.635 . . . . 0.0 110.673 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -108.58 128.55 54.93 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.02 -178.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.133 1.373 . . . . 0.0 109.227 -168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.76 169.28 8.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.003 -1.06 . . . . 0.0 110.845 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.0 -37.21 68.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.074 0.55 . . . . 0.0 111.043 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.97 -5.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 120.882 -1.136 . . . . 0.0 113.509 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -118.94 -12.83 9.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.381 1.073 . . . . 0.0 112.145 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.41 138.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.255 1.389 . . . . 0.0 110.588 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -147.37 176.69 9.82 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.71 0.804 . . . . 0.0 109.47 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.58 168.1 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.074 0.949 . . . . 0.0 110.714 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -28.04 69.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.247 170.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -64.39 116.52 6.16 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.698 0.799 . . . . 0.0 109.168 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -65.85 -24.73 66.94 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -84.14 -36.49 22.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -146.86 165.0 31.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 110.624 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.08 169.19 14.17 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.3 mm -129.18 -13.75 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 124.819 1.248 . . . . 0.0 111.393 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.66 -36.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.54 1.518 . . . . 0.0 112.971 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.05 -30.24 77.2 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.605 1.093 . . . . 0.0 110.642 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -151.2 153.86 35.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.396 2.678 . . . . 0.0 104.28 169.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.65 12.23 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.98 1.264 . . . . 0.0 114.327 -169.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.44 -6.28 59.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.168 0.894 . . . . 0.0 112.266 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.4 -177.91 41.73 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 121.962 0.757 . . . . 0.0 114.04 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -148.21 165.88 29.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.326 1.451 . . . . 0.0 109.53 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -72.28 135.32 45.95 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.511 -0.743 . . . . 0.0 110.571 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -152.15 -171.27 3.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.246 1.818 . . . . 0.0 107.465 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -154.76 -178.73 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.577 1.551 . . . . 0.0 108.762 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 77.6 p -143.2 175.91 9.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.359 1.064 . . . . 0.0 109.931 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 p -116.44 -0.6 12.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.615 1.166 . . . . 0.0 113.232 -169.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -80.98 44.58 0.77 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.592 1.087 . . . . 0.0 110.529 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.31 144.83 48.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.7 m -62.92 -27.69 69.55 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.459 1.104 . . . . 0.0 113.276 -172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -63.89 -25.33 68.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.745 -0.597 . . . . 0.0 112.347 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 373' ' ' LYS . 10.9 mmpt? -68.96 -15.88 63.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.363 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.108 -174.899 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.32 0.105 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.4 m -63.63 151.47 41.61 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.817 0.847 . . . . 0.0 110.728 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -137.62 -15.72 1.38 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.603 1.561 . . . . 0.0 111.508 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 72.18 83.26 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.296 2.638 . . . . 0.0 113.06 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -139.23 -173.65 3.65 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.73 1.612 . . . . 0.0 109.512 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.1 mt -48.96 141.94 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.476 1.11 . . . . 0.0 109.467 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.49 22.25 11.93 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.091 1.756 . . . . 0.0 113.29 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -127.62 170.27 12.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.235 1.014 . . . . 0.0 108.805 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -74.03 149.65 41.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.778 1.231 . . . . 0.0 111.516 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.45 168.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.787 2.035 . . . . 0.0 108.059 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -101.69 130.92 48.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.61 140.2 44.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.997 0.919 . . . . 0.0 109.014 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.1 m -69.73 102.59 1.94 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.815 0.846 . . . . 0.0 110.711 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.91 153.39 41.88 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -58.19 -20.48 41.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.048 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.21 -48.03 77.24 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.09 0.956 . . . . 0.0 112.396 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.8 p -169.59 -72.75 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.586 0.354 . . . . 0.0 111.615 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 -156.14 0.69 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.135 1.374 . . . . 0.0 110.012 -173.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -49.31 139.71 11.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.914 1.686 . . . . 0.0 115.047 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -146.33 156.51 49.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 130.12 3.368 . . . . 0.0 104.246 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.3 147.13 71.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.521 1.481 . . . . 0.0 110.968 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.34 164.69 36.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.182 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -95.24 132.63 40.01 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.526 1.53 . . . . 0.0 107.691 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.26 135.72 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.7 p -112.66 -33.57 6.08 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.849 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.19 164.67 36.87 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 110.723 168.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.58 142.31 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -131.39 119.21 21.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -61.24 -19.76 62.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.409 0.684 . . . . 0.0 112.556 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.6 -30.76 44.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 112.296 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.79 20.54 0.76 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.556 1.074 . . . . 0.0 112.967 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -129.3 169.82 14.38 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.72 1.26 . . . . 0.0 110.394 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -143.44 155.82 44.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.954 2.102 . . . . 0.0 107.728 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -133.0 131.81 41.16 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -140.04 157.32 25.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -122.09 122.83 40.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -78.24 150.24 33.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -64.18 -25.34 68.03 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.08 -26.83 68.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.629 0.772 . . . . 0.0 112.265 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.4 -16.83 5.93 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.102 1.334 . . . . 0.0 113.033 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.14 143.4 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.255 1.027 . . . . 0.0 109.356 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.67 144.41 38.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -152.05 155.9 38.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.269 0.628 . . . . 0.0 110.474 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -109.96 129.79 55.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.37 179.58 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.405 1.482 . . . . 0.0 109.677 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.32 168.51 9.29 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.08 0.952 . . . . 0.0 110.758 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -55.43 -36.83 66.92 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.795 -0.566 . . . . 0.0 111.321 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.8 pt -64.23 -5.06 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -118.05 -11.04 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.315 1.046 . . . . 0.0 112.484 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.91 141.07 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 120.263 1.392 . . . . 0.0 110.991 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -150.47 172.33 15.62 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.305 1.042 . . . . 0.0 109.703 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 166.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.778 1.231 . . . . 0.0 111.59 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -68.1 -8.58 39.35 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.56 -0.713 . . . . 0.0 111.541 169.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -67.97 117.28 9.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.71 -44.27 90.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 112.121 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.62 -67.02 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -151.23 163.36 39.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.741 1.216 . . . . 0.0 109.353 -170.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -84.54 164.18 18.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.075 0.55 . . . . 0.0 111.882 -170.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.7 15.01 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.759 0.824 . . . . 0.0 112.183 -173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.05 158.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 120.397 -1.44 . . . . 0.0 107.413 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.53 3.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.708 1.147 . . . . 0.0 111.992 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -143.72 65.86 1.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.926 2.09 . . . . 0.0 106.259 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.47 132.09 52.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.383 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.89 -2.33 0.93 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.149 0.979 . . . . 0.0 113.035 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.38 -159.29 9.13 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.42 1.009 . . . . 0.0 112.794 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.8 m -139.4 164.69 29.18 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.06 1.744 . . . . 0.0 109.84 -169.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -60.7 145.3 49.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.2 -165.39 1.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.161 2.584 . . . . 0.0 107.1 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.94 169.94 17.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.269 1.028 . . . . 0.0 109.658 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 36.7 m -135.23 179.98 5.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.97 1.308 . . . . 0.0 111.056 -170.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.8 m -134.65 6.17 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.726 0.81 . . . . 0.0 113.039 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -75.88 24.82 0.12 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.408 1.483 . . . . 0.0 112.933 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.71 145.82 43.57 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 109.625 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.3 m -63.82 -31.34 72.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.431 0.692 . . . . 0.0 112.127 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -67.16 -22.28 65.77 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.711 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -68.44 -22.26 64.6 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.815 0.734 . . . . 0.0 111.995 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.999 -1.641 . . . . 0.0 108.999 -179.528 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.38 0.133 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 m -61.76 152.4 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.967 0.907 . . . . 0.0 110.848 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.18 -12.09 1.66 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.742 1.617 . . . . 0.0 111.552 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 72.22 80.96 0.14 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.033 2.533 . . . . 0.0 113.279 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.57 -174.77 3.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.091 1.356 . . . . 0.0 109.523 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.0 mt -53.2 143.58 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.58 17.1 10.15 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.952 1.701 . . . . 0.0 113.258 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -123.27 173.24 8.06 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -84.37 156.45 21.84 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.408 -0.807 . . . . 0.0 111.302 -169.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.97 167.51 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.305 1.842 . . . . 0.0 109.05 170.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.97 127.35 41.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.36 144.14 38.07 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.455 0.702 . . . . 0.0 109.644 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -68.83 108.44 3.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.396 0.679 . . . . 0.0 109.883 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -73.29 162.56 29.22 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.987 0.915 . . . . 0.0 109.726 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 m -58.0 -19.64 32.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.568 1.147 . . . . 0.0 112.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.43 -23.15 56.65 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 113.334 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.2 m 110.7 8.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 130.151 3.38 . . . . 0.0 114.898 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -153.64 -176.93 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.555 1.07 . . . . 0.0 111.229 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.89 140.07 53.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -142.02 158.34 62.04 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 128.341 2.656 . . . . 0.0 106.074 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.23 145.61 73.04 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.612 1.541 . . . . 0.0 111.206 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.31 156.89 37.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.171 1.789 . . . . 0.0 109.044 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.54 133.51 34.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.907 1.283 . . . . 0.0 108.391 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.46 133.77 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 p -111.55 -32.56 6.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.031 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 164.4 38.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.721 1.146 . . . . 0.0 110.676 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.13 141.42 33.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -129.57 128.0 41.84 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.73 -24.49 61.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.805 0.842 . . . . 0.0 112.47 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.29 -27.59 55.92 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 112.732 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.07 19.07 2.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.636 1.112 . . . . 0.0 112.705 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.2 p -123.54 168.98 11.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.502 1.151 . . . . 0.0 110.116 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.05 153.36 42.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 106.965 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -133.26 135.7 45.08 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.94 159.69 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -123.96 120.63 33.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -77.03 150.04 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -64.89 -23.55 67.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -63.39 -24.44 67.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.392 0.677 . . . . 0.0 112.435 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.98 -14.56 7.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.02 1.295 . . . . 0.0 113.009 173.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.48 143.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.288 1.044 . . . . 0.0 108.992 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.76 143.61 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -151.18 155.47 38.94 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.056 0.543 . . . . 0.0 110.699 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -108.97 131.48 55.01 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.01 178.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.748 1.619 . . . . 0.0 108.902 -169.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.69 165.7 12.58 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.018 -1.051 . . . . 0.0 110.496 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.54 -37.07 64.97 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.856 0.862 . . . . 0.0 111.016 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.36 -11.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.005 -1.059 . . . . 0.0 113.547 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -106.6 -8.99 16.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 112.636 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.59 139.54 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.437 1.017 . . . . 0.0 110.99 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -152.12 175.03 13.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.944 0.498 . . . . 0.0 110.682 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.17 165.35 0.52 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.331 1.453 . . . . 0.0 111.728 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -64.25 -16.7 62.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.843 -0.536 . . . . 0.0 111.844 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 m -62.14 116.25 4.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.41 1.084 . . . . 0.0 108.983 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.26 -28.3 67.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.37 -76.76 0.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.153 0.581 . . . . 0.0 111.812 -171.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.18 165.36 29.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 0.0 109.537 -170.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.92 163.58 25.14 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.176 0.512 . . . . 0.0 112.329 -171.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 mt -129.7 28.29 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 124.958 1.303 . . . . 0.0 108.606 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.32 160.46 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.45 1.9 . . . . 0.0 106.207 175.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.66 -62.43 3.53 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.867 1.222 . . . . 0.0 111.716 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -142.0 72.22 1.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.28 130.47 46.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.47 -21.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -171.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.76 -171.17 47.44 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 121.955 0.753 . . . . 0.0 111.832 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.3 m -146.24 159.9 42.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.643 1.977 . . . . 0.0 108.03 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -56.38 127.93 33.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.767 0.427 . . . . 0.0 111.113 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.1 -164.52 1.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.44 1.896 . . . . 0.0 107.4 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -145.23 -180.0 7.01 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 109.748 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 t -142.15 175.34 9.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.355 1.462 . . . . 0.0 108.889 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.2 m -133.0 -10.16 3.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -79.73 111.08 15.68 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 170.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 3.7 pp -153.75 -179.52 7.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 110.301 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 m -66.1 -23.93 66.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 113.518 -170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -78.29 65.91 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.095 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.09 -15.16 63.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.121 0.969 . . . . 0.0 112.092 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.684 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.538 0.208 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -34.56 75.51 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 61.71 -8.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.675 1.99 . . . . 0.0 115.354 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 17.3 m-85 55.14 36.27 26.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.656 1.583 . . . . 0.0 114.155 169.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -82.24 -173.35 4.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.578 0.751 . . . . 0.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.94 142.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 61.87 21.49 12.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.384 1.873 . . . . 0.0 113.337 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.19 170.19 13.28 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.354 1.062 . . . . 0.0 109.192 171.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.19 149.07 50.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.006 2.122 . . . . 0.0 112.534 -174.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.31 164.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 127.932 2.493 . . . . 0.0 108.525 171.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.48 130.21 42.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 168.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.66 145.12 38.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.517 0.727 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -69.02 116.09 9.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.906 0.482 . . . . 0.0 109.714 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -79.62 164.25 23.96 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.224 1.01 . . . . 0.0 110.597 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.9 m -57.23 -24.3 53.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.841 0.856 . . . . 0.0 112.33 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.77 -4.07 18.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.092 1.357 . . . . 0.0 113.459 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.4 m 75.28 156.86 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.633 2.773 . . . . 0.0 111.593 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.65 176.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.079 2.551 . . . . 0.0 115.425 -169.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -71.12 148.53 47.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -144.48 162.32 39.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 129.337 3.055 . . . . 0.0 106.01 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.33 145.89 61.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.892 1.728 . . . . 0.0 110.721 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.58 33.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.536 1.935 . . . . 0.0 108.748 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -101.58 133.78 45.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 107.414 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.79 136.67 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 p -114.02 -32.9 5.9 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.278 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.21 35.28 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.263 0.938 . . . . 0.0 110.63 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.3 t -141.65 140.56 30.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -130.63 123.66 29.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -60.08 -22.97 63.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.722 0.809 . . . . 0.0 112.568 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.27 -28.62 59.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.877 . . . . 0.0 112.278 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.51 22.32 1.2 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.769 1.176 . . . . 0.0 112.782 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.6 p -127.12 169.42 13.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.786 1.293 . . . . 0.0 110.271 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -142.45 156.41 45.18 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.905 2.082 . . . . 0.0 108.022 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -133.92 134.83 43.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.56 157.57 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.85 131.33 53.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.442 1.497 . . . . 0.0 107.186 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.67 148.57 23.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.41 -24.28 66.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -169.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.56 -30.47 71.5 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.298 0.639 . . . . 0.0 112.386 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.23 -15.31 4.23 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.46 1.029 . . . . 0.0 113.545 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.58 143.88 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 109.348 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.0 145.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.46 157.43 42.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.153 0.581 . . . . 0.0 110.719 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -108.74 131.92 54.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.15 178.6 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.307 1.443 . . . . 0.0 109.518 -169.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.71 167.11 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.141 -0.974 . . . . 0.0 110.502 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.28 -39.21 66.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.498 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.7 pt -61.51 -13.38 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -104.25 -8.69 19.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.112 -0.946 . . . . 0.0 112.637 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.8 140.5 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.818 1.19 . . . . 0.0 111.863 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -150.13 177.86 9.51 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 110.34 171.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -60.49 167.97 2.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.026 0.93 . . . . 0.0 111.096 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -69.29 -17.27 63.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.37 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -63.01 122.98 17.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.73 -37.86 77.1 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.354 0.662 . . . . 0.0 112.158 -173.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.6 -69.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -149.7 168.8 22.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.877 0.871 . . . . 0.0 111.204 -169.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.5 155.06 34.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.653 1.581 . . . . 0.0 110.83 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.32 21.27 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 123.987 0.915 . . . . 0.0 112.067 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.98 -46.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.192 -1.567 . . . . 0.0 112.078 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.83 -32.49 82.99 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -145.84 162.9 36.63 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.28 56.24 1.04 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.39 1.45 . . . . 0.0 112.044 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.94 -19.14 9.29 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.95 -177.17 51.44 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 122.277 0.931 . . . . 0.0 112.676 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.7 m -148.67 165.17 32.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.246 2.218 . . . . 0.0 107.388 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -61.33 120.68 10.91 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.394 -0.816 . . . . 0.0 110.154 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -155.01 -170.91 3.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.185 2.194 . . . . 0.0 107.327 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -150.19 171.63 16.61 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.903 0.881 . . . . 0.0 110.179 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.7 m -138.1 178.09 7.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.567 1.547 . . . . 0.0 110.212 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.5 m -127.92 8.77 6.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.88 31.73 0.37 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.404 1.081 . . . . 0.0 111.732 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.84 168.06 8.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.789 1.236 . . . . 0.0 110.589 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.8 m -62.99 -28.85 70.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.391 1.076 . . . . 0.0 112.422 -177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -64.04 -30.07 71.17 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.756 -0.59 . . . . 0.0 111.357 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -79.3 -6.59 57.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.567 0.747 . . . . 0.0 112.092 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.542 -1.144 . . . . 0.0 110.251 177.187 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.423 0.154 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -142.41 37.55 1.52 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.72 1.208 . . . . 0.0 110.348 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.94 115.2 17.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -107.55 127.83 53.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.47 1.108 . . . . 0.0 109.784 -169.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.7 mp0 -144.39 -173.79 4.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.664 1.586 . . . . 0.0 109.257 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.4 mt -51.51 143.71 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.68 22.11 12.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.27 1.828 . . . . 0.0 113.422 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -130.13 169.57 15.16 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.345 1.058 . . . . 0.0 108.83 171.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.4 146.3 53.34 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.779 2.032 . . . . 0.0 112.689 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.29 171.88 5.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 0.0 107.915 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.7 mt -109.82 124.4 51.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 138.97 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.145 0.978 . . . . 0.0 108.649 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.9 m -69.09 134.87 49.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -109.73 156.95 19.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.282 1.433 . . . . 0.0 108.442 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -58.64 -19.78 41.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.503 1.121 . . . . 0.0 112.863 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.57 -50.19 70.74 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.103 0.961 . . . . 0.0 112.461 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -170.68 -67.5 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.94 0.496 . . . . 0.0 111.845 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -155.26 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.732 1.613 . . . . 0.0 109.675 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -51.81 139.08 22.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.897 2.079 . . . . 0.0 115.78 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -142.87 157.34 61.49 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 128.914 2.885 . . . . 0.0 105.582 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.73 145.73 64.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 120.985 1.124 . . . . 0.0 111.092 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.04 164.52 37.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.449 1.5 . . . . 0.0 109.356 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -97.63 132.16 43.54 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.381 1.473 . . . . 0.0 107.789 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.62 138.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 p -115.07 -32.34 5.75 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.249 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 164.86 36.63 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.572 1.078 . . . . 0.0 110.465 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.59 141.65 32.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.27 113.97 13.24 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.7 -19.67 59.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.322 0.649 . . . . 0.0 112.517 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.22 -30.47 38.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.064 0.946 . . . . 0.0 112.421 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.57 22.56 0.61 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.399 1.0 . . . . 0.0 112.743 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.4 p -131.85 169.64 15.97 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.059 1.429 . . . . 0.0 110.589 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -144.37 153.0 41.5 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.496 1.918 . . . . 0.0 107.215 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -130.8 134.07 46.53 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 170.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.12 155.26 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -118.48 125.93 50.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.668 1.587 . . . . 0.0 107.003 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.76 151.69 27.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -65.83 -22.76 66.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.67 -27.49 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.141 0.577 . . . . 0.0 112.196 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.7 -17.74 5.21 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.882 1.23 . . . . 0.0 113.09 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.13 146.07 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.232 1.013 . . . . 0.0 109.478 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.03 144.65 36.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.16 154.3 38.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.188 0.595 . . . . 0.0 110.851 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -108.37 130.23 55.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.79 175.84 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.377 1.471 . . . . 0.0 108.758 -169.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -97.53 168.39 10.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.008 -1.058 . . . . 0.0 110.543 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.53 -39.03 67.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.432 0.693 . . . . 0.0 111.086 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.79 -6.61 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -114.3 -7.67 12.93 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 112.622 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.5 140.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 120.283 1.401 . . . . 0.0 111.71 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -149.42 174.24 12.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.088 0.955 . . . . 0.0 109.958 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.21 168.75 0.67 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.453 1.101 . . . . 0.0 111.265 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -63.13 -20.6 65.52 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.551 -0.718 . . . . 0.0 110.743 169.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.8 m -62.38 123.73 19.03 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.161 0.984 . . . . 0.0 110.561 170.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -60.68 -40.36 91.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.823 0.849 . . . . 0.0 112.128 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.96 -67.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -150.61 168.04 25.5 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.028 0.931 . . . . 0.0 111.049 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.23 156.72 38.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.204 1.402 . . . . 0.0 110.782 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -139.75 24.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.958 0.903 . . . . 0.0 111.44 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.44 -60.66 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 120.603 -1.311 . . . . 0.0 109.93 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.33 -34.38 85.08 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -136.39 163.28 30.83 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.972 2.109 . . . . 0.0 105.779 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.73 18.11 9.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 114.137 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -79.57 -18.11 52.44 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.467 -0.777 . . . . 0.0 112.714 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.75 175.79 51.5 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 119.465 1.03 . . . . 0.0 113.114 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.8 m -149.98 163.77 37.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 107.761 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -61.45 132.04 52.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.477 -0.764 . . . . 0.0 111.279 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.21 -172.46 3.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.551 1.94 . . . . 0.0 108.355 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -146.42 168.72 20.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.538 1.135 . . . . 0.0 110.189 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 15.5 m -135.5 161.96 34.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.894 1.278 . . . . 0.0 109.171 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 p -106.39 -25.98 11.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -73.81 129.12 37.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 109.295 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.65 174.37 15.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.871 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' M2L . . . . . 0.465 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.0 m -66.26 -16.64 64.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 113.826 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -129.74 12.32 5.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.289 1.036 . . . . 0.0 113.075 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.73 144.73 56.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 173.914 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m 58.08 51.82 8.33 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.483 1.513 . . . . 0.0 112.373 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -98.02 13.13 31.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.822 1.249 . . . . 0.0 112.727 -170.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.429 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.9 m-85 72.79 71.49 0.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.212 1.805 . . . . 0.0 113.65 169.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -121.95 -174.29 2.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.742 1.617 . . . . 0.0 109.616 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.51 142.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 60.81 24.14 14.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.723 1.609 . . . . 0.0 113.185 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.27 169.78 13.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.676 1.191 . . . . 0.0 108.137 170.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.74 155.12 40.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.853 0.861 . . . . 0.0 112.603 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.32 164.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.275 2.23 . . . . 0.0 107.902 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.56 128.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.15 141.03 46.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 108.84 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.0 m -69.62 117.53 11.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.21 0.604 . . . . 0.0 109.684 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -84.21 162.56 20.14 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.722 1.209 . . . . 0.0 109.403 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -55.65 -20.12 12.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.071 1.348 . . . . 0.0 112.987 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.35 -51.88 18.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.356 1.463 . . . . 0.0 112.048 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m 161.66 -46.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.74 2.816 . . . . 0.0 111.252 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.38 -168.0 2.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.056 0.844 . . . . 0.0 113.027 -169.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -54.31 141.77 28.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.083 2.153 . . . . 0.0 116.367 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -149.7 160.26 34.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 130.085 3.354 . . . . 0.0 105.168 168.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.16 147.3 66.44 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.489 1.459 . . . . 0.0 110.937 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.43 162.96 40.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.642 1.977 . . . . 0.0 108.952 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -91.47 133.66 35.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.174 1.39 . . . . 0.0 107.578 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.97 134.46 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -111.39 -31.94 6.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.698 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.57 160.74 43.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.592 1.087 . . . . 0.0 110.446 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.3 140.1 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 170.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -132.33 111.95 11.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -62.19 -16.35 52.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.728 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -53.47 -31.46 45.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.732 0.813 . . . . 0.0 112.071 169.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.19 18.18 0.75 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.837 1.208 . . . . 0.0 112.722 174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.1 p -129.41 172.16 11.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.735 1.267 . . . . 0.0 110.256 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -145.98 154.79 42.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.692 1.997 . . . . 0.0 107.178 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -133.0 133.65 43.41 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.87 157.78 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -122.98 124.67 43.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.225 1.41 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -80.09 149.64 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -65.54 -25.37 67.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.32 -25.65 66.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.318 0.647 . . . . 0.0 112.153 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.99 3.94 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.449 1.023 . . . . 0.0 113.766 171.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.61 144.99 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.204 1.002 . . . . 0.0 109.437 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.91 143.95 39.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -149.41 155.03 39.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.826 0.451 . . . . 0.0 110.826 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 128.84 55.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 m -147.44 178.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.133 1.373 . . . . 0.0 109.183 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.3 169.06 10.03 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.229 -0.919 . . . . 0.0 110.837 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -55.55 -38.58 69.49 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.043 0.537 . . . . 0.0 111.042 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.37 -6.32 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.979 -1.076 . . . . 0.0 113.532 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -115.48 -8.5 12.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 112.453 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.5 139.63 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 120.377 1.444 . . . . 0.0 110.932 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.02 172.7 14.32 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.992 0.917 . . . . 0.0 110.012 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -54.65 166.39 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 111.18 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -67.11 -11.44 57.2 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.406 -0.809 . . . . 0.0 111.118 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 121.29 13.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 109.299 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.65 -44.5 90.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.547 0.739 . . . . 0.0 110.848 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -57.39 -61.29 2.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.263 1.425 . . . . 0.0 113.578 -169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -154.87 164.77 38.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.217 1.407 . . . . 0.0 108.373 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.19 171.34 13.15 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.97 -69.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.644 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.33 -19.98 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 121.085 1.766 . . . . 0.0 114.356 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.02 19.56 29.91 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.404 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -152.84 -41.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.907 1.354 . . . . 0.0 113.381 -170.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 60.01 8.86 1.57 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.077 2.551 . . . . 0.0 116.651 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -108.09 -23.67 11.88 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.069 1.304 . . . . 0.0 111.12 173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.81 171.72 25.92 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 122.124 0.847 . . . . 0.0 113.055 174.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.5 m -146.38 159.67 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.876 1.671 . . . . 0.0 109.015 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.95 130.42 45.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.07 -168.54 3.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.317 1.847 . . . . 0.0 107.415 170.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -146.13 167.28 23.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.968 0.907 . . . . 0.0 109.875 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 20.4 m -136.8 -178.05 5.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.67 1.188 . . . . 0.0 111.047 -170.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 10.7 m -132.64 6.87 4.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -76.41 28.53 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.617 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 77.5 mt -62.32 149.54 41.85 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' M2L . . . . . 0.433 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 15.2 m 77.3 -26.79 0.18 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.72 2.808 . . . . 0.0 112.115 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -63.13 -46.31 87.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -82.8 147.77 28.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.398 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -178.735 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -138.6 18.11 2.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.167 0.987 . . . . 0.0 111.234 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.14 109.86 7.55 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -109.46 126.53 53.59 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.623 1.169 . . . . 0.0 109.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.4 mp0 -140.15 -174.03 3.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.686 1.594 . . . . 0.0 108.564 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -47.94 140.97 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.174 0.99 . . . . 0.0 108.504 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 59.5 25.66 14.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.5 1.92 . . . . 0.0 112.926 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -136.04 162.4 33.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.247 1.019 . . . . 0.0 108.976 172.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -65.41 146.21 55.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.588 2.355 . . . . 0.0 113.903 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.84 171.99 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 127.558 2.343 . . . . 0.0 108.487 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.49 124.06 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.68 141.61 47.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.895 0.878 . . . . 0.0 109.069 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 m -69.05 103.77 1.95 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -69.42 155.15 40.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.2 m -58.22 -20.79 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 112.383 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -58.74 -48.91 79.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.296 1.038 . . . . 0.0 113.07 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 p -168.83 -71.61 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -161.62 1.38 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.388 1.875 . . . . 0.0 109.348 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -51.57 136.15 26.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.9 161.61 42.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 129.377 3.071 . . . . 0.0 104.654 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.18 147.22 59.69 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.955 1.77 . . . . 0.0 111.007 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.7 169.22 25.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.858 2.463 . . . . 0.0 107.132 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.07 146.35 41.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.55 1.068 . . . . 0.0 109.735 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.5 142.45 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.021 0.928 . . . . 0.0 108.555 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 p -119.11 -28.64 5.43 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.809 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.93 158.99 43.92 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 119.523 1.056 . . . . 0.0 110.087 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.5 143.05 38.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -134.08 116.74 15.81 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.35 -19.75 62.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.341 0.656 . . . . 0.0 112.409 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.84 -30.51 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.889 0.876 . . . . 0.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.96 23.54 0.77 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.537 1.065 . . . . 0.0 112.691 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.4 p -131.66 169.34 16.3 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.442 1.621 . . . . 0.0 110.46 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.41 150.99 37.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.387 1.875 . . . . 0.0 108.053 -169.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 m -130.59 134.41 46.97 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.05 156.84 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -119.98 127.04 52.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.28 146.4 26.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -60.91 -25.86 67.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -169.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.33 -29.34 70.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.979 0.512 . . . . 0.0 112.195 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.02 -19.07 3.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.47 1.033 . . . . 0.0 113.148 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.45 141.31 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.319 1.047 . . . . 0.0 109.643 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.92 142.3 43.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.01 157.85 39.69 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.895 0.478 . . . . 0.0 110.793 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 84.7 m -106.64 136.66 46.04 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.28 179.97 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.707 2.003 . . . . 0.0 108.375 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.06 168.13 10.46 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.51 -39.05 67.21 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.808 0.843 . . . . 0.0 111.272 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.48 -9.79 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -110.44 -7.24 14.79 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.05 0.94 . . . . 0.0 112.677 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 t -141.95 142.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.873 1.215 . . . . 0.0 111.081 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -148.61 179.03 8.13 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.034 0.934 . . . . 0.0 109.543 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.26 166.62 0.8 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.692 1.197 . . . . 0.0 110.833 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.29 -28.58 69.82 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.492 169.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -64.1 118.37 8.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.746 0.819 . . . . 0.0 109.154 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.21 -24.47 67.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.67 -62.42 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -154.39 167.07 31.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.92 1.288 . . . . 0.0 109.864 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.13 165.96 24.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.806 0.842 . . . . 0.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.6 mt -129.11 -14.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 117.788 -1.101 . . . . 0.0 111.867 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.01 -28.88 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 121.413 1.915 . . . . 0.0 114.018 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.15 -44.64 97.88 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -159.06 121.44 3.54 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.9 104.62 5.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -169.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -137.27 -30.67 0.84 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -171.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -91.95 -174.56 42.52 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.953 0.797 . . . . 0.0 114.168 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 80.4 p -153.31 170.99 19.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.659 1.984 . . . . 0.0 108.152 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -58.04 124.7 20.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.381 0.992 . . . . 0.0 111.526 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -158.53 -172.22 3.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.941 1.696 . . . . 0.0 109.001 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -155.19 -177.77 6.77 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.129 1.771 . . . . 0.0 109.254 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 90.0 p -144.43 -179.07 6.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.229 1.011 . . . . 0.0 110.094 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 m -110.67 4.2 19.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.849 0.86 . . . . 0.0 112.674 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.84 40.62 0.47 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.509 1.123 . . . . 0.0 110.76 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.7 38.98 0.16 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.388 2.275 . . . . 0.0 112.764 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.2 m -118.87 27.34 8.94 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 109.066 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.74 -52.46 0.43 Allowed 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.854 1.261 . . . . 0.0 111.187 -170.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -69.21 -28.81 66.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.646 0.657 . . . . 0.0 110.286 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 172.396 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.462 0.172 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -59.81 149.7 30.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.534 1.133 . . . . 0.0 111.119 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -137.69 -7.53 1.67 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.302 1.441 . . . . 0.0 112.0 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 55.56 37.86 29.43 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.274 1.829 . . . . 0.0 112.521 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.69 -174.4 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.407 1.083 . . . . 0.0 109.921 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.9 143.12 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 61.84 19.01 10.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.127 1.771 . . . . 0.0 113.401 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -125.16 171.56 10.22 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -83.42 159.24 21.83 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.42 167.71 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 126.641 1.977 . . . . 0.0 108.12 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.3 mt -94.97 133.57 38.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.72 142.92 34.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.802 0.841 . . . . 0.0 109.392 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -69.54 109.65 4.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.744 0.818 . . . . 0.0 109.549 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -79.25 159.51 27.26 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -57.86 -19.64 30.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.359 1.463 . . . . 0.0 113.05 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -49.62 -57.45 7.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.902 1.281 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 m 171.27 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 112.375 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.19 -167.62 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.871 0.76 . . . . 0.0 113.012 -169.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -64.9 141.78 58.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.584 1.154 . . . . 0.0 114.07 -169.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.45 157.83 51.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 128.776 2.83 . . . . 0.0 105.138 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.87 149.3 72.29 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.571 1.514 . . . . 0.0 111.046 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.03 158.46 40.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.886 2.074 . . . . 0.0 108.627 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.5 135.33 33.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.03 134.47 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -111.86 -30.33 7.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.423 0.689 . . . . 0.0 110.448 172.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.31 161.73 42.18 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.624 1.102 . . . . 0.0 110.612 169.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.42 141.29 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -127.86 132.87 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.68 -26.01 63.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.947 0.899 . . . . 0.0 112.174 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.94 -24.9 62.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.923 0.889 . . . . 0.0 112.743 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.95 19.13 4.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.75 1.166 . . . . 0.0 112.628 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -120.76 167.93 11.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.297 1.049 . . . . 0.0 110.253 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -140.8 152.79 45.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.815 2.046 . . . . 0.0 107.543 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.4 m -130.47 130.9 44.82 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 169.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.87 153.0 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -120.21 119.7 33.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.312 1.445 . . . . 0.0 107.299 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.43 146.88 38.32 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -64.86 -21.13 66.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 112.935 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.86 -18.63 64.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.812 0.845 . . . . 0.0 112.382 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.41 47.83 1.49 Allowed Glycine 0 C--N 1.342 0.877 0 C-N-CA 124.324 0.964 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.9 t -134.63 142.73 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -132.51 144.71 36.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -150.1 158.46 44.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 110.406 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -109.78 130.36 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.2 -178.54 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.401 1.48 . . . . 0.0 109.832 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -105.69 169.54 8.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.796 1.238 . . . . 0.0 111.051 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -55.17 -38.07 67.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.215 0.606 . . . . 0.0 111.195 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.52 -5.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -117.85 -10.45 10.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.424 1.09 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.46 139.61 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.92 1.236 . . . . 0.0 111.216 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -149.94 169.69 20.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.604 0.762 . . . . 0.0 109.936 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.91 165.33 0.65 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.262 1.025 . . . . 0.0 111.588 172.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.93 -13.34 59.56 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.618 -0.676 . . . . 0.0 111.233 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.7 m -63.04 116.16 5.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.531 1.132 . . . . 0.0 109.332 169.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -58.29 -46.06 86.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.787 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.95 -52.14 46.61 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -151.31 160.84 43.58 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.985 0.914 . . . . 0.0 110.422 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -76.1 171.15 14.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.692 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.9 mm -119.57 -16.67 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.446 1.099 . . . . 0.0 111.049 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 144' ' ' GLY . 9.9 p -150.88 -168.05 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 120.167 1.349 . . . . 0.0 108.808 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' H ' HG22 ' A' ' 143' ' ' VAL . . . 84.63 -37.57 2.93 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.448 -1.408 . . . . 0.0 112.777 169.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -148.02 -46.17 0.16 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.925 0.89 . . . . 0.0 110.145 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.27 25.22 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.25 0.547 . . . . 0.0 112.16 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.34 169.85 9.92 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.841 1.257 . . . . 0.0 109.095 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -161.44 -144.95 4.15 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.954 1.74 . . . . 0.0 109.088 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 t -139.4 149.16 43.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.179 0.992 . . . . 0.0 108.933 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -68.53 140.64 55.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.873 0.469 . . . . 0.0 110.423 -170.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.27 -165.28 2.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.169 1.787 . . . . 0.0 107.316 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -145.6 165.95 27.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.011 0.925 . . . . 0.0 109.729 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 27.8 m -133.84 -173.84 3.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.626 1.17 . . . . 0.0 110.408 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.1 m -132.79 6.47 4.0 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -75.8 22.56 0.14 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.279 1.432 . . . . 0.0 113.208 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.77 145.74 39.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.93 0.892 . . . . 0.0 109.456 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 5.7 p -65.58 -27.91 68.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.938 0.895 . . . . 0.0 112.311 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -79.63 -4.67 52.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.491 1.117 . . . . 0.0 112.929 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -133.15 172.94 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.586 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.365 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.36 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.5 m -142.08 152.96 43.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.696 1.199 . . . . 0.0 109.366 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.45 -1.34 6.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.576 0.75 . . . . 0.0 112.365 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 19.7 m-85 57.03 55.0 6.4 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.286 1.834 . . . . 0.0 115.124 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.01 -173.75 4.89 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.534 0.683 . . . . 0.0 111.992 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.76 143.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 62.11 17.93 9.58 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.158 1.783 . . . . 0.0 113.291 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.66 173.72 6.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.233 1.013 . . . . 0.0 108.421 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -76.32 158.84 31.11 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.808 -0.557 . . . . 0.0 111.307 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.93 175.16 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.861 2.064 . . . . 0.0 108.226 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.5 mt -115.29 123.54 49.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.74 46.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.295 1.038 . . . . 0.0 108.934 -172.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.3 m -69.52 116.07 9.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -81.83 159.11 23.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.422 0.689 . . . . 0.0 109.314 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m -57.73 -20.82 37.21 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.887 1.275 . . . . 0.0 112.637 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.06 -49.76 75.79 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.178 0.591 . . . . 0.0 111.752 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.94 -65.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.084 0.554 . . . . 0.0 112.111 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 -160.86 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 110.909 -170.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -52.64 139.11 26.83 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -146.02 158.79 48.04 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.499 3.12 . . . . 0.0 105.175 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.88 148.37 64.17 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.627 1.551 . . . . 0.0 110.717 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.08 167.52 30.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.5 135.56 41.74 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.351 1.461 . . . . 0.0 108.083 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 138.94 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -117.44 -32.83 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.211 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.63 162.08 41.72 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.887 1.222 . . . . 0.0 110.315 168.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.7 134.21 45.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -129.4 115.42 17.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -169.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.43 -21.42 59.97 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.733 0.813 . . . . 0.0 112.466 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.36 -29.89 36.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 112.725 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.6 17.02 1.41 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.813 1.197 . . . . 0.0 112.756 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.1 p -127.19 169.03 13.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.861 1.33 . . . . 0.0 109.645 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.75 149.41 31.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 m -132.22 136.18 46.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.85 161.68 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -122.29 124.74 44.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -80.86 150.67 29.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.24 -23.61 66.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.152 0.581 . . . . 0.0 112.092 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.83 -15.18 5.96 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.234 1.397 . . . . 0.0 113.262 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.78 145.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 118.466 1.133 . . . . 0.0 109.266 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.21 144.21 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -149.75 156.44 41.86 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.913 0.485 . . . . 0.0 111.02 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -114.37 130.8 56.7 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.86 179.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.987 1.715 . . . . 0.0 108.346 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -85.89 164.73 17.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.793 -1.192 . . . . 0.0 110.054 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -54.44 -40.55 68.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.719 0.808 . . . . 0.0 110.827 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.2 pt -60.39 -16.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -97.55 -4.5 37.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.204 0.911 . . . . 0.0 112.684 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.1 146.91 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.758 1.163 . . . . 0.0 111.481 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -151.53 173.37 14.69 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.37 1.068 . . . . 0.0 108.68 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.28 169.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.879 1.272 . . . . 0.0 110.943 173.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -68.8 2.26 2.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.096 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 m -63.21 142.41 58.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.831 -1.168 . . . . 0.0 109.838 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -66.47 -55.59 14.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.855 0.462 . . . . 0.0 110.647 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.58 -66.94 0.56 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -146.44 -178.94 6.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 0.0 111.209 -169.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -73.17 171.26 13.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.444 1.498 . . . . 0.0 111.714 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -131.72 -19.73 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 125.455 1.502 . . . . 0.0 111.156 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.59 -38.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.803 -1.185 . . . . 0.0 111.996 -170.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.06 -49.14 42.73 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -161.24 117.12 2.16 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.31 128.2 35.39 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.467 0.576 . . . . 0.0 112.412 -169.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -146.9 -19.85 0.41 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.962 1.305 . . . . 0.0 113.149 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.65 165.6 36.6 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 119.745 1.157 . . . . 0.0 112.754 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 72.0 p -147.43 -17.39 0.38 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -152.53 146.43 25.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.814 1.188 . . . . 0.0 108.684 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.85 152.38 36.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.791 0.837 . . . . 0.0 111.18 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -78.27 172.95 12.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.776 0.831 . . . . 0.0 110.794 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 4.0 p -149.66 8.2 0.67 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.526 1.13 . . . . 0.0 112.455 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 m -141.21 -178.71 5.72 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.087 0.955 . . . . 0.0 110.387 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 24.5 m80 58.88 27.97 16.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.58 1.552 . . . . 0.0 113.511 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 70.7 mt -71.12 158.5 36.35 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' M2L . . . . . 0.436 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 16.9 m 72.07 -28.05 0.18 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.483 2.713 . . . . 0.0 113.65 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.34 -23.96 66.12 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.035 -1.041 . . . . 0.0 111.571 170.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.34 -17.74 64.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.499 -0.763 . . . . 0.0 112.826 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.486 -1.175 . . . . 0.0 110.587 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m -134.4 33.09 3.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.453 0.701 . . . . 0.0 111.441 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 61.86 -40.85 0.14 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.837 3.255 . . . . 0.0 119.287 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.439 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.2 m-85 55.11 24.07 5.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -88.74 -173.02 3.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.151 0.98 . . . . 0.0 110.039 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.2 mt -50.81 141.18 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.326 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.77 25.18 15.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.277 1.831 . . . . 0.0 113.206 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.89 168.96 18.56 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.187 0.995 . . . . 0.0 110.067 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.23 145.6 55.71 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.849 2.059 . . . . 0.0 113.638 -171.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.63 160.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 128.113 2.565 . . . . 0.0 107.88 169.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.5 mt -97.49 122.83 41.0 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 143.19 42.65 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.566 0.746 . . . . 0.0 109.049 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.9 m -68.66 105.73 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -68.87 157.62 36.2 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 m -58.94 -16.35 17.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.403 1.081 . . . . 0.0 112.544 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.18 -57.48 9.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.795 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.6 p 170.02 -38.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.404 1.882 . . . . 0.0 113.991 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -173.46 3.95 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.38 0.991 . . . . 0.0 112.807 -169.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.35 141.08 58.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 113.329 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.6 161.39 49.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 128.732 2.813 . . . . 0.0 104.737 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.72 146.68 61.16 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 120.22 1.114 . . . . 0.0 110.186 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.76 165.86 34.69 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.809 2.044 . . . . 0.0 108.453 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -102.36 132.4 48.37 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.648 1.179 . . . . 0.0 107.878 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.74 139.8 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -114.45 -33.69 5.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.72 160.27 43.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.596 1.089 . . . . 0.0 110.344 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.6 t -133.0 145.56 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -131.96 120.22 22.18 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -59.48 -23.4 62.72 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.001 0.921 . . . . 0.0 112.804 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.69 -30.46 61.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.921 0.889 . . . . 0.0 112.386 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.91 24.67 0.79 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.465 1.031 . . . . 0.0 112.952 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.1 p -130.86 170.36 14.51 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.748 1.274 . . . . 0.0 110.331 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -142.39 156.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.824 2.049 . . . . 0.0 108.246 -169.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.2 m -135.22 132.67 38.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.86 156.78 32.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -119.12 120.39 36.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -79.21 145.5 33.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -63.48 -24.98 68.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.21 -26.47 68.38 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.636 0.774 . . . . 0.0 112.125 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.46 -14.92 5.55 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.943 1.258 . . . . 0.0 113.327 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.89 143.9 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.574 1.187 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.29 139.28 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -155.72 155.89 33.92 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.969 0.507 . . . . 0.0 111.684 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -95.31 139.37 31.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.31 172.65 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.935 1.694 . . . . 0.0 108.684 -169.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -97.47 167.97 10.66 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.573 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -56.01 -36.79 68.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.29 0.636 . . . . 0.0 111.06 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 pt -64.17 -7.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.049 -1.032 . . . . 0.0 113.524 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -113.47 -9.2 13.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.316 1.046 . . . . 0.0 112.432 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.9 t -142.27 142.21 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.954 1.252 . . . . 0.0 111.644 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -147.09 172.2 14.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.188 1.395 . . . . 0.0 108.856 170.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.26 169.9 0.24 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.084 1.354 . . . . 0.0 110.842 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -65.8 -2.67 3.95 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.43 -0.794 . . . . 0.0 111.397 169.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.5 m -62.27 125.78 25.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.055 1.742 . . . . 0.0 108.997 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.25 -39.31 68.54 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.676 -0.64 . . . . 0.0 111.922 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.57 -60.95 1.96 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.813 0.278 . . . . 0.0 111.504 -169.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -152.64 172.75 16.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.766 1.626 . . . . 0.0 108.321 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -77.29 176.39 8.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.394 0.678 . . . . 0.0 112.373 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.7 mm -123.62 -62.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.615 1.566 . . . . 0.0 110.096 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.0 -32.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.482 1.037 . . . . 0.0 113.063 -169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.87 -48.88 58.55 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -160.62 136.1 8.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.29 116.71 26.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.808 0.731 . . . . 0.0 112.596 -169.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -144.42 -18.47 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.306 169.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.96 161.81 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 120.113 1.324 . . . . 0.0 113.093 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 44.0 m -147.18 -21.33 0.4 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.89 139.92 31.0 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.631 1.559 . . . . 0.0 109.282 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.86 154.66 41.66 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.816 0.846 . . . . 0.0 110.845 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.73 165.7 21.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.414 0.686 . . . . 0.0 112.15 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 m -147.21 6.94 0.88 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.262 1.025 . . . . 0.0 113.279 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.2 m -135.68 174.89 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.536 1.062 . . . . 0.0 112.28 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 86.5 t60 55.06 -97.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.797 2.039 . . . . 0.0 111.114 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.5 mt 58.28 173.35 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.754 2.021 . . . . 0.0 111.977 -169.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 15.2 m 61.52 8.76 2.37 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.838 2.055 . . . . 0.0 114.151 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -144.0 13.21 1.65 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.305 1.442 . . . . 0.0 112.305 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -63.59 142.15 58.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 173.497 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.29 0.091 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 m -75.73 78.24 2.68 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.373 1.469 . . . . 0.0 110.967 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -148.57 137.48 21.59 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -120.76 134.94 55.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.065 1.746 . . . . 0.0 108.253 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.5 mp0 -139.17 -174.43 3.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.091 1.357 . . . . 0.0 109.871 -175.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.17 142.43 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.72 24.73 13.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.011 1.725 . . . . 0.0 112.864 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -132.39 168.18 18.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.232 1.013 . . . . 0.0 108.749 170.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -73.25 147.99 44.08 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.311 1.845 . . . . 0.0 113.893 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.27 165.68 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 127.448 2.299 . . . . 0.0 108.101 171.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -96.26 131.13 43.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.75 141.44 43.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -69.49 113.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.227 0.611 . . . . 0.0 109.706 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -77.8 157.92 29.75 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.985 0.914 . . . . 0.0 109.32 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 m -58.07 -20.39 39.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.175 0.99 . . . . 0.0 112.748 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.06 -49.53 76.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.054 0.542 . . . . 0.0 112.086 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.89 -66.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -161.79 1.41 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.736 1.215 . . . . 0.0 111.069 -170.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -53.73 141.09 27.61 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -147.23 158.3 44.51 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 129.564 3.145 . . . . 0.0 105.072 168.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 145.01 66.17 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.471 1.447 . . . . 0.0 110.607 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.49 166.0 32.45 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.511 1.925 . . . . 0.0 108.499 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -103.97 133.72 48.45 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.64 138.84 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -114.76 -32.01 5.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.306 0.642 . . . . 0.0 109.77 169.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.4 41.14 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.608 1.094 . . . . 0.0 110.385 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.2 t -136.43 139.31 45.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -132.04 110.36 10.67 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -61.61 -17.34 54.81 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.22 -31.82 45.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.942 0.897 . . . . 0.0 112.137 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.73 20.27 0.54 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.653 1.12 . . . . 0.0 112.928 173.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.3 p -131.65 171.57 13.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.122 1.461 . . . . 0.0 110.075 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 155.89 43.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.354 1.862 . . . . 0.0 107.759 -169.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -133.23 132.88 42.0 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.52 155.69 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.01 126.59 50.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.85 1.66 . . . . 0.0 107.356 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -82.93 154.71 24.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -60.58 -30.54 69.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.48 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -25.85 68.57 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.639 0.776 . . . . 0.0 112.364 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.07 -14.96 7.4 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.997 1.284 . . . . 0.0 113.116 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.55 144.43 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.494 1.147 . . . . 0.0 109.247 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.3 t -131.63 143.26 40.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.95 156.7 42.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.216 0.606 . . . . 0.0 110.84 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -109.35 129.15 55.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 169.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.24 177.91 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.197 1.399 . . . . 0.0 109.428 -169.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.66 169.15 9.47 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.245 -0.909 . . . . 0.0 110.677 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -54.64 -38.46 66.88 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.517 0.727 . . . . 0.0 111.325 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.0 pt -63.98 -7.89 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -113.67 -6.98 13.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.172 0.989 . . . . 0.0 112.576 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.6 t -142.11 140.47 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.054 1.297 . . . . 0.0 110.872 -175.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -145.94 174.3 11.38 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.822 0.849 . . . . 0.0 109.841 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 137' ' ' SER . . . -59.12 166.94 1.89 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -81.52 47.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 168.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 135' ' ' ALA . 41.0 m -127.1 139.75 52.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 172.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -63.07 -41.77 99.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.001 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.82 -68.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -168.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -150.59 178.85 8.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.73 1.212 . . . . 0.0 111.022 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -75.89 159.1 31.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.11 1.764 . . . . 0.0 111.76 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -139.75 34.14 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.515 1.126 . . . . 0.0 110.976 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.0 p -154.16 -49.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 120.479 -1.388 . . . . 0.0 110.874 169.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.33 -32.03 71.84 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -146.1 165.78 28.08 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.75 51.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.136 1.335 . . . . 0.0 112.632 -168.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -120.05 -5.49 10.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.03 162.79 38.85 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 122.18 0.878 . . . . 0.0 115.01 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 t -164.27 171.46 14.87 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 127.272 2.229 . . . . 0.0 106.73 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 52.65 76.28 0.2 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.192 1.397 . . . . 0.0 109.124 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.0 25.92 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -158.45 161.79 37.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.768 1.167 . . . . 0.0 109.953 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 3.2 m -142.86 147.96 36.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.608 0.763 . . . . 0.0 109.994 -169.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.9 m -82.45 -7.52 59.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.986 0.914 . . . . 0.0 113.265 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.57 27.0 0.05 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.703 2.001 . . . . 0.0 114.267 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.82 146.54 49.3 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.043 -1.036 . . . . 0.0 109.825 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.0 m -67.42 -31.65 72.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.292 0.637 . . . . 0.0 111.577 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.48 -12.27 56.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.959 0.904 . . . . 0.0 112.674 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -66.37 146.74 54.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.152 0.887 . . . . 0.0 108.86 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 172.93 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m -139.22 32.53 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.255 1.022 . . . . 0.0 110.761 -169.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.64 64.69 0.77 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 9.3 m-85 -53.3 111.47 0.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.38 2.272 . . . . 0.0 110.431 -173.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 36.2 mt-30 -145.24 -175.35 4.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.356 2.262 . . . . 0.0 107.542 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.69 142.85 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.5 22.59 12.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.547 1.539 . . . . 0.0 113.307 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.518 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.2 tp10 -131.29 169.81 15.47 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -81.3 158.59 24.71 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.658 -0.651 . . . . 0.0 111.164 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.16 169.57 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 126.659 1.983 . . . . 0.0 107.969 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.39 122.72 44.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.2 139.26 46.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.533 1.133 . . . . 0.0 108.58 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.8 m -68.96 135.12 50.46 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.806 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -112.18 154.79 24.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.926 1.691 . . . . 0.0 108.148 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.8 m -58.38 -20.71 46.23 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.647 1.179 . . . . 0.0 113.009 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.84 -47.92 79.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.251 1.02 . . . . 0.0 112.791 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.6 p -168.11 -68.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.886 0.475 . . . . 0.0 111.907 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -156.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.351 1.861 . . . . 0.0 109.253 -169.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -46.56 138.08 6.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.504 2.322 . . . . 0.0 115.854 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -145.49 157.08 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.202 3.001 . . . . 0.0 105.313 169.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.02 145.73 56.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.48 1.454 . . . . 0.0 110.75 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.77 155.7 37.68 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.575 1.55 . . . . 0.0 109.176 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.08 134.89 35.37 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.6 133.16 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.069 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -110.41 -31.46 7.27 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.276 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.12 163.91 38.39 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.52 1.054 . . . . 0.0 110.714 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.32 140.9 39.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -131.21 115.48 16.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -172.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.21 -21.02 61.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.584 0.753 . . . . 0.0 112.624 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.86 -31.39 39.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.083 0.953 . . . . 0.0 112.449 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.23 23.37 0.68 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.447 1.022 . . . . 0.0 112.697 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 p -131.75 169.88 15.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.988 1.394 . . . . 0.0 110.48 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -143.16 152.62 41.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.5 1.92 . . . . 0.0 107.504 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -130.69 131.57 44.9 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 m -138.95 155.44 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -120.73 122.39 40.3 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.195 1.398 . . . . 0.0 107.453 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -77.93 148.34 34.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.6 -21.92 66.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.197 0.599 . . . . 0.0 112.525 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.77 -26.85 68.92 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.691 0.796 . . . . 0.0 112.305 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.2 5.91 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.052 1.311 . . . . 0.0 112.83 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.03 144.85 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.345 1.073 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.11 144.41 38.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.2 155.21 40.27 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.128 0.571 . . . . 0.0 110.658 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.8 129.28 55.38 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.56 176.56 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.245 1.418 . . . . 0.0 109.087 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.3 168.43 9.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 -170.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -55.35 -37.13 67.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.561 0.744 . . . . 0.0 110.957 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.0 pt -64.88 -7.09 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -115.37 -7.52 12.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.188 0.995 . . . . 0.0 112.511 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.08 141.04 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 119.758 1.163 . . . . 0.0 110.847 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -150.17 176.96 10.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.702 0.801 . . . . 0.0 109.968 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.52 168.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.635 1.174 . . . . 0.0 111.054 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -62.67 -21.6 65.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.055 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -62.45 120.51 11.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.926 0.891 . . . . 0.0 110.596 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.5 -40.59 79.02 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.154 0.982 . . . . 0.0 111.942 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.44 -64.52 0.84 Allowed 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -150.16 166.37 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.57 0.7 . . . . 0.0 112.628 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.84 153.25 36.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.271 1.829 . . . . 0.0 111.393 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -138.98 23.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.555 0.742 . . . . 0.0 112.08 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.72 -51.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 112.943 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.49 60.83 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.415 1.007 . . . . 0.0 111.93 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -150.99 60.21 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.27 126.06 24.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.01 17.85 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.548 1.139 . . . . 0.0 112.962 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -147.5 -169.33 14.73 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.237 0.926 . . . . 0.0 112.773 -170.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -146.59 170.9 15.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.887 1.275 . . . . 0.0 110.751 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -57.84 135.61 56.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.534 0.734 . . . . 0.0 111.598 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.72 -170.84 2.7 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.716 2.006 . . . . 0.0 108.23 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -151.43 173.67 14.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.851 1.261 . . . . 0.0 110.115 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 35.2 p -152.1 167.91 26.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.234 1.014 . . . . 0.0 109.821 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.4 m -79.61 -1.11 36.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.685 1.194 . . . . 0.0 113.409 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -72.97 89.68 1.44 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.979 0.912 . . . . 0.0 109.597 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.93 169.53 17.54 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.145 1.778 . . . . 0.0 108.535 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.0 m -62.79 -30.7 71.66 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.828 1.251 . . . . 0.0 113.757 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -81.52 60.79 4.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.723 0.809 . . . . 0.0 109.113 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -57.83 154.15 12.6 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 109.406 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 169.801 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.237 0.397 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -104.19 128.77 51.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.218 1.007 . . . . 0.0 110.159 -169.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.8 mp0 -144.45 -172.87 3.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.021 1.728 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.61 144.07 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 66.95 7.07 5.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.802 2.441 . . . . 0.0 114.101 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.3 tp10 -120.24 170.22 9.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 109.668 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.6 144.38 51.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.782 2.033 . . . . 0.0 113.058 -170.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.7 164.24 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 127.189 2.196 . . . . 0.0 108.543 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.07 127.69 42.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.18 47.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -68.8 104.89 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -66.82 154.37 41.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m -58.04 -20.29 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 112.424 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.39 -49.63 76.83 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.2 p -171.72 -68.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.15 -162.83 1.58 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.906 1.282 . . . . 0.0 110.808 -169.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -58.55 138.76 56.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -144.28 157.5 56.44 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 128.577 2.751 . . . . 0.0 104.71 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.53 146.96 75.84 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.302 1.335 . . . . 0.0 110.432 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.96 162.11 41.72 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.243 1.817 . . . . 0.0 108.622 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.64 129.72 42.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.57 1.548 . . . . 0.0 107.118 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.53 138.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.942 1.247 . . . . 0.0 107.97 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 p -118.03 -30.52 5.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.291 0.636 . . . . 0.0 110.572 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.2 164.3 37.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.468 1.031 . . . . 0.0 110.248 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.3 t -143.61 147.75 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -133.77 130.26 37.77 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -60.1 -22.97 63.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.149 0.979 . . . . 0.0 112.36 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -54.5 -30.47 53.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.842 0.857 . . . . 0.0 112.342 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.36 26.15 0.75 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.308 0.956 . . . . 0.0 113.024 172.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.2 p -129.4 165.74 20.95 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.807 1.303 . . . . 0.0 110.839 -171.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.48 145.91 37.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.411 2.284 . . . . 0.0 107.382 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.4 m -124.88 131.94 53.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 169.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.66 149.9 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -114.19 119.95 38.82 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.392 1.477 . . . . 0.0 107.021 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.91 140.76 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -63.0 -21.13 65.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.852 0.861 . . . . 0.0 112.986 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.87 -19.9 63.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.797 0.839 . . . . 0.0 112.178 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.86 46.72 1.16 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.83 1.205 . . . . 0.0 110.725 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.3 t -133.96 138.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.5 140.67 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.03 159.73 41.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.335 0.654 . . . . 0.0 110.64 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.1 m -107.76 136.41 47.55 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.55 -179.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.248 2.219 . . . . 0.0 108.379 -169.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.9 168.93 8.9 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.218 -0.926 . . . . 0.0 110.682 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -53.39 -40.21 64.86 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.361 0.664 . . . . 0.0 110.864 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.1 pt -63.61 -5.9 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -115.9 -7.58 11.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 112.636 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.8 t -142.65 139.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 120.076 1.307 . . . . 0.0 111.651 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -148.16 174.3 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 110.055 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.34 167.91 1.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.758 0.823 . . . . 0.0 110.875 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.15 -18.15 65.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.391 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.18 116.85 6.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -61.63 -31.02 71.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -69.28 -55.9 9.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -152.14 165.16 35.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.662 0.744 . . . . 0.0 112.988 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.74 156.15 38.18 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.192 1.397 . . . . 0.0 110.468 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.98 23.53 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.938 0.895 . . . . 0.0 111.256 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.9 -62.89 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 120.707 -1.246 . . . . 0.0 109.686 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.57 -27.91 72.88 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -141.28 165.99 26.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.35 22.74 7.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.642 1.11 . . . . 0.0 113.427 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -77.62 -21.26 52.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.362 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -79.15 175.65 55.01 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.308 0.949 . . . . 0.0 112.987 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.6 m -150.54 171.21 17.44 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.183 2.193 . . . . 0.0 107.949 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -60.15 120.21 9.32 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.66 -164.13 1.58 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.371 1.868 . . . . 0.0 107.655 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -148.18 -176.89 5.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 66.2 m -129.54 169.11 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.149 1.38 . . . . 0.0 111.031 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -127.89 17.65 6.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -168.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -138.71 134.78 34.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 C-N-CA 125.795 1.638 . . . . 0.0 109.629 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 8.5 m-85 46.32 38.31 5.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 128.5 2.72 . . . . 0.0 115.43 170.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -110.06 -173.05 2.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 108.12 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -49.23 138.8 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.687 0.795 . . . . 0.0 109.273 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 62.41 25.79 15.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.194 1.798 . . . . 0.0 113.18 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -135.57 167.27 21.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.887 1.275 . . . . 0.0 108.551 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -69.7 156.05 39.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.846 1.258 . . . . 0.0 113.364 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.88 162.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.826 2.45 . . . . 0.0 107.045 169.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 mt -96.07 127.68 42.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.71 44.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.625 0.77 . . . . 0.0 109.406 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -68.84 107.89 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.966 0.507 . . . . 0.0 110.0 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.23 163.91 23.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.341 1.056 . . . . 0.0 109.548 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -57.33 -18.08 15.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.294 1.038 . . . . 0.0 113.201 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -11.68 49.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.41 1.484 . . . . 0.0 113.487 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.5 m 92.54 17.83 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.5 2.72 . . . . 0.0 114.988 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.56 8.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.007 0.821 . . . . 0.0 110.762 169.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -70.76 141.56 51.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.62 160.74 43.55 Favored Pre-proline 0 C--O 1.241 0.634 0 C-N-CA 128.337 2.655 . . . . 0.0 105.529 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.69 147.52 69.82 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.401 1.4 . . . . 0.0 111.039 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.41 161.07 43.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.177 1.791 . . . . 0.0 108.459 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -91.83 131.29 37.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.513 1.525 . . . . 0.0 107.814 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.6 134.16 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.7 p -112.02 -31.52 6.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.445 0.698 . . . . 0.0 110.201 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 164.14 38.09 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.49 1.041 . . . . 0.0 110.418 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.65 142.92 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -130.99 119.24 21.78 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -61.31 -20.63 63.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.499 0.72 . . . . 0.0 112.74 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -52.7 -31.69 38.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.201 1.001 . . . . 0.0 112.42 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.54 25.3 0.51 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.373 0.987 . . . . 0.0 112.885 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.1 p -131.35 169.05 16.53 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.073 1.437 . . . . 0.0 110.606 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -141.82 156.04 45.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.982 2.113 . . . . 0.0 108.104 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -134.2 132.32 39.6 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.03 155.78 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -119.46 123.39 43.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -82.57 151.06 26.57 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.63 -27.1 68.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.673 0.789 . . . . 0.0 112.648 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.05 -23.03 67.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.644 0.777 . . . . 0.0 112.074 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.23 -14.21 8.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.491 1.519 . . . . 0.0 113.108 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.28 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.351 1.075 . . . . 0.0 108.801 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.47 139.06 52.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -153.67 155.38 35.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 110.984 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 m -98.31 138.13 36.01 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.89 171.91 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.093 1.757 . . . . 0.0 108.777 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.3 167.75 10.22 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.35 -0.844 . . . . 0.0 110.403 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -55.08 -37.71 67.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.524 0.73 . . . . 0.0 111.341 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.9 pt -62.79 -10.82 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -109.52 -9.34 14.91 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.234 0.924 . . . . 0.0 112.735 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.05 141.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.733 1.152 . . . . 0.0 111.348 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -146.95 175.2 10.85 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.019 0.928 . . . . 0.0 110.18 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.69 168.09 1.83 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.388 1.075 . . . . 0.0 111.325 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -68.33 -14.79 63.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.818 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.0 m -62.17 120.48 10.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.222 0.919 . . . . 0.0 108.526 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -61.32 -35.75 78.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.2 -42.54 20.64 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -148.86 162.91 38.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.755 0.707 . . . . 0.0 111.961 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -76.73 167.37 21.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 110.214 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.6 mm -129.16 -19.1 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.464 1.505 . . . . 0.0 111.466 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.08 -35.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.412 1.46 . . . . 0.0 112.244 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.86 -30.37 63.01 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -149.77 150.81 32.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.46 64.59 3.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.051 1.341 . . . . 0.0 110.54 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -171.52 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.721 2.008 . . . . 0.0 109.565 -169.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 57.97 -168.11 5.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.09 1.805 . . . . 0.0 116.806 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.6 m -151.09 155.66 39.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.069 2.548 . . . . 0.0 107.045 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -66.08 122.02 16.46 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.03 -163.21 1.58 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.814 1.646 . . . . 0.0 108.472 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -144.9 -179.51 6.65 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 110.9 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 13.8 p -149.38 -178.61 6.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.769 2.028 . . . . 0.0 109.493 -174.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -130.21 6.13 4.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.1 35.87 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.101 1.36 . . . . 0.0 111.812 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 109.979 178.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--O 1.236 0.35 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.46 129.86 55.9 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.33 1.052 . . . . 0.0 110.929 -167.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.485 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.0 mp0 -142.84 -174.43 4.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.675 1.99 . . . . 0.0 108.48 -177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.88 143.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 60.06 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 112.959 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.5 tp10 -128.34 170.1 13.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.435 1.094 . . . . 0.0 108.263 171.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -77.28 155.59 31.96 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.758 -0.589 . . . . 0.0 112.102 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.45 167.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.551 1.94 . . . . 0.0 108.613 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.4 125.62 43.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.04 138.91 48.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 m -68.82 142.05 54.97 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.355 0.598 . . . . 0.0 110.901 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -119.03 154.93 32.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.765 1.626 . . . . 0.0 108.061 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -58.45 -19.8 39.69 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.64 1.176 . . . . 0.0 113.248 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.24 -47.63 80.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.151 0.981 . . . . 0.0 112.699 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.3 p -168.68 -68.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.896 0.478 . . . . 0.0 112.156 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -158.0 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.234 1.813 . . . . 0.0 109.303 -169.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -46.19 139.23 4.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.608 2.363 . . . . 0.0 115.66 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -145.77 157.51 51.09 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.5 3.12 . . . . 0.0 105.314 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.83 146.22 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.772 1.648 . . . . 0.0 110.869 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.64 162.68 41.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.912 1.685 . . . . 0.0 108.878 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -95.66 135.65 37.07 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.36 137.08 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 p -114.21 -30.88 6.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.279 0.632 . . . . 0.0 110.165 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.81 40.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.499 1.045 . . . . 0.0 110.303 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.36 140.55 41.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -131.06 118.49 20.63 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -59.05 -23.31 61.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.214 1.006 . . . . 0.0 112.475 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.26 -30.43 60.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.741 0.816 . . . . 0.0 112.491 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.17 23.75 0.82 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.567 1.079 . . . . 0.0 112.71 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.7 p -130.89 171.84 12.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.757 1.278 . . . . 0.0 110.382 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.27 154.19 42.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.657 1.983 . . . . 0.0 107.476 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -131.98 131.1 42.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.65 153.94 26.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.17 125.29 49.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.358 1.463 . . . . 0.0 107.332 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.11 151.3 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.45 -23.04 66.22 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.12 -25.0 65.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.971 0.508 . . . . 0.0 111.987 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.0 5.23 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.096 1.332 . . . . 0.0 113.188 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 146.93 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.397 1.098 . . . . 0.0 109.416 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.69 145.16 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -148.67 154.39 39.6 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.195 0.598 . . . . 0.0 110.864 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -107.57 130.74 54.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.29 175.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.335 1.454 . . . . 0.0 109.183 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.88 168.14 10.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.337 -0.852 . . . . 0.0 110.798 -171.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.08 -39.85 66.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.046 0.538 . . . . 0.0 111.232 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.87 -8.18 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -113.21 -6.3 13.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.09 139.3 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.145 1.339 . . . . 0.0 111.341 -172.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -147.57 177.29 9.38 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.736 0.815 . . . . 0.0 110.25 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.64 167.23 3.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.135 0.974 . . . . 0.0 110.933 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -69.49 -17.68 63.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.078 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.9 m -63.16 124.44 21.17 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.11 -34.24 71.79 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.81 -68.96 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -149.24 167.78 25.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.093 0.957 . . . . 0.0 110.69 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.5 159.09 33.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 110.843 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -136.6 15.66 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.196 0.998 . . . . 0.0 111.401 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.06 -44.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 120.447 -1.408 . . . . 0.0 111.791 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.91 75.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.124 0.875 . . . . 0.0 110.941 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.97 165.48 31.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.067 2.547 . . . . 0.0 104.435 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.91 16.04 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.458 1.481 . . . . 0.0 114.031 -169.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -79.82 -18.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.899 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.69 179.8 43.48 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 119.153 0.888 . . . . 0.0 112.962 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.8 m -146.71 163.64 35.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.782 1.633 . . . . 0.0 108.698 -169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -64.5 113.71 3.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.16 -166.13 1.76 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.735 1.614 . . . . 0.0 108.67 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -148.23 -173.4 4.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.984 1.314 . . . . 0.0 109.821 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 24.3 p -151.12 176.85 10.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.101 1.761 . . . . 0.0 109.681 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -121.82 -1.61 9.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -71.81 119.04 15.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.433 1.493 . . . . 0.0 107.141 179.342 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -103.03 124.95 49.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.237 1.015 . . . . 0.0 109.819 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.408 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.4 mp0 -144.57 -173.28 4.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.528 1.531 . . . . 0.0 108.908 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.5 141.95 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 58.4 25.03 12.39 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.866 1.667 . . . . 0.0 113.438 -175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.0 tp10 -134.75 162.82 31.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.429 1.092 . . . . 0.0 108.395 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -65.44 150.09 48.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.628 2.371 . . . . 0.0 113.777 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.71 168.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 128.198 2.599 . . . . 0.0 107.961 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.25 127.17 46.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.36 138.45 41.63 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.739 0.816 . . . . 0.0 109.371 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 m -69.11 121.01 15.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 110.712 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -93.45 155.46 17.34 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.745 1.218 . . . . 0.0 108.652 174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -58.64 -20.89 51.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.749 1.22 . . . . 0.0 112.911 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.23 -46.35 83.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.328 1.051 . . . . 0.0 112.634 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -168.57 -68.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.189 0.45 . . . . 0.0 112.146 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.27 -157.79 0.74 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.187 1.795 . . . . 0.0 108.948 -170.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -46.25 138.85 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.615 1.966 . . . . 0.0 115.643 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -145.16 156.82 54.34 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 129.793 3.237 . . . . 0.0 103.988 168.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.57 145.57 52.8 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.449 1.433 . . . . 0.0 110.616 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.11 168.36 27.53 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.797 2.439 . . . . 0.0 107.152 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -110.45 147.92 33.1 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.982 1.265 . . . . 0.0 109.742 169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.35 140.78 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -115.67 -33.24 5.25 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.767 0.827 . . . . 0.0 109.179 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 163.89 38.58 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.166 0.986 . . . . 0.0 110.494 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.7 146.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -134.74 125.25 26.6 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.66 -23.75 63.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.673 0.789 . . . . 0.0 112.11 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.65 -27.65 58.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.552 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.5 21.6 2.2 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.563 1.077 . . . . 0.0 112.212 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 p -125.36 169.11 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.364 1.082 . . . . 0.0 110.02 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.72 153.5 41.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.444 1.898 . . . . 0.0 107.603 -168.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.8 m -132.16 136.16 46.87 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.55 158.59 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -123.89 126.94 47.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.98 154.69 26.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.16 -26.3 68.74 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.143 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.36 -18.85 5.74 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.831 1.205 . . . . 0.0 112.858 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.55 143.47 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 109.619 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.83 144.98 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -150.38 154.4 37.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.03 0.532 . . . . 0.0 110.635 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.44 129.18 55.27 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.91 179.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.536 1.534 . . . . 0.0 109.271 -169.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.95 167.23 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.095 -1.003 . . . . 0.0 110.529 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -54.36 -38.55 66.22 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.539 0.736 . . . . 0.0 110.882 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -63.26 -8.78 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -111.24 -8.03 14.4 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.005 0.922 . . . . 0.0 112.595 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.01 141.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 120.182 1.355 . . . . 0.0 110.992 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -150.12 173.43 13.9 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.421 0.688 . . . . 0.0 110.106 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.05 165.78 0.62 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.238 1.415 . . . . 0.0 111.039 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -67.27 -16.08 64.07 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.703 -0.623 . . . . 0.0 111.911 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 m -62.78 116.16 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.79 -32.98 72.3 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.46 -65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.723 0.809 . . . . 0.0 112.693 -169.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -152.75 162.67 40.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.268 1.427 . . . . 0.0 108.609 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -73.7 166.67 22.87 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.549 0.214 . . . . 0.0 111.027 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.34 -22.42 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.103 0.961 . . . . 0.0 110.954 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.81 -45.32 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 119.645 1.111 . . . . 0.0 110.906 -172.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.7 97.58 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -159.27 154.42 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.923 2.089 . . . . 0.0 105.42 169.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.19 58.37 2.03 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.983 0.913 . . . . 0.0 112.219 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -74.4 -44.73 50.7 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.435 -0.791 . . . . 0.0 110.717 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -94.82 -168.22 36.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.559 1.076 . . . . 0.0 111.731 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.4 t -147.73 177.55 9.21 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.324 1.45 . . . . 0.0 108.168 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -57.28 120.34 7.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.478 0.711 . . . . 0.0 110.469 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.91 -165.16 1.44 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.438 1.895 . . . . 0.0 107.416 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -147.85 -174.0 4.44 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.815 1.246 . . . . 0.0 109.663 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.8 t -145.76 174.12 11.5 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.042 1.337 . . . . 0.0 109.739 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 14.5 m -128.93 4.63 5.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.566 1.547 . . . . 0.0 111.523 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.93 42.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.508 1.123 . . . . 0.0 110.796 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 C--O 1.236 0.36 0 C-N-CA 124.838 1.255 . . . . 0.0 109.474 172.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.93 137.38 53.52 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.196 0.998 . . . . 0.0 109.898 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 6.0 mp0 -144.36 -173.98 4.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 109.186 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -53.36 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 61.68 22.33 12.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.495 1.918 . . . . 0.0 113.095 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -127.87 169.28 14.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.18 0.992 . . . . 0.0 108.904 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -68.04 146.96 53.02 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.353 1.461 . . . . 0.0 112.864 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.64 166.34 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.69 1.996 . . . . 0.0 108.085 169.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.53 124.06 47.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.47 140.45 41.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.173 0.989 . . . . 0.0 109.209 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -69.25 111.82 5.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.541 0.736 . . . . 0.0 109.871 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -82.41 152.73 26.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 m -58.46 -20.06 42.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.67 1.188 . . . . 0.0 112.841 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.15 -48.28 76.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.395 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 p -169.82 -67.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.498 0.59 . . . . 0.0 112.367 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.23 -158.12 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.033 1.333 . . . . 0.0 110.208 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -54.25 141.26 30.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.75 1.22 . . . . 0.0 113.254 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -140.75 159.3 63.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 129.174 2.99 . . . . 0.0 105.593 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.77 143.09 72.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.296 1.331 . . . . 0.0 110.262 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.52 165.39 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.99 1.716 . . . . 0.0 108.591 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.05 130.41 47.06 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.6 137.77 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 p -114.12 -30.86 6.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.454 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.49 163.35 39.73 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.174 0.99 . . . . 0.0 110.521 168.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.91 140.88 37.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -132.58 122.87 25.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -58.53 -25.03 62.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.078 0.951 . . . . 0.0 112.488 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -56.74 -28.74 61.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.95 0.9 . . . . 0.0 112.491 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 128.14 22.86 1.34 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.488 1.042 . . . . 0.0 112.677 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 p -127.53 168.51 14.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.633 1.216 . . . . 0.0 110.036 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.54 153.95 43.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.282 1.833 . . . . 0.0 107.465 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -132.04 134.37 45.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.44 158.36 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -122.01 128.99 52.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.641 1.576 . . . . 0.0 107.019 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -87.8 151.62 22.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -61.89 -25.94 67.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.53 -27.2 69.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.674 0.79 . . . . 0.0 112.309 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.07 -14.45 7.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.072 1.32 . . . . 0.0 113.178 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.44 143.96 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.521 1.16 . . . . 0.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.1 143.7 38.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.27 155.68 39.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.278 0.631 . . . . 0.0 110.893 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 m -108.38 130.26 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.61 -179.27 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.408 1.483 . . . . 0.0 109.474 -169.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -103.38 169.37 8.58 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.191 -0.943 . . . . 0.0 110.775 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.14 -37.38 66.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.838 -0.539 . . . . 0.0 111.25 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.68 -5.48 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.025 -1.047 . . . . 0.0 113.551 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -118.41 -10.23 10.2 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.358 1.063 . . . . 0.0 112.287 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.5 t -143.11 141.54 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.904 1.229 . . . . 0.0 111.331 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -147.89 179.15 7.94 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.88 0.872 . . . . 0.0 109.23 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.9 165.6 0.9 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.659 1.184 . . . . 0.0 110.989 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.82 -29.75 70.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.563 169.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.34 115.81 5.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.61 -23.33 67.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.98 -63.74 1.0 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.66 0.664 . . . . 0.0 112.385 -170.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -153.66 164.29 38.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.035 1.334 . . . . 0.0 109.339 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -75.42 157.57 33.93 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.396 1.079 . . . . 0.0 110.747 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.38 21.99 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.932 0.893 . . . . 0.0 111.722 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.74 -48.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.518 -1.364 . . . . 0.0 111.847 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.76 -34.17 88.02 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -146.07 160.92 41.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.7 67.89 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.825 1.193 . . . . 0.0 110.393 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -123.27 -22.06 5.21 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.24 -179.97 51.72 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.232 0.907 . . . . 0.0 113.671 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.4 m -150.81 166.14 31.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.258 2.623 . . . . 0.0 106.994 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -56.15 128.78 37.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.954 0.797 . . . . 0.0 111.725 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.71 -176.47 5.56 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.023 1.729 . . . . 0.0 108.581 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -155.74 179.11 9.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.613 1.565 . . . . 0.0 109.343 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 74.3 m -129.91 152.34 49.49 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.736 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 p -78.44 -31.47 48.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.523 1.129 . . . . 0.0 112.001 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -67.01 119.21 11.6 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 0.0 108.247 169.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 50.33 36.17 12.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.766 1.626 . . . . 0.0 114.102 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 -173.8 4.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.097 0.959 . . . . 0.0 110.521 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.1 143.51 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 60.3 22.58 12.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.235 1.814 . . . . 0.0 113.07 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -130.12 169.28 15.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.365 1.066 . . . . 0.0 108.47 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.92 150.62 48.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.646 1.978 . . . . 0.0 112.719 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.91 163.01 3.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.843 2.457 . . . . 0.0 107.909 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.59 124.4 40.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.652 -2.722 . . . . 0.0 103.652 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.58 137.89 49.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.1 m -68.77 144.78 54.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -123.51 154.92 38.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.975 1.71 . . . . 0.0 108.141 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.9 m -58.13 -20.5 40.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.673 1.189 . . . . 0.0 112.981 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.02 -48.04 79.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.115 0.966 . . . . 0.0 112.627 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.8 p -169.49 -67.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.128 0.571 . . . . 0.0 112.131 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.52 -157.59 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.042 1.737 . . . . 0.0 109.529 -169.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -47.09 140.71 4.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.0 2.12 . . . . 0.0 115.757 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -145.97 157.95 49.6 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 129.306 3.042 . . . . 0.0 105.399 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 144.46 56.8 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.177 1.918 . . . . 0.0 110.743 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.89 165.05 37.3 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.729 1.612 . . . . 0.0 109.247 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -98.98 130.87 45.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.774 1.63 . . . . 0.0 107.611 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.96 137.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.7 p -114.6 -32.61 5.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.321 0.648 . . . . 0.0 110.522 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.32 163.3 39.74 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.415 1.086 . . . . 0.0 110.27 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -138.0 142.47 35.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -129.54 118.89 22.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -61.58 -20.02 62.84 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.427 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.34 -31.62 54.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.915 0.886 . . . . 0.0 112.285 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.94 24.95 0.7 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.564 1.078 . . . . 0.0 112.697 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.3 p -130.83 169.05 16.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.371 1.585 . . . . 0.0 110.424 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -140.53 152.95 45.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.491 1.916 . . . . 0.0 107.636 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -130.8 131.56 44.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.22 155.14 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -118.52 127.8 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.747 1.619 . . . . 0.0 107.05 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -83.19 150.26 26.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -64.42 -24.24 67.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.47 -23.99 65.56 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.08 0.552 . . . . 0.0 112.345 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 131.47 -16.51 5.13 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.716 1.15 . . . . 0.0 113.607 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.59 147.21 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.413 1.107 . . . . 0.0 109.39 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -132.98 144.83 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.86 158.01 43.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.116 0.566 . . . . 0.0 110.739 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -111.8 130.82 55.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.49 176.7 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.192 1.397 . . . . 0.0 109.192 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.89 167.43 10.52 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.043 -1.036 . . . . 0.0 110.474 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.42 -39.6 67.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 0.0 111.135 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.81 -11.88 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -108.34 -5.24 16.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.855 0.862 . . . . 0.0 112.485 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.18 140.58 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.211 1.369 . . . . 0.0 111.858 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -148.37 177.83 9.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.32 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 168.68 1.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 110.51 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -68.43 -17.46 64.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.623 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 124.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.827 0.851 . . . . 0.0 109.191 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -60.17 -32.72 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.43 -61.62 2.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.852 1.261 . . . . 0.0 114.329 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -153.17 167.25 29.92 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.36 1.064 . . . . 0.0 110.535 -169.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -73.77 169.5 17.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.799 0.84 . . . . 0.0 109.302 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.5 mt -131.41 -13.81 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 111.323 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.01 -40.5 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.103 1.32 . . . . 0.0 111.854 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.29 -29.89 75.88 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -151.15 148.44 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.286 2.234 . . . . 0.0 105.313 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.4 -167.45 1.6 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.961 0.904 . . . . 0.0 110.325 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 77.73 -3.06 2.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.443 2.297 . . . . 0.0 114.503 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.35 179.25 53.49 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 119.123 0.874 . . . . 0.0 111.828 169.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.0 m -147.42 155.4 41.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.959 1.703 . . . . 0.0 108.397 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -66.61 131.07 45.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.22 -158.3 0.85 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.37 1.868 . . . . 0.0 107.063 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -144.17 -179.31 6.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.202 1.001 . . . . 0.0 109.87 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 44.9 m -142.07 155.7 45.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.048 1.339 . . . . 0.0 110.194 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 m -80.88 -24.32 38.41 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.72 122.32 17.39 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.211 0.605 . . . . 0.0 109.596 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 125.944 1.698 . . . . 0.0 107.561 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 56.9 35.34 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.954 1.702 . . . . 0.0 112.904 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -82.92 -173.77 4.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.441 1.096 . . . . 0.0 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.0 mt -50.6 142.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 60.62 21.89 11.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.309 1.844 . . . . 0.0 113.35 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -128.34 170.06 13.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.21 1.004 . . . . 0.0 109.136 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -70.46 149.43 47.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.63 1.172 . . . . 0.0 111.359 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.39 166.08 4.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 126.937 2.095 . . . . 0.0 108.324 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -100.73 124.3 46.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.26 138.9 48.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.0 m -69.28 144.87 53.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.474 0.654 . . . . 0.0 110.9 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -121.41 155.54 34.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.782 1.633 . . . . 0.0 107.991 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -58.24 -20.54 42.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.838 1.255 . . . . 0.0 112.994 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.65 -47.5 79.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.057 0.943 . . . . 0.0 112.48 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.4 p -169.13 -67.99 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.924 0.49 . . . . 0.0 112.238 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.21 -158.19 0.78 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.479 1.911 . . . . 0.0 109.047 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -43.96 137.99 3.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.944 2.498 . . . . 0.0 116.048 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -145.86 157.44 50.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.345 3.058 . . . . 0.0 104.943 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 145.14 48.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.912 1.741 . . . . 0.0 110.77 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.13 165.31 36.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.717 1.607 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -98.5 133.1 43.33 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.149 1.38 . . . . 0.0 107.73 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 136.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -113.73 -32.26 6.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.34 0.656 . . . . 0.0 110.306 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.01 38.1 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.604 1.093 . . . . 0.0 110.502 169.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -138.88 140.8 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -129.42 122.81 30.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.22 -21.2 61.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.772 0.829 . . . . 0.0 112.439 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.28 -29.72 61.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.25 23.93 1.09 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.68 1.133 . . . . 0.0 112.608 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 171.48 12.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.627 1.214 . . . . 0.0 110.609 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.99 154.3 43.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.863 2.065 . . . . 0.0 107.764 -169.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -132.23 132.19 42.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.81 154.82 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.88 125.63 50.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.476 1.51 . . . . 0.0 107.423 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.99 150.53 28.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -64.32 -23.64 67.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.08 -27.92 69.43 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.451 0.7 . . . . 0.0 112.068 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.54 -18.74 5.14 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.943 1.259 . . . . 0.0 113.066 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.36 146.3 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.199 1.0 . . . . 0.0 109.588 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.3 144.71 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.51 154.38 40.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.226 0.61 . . . . 0.0 110.276 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -107.46 131.87 53.82 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 169.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.09 175.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.421 1.488 . . . . 0.0 109.375 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -99.32 168.5 9.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.139 -0.975 . . . . 0.0 110.419 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -53.17 -42.38 66.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.728 0.411 . . . . 0.0 111.023 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.6 pt -60.97 -12.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -105.79 -6.31 19.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.548 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 t -141.76 139.4 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.723 1.601 . . . . 0.0 112.686 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -150.3 176.66 10.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.75 169.27 1.92 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -65.69 -16.29 63.61 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.857 -0.527 . . . . 0.0 111.071 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -62.14 119.17 8.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.203 1.401 . . . . 0.0 108.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -59.54 -30.79 68.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.64 -70.3 0.25 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -150.83 173.34 14.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.764 0.792 . . . . 0.0 111.731 -169.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -72.92 154.23 40.64 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.767 1.627 . . . . 0.0 110.888 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.8 mt -139.22 22.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-N 118.872 0.76 . . . . 0.0 111.852 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 -51.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 120.216 -1.553 . . . . 0.0 112.457 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -37.73 94.74 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.592 1.087 . . . . 0.0 111.654 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -152.26 76.1 1.15 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.9 134.09 56.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -150.23 -45.43 0.13 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.938 1.695 . . . . 0.0 110.756 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -90.25 -163.57 39.19 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 122.287 0.937 . . . . 0.0 112.873 -170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.0 m -146.77 146.53 30.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 106.583 -170.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -61.02 132.85 55.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 111.408 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.64 -152.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.695 1.998 . . . . 0.0 106.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -146.11 -175.86 4.93 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.175 0.99 . . . . 0.0 110.486 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 28.5 t -150.82 179.76 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.783 2.033 . . . . 0.0 108.143 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -124.59 0.15 8.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.15 1.38 . . . . 0.0 111.821 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -70.1 114.58 8.4 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.234 0.269 0 C-N-CA 126.742 2.017 . . . . 0.0 106.714 179.134 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 . . . . . 0 CA--C 1.545 0.765 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 51.31 39.82 24.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.412 2.285 . . . . 0.0 113.65 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -83.05 -174.17 5.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.317 1.047 . . . . 0.0 111.849 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.0 mt -53.49 143.86 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.237 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 64.63 -0.24 0.99 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.815 2.446 . . . . 0.0 114.04 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.75 172.04 8.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.755 1.162 . . . . 0.0 109.396 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -69.53 149.02 48.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.711 1.204 . . . . 0.0 110.884 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.94 171.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 127.278 2.231 . . . . 0.0 108.847 169.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.34 128.96 54.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 168.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.24 143.74 44.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 m -69.21 103.07 1.83 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -68.22 156.29 37.92 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -58.57 -19.47 38.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.402 1.081 . . . . 0.0 112.212 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.31 -51.57 69.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.124 0.97 . . . . 0.0 112.906 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 p -169.55 -74.66 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.48 -157.25 0.75 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.676 1.59 . . . . 0.0 109.808 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.63 135.9 46.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.725 1.61 . . . . 0.0 114.691 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.62 162.09 46.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 129.589 3.156 . . . . 0.0 105.375 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.67 146.0 77.59 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 121.724 1.616 . . . . 0.0 110.712 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.93 31.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.457 1.903 . . . . 0.0 109.03 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -102.2 134.26 45.75 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.6 1.56 . . . . 0.0 107.27 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.67 139.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.421 1.009 . . . . 0.0 108.324 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -116.05 -32.27 5.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.927 -0.559 . . . . 0.0 109.794 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.62 162.58 41.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.478 1.035 . . . . 0.0 110.165 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.5 t -137.42 138.26 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -130.49 117.84 20.22 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.28 -20.52 59.41 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.672 0.789 . . . . 0.0 112.763 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.57 -30.75 55.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.842 0.857 . . . . 0.0 112.285 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.26 23.11 0.85 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 124.675 1.131 . . . . 0.0 112.801 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -130.97 171.12 13.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.647 1.223 . . . . 0.0 110.166 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.2 156.26 43.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.795 2.038 . . . . 0.0 107.605 -169.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -134.99 133.53 39.57 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.23 155.64 23.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.98 129.59 55.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.697 1.599 . . . . 0.0 107.051 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -92.64 146.32 23.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -61.67 -21.07 64.11 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -169.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.04 -19.65 65.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.261 0.625 . . . . 0.0 112.288 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.45 46.24 1.34 Allowed Glycine 0 C--N 1.342 0.884 0 C-N-CA 124.184 0.897 . . . . 0.0 110.983 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.81 140.09 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.7 141.66 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.5 153.98 36.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.236 0.614 . . . . 0.0 110.655 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 m -100.05 135.94 40.71 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.3 176.93 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.978 1.711 . . . . 0.0 109.125 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.54 166.84 11.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.096 -1.003 . . . . 0.0 110.715 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -54.81 -38.48 67.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.824 0.849 . . . . 0.0 111.233 171.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.5 pt -61.73 -13.95 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.85 -7.66 19.25 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.253 0.933 . . . . 0.0 112.685 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.76 140.2 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 120.275 1.398 . . . . 0.0 111.173 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -149.07 175.42 11.35 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.259 1.024 . . . . 0.0 109.8 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.0 167.1 1.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.287 1.035 . . . . 0.0 110.931 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.4 -23.7 67.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.103 169.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.2 m -63.15 102.89 0.42 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.89 -24.78 66.23 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.72 -54.19 42.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.209 1.004 . . . . 0.0 112.516 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -154.91 157.63 38.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.45 1.1 . . . . 0.0 110.912 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -73.73 153.69 39.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 109.253 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.93 21.75 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 124.031 0.932 . . . . 0.0 111.557 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.38 -41.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 120.67 -1.269 . . . . 0.0 110.975 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -21.13 79.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.602 0.637 . . . . 0.0 111.95 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -142.67 152.13 42.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.964 2.105 . . . . 0.0 106.045 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.47 2.05 35.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -108.23 2.64 22.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.341 0.973 . . . . 0.0 113.471 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.24 175.25 36.34 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.859 0.754 . . . . 0.0 112.921 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 m -148.22 159.5 43.91 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.646 1.578 . . . . 0.0 109.274 -169.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -59.11 141.58 53.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.105 0.562 . . . . 0.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.79 179.14 8.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 108.278 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -171.38 -152.4 0.08 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.728 1.611 . . . . 0.0 108.161 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 34.0 m 58.78 42.1 20.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.013 1.325 . . . . 0.0 110.817 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m -85.69 170.59 12.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.231 2.212 . . . . 0.0 110.878 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -63.68 146.84 53.05 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.831 -0.543 . . . . 0.0 110.061 170.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 107.474 173.636 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -116.84 136.68 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.362 1.065 . . . . 0.0 109.179 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.6 mp0 -144.35 -173.48 4.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.518 1.927 . . . . 0.0 108.63 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.91 142.67 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 61.59 21.78 12.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.115 1.766 . . . . 0.0 113.411 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.2 tp10 -128.12 170.29 13.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.538 1.135 . . . . 0.0 108.372 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.08 146.11 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.576 1.55 . . . . 0.0 112.3 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.42 173.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 127.735 2.414 . . . . 0.0 108.534 172.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.1 mt -107.36 129.23 54.94 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 141.15 42.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.99 0.916 . . . . 0.0 109.463 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.2 m -70.24 102.83 2.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.317 1.047 . . . . 0.0 110.525 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -68.21 154.44 41.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -59.56 -17.98 37.1 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.361 1.064 . . . . 0.0 113.049 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.13 -50.13 73.75 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.441 0.697 . . . . 0.0 111.911 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -171.96 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.28 0.632 . . . . 0.0 111.947 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.36 -160.51 1.18 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 111.385 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.79 134.97 36.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.919 2.088 . . . . 0.0 115.936 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -140.61 159.48 62.75 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 129.173 2.989 . . . . 0.0 105.342 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.82 144.97 79.37 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.718 1.612 . . . . 0.0 110.536 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.83 165.14 36.33 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.774 1.63 . . . . 0.0 109.084 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -98.69 131.11 45.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.133 1.373 . . . . 0.0 107.366 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.11 138.35 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 p -114.7 -31.3 6.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.513 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.98 163.06 40.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.581 1.082 . . . . 0.0 110.257 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -134.98 142.3 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -133.4 112.23 11.42 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.71 -19.97 53.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.716 0.806 . . . . 0.0 112.833 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.71 -31.64 38.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.079 0.952 . . . . 0.0 112.454 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.83 18.96 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.527 1.061 . . . . 0.0 113.052 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.7 p -129.8 170.13 14.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.923 1.361 . . . . 0.0 110.164 -170.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.66 154.81 41.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.904 1.682 . . . . 0.0 107.396 -169.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -131.69 134.83 46.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.4 m -142.32 158.85 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.23 125.23 44.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.274 1.43 . . . . 0.0 107.184 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.58 151.18 26.5 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -64.81 -24.34 67.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.71 -26.5 68.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.6 0.76 . . . . 0.0 112.247 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.32 -13.95 6.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.976 1.274 . . . . 0.0 113.306 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.47 143.05 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.445 1.122 . . . . 0.0 109.141 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.69 144.1 38.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.38 153.31 33.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.289 0.635 . . . . 0.0 110.673 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -108.58 128.55 54.93 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.02 -178.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.133 1.373 . . . . 0.0 109.227 -168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.76 169.28 8.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.003 -1.06 . . . . 0.0 110.845 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.0 -37.21 68.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.074 0.55 . . . . 0.0 111.043 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.97 -5.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 120.882 -1.136 . . . . 0.0 113.509 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -118.94 -12.83 9.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.381 1.073 . . . . 0.0 112.145 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.41 138.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.255 1.389 . . . . 0.0 110.588 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -147.37 176.69 9.82 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.71 0.804 . . . . 0.0 109.47 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.58 168.1 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.074 0.949 . . . . 0.0 110.714 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -28.04 69.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.247 170.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -64.39 116.52 6.16 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.698 0.799 . . . . 0.0 109.168 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -65.85 -24.73 66.94 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -84.14 -36.49 22.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -146.86 165.0 31.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 110.624 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.08 169.19 14.17 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.3 mm -129.18 -13.75 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 124.819 1.248 . . . . 0.0 111.393 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.66 -36.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.54 1.518 . . . . 0.0 112.971 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.05 -30.24 77.2 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.605 1.093 . . . . 0.0 110.642 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -151.2 153.86 35.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.396 2.678 . . . . 0.0 104.28 169.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.65 12.23 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.98 1.264 . . . . 0.0 114.327 -169.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.44 -6.28 59.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.168 0.894 . . . . 0.0 112.266 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.4 -177.91 41.73 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 121.962 0.757 . . . . 0.0 114.04 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -148.21 165.88 29.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.326 1.451 . . . . 0.0 109.53 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -72.28 135.32 45.95 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.511 -0.743 . . . . 0.0 110.571 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -152.15 -171.27 3.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.246 1.818 . . . . 0.0 107.465 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -154.76 -178.73 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.577 1.551 . . . . 0.0 108.762 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 77.6 p -143.2 175.91 9.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.359 1.064 . . . . 0.0 109.931 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 p -116.44 -0.6 12.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.615 1.166 . . . . 0.0 113.232 -169.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -80.98 44.58 0.77 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.592 1.087 . . . . 0.0 110.529 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 48.8 mt . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.726 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 72.18 83.26 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.296 2.638 . . . . 0.0 113.06 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -139.23 -173.65 3.65 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.73 1.612 . . . . 0.0 109.512 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.1 mt -48.96 141.94 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.476 1.11 . . . . 0.0 109.467 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.49 22.25 11.93 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.091 1.756 . . . . 0.0 113.29 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -127.62 170.27 12.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.235 1.014 . . . . 0.0 108.805 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -74.03 149.65 41.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.778 1.231 . . . . 0.0 111.516 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.45 168.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.787 2.035 . . . . 0.0 108.059 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -101.69 130.92 48.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.61 140.2 44.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.997 0.919 . . . . 0.0 109.014 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.1 m -69.73 102.59 1.94 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.815 0.846 . . . . 0.0 110.711 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.91 153.39 41.88 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -58.19 -20.48 41.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.048 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.21 -48.03 77.24 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.09 0.956 . . . . 0.0 112.396 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.8 p -169.59 -72.75 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.586 0.354 . . . . 0.0 111.615 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 -156.14 0.69 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.135 1.374 . . . . 0.0 110.012 -173.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -49.31 139.71 11.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.914 1.686 . . . . 0.0 115.047 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -146.33 156.51 49.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 130.12 3.368 . . . . 0.0 104.246 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.3 147.13 71.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.521 1.481 . . . . 0.0 110.968 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.34 164.69 36.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.182 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -95.24 132.63 40.01 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.526 1.53 . . . . 0.0 107.691 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.26 135.72 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.7 p -112.66 -33.57 6.08 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.849 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.19 164.67 36.87 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 110.723 168.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.58 142.31 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -131.39 119.21 21.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -61.24 -19.76 62.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.409 0.684 . . . . 0.0 112.556 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.6 -30.76 44.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 112.296 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.79 20.54 0.76 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.556 1.074 . . . . 0.0 112.967 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -129.3 169.82 14.38 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.72 1.26 . . . . 0.0 110.394 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -143.44 155.82 44.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.954 2.102 . . . . 0.0 107.728 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -133.0 131.81 41.16 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -140.04 157.32 25.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -122.09 122.83 40.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -78.24 150.24 33.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -64.18 -25.34 68.03 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.08 -26.83 68.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.629 0.772 . . . . 0.0 112.265 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.4 -16.83 5.93 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.102 1.334 . . . . 0.0 113.033 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.14 143.4 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.255 1.027 . . . . 0.0 109.356 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.67 144.41 38.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -152.05 155.9 38.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.269 0.628 . . . . 0.0 110.474 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -109.96 129.79 55.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.37 179.58 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.405 1.482 . . . . 0.0 109.677 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.32 168.51 9.29 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.08 0.952 . . . . 0.0 110.758 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -55.43 -36.83 66.92 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.795 -0.566 . . . . 0.0 111.321 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.8 pt -64.23 -5.06 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -118.05 -11.04 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.315 1.046 . . . . 0.0 112.484 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.91 141.07 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 120.263 1.392 . . . . 0.0 110.991 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -150.47 172.33 15.62 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.305 1.042 . . . . 0.0 109.703 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 166.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.778 1.231 . . . . 0.0 111.59 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -68.1 -8.58 39.35 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.56 -0.713 . . . . 0.0 111.541 169.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -67.97 117.28 9.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.71 -44.27 90.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 112.121 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.62 -67.02 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -151.23 163.36 39.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.741 1.216 . . . . 0.0 109.353 -170.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -84.54 164.18 18.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.075 0.55 . . . . 0.0 111.882 -170.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.7 15.01 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.759 0.824 . . . . 0.0 112.183 -173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.05 158.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 120.397 -1.44 . . . . 0.0 107.413 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.53 3.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.708 1.147 . . . . 0.0 111.992 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -143.72 65.86 1.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.926 2.09 . . . . 0.0 106.259 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.47 132.09 52.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.383 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.89 -2.33 0.93 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.149 0.979 . . . . 0.0 113.035 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.38 -159.29 9.13 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.42 1.009 . . . . 0.0 112.794 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.8 m -139.4 164.69 29.18 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.06 1.744 . . . . 0.0 109.84 -169.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -60.7 145.3 49.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.2 -165.39 1.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.161 2.584 . . . . 0.0 107.1 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.94 169.94 17.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.269 1.028 . . . . 0.0 109.658 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 36.7 m -135.23 179.98 5.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.97 1.308 . . . . 0.0 111.056 -170.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.8 m -134.65 6.17 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.726 0.81 . . . . 0.0 113.039 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -75.88 24.82 0.12 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.408 1.483 . . . . 0.0 112.933 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.235 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 109.625 -178.454 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 118.657 -0.687 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 72.22 80.96 0.14 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.033 2.533 . . . . 0.0 113.279 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.57 -174.77 3.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.091 1.356 . . . . 0.0 109.523 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.0 mt -53.2 143.58 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.58 17.1 10.15 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.952 1.701 . . . . 0.0 113.258 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -123.27 173.24 8.06 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -84.37 156.45 21.84 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.408 -0.807 . . . . 0.0 111.302 -169.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.97 167.51 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.305 1.842 . . . . 0.0 109.05 170.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.97 127.35 41.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.36 144.14 38.07 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.455 0.702 . . . . 0.0 109.644 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -68.83 108.44 3.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.396 0.679 . . . . 0.0 109.883 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -73.29 162.56 29.22 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.987 0.915 . . . . 0.0 109.726 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 m -58.0 -19.64 32.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.568 1.147 . . . . 0.0 112.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.43 -23.15 56.65 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 113.334 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.2 m 110.7 8.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 130.151 3.38 . . . . 0.0 114.898 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -153.64 -176.93 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.555 1.07 . . . . 0.0 111.229 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.89 140.07 53.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -142.02 158.34 62.04 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 128.341 2.656 . . . . 0.0 106.074 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.23 145.61 73.04 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.612 1.541 . . . . 0.0 111.206 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.31 156.89 37.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.171 1.789 . . . . 0.0 109.044 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.54 133.51 34.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.907 1.283 . . . . 0.0 108.391 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.46 133.77 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 p -111.55 -32.56 6.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.031 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 164.4 38.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.721 1.146 . . . . 0.0 110.676 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.13 141.42 33.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -129.57 128.0 41.84 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.73 -24.49 61.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.805 0.842 . . . . 0.0 112.47 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.29 -27.59 55.92 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 112.732 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.07 19.07 2.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.636 1.112 . . . . 0.0 112.705 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.2 p -123.54 168.98 11.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.502 1.151 . . . . 0.0 110.116 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.05 153.36 42.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 106.965 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -133.26 135.7 45.08 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.94 159.69 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -123.96 120.63 33.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -77.03 150.04 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -64.89 -23.55 67.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -63.39 -24.44 67.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.392 0.677 . . . . 0.0 112.435 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.98 -14.56 7.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.02 1.295 . . . . 0.0 113.009 173.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.48 143.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.288 1.044 . . . . 0.0 108.992 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.76 143.61 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -151.18 155.47 38.94 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.056 0.543 . . . . 0.0 110.699 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -108.97 131.48 55.01 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.01 178.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.748 1.619 . . . . 0.0 108.902 -169.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.69 165.7 12.58 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.018 -1.051 . . . . 0.0 110.496 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.54 -37.07 64.97 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.856 0.862 . . . . 0.0 111.016 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.36 -11.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.005 -1.059 . . . . 0.0 113.547 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -106.6 -8.99 16.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 112.636 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.59 139.54 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.437 1.017 . . . . 0.0 110.99 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -152.12 175.03 13.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.944 0.498 . . . . 0.0 110.682 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.17 165.35 0.52 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.331 1.453 . . . . 0.0 111.728 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -64.25 -16.7 62.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.843 -0.536 . . . . 0.0 111.844 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 m -62.14 116.25 4.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.41 1.084 . . . . 0.0 108.983 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.26 -28.3 67.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.37 -76.76 0.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.153 0.581 . . . . 0.0 111.812 -171.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.18 165.36 29.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 0.0 109.537 -170.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.92 163.58 25.14 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.176 0.512 . . . . 0.0 112.329 -171.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 mt -129.7 28.29 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 124.958 1.303 . . . . 0.0 108.606 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.32 160.46 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.45 1.9 . . . . 0.0 106.207 175.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.66 -62.43 3.53 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.867 1.222 . . . . 0.0 111.716 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -142.0 72.22 1.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.28 130.47 46.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.47 -21.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -171.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.76 -171.17 47.44 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 121.955 0.753 . . . . 0.0 111.832 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.3 m -146.24 159.9 42.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.643 1.977 . . . . 0.0 108.03 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -56.38 127.93 33.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.767 0.427 . . . . 0.0 111.113 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.1 -164.52 1.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.44 1.896 . . . . 0.0 107.4 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -145.23 -180.0 7.01 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 109.748 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 t -142.15 175.34 9.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.355 1.462 . . . . 0.0 108.889 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.2 m -133.0 -10.16 3.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -79.73 111.08 15.68 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 170.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 110.301 -178.402 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 17.3 m-85 55.14 36.27 26.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.656 1.583 . . . . 0.0 114.155 169.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -82.24 -173.35 4.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.578 0.751 . . . . 0.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.94 142.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 61.87 21.49 12.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.384 1.873 . . . . 0.0 113.337 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.19 170.19 13.28 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.354 1.062 . . . . 0.0 109.192 171.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.19 149.07 50.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.006 2.122 . . . . 0.0 112.534 -174.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.31 164.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 127.932 2.493 . . . . 0.0 108.525 171.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.48 130.21 42.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 168.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.66 145.12 38.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.517 0.727 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -69.02 116.09 9.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.906 0.482 . . . . 0.0 109.714 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -79.62 164.25 23.96 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.224 1.01 . . . . 0.0 110.597 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.9 m -57.23 -24.3 53.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.841 0.856 . . . . 0.0 112.33 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.77 -4.07 18.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.092 1.357 . . . . 0.0 113.459 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.4 m 75.28 156.86 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.633 2.773 . . . . 0.0 111.593 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.65 176.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.079 2.551 . . . . 0.0 115.425 -169.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -71.12 148.53 47.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -144.48 162.32 39.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 129.337 3.055 . . . . 0.0 106.01 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.33 145.89 61.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.892 1.728 . . . . 0.0 110.721 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.58 33.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.536 1.935 . . . . 0.0 108.748 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -101.58 133.78 45.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 107.414 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.79 136.67 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 p -114.02 -32.9 5.9 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.278 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.21 35.28 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.263 0.938 . . . . 0.0 110.63 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.3 t -141.65 140.56 30.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -130.63 123.66 29.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -60.08 -22.97 63.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.722 0.809 . . . . 0.0 112.568 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.27 -28.62 59.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.877 . . . . 0.0 112.278 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.51 22.32 1.2 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.769 1.176 . . . . 0.0 112.782 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.6 p -127.12 169.42 13.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.786 1.293 . . . . 0.0 110.271 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -142.45 156.41 45.18 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.905 2.082 . . . . 0.0 108.022 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -133.92 134.83 43.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.56 157.57 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.85 131.33 53.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.442 1.497 . . . . 0.0 107.186 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.67 148.57 23.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.41 -24.28 66.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -169.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.56 -30.47 71.5 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.298 0.639 . . . . 0.0 112.386 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.23 -15.31 4.23 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.46 1.029 . . . . 0.0 113.545 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.58 143.88 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 109.348 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.0 145.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.46 157.43 42.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.153 0.581 . . . . 0.0 110.719 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -108.74 131.92 54.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.15 178.6 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.307 1.443 . . . . 0.0 109.518 -169.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.71 167.11 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.141 -0.974 . . . . 0.0 110.502 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.28 -39.21 66.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.498 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.7 pt -61.51 -13.38 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -104.25 -8.69 19.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.112 -0.946 . . . . 0.0 112.637 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.8 140.5 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.818 1.19 . . . . 0.0 111.863 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -150.13 177.86 9.51 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 110.34 171.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -60.49 167.97 2.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.026 0.93 . . . . 0.0 111.096 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -69.29 -17.27 63.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.37 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -63.01 122.98 17.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.73 -37.86 77.1 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.354 0.662 . . . . 0.0 112.158 -173.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.6 -69.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -149.7 168.8 22.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.877 0.871 . . . . 0.0 111.204 -169.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.5 155.06 34.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.653 1.581 . . . . 0.0 110.83 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.32 21.27 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 123.987 0.915 . . . . 0.0 112.067 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.98 -46.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.192 -1.567 . . . . 0.0 112.078 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.83 -32.49 82.99 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -145.84 162.9 36.63 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.28 56.24 1.04 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.39 1.45 . . . . 0.0 112.044 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.94 -19.14 9.29 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.95 -177.17 51.44 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 122.277 0.931 . . . . 0.0 112.676 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.7 m -148.67 165.17 32.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.246 2.218 . . . . 0.0 107.388 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -61.33 120.68 10.91 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.394 -0.816 . . . . 0.0 110.154 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -155.01 -170.91 3.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.185 2.194 . . . . 0.0 107.327 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -150.19 171.63 16.61 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.903 0.881 . . . . 0.0 110.179 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.7 m -138.1 178.09 7.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.567 1.547 . . . . 0.0 110.212 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.5 m -127.92 8.77 6.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.88 31.73 0.37 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.404 1.081 . . . . 0.0 111.732 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.789 1.236 . . . . 0.0 110.589 -179.909 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -107.55 127.83 53.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.47 1.108 . . . . 0.0 109.784 -169.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.7 mp0 -144.39 -173.79 4.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.664 1.586 . . . . 0.0 109.257 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.4 mt -51.51 143.71 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.68 22.11 12.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.27 1.828 . . . . 0.0 113.422 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -130.13 169.57 15.16 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.345 1.058 . . . . 0.0 108.83 171.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.4 146.3 53.34 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.779 2.032 . . . . 0.0 112.689 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.29 171.88 5.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 0.0 107.915 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.7 mt -109.82 124.4 51.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 138.97 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.145 0.978 . . . . 0.0 108.649 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.9 m -69.09 134.87 49.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -109.73 156.95 19.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.282 1.433 . . . . 0.0 108.442 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -58.64 -19.78 41.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.503 1.121 . . . . 0.0 112.863 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.57 -50.19 70.74 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.103 0.961 . . . . 0.0 112.461 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -170.68 -67.5 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.94 0.496 . . . . 0.0 111.845 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -155.26 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.732 1.613 . . . . 0.0 109.675 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -51.81 139.08 22.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.897 2.079 . . . . 0.0 115.78 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -142.87 157.34 61.49 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 128.914 2.885 . . . . 0.0 105.582 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.73 145.73 64.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 120.985 1.124 . . . . 0.0 111.092 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.04 164.52 37.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.449 1.5 . . . . 0.0 109.356 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -97.63 132.16 43.54 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.381 1.473 . . . . 0.0 107.789 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.62 138.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 p -115.07 -32.34 5.75 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.249 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 164.86 36.63 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.572 1.078 . . . . 0.0 110.465 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.59 141.65 32.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.27 113.97 13.24 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.7 -19.67 59.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.322 0.649 . . . . 0.0 112.517 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.22 -30.47 38.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.064 0.946 . . . . 0.0 112.421 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.57 22.56 0.61 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.399 1.0 . . . . 0.0 112.743 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.4 p -131.85 169.64 15.97 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.059 1.429 . . . . 0.0 110.589 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -144.37 153.0 41.5 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.496 1.918 . . . . 0.0 107.215 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -130.8 134.07 46.53 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 170.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.12 155.26 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -118.48 125.93 50.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.668 1.587 . . . . 0.0 107.003 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.76 151.69 27.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -65.83 -22.76 66.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.67 -27.49 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.141 0.577 . . . . 0.0 112.196 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.7 -17.74 5.21 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.882 1.23 . . . . 0.0 113.09 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.13 146.07 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.232 1.013 . . . . 0.0 109.478 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.03 144.65 36.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.16 154.3 38.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.188 0.595 . . . . 0.0 110.851 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -108.37 130.23 55.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.79 175.84 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.377 1.471 . . . . 0.0 108.758 -169.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -97.53 168.39 10.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.008 -1.058 . . . . 0.0 110.543 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.53 -39.03 67.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.432 0.693 . . . . 0.0 111.086 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.79 -6.61 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -114.3 -7.67 12.93 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 112.622 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.5 140.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 120.283 1.401 . . . . 0.0 111.71 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -149.42 174.24 12.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.088 0.955 . . . . 0.0 109.958 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.21 168.75 0.67 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.453 1.101 . . . . 0.0 111.265 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -63.13 -20.6 65.52 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.551 -0.718 . . . . 0.0 110.743 169.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.8 m -62.38 123.73 19.03 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.161 0.984 . . . . 0.0 110.561 170.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -60.68 -40.36 91.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.823 0.849 . . . . 0.0 112.128 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.96 -67.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -150.61 168.04 25.5 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.028 0.931 . . . . 0.0 111.049 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.23 156.72 38.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.204 1.402 . . . . 0.0 110.782 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -139.75 24.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.958 0.903 . . . . 0.0 111.44 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.44 -60.66 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 120.603 -1.311 . . . . 0.0 109.93 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.33 -34.38 85.08 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -136.39 163.28 30.83 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.972 2.109 . . . . 0.0 105.779 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.73 18.11 9.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 114.137 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -79.57 -18.11 52.44 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.467 -0.777 . . . . 0.0 112.714 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.75 175.79 51.5 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 119.465 1.03 . . . . 0.0 113.114 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.8 m -149.98 163.77 37.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 107.761 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -61.45 132.04 52.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.477 -0.764 . . . . 0.0 111.279 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.21 -172.46 3.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.551 1.94 . . . . 0.0 108.355 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -146.42 168.72 20.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.538 1.135 . . . . 0.0 110.189 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 15.5 m -135.5 161.96 34.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.894 1.278 . . . . 0.0 109.171 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 p -106.39 -25.98 11.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -73.81 129.12 37.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 109.295 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.871 175.113 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.429 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.9 m-85 72.79 71.49 0.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.212 1.805 . . . . 0.0 113.65 169.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -121.95 -174.29 2.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.742 1.617 . . . . 0.0 109.616 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.51 142.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 60.81 24.14 14.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.723 1.609 . . . . 0.0 113.185 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.27 169.78 13.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.676 1.191 . . . . 0.0 108.137 170.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.74 155.12 40.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.853 0.861 . . . . 0.0 112.603 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.32 164.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.275 2.23 . . . . 0.0 107.902 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.56 128.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.15 141.03 46.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 108.84 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.0 m -69.62 117.53 11.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.21 0.604 . . . . 0.0 109.684 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -84.21 162.56 20.14 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.722 1.209 . . . . 0.0 109.403 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -55.65 -20.12 12.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.071 1.348 . . . . 0.0 112.987 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.35 -51.88 18.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.356 1.463 . . . . 0.0 112.048 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m 161.66 -46.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.74 2.816 . . . . 0.0 111.252 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.38 -168.0 2.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.056 0.844 . . . . 0.0 113.027 -169.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -54.31 141.77 28.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.083 2.153 . . . . 0.0 116.367 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -149.7 160.26 34.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 130.085 3.354 . . . . 0.0 105.168 168.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.16 147.3 66.44 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.489 1.459 . . . . 0.0 110.937 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.43 162.96 40.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.642 1.977 . . . . 0.0 108.952 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -91.47 133.66 35.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.174 1.39 . . . . 0.0 107.578 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.97 134.46 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -111.39 -31.94 6.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.698 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.57 160.74 43.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.592 1.087 . . . . 0.0 110.446 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.3 140.1 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 170.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -132.33 111.95 11.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -62.19 -16.35 52.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.728 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -53.47 -31.46 45.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.732 0.813 . . . . 0.0 112.071 169.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.19 18.18 0.75 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.837 1.208 . . . . 0.0 112.722 174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.1 p -129.41 172.16 11.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.735 1.267 . . . . 0.0 110.256 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -145.98 154.79 42.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.692 1.997 . . . . 0.0 107.178 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -133.0 133.65 43.41 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.87 157.78 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -122.98 124.67 43.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.225 1.41 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -80.09 149.64 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -65.54 -25.37 67.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.32 -25.65 66.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.318 0.647 . . . . 0.0 112.153 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.99 3.94 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.449 1.023 . . . . 0.0 113.766 171.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.61 144.99 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.204 1.002 . . . . 0.0 109.437 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.91 143.95 39.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -149.41 155.03 39.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.826 0.451 . . . . 0.0 110.826 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 128.84 55.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 m -147.44 178.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.133 1.373 . . . . 0.0 109.183 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.3 169.06 10.03 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.229 -0.919 . . . . 0.0 110.837 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -55.55 -38.58 69.49 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.043 0.537 . . . . 0.0 111.042 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.37 -6.32 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.979 -1.076 . . . . 0.0 113.532 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -115.48 -8.5 12.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 112.453 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.5 139.63 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 120.377 1.444 . . . . 0.0 110.932 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.02 172.7 14.32 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.992 0.917 . . . . 0.0 110.012 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -54.65 166.39 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 111.18 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -67.11 -11.44 57.2 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.406 -0.809 . . . . 0.0 111.118 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 121.29 13.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 109.299 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.65 -44.5 90.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.547 0.739 . . . . 0.0 110.848 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -57.39 -61.29 2.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.263 1.425 . . . . 0.0 113.578 -169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -154.87 164.77 38.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.217 1.407 . . . . 0.0 108.373 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.19 171.34 13.15 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.97 -69.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.644 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.33 -19.98 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 121.085 1.766 . . . . 0.0 114.356 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.02 19.56 29.91 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.404 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -152.84 -41.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.907 1.354 . . . . 0.0 113.381 -170.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 60.01 8.86 1.57 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.077 2.551 . . . . 0.0 116.651 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -108.09 -23.67 11.88 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.069 1.304 . . . . 0.0 111.12 173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.81 171.72 25.92 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 122.124 0.847 . . . . 0.0 113.055 174.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.5 m -146.38 159.67 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.876 1.671 . . . . 0.0 109.015 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.95 130.42 45.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.07 -168.54 3.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.317 1.847 . . . . 0.0 107.415 170.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -146.13 167.28 23.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.968 0.907 . . . . 0.0 109.875 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 20.4 m -136.8 -178.05 5.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.67 1.188 . . . . 0.0 111.047 -170.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 10.7 m -132.64 6.87 4.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -76.41 28.53 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.617 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 CA--C 1.536 0.424 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -176.612 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -109.46 126.53 53.59 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.623 1.169 . . . . 0.0 109.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.4 mp0 -140.15 -174.03 3.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.686 1.594 . . . . 0.0 108.564 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -47.94 140.97 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.174 0.99 . . . . 0.0 108.504 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 59.5 25.66 14.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.5 1.92 . . . . 0.0 112.926 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -136.04 162.4 33.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.247 1.019 . . . . 0.0 108.976 172.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -65.41 146.21 55.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.588 2.355 . . . . 0.0 113.903 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.84 171.99 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 127.558 2.343 . . . . 0.0 108.487 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.49 124.06 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.68 141.61 47.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.895 0.878 . . . . 0.0 109.069 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 m -69.05 103.77 1.95 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -69.42 155.15 40.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.2 m -58.22 -20.79 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 112.383 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -58.74 -48.91 79.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.296 1.038 . . . . 0.0 113.07 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 p -168.83 -71.61 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -161.62 1.38 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.388 1.875 . . . . 0.0 109.348 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -51.57 136.15 26.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.9 161.61 42.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 129.377 3.071 . . . . 0.0 104.654 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.18 147.22 59.69 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.955 1.77 . . . . 0.0 111.007 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.7 169.22 25.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.858 2.463 . . . . 0.0 107.132 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.07 146.35 41.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.55 1.068 . . . . 0.0 109.735 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.5 142.45 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.021 0.928 . . . . 0.0 108.555 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 p -119.11 -28.64 5.43 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.809 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.93 158.99 43.92 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 119.523 1.056 . . . . 0.0 110.087 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.5 143.05 38.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -134.08 116.74 15.81 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.35 -19.75 62.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.341 0.656 . . . . 0.0 112.409 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.84 -30.51 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.889 0.876 . . . . 0.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.96 23.54 0.77 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.537 1.065 . . . . 0.0 112.691 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.4 p -131.66 169.34 16.3 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.442 1.621 . . . . 0.0 110.46 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.41 150.99 37.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.387 1.875 . . . . 0.0 108.053 -169.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 m -130.59 134.41 46.97 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.05 156.84 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -119.98 127.04 52.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.28 146.4 26.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -60.91 -25.86 67.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -169.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.33 -29.34 70.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.979 0.512 . . . . 0.0 112.195 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.02 -19.07 3.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.47 1.033 . . . . 0.0 113.148 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.45 141.31 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.319 1.047 . . . . 0.0 109.643 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.92 142.3 43.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.01 157.85 39.69 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.895 0.478 . . . . 0.0 110.793 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 84.7 m -106.64 136.66 46.04 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.28 179.97 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.707 2.003 . . . . 0.0 108.375 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.06 168.13 10.46 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.51 -39.05 67.21 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.808 0.843 . . . . 0.0 111.272 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.48 -9.79 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -110.44 -7.24 14.79 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.05 0.94 . . . . 0.0 112.677 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 t -141.95 142.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.873 1.215 . . . . 0.0 111.081 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -148.61 179.03 8.13 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.034 0.934 . . . . 0.0 109.543 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.26 166.62 0.8 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.692 1.197 . . . . 0.0 110.833 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.29 -28.58 69.82 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.492 169.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -64.1 118.37 8.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.746 0.819 . . . . 0.0 109.154 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.21 -24.47 67.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.67 -62.42 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -154.39 167.07 31.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.92 1.288 . . . . 0.0 109.864 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.13 165.96 24.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.806 0.842 . . . . 0.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.6 mt -129.11 -14.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 117.788 -1.101 . . . . 0.0 111.867 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.01 -28.88 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 121.413 1.915 . . . . 0.0 114.018 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.15 -44.64 97.88 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -159.06 121.44 3.54 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.9 104.62 5.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -169.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -137.27 -30.67 0.84 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -171.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -91.95 -174.56 42.52 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.953 0.797 . . . . 0.0 114.168 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 80.4 p -153.31 170.99 19.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.659 1.984 . . . . 0.0 108.152 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -58.04 124.7 20.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.381 0.992 . . . . 0.0 111.526 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -158.53 -172.22 3.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.941 1.696 . . . . 0.0 109.001 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -155.19 -177.77 6.77 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.129 1.771 . . . . 0.0 109.254 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 90.0 p -144.43 -179.07 6.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.229 1.011 . . . . 0.0 110.094 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 m -110.67 4.2 19.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.849 0.86 . . . . 0.0 112.674 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.84 40.62 0.47 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.509 1.123 . . . . 0.0 110.76 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 127.388 2.275 . . . . 0.0 112.764 -169.498 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 119.284 -0.389 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 55.56 37.86 29.43 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.274 1.829 . . . . 0.0 112.521 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.69 -174.4 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.407 1.083 . . . . 0.0 109.921 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.9 143.12 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 61.84 19.01 10.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.127 1.771 . . . . 0.0 113.401 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -125.16 171.56 10.22 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -83.42 159.24 21.83 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.42 167.71 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 126.641 1.977 . . . . 0.0 108.12 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.3 mt -94.97 133.57 38.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.72 142.92 34.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.802 0.841 . . . . 0.0 109.392 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -69.54 109.65 4.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.744 0.818 . . . . 0.0 109.549 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -79.25 159.51 27.26 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -57.86 -19.64 30.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.359 1.463 . . . . 0.0 113.05 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -49.62 -57.45 7.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.902 1.281 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 m 171.27 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 112.375 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.19 -167.62 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.871 0.76 . . . . 0.0 113.012 -169.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -64.9 141.78 58.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.584 1.154 . . . . 0.0 114.07 -169.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.45 157.83 51.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 128.776 2.83 . . . . 0.0 105.138 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.87 149.3 72.29 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.571 1.514 . . . . 0.0 111.046 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.03 158.46 40.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.886 2.074 . . . . 0.0 108.627 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.5 135.33 33.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.03 134.47 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -111.86 -30.33 7.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.423 0.689 . . . . 0.0 110.448 172.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.31 161.73 42.18 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.624 1.102 . . . . 0.0 110.612 169.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.42 141.29 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -127.86 132.87 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.68 -26.01 63.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.947 0.899 . . . . 0.0 112.174 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.94 -24.9 62.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.923 0.889 . . . . 0.0 112.743 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.95 19.13 4.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.75 1.166 . . . . 0.0 112.628 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -120.76 167.93 11.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.297 1.049 . . . . 0.0 110.253 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -140.8 152.79 45.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.815 2.046 . . . . 0.0 107.543 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.4 m -130.47 130.9 44.82 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 169.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.87 153.0 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -120.21 119.7 33.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.312 1.445 . . . . 0.0 107.299 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.43 146.88 38.32 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -64.86 -21.13 66.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 112.935 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.86 -18.63 64.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.812 0.845 . . . . 0.0 112.382 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.41 47.83 1.49 Allowed Glycine 0 C--N 1.342 0.877 0 C-N-CA 124.324 0.964 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.9 t -134.63 142.73 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -132.51 144.71 36.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -150.1 158.46 44.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 110.406 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -109.78 130.36 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.2 -178.54 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.401 1.48 . . . . 0.0 109.832 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -105.69 169.54 8.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.796 1.238 . . . . 0.0 111.051 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -55.17 -38.07 67.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.215 0.606 . . . . 0.0 111.195 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.52 -5.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -117.85 -10.45 10.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.424 1.09 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.46 139.61 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.92 1.236 . . . . 0.0 111.216 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -149.94 169.69 20.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.604 0.762 . . . . 0.0 109.936 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.91 165.33 0.65 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.262 1.025 . . . . 0.0 111.588 172.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.93 -13.34 59.56 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.618 -0.676 . . . . 0.0 111.233 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.7 m -63.04 116.16 5.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.531 1.132 . . . . 0.0 109.332 169.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -58.29 -46.06 86.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.787 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.95 -52.14 46.61 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -151.31 160.84 43.58 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.985 0.914 . . . . 0.0 110.422 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -76.1 171.15 14.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.692 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.9 mm -119.57 -16.67 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.446 1.099 . . . . 0.0 111.049 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 144' ' ' GLY . 9.9 p -150.88 -168.05 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 120.167 1.349 . . . . 0.0 108.808 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' H ' HG22 ' A' ' 143' ' ' VAL . . . 84.63 -37.57 2.93 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.448 -1.408 . . . . 0.0 112.777 169.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -148.02 -46.17 0.16 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.925 0.89 . . . . 0.0 110.145 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.27 25.22 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.25 0.547 . . . . 0.0 112.16 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.34 169.85 9.92 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.841 1.257 . . . . 0.0 109.095 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -161.44 -144.95 4.15 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.954 1.74 . . . . 0.0 109.088 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 t -139.4 149.16 43.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.179 0.992 . . . . 0.0 108.933 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -68.53 140.64 55.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.873 0.469 . . . . 0.0 110.423 -170.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.27 -165.28 2.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.169 1.787 . . . . 0.0 107.316 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -145.6 165.95 27.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.011 0.925 . . . . 0.0 109.729 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 27.8 m -133.84 -173.84 3.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.626 1.17 . . . . 0.0 110.408 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.1 m -132.79 6.47 4.0 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -75.8 22.56 0.14 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.279 1.432 . . . . 0.0 113.208 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--O 1.238 0.474 0 C-N-CA 123.93 0.892 . . . . 0.0 109.456 -178.804 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 19.7 m-85 57.03 55.0 6.4 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.286 1.834 . . . . 0.0 115.124 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.01 -173.75 4.89 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.534 0.683 . . . . 0.0 111.992 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.76 143.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 62.11 17.93 9.58 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.158 1.783 . . . . 0.0 113.291 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.66 173.72 6.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.233 1.013 . . . . 0.0 108.421 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -76.32 158.84 31.11 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.808 -0.557 . . . . 0.0 111.307 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.93 175.16 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.861 2.064 . . . . 0.0 108.226 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.5 mt -115.29 123.54 49.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.74 46.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.295 1.038 . . . . 0.0 108.934 -172.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.3 m -69.52 116.07 9.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -81.83 159.11 23.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.422 0.689 . . . . 0.0 109.314 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m -57.73 -20.82 37.21 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.887 1.275 . . . . 0.0 112.637 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.06 -49.76 75.79 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.178 0.591 . . . . 0.0 111.752 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.94 -65.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.084 0.554 . . . . 0.0 112.111 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 -160.86 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 110.909 -170.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -52.64 139.11 26.83 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -146.02 158.79 48.04 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.499 3.12 . . . . 0.0 105.175 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.88 148.37 64.17 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.627 1.551 . . . . 0.0 110.717 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.08 167.52 30.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.5 135.56 41.74 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.351 1.461 . . . . 0.0 108.083 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 138.94 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -117.44 -32.83 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.211 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.63 162.08 41.72 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.887 1.222 . . . . 0.0 110.315 168.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.7 134.21 45.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -129.4 115.42 17.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -169.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.43 -21.42 59.97 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.733 0.813 . . . . 0.0 112.466 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.36 -29.89 36.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 112.725 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.6 17.02 1.41 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.813 1.197 . . . . 0.0 112.756 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.1 p -127.19 169.03 13.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.861 1.33 . . . . 0.0 109.645 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.75 149.41 31.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 m -132.22 136.18 46.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.85 161.68 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -122.29 124.74 44.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -80.86 150.67 29.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.24 -23.61 66.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.152 0.581 . . . . 0.0 112.092 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.83 -15.18 5.96 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.234 1.397 . . . . 0.0 113.262 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.78 145.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 118.466 1.133 . . . . 0.0 109.266 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.21 144.21 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -149.75 156.44 41.86 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.913 0.485 . . . . 0.0 111.02 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -114.37 130.8 56.7 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.86 179.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.987 1.715 . . . . 0.0 108.346 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -85.89 164.73 17.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.793 -1.192 . . . . 0.0 110.054 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -54.44 -40.55 68.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.719 0.808 . . . . 0.0 110.827 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.2 pt -60.39 -16.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -97.55 -4.5 37.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.204 0.911 . . . . 0.0 112.684 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.1 146.91 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.758 1.163 . . . . 0.0 111.481 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -151.53 173.37 14.69 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.37 1.068 . . . . 0.0 108.68 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.28 169.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.879 1.272 . . . . 0.0 110.943 173.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -68.8 2.26 2.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.096 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 m -63.21 142.41 58.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.831 -1.168 . . . . 0.0 109.838 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -66.47 -55.59 14.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.855 0.462 . . . . 0.0 110.647 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.58 -66.94 0.56 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -146.44 -178.94 6.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 0.0 111.209 -169.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -73.17 171.26 13.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.444 1.498 . . . . 0.0 111.714 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -131.72 -19.73 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 125.455 1.502 . . . . 0.0 111.156 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.59 -38.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.803 -1.185 . . . . 0.0 111.996 -170.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.06 -49.14 42.73 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -161.24 117.12 2.16 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.31 128.2 35.39 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.467 0.576 . . . . 0.0 112.412 -169.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -146.9 -19.85 0.41 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.962 1.305 . . . . 0.0 113.149 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.65 165.6 36.6 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 119.745 1.157 . . . . 0.0 112.754 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 72.0 p -147.43 -17.39 0.38 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -152.53 146.43 25.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.814 1.188 . . . . 0.0 108.684 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.85 152.38 36.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.791 0.837 . . . . 0.0 111.18 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -78.27 172.95 12.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.776 0.831 . . . . 0.0 110.794 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 4.0 p -149.66 8.2 0.67 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.526 1.13 . . . . 0.0 112.455 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 m -141.21 -178.71 5.72 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.087 0.955 . . . . 0.0 110.387 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 24.5 m80 58.88 27.97 16.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.58 1.552 . . . . 0.0 113.511 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.545 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.439 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.2 m-85 55.11 24.07 5.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -88.74 -173.02 3.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.151 0.98 . . . . 0.0 110.039 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.2 mt -50.81 141.18 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.326 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.77 25.18 15.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.277 1.831 . . . . 0.0 113.206 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.89 168.96 18.56 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.187 0.995 . . . . 0.0 110.067 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.23 145.6 55.71 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.849 2.059 . . . . 0.0 113.638 -171.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.63 160.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 128.113 2.565 . . . . 0.0 107.88 169.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.5 mt -97.49 122.83 41.0 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 143.19 42.65 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.566 0.746 . . . . 0.0 109.049 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.9 m -68.66 105.73 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -68.87 157.62 36.2 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 m -58.94 -16.35 17.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.403 1.081 . . . . 0.0 112.544 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.18 -57.48 9.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.795 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.6 p 170.02 -38.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.404 1.882 . . . . 0.0 113.991 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -173.46 3.95 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.38 0.991 . . . . 0.0 112.807 -169.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.35 141.08 58.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 113.329 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.6 161.39 49.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 128.732 2.813 . . . . 0.0 104.737 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.72 146.68 61.16 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 120.22 1.114 . . . . 0.0 110.186 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.76 165.86 34.69 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.809 2.044 . . . . 0.0 108.453 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -102.36 132.4 48.37 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.648 1.179 . . . . 0.0 107.878 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.74 139.8 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -114.45 -33.69 5.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.72 160.27 43.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.596 1.089 . . . . 0.0 110.344 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.6 t -133.0 145.56 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -131.96 120.22 22.18 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -59.48 -23.4 62.72 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.001 0.921 . . . . 0.0 112.804 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.69 -30.46 61.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.921 0.889 . . . . 0.0 112.386 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.91 24.67 0.79 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.465 1.031 . . . . 0.0 112.952 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.1 p -130.86 170.36 14.51 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.748 1.274 . . . . 0.0 110.331 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -142.39 156.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.824 2.049 . . . . 0.0 108.246 -169.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.2 m -135.22 132.67 38.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.86 156.78 32.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -119.12 120.39 36.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -79.21 145.5 33.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -63.48 -24.98 68.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.21 -26.47 68.38 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.636 0.774 . . . . 0.0 112.125 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.46 -14.92 5.55 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.943 1.258 . . . . 0.0 113.327 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.89 143.9 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.574 1.187 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.29 139.28 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -155.72 155.89 33.92 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.969 0.507 . . . . 0.0 111.684 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -95.31 139.37 31.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.31 172.65 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.935 1.694 . . . . 0.0 108.684 -169.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -97.47 167.97 10.66 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.573 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -56.01 -36.79 68.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.29 0.636 . . . . 0.0 111.06 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 pt -64.17 -7.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.049 -1.032 . . . . 0.0 113.524 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -113.47 -9.2 13.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.316 1.046 . . . . 0.0 112.432 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.9 t -142.27 142.21 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.954 1.252 . . . . 0.0 111.644 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -147.09 172.2 14.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.188 1.395 . . . . 0.0 108.856 170.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.26 169.9 0.24 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.084 1.354 . . . . 0.0 110.842 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -65.8 -2.67 3.95 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.43 -0.794 . . . . 0.0 111.397 169.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.5 m -62.27 125.78 25.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.055 1.742 . . . . 0.0 108.997 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.25 -39.31 68.54 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.676 -0.64 . . . . 0.0 111.922 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.57 -60.95 1.96 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.813 0.278 . . . . 0.0 111.504 -169.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -152.64 172.75 16.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.766 1.626 . . . . 0.0 108.321 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -77.29 176.39 8.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.394 0.678 . . . . 0.0 112.373 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.7 mm -123.62 -62.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.615 1.566 . . . . 0.0 110.096 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.0 -32.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.482 1.037 . . . . 0.0 113.063 -169.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.87 -48.88 58.55 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -160.62 136.1 8.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.29 116.71 26.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.808 0.731 . . . . 0.0 112.596 -169.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -144.42 -18.47 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.306 169.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.96 161.81 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 120.113 1.324 . . . . 0.0 113.093 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 44.0 m -147.18 -21.33 0.4 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.89 139.92 31.0 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.631 1.559 . . . . 0.0 109.282 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.86 154.66 41.66 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.816 0.846 . . . . 0.0 110.845 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.73 165.7 21.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.414 0.686 . . . . 0.0 112.15 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 m -147.21 6.94 0.88 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.262 1.025 . . . . 0.0 113.279 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.2 m -135.68 174.89 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.536 1.062 . . . . 0.0 112.28 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 86.5 t60 55.06 -97.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.797 2.039 . . . . 0.0 111.114 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 126.754 2.021 . . . . 0.0 111.977 -169.372 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -120.76 134.94 55.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.065 1.746 . . . . 0.0 108.253 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.5 mp0 -139.17 -174.43 3.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.091 1.357 . . . . 0.0 109.871 -175.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.17 142.43 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.72 24.73 13.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.011 1.725 . . . . 0.0 112.864 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -132.39 168.18 18.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.232 1.013 . . . . 0.0 108.749 170.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -73.25 147.99 44.08 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.311 1.845 . . . . 0.0 113.893 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.27 165.68 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 127.448 2.299 . . . . 0.0 108.101 171.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -96.26 131.13 43.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.75 141.44 43.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -69.49 113.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.227 0.611 . . . . 0.0 109.706 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -77.8 157.92 29.75 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.985 0.914 . . . . 0.0 109.32 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 m -58.07 -20.39 39.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.175 0.99 . . . . 0.0 112.748 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.06 -49.53 76.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.054 0.542 . . . . 0.0 112.086 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.89 -66.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -161.79 1.41 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.736 1.215 . . . . 0.0 111.069 -170.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -53.73 141.09 27.61 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -147.23 158.3 44.51 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 129.564 3.145 . . . . 0.0 105.072 168.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 145.01 66.17 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.471 1.447 . . . . 0.0 110.607 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.49 166.0 32.45 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.511 1.925 . . . . 0.0 108.499 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -103.97 133.72 48.45 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.64 138.84 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -114.76 -32.01 5.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.306 0.642 . . . . 0.0 109.77 169.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.4 41.14 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.608 1.094 . . . . 0.0 110.385 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.2 t -136.43 139.31 45.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -132.04 110.36 10.67 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -61.61 -17.34 54.81 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.22 -31.82 45.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.942 0.897 . . . . 0.0 112.137 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.73 20.27 0.54 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.653 1.12 . . . . 0.0 112.928 173.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.3 p -131.65 171.57 13.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.122 1.461 . . . . 0.0 110.075 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 155.89 43.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.354 1.862 . . . . 0.0 107.759 -169.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -133.23 132.88 42.0 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.52 155.69 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.01 126.59 50.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.85 1.66 . . . . 0.0 107.356 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -82.93 154.71 24.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -60.58 -30.54 69.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.48 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -25.85 68.57 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.639 0.776 . . . . 0.0 112.364 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.07 -14.96 7.4 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.997 1.284 . . . . 0.0 113.116 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.55 144.43 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.494 1.147 . . . . 0.0 109.247 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.3 t -131.63 143.26 40.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.95 156.7 42.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.216 0.606 . . . . 0.0 110.84 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -109.35 129.15 55.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 169.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.24 177.91 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.197 1.399 . . . . 0.0 109.428 -169.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.66 169.15 9.47 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.245 -0.909 . . . . 0.0 110.677 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -54.64 -38.46 66.88 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.517 0.727 . . . . 0.0 111.325 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.0 pt -63.98 -7.89 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -113.67 -6.98 13.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.172 0.989 . . . . 0.0 112.576 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.6 t -142.11 140.47 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.054 1.297 . . . . 0.0 110.872 -175.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -145.94 174.3 11.38 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.822 0.849 . . . . 0.0 109.841 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 137' ' ' SER . . . -59.12 166.94 1.89 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -81.52 47.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 168.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 135' ' ' ALA . 41.0 m -127.1 139.75 52.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 172.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -63.07 -41.77 99.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.001 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.82 -68.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -168.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -150.59 178.85 8.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.73 1.212 . . . . 0.0 111.022 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -75.89 159.1 31.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.11 1.764 . . . . 0.0 111.76 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -139.75 34.14 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.515 1.126 . . . . 0.0 110.976 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.0 p -154.16 -49.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 120.479 -1.388 . . . . 0.0 110.874 169.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.33 -32.03 71.84 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -146.1 165.78 28.08 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.75 51.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.136 1.335 . . . . 0.0 112.632 -168.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -120.05 -5.49 10.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.03 162.79 38.85 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 122.18 0.878 . . . . 0.0 115.01 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 t -164.27 171.46 14.87 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 127.272 2.229 . . . . 0.0 106.73 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 52.65 76.28 0.2 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.192 1.397 . . . . 0.0 109.124 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.0 25.92 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -158.45 161.79 37.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.768 1.167 . . . . 0.0 109.953 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 3.2 m -142.86 147.96 36.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.608 0.763 . . . . 0.0 109.994 -169.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.9 m -82.45 -7.52 59.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.986 0.914 . . . . 0.0 113.265 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.57 27.0 0.05 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.703 2.001 . . . . 0.0 114.267 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.235 0.323 0 O-C-N 121.043 -1.036 . . . . 0.0 109.825 178.06 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 9.3 m-85 -53.3 111.47 0.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.38 2.272 . . . . 0.0 110.431 -173.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 36.2 mt-30 -145.24 -175.35 4.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.356 2.262 . . . . 0.0 107.542 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.69 142.85 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.5 22.59 12.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.547 1.539 . . . . 0.0 113.307 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.518 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.2 tp10 -131.29 169.81 15.47 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -81.3 158.59 24.71 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.658 -0.651 . . . . 0.0 111.164 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.16 169.57 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 126.659 1.983 . . . . 0.0 107.969 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.39 122.72 44.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.2 139.26 46.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.533 1.133 . . . . 0.0 108.58 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.8 m -68.96 135.12 50.46 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.806 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -112.18 154.79 24.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.926 1.691 . . . . 0.0 108.148 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.8 m -58.38 -20.71 46.23 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.647 1.179 . . . . 0.0 113.009 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.84 -47.92 79.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.251 1.02 . . . . 0.0 112.791 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.6 p -168.11 -68.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.886 0.475 . . . . 0.0 111.907 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -156.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.351 1.861 . . . . 0.0 109.253 -169.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -46.56 138.08 6.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.504 2.322 . . . . 0.0 115.854 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -145.49 157.08 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.202 3.001 . . . . 0.0 105.313 169.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.02 145.73 56.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.48 1.454 . . . . 0.0 110.75 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.77 155.7 37.68 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.575 1.55 . . . . 0.0 109.176 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.08 134.89 35.37 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.6 133.16 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.069 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -110.41 -31.46 7.27 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.276 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.12 163.91 38.39 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.52 1.054 . . . . 0.0 110.714 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.32 140.9 39.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -131.21 115.48 16.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -172.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.21 -21.02 61.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.584 0.753 . . . . 0.0 112.624 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.86 -31.39 39.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.083 0.953 . . . . 0.0 112.449 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.23 23.37 0.68 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.447 1.022 . . . . 0.0 112.697 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 p -131.75 169.88 15.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.988 1.394 . . . . 0.0 110.48 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -143.16 152.62 41.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.5 1.92 . . . . 0.0 107.504 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -130.69 131.57 44.9 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 m -138.95 155.44 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -120.73 122.39 40.3 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.195 1.398 . . . . 0.0 107.453 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -77.93 148.34 34.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.6 -21.92 66.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.197 0.599 . . . . 0.0 112.525 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.77 -26.85 68.92 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.691 0.796 . . . . 0.0 112.305 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.2 5.91 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.052 1.311 . . . . 0.0 112.83 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.03 144.85 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.345 1.073 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.11 144.41 38.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.2 155.21 40.27 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.128 0.571 . . . . 0.0 110.658 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.8 129.28 55.38 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.56 176.56 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.245 1.418 . . . . 0.0 109.087 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.3 168.43 9.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 -170.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -55.35 -37.13 67.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.561 0.744 . . . . 0.0 110.957 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.0 pt -64.88 -7.09 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -115.37 -7.52 12.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.188 0.995 . . . . 0.0 112.511 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.08 141.04 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 119.758 1.163 . . . . 0.0 110.847 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -150.17 176.96 10.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.702 0.801 . . . . 0.0 109.968 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.52 168.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.635 1.174 . . . . 0.0 111.054 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -62.67 -21.6 65.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.055 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -62.45 120.51 11.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.926 0.891 . . . . 0.0 110.596 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.5 -40.59 79.02 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.154 0.982 . . . . 0.0 111.942 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.44 -64.52 0.84 Allowed 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -150.16 166.37 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.57 0.7 . . . . 0.0 112.628 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.84 153.25 36.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.271 1.829 . . . . 0.0 111.393 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -138.98 23.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.555 0.742 . . . . 0.0 112.08 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.72 -51.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 112.943 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.49 60.83 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.415 1.007 . . . . 0.0 111.93 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -150.99 60.21 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.27 126.06 24.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.01 17.85 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.548 1.139 . . . . 0.0 112.962 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -147.5 -169.33 14.73 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.237 0.926 . . . . 0.0 112.773 -170.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -146.59 170.9 15.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.887 1.275 . . . . 0.0 110.751 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -57.84 135.61 56.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.534 0.734 . . . . 0.0 111.598 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.72 -170.84 2.7 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.716 2.006 . . . . 0.0 108.23 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -151.43 173.67 14.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.851 1.261 . . . . 0.0 110.115 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 35.2 p -152.1 167.91 26.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.234 1.014 . . . . 0.0 109.821 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.4 m -79.61 -1.11 36.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.685 1.194 . . . . 0.0 113.409 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -72.97 89.68 1.44 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.979 0.912 . . . . 0.0 109.597 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.235 0.297 0 C-N-CA 126.145 1.778 . . . . 0.0 108.535 -178.218 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 110.824 -0.065 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -141.03 51.75 1.6 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.722 1.209 . . . . 0.0 109.557 -173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.44 119.53 20.76 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -104.19 128.77 51.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.218 1.007 . . . . 0.0 110.159 -169.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.8 mp0 -144.45 -172.87 3.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.021 1.728 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.61 144.07 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 66.95 7.07 5.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.802 2.441 . . . . 0.0 114.101 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.3 tp10 -120.24 170.22 9.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 109.668 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.6 144.38 51.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.782 2.033 . . . . 0.0 113.058 -170.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 m -146.7 164.24 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 127.189 2.196 . . . . 0.0 108.543 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.07 127.69 42.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 168.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.18 47.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -68.8 104.89 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -66.82 154.37 41.05 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m -58.04 -20.29 37.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 112.424 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.39 -49.63 76.83 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.697 0.799 . . . . 0.0 112.704 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.2 p -171.72 -68.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.15 -162.83 1.58 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.906 1.282 . . . . 0.0 110.808 -169.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -58.55 138.76 56.6 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -144.28 157.5 56.44 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 128.577 2.751 . . . . 0.0 104.71 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.53 146.96 75.84 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.302 1.335 . . . . 0.0 110.432 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.96 162.11 41.72 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.243 1.817 . . . . 0.0 108.622 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.64 129.72 42.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.57 1.548 . . . . 0.0 107.118 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -66.53 138.43 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.942 1.247 . . . . 0.0 107.97 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 19.3 p -118.03 -30.52 5.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.291 0.636 . . . . 0.0 110.572 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.2 164.3 37.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.468 1.031 . . . . 0.0 110.248 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.3 t -143.61 147.75 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -133.77 130.26 37.77 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -60.1 -22.97 63.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.149 0.979 . . . . 0.0 112.36 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -54.5 -30.47 53.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.842 0.857 . . . . 0.0 112.342 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.36 26.15 0.75 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.308 0.956 . . . . 0.0 113.024 172.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.2 p -129.4 165.74 20.95 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.807 1.303 . . . . 0.0 110.839 -171.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -140.48 145.91 37.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.411 2.284 . . . . 0.0 107.382 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.4 m -124.88 131.94 53.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 169.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.66 149.9 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -114.19 119.95 38.82 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.392 1.477 . . . . 0.0 107.021 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.91 140.76 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -63.0 -21.13 65.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.852 0.861 . . . . 0.0 112.986 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.87 -19.9 63.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.797 0.839 . . . . 0.0 112.178 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.86 46.72 1.16 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.83 1.205 . . . . 0.0 110.725 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.3 t -133.96 138.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.5 140.67 46.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.03 159.73 41.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.335 0.654 . . . . 0.0 110.64 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.1 m -107.76 136.41 47.55 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.55 -179.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.248 2.219 . . . . 0.0 108.379 -169.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.9 168.93 8.9 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.218 -0.926 . . . . 0.0 110.682 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -53.39 -40.21 64.86 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.361 0.664 . . . . 0.0 110.864 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 29.1 pt -63.61 -5.9 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -115.9 -7.58 11.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 112.636 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.8 t -142.65 139.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 120.076 1.307 . . . . 0.0 111.651 -174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -148.16 174.3 12.1 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 110.055 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.34 167.91 1.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.758 0.823 . . . . 0.0 110.875 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.15 -18.15 65.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.391 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.18 116.85 6.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -61.63 -31.02 71.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -69.28 -55.9 9.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -169.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -152.14 165.16 35.64 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.662 0.744 . . . . 0.0 112.988 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.74 156.15 38.18 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.192 1.397 . . . . 0.0 110.468 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.98 23.53 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.938 0.895 . . . . 0.0 111.256 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.9 -62.89 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 120.707 -1.246 . . . . 0.0 109.686 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.57 -27.91 72.88 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -141.28 165.99 26.01 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.35 22.74 7.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.642 1.11 . . . . 0.0 113.427 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -77.62 -21.26 52.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.362 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -79.15 175.65 55.01 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.308 0.949 . . . . 0.0 112.987 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.6 m -150.54 171.21 17.44 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.183 2.193 . . . . 0.0 107.949 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -60.15 120.21 9.32 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.441 -0.787 . . . . 0.0 109.656 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.66 -164.13 1.58 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.371 1.868 . . . . 0.0 107.655 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -148.18 -176.89 5.47 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 109.471 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 66.2 m -129.54 169.11 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.149 1.38 . . . . 0.0 111.031 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -127.89 17.65 6.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -168.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -138.71 134.78 34.02 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -162.71 169.56 19.83 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.795 1.638 . . . . 0.0 109.629 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.5 m -64.08 -27.99 69.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.384 1.074 . . . . 0.0 113.591 -174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -87.14 2.34 50.16 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.31 142.95 41.58 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 170.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 111.352 0.13 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m 63.43 39.46 9.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.811 1.644 . . . . 0.0 113.526 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -106.42 2.38 26.38 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 111.743 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 8.5 m-85 46.32 38.31 5.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 128.5 2.72 . . . . 0.0 115.43 170.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -110.06 -173.05 2.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 108.12 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -49.23 138.8 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.687 0.795 . . . . 0.0 109.273 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 62.41 25.79 15.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.194 1.798 . . . . 0.0 113.18 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -135.57 167.27 21.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.887 1.275 . . . . 0.0 108.551 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -69.7 156.05 39.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.846 1.258 . . . . 0.0 113.364 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.88 162.11 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.826 2.45 . . . . 0.0 107.045 169.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.0 mt -96.07 127.68 42.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.71 44.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.625 0.77 . . . . 0.0 109.406 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -68.84 107.89 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.966 0.507 . . . . 0.0 110.0 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -69.23 163.91 23.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.341 1.056 . . . . 0.0 109.548 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -57.33 -18.08 15.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.294 1.038 . . . . 0.0 113.201 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -11.68 49.55 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.41 1.484 . . . . 0.0 113.487 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.5 m 92.54 17.83 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.5 2.72 . . . . 0.0 114.988 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.56 8.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.007 0.821 . . . . 0.0 110.762 169.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -70.76 141.56 51.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.62 160.74 43.55 Favored Pre-proline 0 C--O 1.241 0.634 0 C-N-CA 128.337 2.655 . . . . 0.0 105.529 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.69 147.52 69.82 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.401 1.4 . . . . 0.0 111.039 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.41 161.07 43.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.177 1.791 . . . . 0.0 108.459 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -91.83 131.29 37.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.513 1.525 . . . . 0.0 107.814 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.6 134.16 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.7 p -112.02 -31.52 6.88 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.445 0.698 . . . . 0.0 110.201 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 164.14 38.09 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.49 1.041 . . . . 0.0 110.418 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.65 142.92 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -130.99 119.24 21.78 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -61.31 -20.63 63.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.499 0.72 . . . . 0.0 112.74 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -52.7 -31.69 38.81 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.201 1.001 . . . . 0.0 112.42 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.54 25.3 0.51 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 124.373 0.987 . . . . 0.0 112.885 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.1 p -131.35 169.05 16.53 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.073 1.437 . . . . 0.0 110.606 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -141.82 156.04 45.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.982 2.113 . . . . 0.0 108.104 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -134.2 132.32 39.6 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 169.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.03 155.78 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -119.46 123.39 43.93 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -82.57 151.06 26.57 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -62.63 -27.1 68.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.673 0.789 . . . . 0.0 112.648 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.05 -23.03 67.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.644 0.777 . . . . 0.0 112.074 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.23 -14.21 8.32 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.491 1.519 . . . . 0.0 113.108 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.28 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.351 1.075 . . . . 0.0 108.801 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.47 139.06 52.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -153.67 155.38 35.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.187 0.449 . . . . 0.0 110.984 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 m -98.31 138.13 36.01 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.89 171.91 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.093 1.757 . . . . 0.0 108.777 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.3 167.75 10.22 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.35 -0.844 . . . . 0.0 110.403 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -55.08 -37.71 67.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.524 0.73 . . . . 0.0 111.341 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.9 pt -62.79 -10.82 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -109.52 -9.34 14.91 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.234 0.924 . . . . 0.0 112.735 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.05 141.37 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.733 1.152 . . . . 0.0 111.348 -170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -146.95 175.2 10.85 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.019 0.928 . . . . 0.0 110.18 170.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.69 168.09 1.83 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.388 1.075 . . . . 0.0 111.325 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -68.33 -14.79 63.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.818 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.0 m -62.17 120.48 10.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.222 0.919 . . . . 0.0 108.526 169.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -61.32 -35.75 78.23 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.2 -42.54 20.64 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -148.86 162.91 38.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.755 0.707 . . . . 0.0 111.961 -169.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -76.73 167.37 21.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 110.214 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.6 mm -129.16 -19.1 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.464 1.505 . . . . 0.0 111.466 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.3 p -135.08 -35.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.412 1.46 . . . . 0.0 112.244 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.86 -30.37 63.01 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -149.77 150.81 32.59 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.46 64.59 3.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.051 1.341 . . . . 0.0 110.54 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.97 -171.52 2.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.721 2.008 . . . . 0.0 109.565 -169.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 57.97 -168.11 5.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.09 1.805 . . . . 0.0 116.806 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.6 m -151.09 155.66 39.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.069 2.548 . . . . 0.0 107.045 -172.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -66.08 122.02 16.46 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.03 -163.21 1.58 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.814 1.646 . . . . 0.0 108.472 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -144.9 -179.51 6.65 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 110.9 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 13.8 p -149.38 -178.61 6.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.769 2.028 . . . . 0.0 109.493 -174.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -130.21 6.13 4.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -79.1 35.87 0.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.101 1.36 . . . . 0.0 111.812 -173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.25 152.6 40.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 109.979 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.7 m -68.07 -15.28 63.53 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.235 1.014 . . . . 0.0 113.214 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -136.55 26.6 3.11 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.132 1.373 . . . . 0.0 111.739 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -57.81 -46.11 85.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.699 0.4 . . . . 0.0 110.862 -175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -169.685 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 m -137.19 23.84 3.0 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.812 0.845 . . . . 0.0 111.748 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -125.18 125.93 44.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 169.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -111.46 129.86 55.9 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.33 1.052 . . . . 0.0 110.929 -167.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.485 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.0 mp0 -142.84 -174.43 4.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.675 1.99 . . . . 0.0 108.48 -177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.88 143.96 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 60.06 21.99 11.18 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.101 1.76 . . . . 0.0 112.959 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.5 tp10 -128.34 170.1 13.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.435 1.094 . . . . 0.0 108.263 171.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -77.28 155.59 31.96 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.758 -0.589 . . . . 0.0 112.102 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.45 167.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.551 1.94 . . . . 0.0 108.613 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.4 125.62 43.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.04 138.91 48.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 m -68.82 142.05 54.97 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.355 0.598 . . . . 0.0 110.901 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -119.03 154.93 32.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.765 1.626 . . . . 0.0 108.061 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -58.45 -19.8 39.69 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.64 1.176 . . . . 0.0 113.248 -174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.24 -47.63 80.88 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.151 0.981 . . . . 0.0 112.699 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.3 p -168.68 -68.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.896 0.478 . . . . 0.0 112.156 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -158.0 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.234 1.813 . . . . 0.0 109.303 -169.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -46.19 139.23 4.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.608 2.363 . . . . 0.0 115.66 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -145.77 157.51 51.09 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.5 3.12 . . . . 0.0 105.314 168.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.83 146.22 53.01 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.772 1.648 . . . . 0.0 110.869 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.64 162.68 41.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.912 1.685 . . . . 0.0 108.878 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -95.66 135.65 37.07 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.36 137.08 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 p -114.21 -30.88 6.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.279 0.632 . . . . 0.0 110.165 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.81 40.54 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.499 1.045 . . . . 0.0 110.303 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.36 140.55 41.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -131.06 118.49 20.63 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -59.05 -23.31 61.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.214 1.006 . . . . 0.0 112.475 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.26 -30.43 60.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.741 0.816 . . . . 0.0 112.491 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.17 23.75 0.82 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.567 1.079 . . . . 0.0 112.71 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.7 p -130.89 171.84 12.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.757 1.278 . . . . 0.0 110.382 -171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.27 154.19 42.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.657 1.983 . . . . 0.0 107.476 -169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -131.98 131.1 42.27 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.6 m -138.65 153.94 26.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -173.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.17 125.29 49.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.358 1.463 . . . . 0.0 107.332 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -81.11 151.3 28.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -66.45 -23.04 66.22 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.12 -25.0 65.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.971 0.508 . . . . 0.0 111.987 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.0 5.23 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.096 1.332 . . . . 0.0 113.188 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 146.93 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 118.397 1.098 . . . . 0.0 109.416 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.69 145.16 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -148.67 154.39 39.6 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.195 0.598 . . . . 0.0 110.864 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -107.57 130.74 54.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.29 175.26 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.335 1.454 . . . . 0.0 109.183 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.88 168.14 10.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.337 -0.852 . . . . 0.0 110.798 -171.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -54.08 -39.85 66.67 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.046 0.538 . . . . 0.0 111.232 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.87 -8.18 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -113.21 -6.3 13.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.154 0.982 . . . . 0.0 112.32 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.09 139.3 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.145 1.339 . . . . 0.0 111.341 -172.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -147.57 177.29 9.38 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.736 0.815 . . . . 0.0 110.25 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.64 167.23 3.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.135 0.974 . . . . 0.0 110.933 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -69.49 -17.68 63.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.078 169.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 68.9 m -63.16 124.44 21.17 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -59.11 -34.24 71.79 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.81 -68.96 0.4 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -149.24 167.78 25.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.093 0.957 . . . . 0.0 110.69 -169.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -73.5 159.09 33.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 110.843 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -136.6 15.66 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 124.196 0.998 . . . . 0.0 111.401 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.4 p -145.06 -44.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 120.447 -1.408 . . . . 0.0 111.791 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.12 -29.91 75.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.124 0.875 . . . . 0.0 110.941 171.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.97 165.48 31.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.067 2.547 . . . . 0.0 104.435 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -118.91 16.04 13.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.458 1.481 . . . . 0.0 114.031 -169.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -79.82 -18.1 51.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.899 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.69 179.8 43.48 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 119.153 0.888 . . . . 0.0 112.962 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.8 m -146.71 163.64 35.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.782 1.633 . . . . 0.0 108.698 -169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -64.5 113.71 3.86 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.16 -166.13 1.76 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.735 1.614 . . . . 0.0 108.67 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -148.23 -173.4 4.31 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.984 1.314 . . . . 0.0 109.821 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 24.3 p -151.12 176.85 10.77 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.101 1.761 . . . . 0.0 109.681 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.8 m -121.82 -1.61 9.4 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -71.81 119.04 15.42 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.74 151.53 41.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.433 1.493 . . . . 0.0 107.141 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . 0.437 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.5 m -65.69 -30.91 71.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.654 0.781 . . . . 0.0 111.588 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -62.15 -23.23 66.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.941 0.897 . . . . 0.0 112.654 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -68.48 -20.6 64.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.761 0.71 . . . . 0.0 112.083 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -178.485 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.294 0.092 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.8 m 58.52 48.7 11.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.536 1.134 . . . . 0.0 111.075 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -127.85 109.07 11.26 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -103.03 124.95 49.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.237 1.015 . . . . 0.0 109.819 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.408 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.4 mp0 -144.57 -173.28 4.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.528 1.531 . . . . 0.0 108.908 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.5 141.95 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 58.4 25.03 12.39 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.866 1.667 . . . . 0.0 113.438 -175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.0 tp10 -134.75 162.82 31.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.429 1.092 . . . . 0.0 108.395 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -65.44 150.09 48.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.628 2.371 . . . . 0.0 113.777 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.71 168.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 128.198 2.599 . . . . 0.0 107.961 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.25 127.17 46.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.36 138.45 41.63 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.739 0.816 . . . . 0.0 109.371 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 m -69.11 121.01 15.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 110.712 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -93.45 155.46 17.34 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.745 1.218 . . . . 0.0 108.652 174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -58.64 -20.89 51.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.749 1.22 . . . . 0.0 112.911 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.23 -46.35 83.05 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.328 1.051 . . . . 0.0 112.634 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -168.57 -68.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.189 0.45 . . . . 0.0 112.146 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.27 -157.79 0.74 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.187 1.795 . . . . 0.0 108.948 -170.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -46.25 138.85 5.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.615 1.966 . . . . 0.0 115.643 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -145.16 156.82 54.34 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 129.793 3.237 . . . . 0.0 103.988 168.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.57 145.57 52.8 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.449 1.433 . . . . 0.0 110.616 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.11 168.36 27.53 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.797 2.439 . . . . 0.0 107.152 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -110.45 147.92 33.1 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.982 1.265 . . . . 0.0 109.742 169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.35 140.78 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -115.67 -33.24 5.25 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.767 0.827 . . . . 0.0 109.179 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 163.89 38.58 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.166 0.986 . . . . 0.0 110.494 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.7 146.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -134.74 125.25 26.6 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.66 -23.75 63.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.673 0.789 . . . . 0.0 112.11 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.65 -27.65 58.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.029 0.932 . . . . 0.0 112.552 175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.5 21.6 2.2 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.563 1.077 . . . . 0.0 112.212 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 p -125.36 169.11 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.364 1.082 . . . . 0.0 110.02 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.72 153.5 41.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.444 1.898 . . . . 0.0 107.603 -168.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.8 m -132.16 136.16 46.87 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -140.55 158.59 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -123.89 126.94 47.27 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.98 154.69 26.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.16 -26.3 68.74 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.143 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.36 -18.85 5.74 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.831 1.205 . . . . 0.0 112.858 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.55 143.47 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 109.619 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.83 144.98 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -150.38 154.4 37.7 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.03 0.532 . . . . 0.0 110.635 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.44 129.18 55.27 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -146.91 179.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.536 1.534 . . . . 0.0 109.271 -169.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.95 167.23 11.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.095 -1.003 . . . . 0.0 110.529 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -54.36 -38.55 66.22 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.539 0.736 . . . . 0.0 110.882 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -63.26 -8.78 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -111.24 -8.03 14.4 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.005 0.922 . . . . 0.0 112.595 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.01 141.59 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 120.182 1.355 . . . . 0.0 110.992 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -150.12 173.43 13.9 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.421 0.688 . . . . 0.0 110.106 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.05 165.78 0.62 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.238 1.415 . . . . 0.0 111.039 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -67.27 -16.08 64.07 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.703 -0.623 . . . . 0.0 111.911 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 40.9 m -62.78 116.16 4.98 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.79 -32.98 72.3 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.46 -65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.723 0.809 . . . . 0.0 112.693 -169.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -152.75 162.67 40.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.268 1.427 . . . . 0.0 108.609 -172.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -73.7 166.67 22.87 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.549 0.214 . . . . 0.0 111.027 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.34 -22.42 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.103 0.961 . . . . 0.0 110.954 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.81 -45.32 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 119.645 1.111 . . . . 0.0 110.906 -172.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.66 -44.7 97.58 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -159.27 154.42 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.923 2.089 . . . . 0.0 105.42 169.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.19 58.37 2.03 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.983 0.913 . . . . 0.0 112.219 -170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -74.4 -44.73 50.7 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.435 -0.791 . . . . 0.0 110.717 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -94.82 -168.22 36.47 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.559 1.076 . . . . 0.0 111.731 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.4 t -147.73 177.55 9.21 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.324 1.45 . . . . 0.0 108.168 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -57.28 120.34 7.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.478 0.711 . . . . 0.0 110.469 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -159.91 -165.16 1.44 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.438 1.895 . . . . 0.0 107.416 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -147.85 -174.0 4.44 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.815 1.246 . . . . 0.0 109.663 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.8 t -145.76 174.12 11.5 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.042 1.337 . . . . 0.0 109.739 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 14.5 m -128.93 4.63 5.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.566 1.547 . . . . 0.0 111.523 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -78.93 42.71 0.47 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.508 1.123 . . . . 0.0 110.796 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.9 157.95 26.58 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.838 1.255 . . . . 0.0 109.474 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.3 m -66.32 -31.92 73.0 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.306 0.642 . . . . 0.0 111.762 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -75.98 -11.83 60.03 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.92 0.888 . . . . 0.0 112.707 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -140.53 35.27 1.84 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.487 1.115 . . . . 0.0 110.37 -169.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -176.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.329 0.109 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -76.35 75.85 3.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.028 1.331 . . . . 0.0 110.907 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.67 134.83 47.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.93 137.38 53.52 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.196 0.998 . . . . 0.0 109.898 -169.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 6.0 mp0 -144.36 -173.98 4.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.623 1.569 . . . . 0.0 109.186 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 77.6 mt -53.36 143.14 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 61.68 22.33 12.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.495 1.918 . . . . 0.0 113.095 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -127.87 169.28 14.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.18 0.992 . . . . 0.0 108.904 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -68.04 146.96 53.02 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.353 1.461 . . . . 0.0 112.864 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.64 166.34 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.69 1.996 . . . . 0.0 108.085 169.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.53 124.06 47.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -137.47 140.45 41.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.173 0.989 . . . . 0.0 109.209 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -69.25 111.82 5.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.541 0.736 . . . . 0.0 109.871 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -82.41 152.73 26.03 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 m -58.46 -20.06 42.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.67 1.188 . . . . 0.0 112.841 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.15 -48.28 76.58 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.961 0.904 . . . . 0.0 112.395 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 p -169.82 -67.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.498 0.59 . . . . 0.0 112.367 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.23 -158.12 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.033 1.333 . . . . 0.0 110.208 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -54.25 141.26 30.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.75 1.22 . . . . 0.0 113.254 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -140.75 159.3 63.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 129.174 2.99 . . . . 0.0 105.593 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.77 143.09 72.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.296 1.331 . . . . 0.0 110.262 169.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.52 165.39 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.99 1.716 . . . . 0.0 108.591 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -101.05 130.41 47.06 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.6 137.77 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.6 p -114.12 -30.86 6.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.885 -0.579 . . . . 0.0 110.454 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.49 163.35 39.73 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.174 0.99 . . . . 0.0 110.521 168.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.91 140.88 37.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -132.58 122.87 25.42 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -58.53 -25.03 62.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.078 0.951 . . . . 0.0 112.488 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -56.74 -28.74 61.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.95 0.9 . . . . 0.0 112.491 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 128.14 22.86 1.34 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.488 1.042 . . . . 0.0 112.677 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.7 p -127.53 168.51 14.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.633 1.216 . . . . 0.0 110.036 -172.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.54 153.95 43.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.282 1.833 . . . . 0.0 107.465 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -132.04 134.37 45.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.44 158.36 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -122.01 128.99 52.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.641 1.576 . . . . 0.0 107.019 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -87.8 151.62 22.74 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -61.89 -25.94 67.86 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.53 -27.2 69.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.674 0.79 . . . . 0.0 112.309 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.07 -14.45 7.02 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.072 1.32 . . . . 0.0 113.178 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.44 143.96 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.521 1.16 . . . . 0.0 109.103 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.1 143.7 38.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.27 155.68 39.28 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.278 0.631 . . . . 0.0 110.893 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.4 m -108.38 130.26 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.61 -179.27 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.408 1.483 . . . . 0.0 109.474 -169.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -103.38 169.37 8.58 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.191 -0.943 . . . . 0.0 110.775 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.14 -37.38 66.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.838 -0.539 . . . . 0.0 111.25 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.68 -5.48 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.025 -1.047 . . . . 0.0 113.551 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -118.41 -10.23 10.2 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.358 1.063 . . . . 0.0 112.287 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.5 t -143.11 141.54 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.904 1.229 . . . . 0.0 111.331 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -147.89 179.15 7.94 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.88 0.872 . . . . 0.0 109.23 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.9 165.6 0.9 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.659 1.184 . . . . 0.0 110.989 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.82 -29.75 70.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.563 169.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.3 m -64.34 115.81 5.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -63.61 -23.33 67.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -174.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.98 -63.74 1.0 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.66 0.664 . . . . 0.0 112.385 -170.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -153.66 164.29 38.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.035 1.334 . . . . 0.0 109.339 -170.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -75.42 157.57 33.93 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.396 1.079 . . . . 0.0 110.747 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.38 21.99 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 123.932 0.893 . . . . 0.0 111.722 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.74 -48.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 120.518 -1.364 . . . . 0.0 111.847 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.76 -34.17 88.02 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -146.07 160.92 41.23 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.7 67.89 0.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.825 1.193 . . . . 0.0 110.393 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -123.27 -22.06 5.21 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.24 -179.97 51.72 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.232 0.907 . . . . 0.0 113.671 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.4 m -150.81 166.14 31.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.258 2.623 . . . . 0.0 106.994 -169.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -56.15 128.78 37.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.954 0.797 . . . . 0.0 111.725 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.71 -176.47 5.56 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.023 1.729 . . . . 0.0 108.581 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -155.74 179.11 9.51 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.613 1.565 . . . . 0.0 109.343 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 74.3 m -129.91 152.34 49.49 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.736 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.3 p -78.44 -31.47 48.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.523 1.129 . . . . 0.0 112.001 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -67.01 119.21 11.6 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 4.3 pp -160.9 -177.77 6.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.123 1.769 . . . . 0.0 108.247 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 9.4 m -74.02 -26.88 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.33 1.052 . . . . 0.0 113.432 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -87.01 14.05 8.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.92 0.888 . . . . 0.0 111.639 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -61.81 150.67 36.48 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 121.15 -0.969 . . . . 0.0 109.605 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 169.204 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.45 0.167 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 m -58.21 139.7 54.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.238 1.015 . . . . 0.0 110.941 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -137.52 0.7 2.29 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 50.33 36.17 12.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.766 1.626 . . . . 0.0 114.102 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -83.15 -173.8 4.92 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.097 0.959 . . . . 0.0 110.521 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.1 143.51 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 60.3 22.58 12.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.235 1.814 . . . . 0.0 113.07 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -130.12 169.28 15.53 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.365 1.066 . . . . 0.0 108.47 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.92 150.62 48.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.646 1.978 . . . . 0.0 112.719 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -150.91 163.01 3.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.843 2.457 . . . . 0.0 107.909 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.59 124.4 40.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.652 -2.722 . . . . 0.0 103.652 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.58 137.89 49.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.1 m -68.77 144.78 54.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -123.51 154.92 38.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.975 1.71 . . . . 0.0 108.141 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.9 m -58.13 -20.5 40.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.673 1.189 . . . . 0.0 112.981 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.02 -48.04 79.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.115 0.966 . . . . 0.0 112.627 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.8 p -169.49 -67.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.128 0.571 . . . . 0.0 112.131 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.52 -157.59 0.78 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.042 1.737 . . . . 0.0 109.529 -169.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -47.09 140.71 4.81 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.0 2.12 . . . . 0.0 115.757 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -145.97 157.95 49.6 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 129.306 3.042 . . . . 0.0 105.399 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 144.46 56.8 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.177 1.918 . . . . 0.0 110.743 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.89 165.05 37.3 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.729 1.612 . . . . 0.0 109.247 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -98.98 130.87 45.36 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.774 1.63 . . . . 0.0 107.611 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.96 137.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.7 p -114.6 -32.61 5.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.321 0.648 . . . . 0.0 110.522 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.32 163.3 39.74 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.415 1.086 . . . . 0.0 110.27 168.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -138.0 142.47 35.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -129.54 118.89 22.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -171.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -61.58 -20.02 62.84 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.528 0.731 . . . . 0.0 112.427 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -54.34 -31.62 54.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.915 0.886 . . . . 0.0 112.285 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.94 24.95 0.7 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.564 1.078 . . . . 0.0 112.697 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.3 p -130.83 169.05 16.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.371 1.585 . . . . 0.0 110.424 -172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -140.53 152.95 45.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.491 1.916 . . . . 0.0 107.636 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -130.8 131.56 44.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.22 155.14 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -118.52 127.8 53.97 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.747 1.619 . . . . 0.0 107.05 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -83.19 150.26 26.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -64.42 -24.24 67.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.47 -23.99 65.56 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.08 0.552 . . . . 0.0 112.345 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 131.47 -16.51 5.13 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.716 1.15 . . . . 0.0 113.607 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.59 147.21 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 118.413 1.107 . . . . 0.0 109.39 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -132.98 144.83 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.86 158.01 43.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.116 0.566 . . . . 0.0 110.739 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -111.8 130.82 55.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.49 176.7 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.192 1.397 . . . . 0.0 109.192 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.89 167.43 10.52 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.043 -1.036 . . . . 0.0 110.474 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.42 -39.6 67.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 0.0 111.135 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.81 -11.88 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -108.34 -5.24 16.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.855 0.862 . . . . 0.0 112.485 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.18 140.58 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 120.211 1.369 . . . . 0.0 111.858 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -148.37 177.83 9.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.928 0.891 . . . . 0.0 110.32 171.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 168.68 1.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 110.51 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -68.43 -17.46 64.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.623 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.6 m -62.77 124.72 21.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.827 0.851 . . . . 0.0 109.191 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -60.17 -32.72 71.32 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.43 -61.62 2.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.852 1.261 . . . . 0.0 114.329 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -153.17 167.25 29.92 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.36 1.064 . . . . 0.0 110.535 -169.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -73.77 169.5 17.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.799 0.84 . . . . 0.0 109.302 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.5 mt -131.41 -13.81 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.661 1.584 . . . . 0.0 111.323 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.01 -40.5 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.103 1.32 . . . . 0.0 111.854 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.29 -29.89 75.88 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -151.15 148.44 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.286 2.234 . . . . 0.0 105.313 169.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.4 -167.45 1.6 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.961 0.904 . . . . 0.0 110.325 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 77.73 -3.06 2.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.443 2.297 . . . . 0.0 114.503 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.35 179.25 53.49 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 119.123 0.874 . . . . 0.0 111.828 169.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 38.0 m -147.42 155.4 41.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.959 1.703 . . . . 0.0 108.397 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -66.61 131.07 45.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -154.22 -158.3 0.85 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.37 1.868 . . . . 0.0 107.063 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -144.17 -179.31 6.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.202 1.001 . . . . 0.0 109.87 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 44.9 m -142.07 155.7 45.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.048 1.339 . . . . 0.0 110.194 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 m -80.88 -24.32 38.41 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.72 122.32 17.39 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.211 0.605 . . . . 0.0 109.596 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 87.5 mt -146.74 151.29 36.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.944 1.698 . . . . 0.0 107.561 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . 0.422 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.8 m -66.73 -12.28 57.96 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.125 1.37 . . . . 0.0 113.856 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -122.37 17.92 10.58 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.706 1.202 . . . . 0.0 112.966 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -129.44 17.63 5.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.072 1.349 . . . . 0.0 110.583 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.467 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -141.11 46.66 1.73 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.732 1.213 . . . . 0.0 109.072 -172.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -134.17 -5.77 2.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.566 1.147 . . . . 0.0 112.409 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 56.9 35.34 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.954 1.702 . . . . 0.0 112.904 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -82.92 -173.77 4.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.441 1.096 . . . . 0.0 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.0 mt -50.6 142.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 60.62 21.89 11.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.309 1.844 . . . . 0.0 113.35 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -128.34 170.06 13.52 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.21 1.004 . . . . 0.0 109.136 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -70.46 149.43 47.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.63 1.172 . . . . 0.0 111.359 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.39 166.08 4.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 126.937 2.095 . . . . 0.0 108.324 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -100.73 124.3 46.16 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -132.26 138.9 48.06 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.0 m -69.28 144.87 53.47 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.474 0.654 . . . . 0.0 110.9 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -121.41 155.54 34.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.782 1.633 . . . . 0.0 107.991 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.2 m -58.24 -20.54 42.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.838 1.255 . . . . 0.0 112.994 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.65 -47.5 79.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.057 0.943 . . . . 0.0 112.48 174.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.4 p -169.13 -67.99 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.924 0.49 . . . . 0.0 112.238 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.21 -158.19 0.78 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.479 1.911 . . . . 0.0 109.047 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -43.96 137.99 3.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.944 2.498 . . . . 0.0 116.048 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -145.86 157.44 50.86 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.345 3.058 . . . . 0.0 104.943 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 145.14 48.19 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.912 1.741 . . . . 0.0 110.77 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.13 165.31 36.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.717 1.607 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -98.5 133.1 43.33 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.149 1.38 . . . . 0.0 107.73 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.24 136.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -113.73 -32.26 6.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.34 0.656 . . . . 0.0 110.306 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.01 38.1 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.604 1.093 . . . . 0.0 110.502 169.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.4 t -138.88 140.8 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -129.42 122.81 30.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -60.22 -21.2 61.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.772 0.829 . . . . 0.0 112.439 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.28 -29.72 61.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.862 0.865 . . . . 0.0 112.118 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.25 23.93 1.09 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.68 1.133 . . . . 0.0 112.608 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 171.48 12.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.627 1.214 . . . . 0.0 110.609 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.99 154.3 43.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 126.863 2.065 . . . . 0.0 107.764 -169.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -132.23 132.19 42.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.81 154.82 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.88 125.63 50.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.476 1.51 . . . . 0.0 107.423 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -80.99 150.53 28.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -64.32 -23.64 67.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.08 -27.92 69.43 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.451 0.7 . . . . 0.0 112.068 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.54 -18.74 5.14 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.943 1.259 . . . . 0.0 113.066 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.36 146.3 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.199 1.0 . . . . 0.0 109.588 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.3 144.71 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.51 154.38 40.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.226 0.61 . . . . 0.0 110.276 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.9 m -107.46 131.87 53.82 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 169.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 m -147.09 175.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.421 1.488 . . . . 0.0 109.375 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -99.32 168.5 9.98 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.139 -0.975 . . . . 0.0 110.419 -172.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -53.17 -42.38 66.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.728 0.411 . . . . 0.0 111.023 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.6 pt -60.97 -12.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -105.79 -6.31 19.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.548 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.1 t -141.76 139.4 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-N 120.723 1.601 . . . . 0.0 112.686 -172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -150.3 176.66 10.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.75 169.27 1.92 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.922 0.889 . . . . 0.0 111.136 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -65.69 -16.29 63.61 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.857 -0.527 . . . . 0.0 111.071 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.1 m -62.14 119.17 8.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.203 1.401 . . . . 0.0 108.12 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -59.54 -30.79 68.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -65.64 -70.3 0.25 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -169.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -150.83 173.34 14.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.764 0.792 . . . . 0.0 111.731 -169.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -72.92 154.23 40.64 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.767 1.627 . . . . 0.0 110.888 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.8 mt -139.22 22.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-N 118.872 0.76 . . . . 0.0 111.852 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 -51.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 120.216 -1.553 . . . . 0.0 112.457 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.68 -37.73 94.74 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.592 1.087 . . . . 0.0 111.654 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -152.26 76.1 1.15 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.9 134.09 56.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -150.23 -45.43 0.13 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.938 1.695 . . . . 0.0 110.756 -171.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -90.25 -163.57 39.19 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 122.287 0.937 . . . . 0.0 112.873 -170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.0 m -146.77 146.53 30.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.956 2.102 . . . . 0.0 106.583 -170.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -61.02 132.85 55.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.014 0.37 . . . . 0.0 111.408 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -156.64 -152.7 0.38 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.695 1.998 . . . . 0.0 106.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -146.11 -175.86 4.93 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.175 0.99 . . . . 0.0 110.486 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 28.5 t -150.82 179.76 7.95 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.783 2.033 . . . . 0.0 108.143 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.0 m -124.59 0.15 8.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.15 1.38 . . . . 0.0 111.821 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -70.1 114.58 8.4 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.05 157.17 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.742 2.017 . . . . 0.0 106.714 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . 0.528 ' SG ' HM1B ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.6 m -65.9 -28.41 68.92 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.662 0.785 . . . . 0.0 112.488 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.8 -26.24 61.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.596 0.758 . . . . 0.0 111.658 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -64.14 149.67 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.462 0.574 . . . . 0.0 109.824 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.379 0 N-CA-C 107.796 -2.121 . . . . 0.0 107.796 169.56 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.7 m -143.41 155.45 44.4 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 109.359 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -142.39 -3.4 1.05 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.553 1.141 . . . . 0.0 111.77 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 51.31 39.82 24.89 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.412 2.285 . . . . 0.0 113.65 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -83.05 -174.17 5.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.317 1.047 . . . . 0.0 111.849 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.0 mt -53.49 143.86 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 O-C-N 121.305 -0.872 . . . . 0.0 109.237 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 64.63 -0.24 0.99 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.815 2.446 . . . . 0.0 114.04 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -95.75 172.04 8.29 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.755 1.162 . . . . 0.0 109.396 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -69.53 149.02 48.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.711 1.204 . . . . 0.0 110.884 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.94 171.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 127.278 2.231 . . . . 0.0 108.847 169.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.34 128.96 54.39 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 168.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.24 143.74 44.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.8 m -69.21 103.07 1.83 Allowed 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -68.22 156.29 37.92 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -58.57 -19.47 38.4 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.402 1.081 . . . . 0.0 112.212 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.31 -51.57 69.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.124 0.97 . . . . 0.0 112.906 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.8 p -169.55 -74.66 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.48 -157.25 0.75 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.676 1.59 . . . . 0.0 109.808 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.63 135.9 46.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.725 1.61 . . . . 0.0 114.691 -169.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.62 162.09 46.14 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 129.589 3.156 . . . . 0.0 105.375 168.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.67 146.0 77.59 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 121.724 1.616 . . . . 0.0 110.712 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.7 166.93 31.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.457 1.903 . . . . 0.0 109.03 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -102.2 134.26 45.75 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.6 1.56 . . . . 0.0 107.27 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.7 t -68.67 139.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.421 1.009 . . . . 0.0 108.324 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -116.05 -32.27 5.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.927 -0.559 . . . . 0.0 109.794 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.62 162.58 41.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.478 1.035 . . . . 0.0 110.165 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.5 t -137.42 138.26 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -130.49 117.84 20.22 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.28 -20.52 59.41 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.672 0.789 . . . . 0.0 112.763 -176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.57 -30.75 55.18 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.842 0.857 . . . . 0.0 112.285 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.26 23.11 0.85 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 124.675 1.131 . . . . 0.0 112.801 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -130.97 171.12 13.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.647 1.223 . . . . 0.0 110.166 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.2 156.26 43.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.795 2.038 . . . . 0.0 107.605 -169.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 m -134.99 133.53 39.57 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.23 155.64 23.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.98 129.59 55.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.697 1.599 . . . . 0.0 107.051 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -92.64 146.32 23.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -61.67 -21.07 64.11 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -169.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.04 -19.65 65.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.261 0.625 . . . . 0.0 112.288 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.45 46.24 1.34 Allowed Glycine 0 C--N 1.342 0.884 0 C-N-CA 124.184 0.897 . . . . 0.0 110.983 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.81 140.09 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.7 141.66 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -150.5 153.98 36.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.236 0.614 . . . . 0.0 110.655 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.1 m -100.05 135.94 40.71 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.3 176.93 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.978 1.711 . . . . 0.0 109.125 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -95.54 166.84 11.65 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.096 -1.003 . . . . 0.0 110.715 -175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -54.81 -38.48 67.38 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.824 0.849 . . . . 0.0 111.233 171.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.5 pt -61.73 -13.95 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.85 -7.66 19.25 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.253 0.933 . . . . 0.0 112.685 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.76 140.2 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 120.275 1.398 . . . . 0.0 111.173 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -149.07 175.42 11.35 Favored 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 124.259 1.024 . . . . 0.0 109.8 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.0 167.1 1.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.287 1.035 . . . . 0.0 110.931 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.4 -23.7 67.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.103 169.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.2 m -63.15 102.89 0.42 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -60.89 -24.78 66.23 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -170.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.72 -54.19 42.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.209 1.004 . . . . 0.0 112.516 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -154.91 157.63 38.06 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.45 1.1 . . . . 0.0 110.912 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -73.73 153.69 39.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 109.253 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -133.93 21.75 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 124.031 0.932 . . . . 0.0 111.557 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.38 -41.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 120.67 -1.269 . . . . 0.0 110.975 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -21.13 79.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.602 0.637 . . . . 0.0 111.95 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -142.67 152.13 42.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.964 2.105 . . . . 0.0 106.045 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.47 2.05 35.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -108.23 2.64 22.9 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.341 0.973 . . . . 0.0 113.471 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.24 175.25 36.34 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.859 0.754 . . . . 0.0 112.921 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.9 m -148.22 159.5 43.91 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.646 1.578 . . . . 0.0 109.274 -169.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -59.11 141.58 53.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.105 0.562 . . . . 0.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.79 179.14 8.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 108.278 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -171.38 -152.4 0.08 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.728 1.611 . . . . 0.0 108.161 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 34.0 m 58.78 42.1 20.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.013 1.325 . . . . 0.0 110.817 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m -85.69 170.59 12.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.231 2.212 . . . . 0.0 110.878 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -63.68 146.84 53.05 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.831 -0.543 . . . . 0.0 110.061 170.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 89.3 mt -142.58 152.27 42.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.742 1.617 . . . . 0.0 107.474 173.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 5.1 p -66.03 -33.84 76.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.712 0.805 . . . . 0.0 111.019 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -64.81 -21.21 66.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.96 0.904 . . . . 0.0 111.951 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 373' ' ' LYS . 0.6 OUTLIER -61.27 -29.87 70.12 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.887 0.767 . . . . 0.0 111.349 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -177.829 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.0 m -144.75 26.64 1.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.478 1.111 . . . . 0.0 112.007 -170.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.09 131.61 35.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -116.84 136.68 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.362 1.065 . . . . 0.0 109.179 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.6 mp0 -144.35 -173.48 4.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.518 1.927 . . . . 0.0 108.63 -175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.2 mt -52.91 142.67 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 61.59 21.78 12.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.115 1.766 . . . . 0.0 113.411 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 10.2 tp10 -128.12 170.29 13.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.538 1.135 . . . . 0.0 108.372 172.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -74.08 146.11 43.87 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.576 1.55 . . . . 0.0 112.3 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.42 173.2 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 127.735 2.414 . . . . 0.0 108.534 172.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.1 mt -107.36 129.23 54.94 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 141.15 42.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.99 0.916 . . . . 0.0 109.463 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.2 m -70.24 102.83 2.2 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.317 1.047 . . . . 0.0 110.525 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -68.21 154.44 41.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -59.56 -17.98 37.1 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.361 1.064 . . . . 0.0 113.049 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.13 -50.13 73.75 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.441 0.697 . . . . 0.0 111.911 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.9 p -171.96 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.28 0.632 . . . . 0.0 111.947 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.36 -160.51 1.18 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 111.385 -170.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.79 134.97 36.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.919 2.088 . . . . 0.0 115.936 -169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -140.61 159.48 62.75 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 129.173 2.989 . . . . 0.0 105.342 168.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.82 144.97 79.37 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 121.718 1.612 . . . . 0.0 110.536 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.83 165.14 36.33 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.774 1.63 . . . . 0.0 109.084 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -98.69 131.11 45.11 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.133 1.373 . . . . 0.0 107.366 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.11 138.35 23.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.7 p -114.7 -31.3 6.2 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.513 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.98 163.06 40.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.581 1.082 . . . . 0.0 110.257 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.7 t -134.98 142.3 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 171.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -133.4 112.23 11.42 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -59.71 -19.97 53.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.716 0.806 . . . . 0.0 112.833 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.71 -31.64 38.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.079 0.952 . . . . 0.0 112.454 170.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.83 18.96 0.66 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.527 1.061 . . . . 0.0 113.052 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.7 p -129.8 170.13 14.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.923 1.361 . . . . 0.0 110.164 -170.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.66 154.81 41.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.904 1.682 . . . . 0.0 107.396 -169.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -131.69 134.83 46.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.4 m -142.32 158.85 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -123.23 125.23 44.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.274 1.43 . . . . 0.0 107.184 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -82.58 151.18 26.5 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -64.81 -24.34 67.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -62.71 -26.5 68.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.6 0.76 . . . . 0.0 112.247 174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.32 -13.95 6.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.976 1.274 . . . . 0.0 113.306 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -64.47 143.05 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.445 1.122 . . . . 0.0 109.141 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.69 144.1 38.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.38 153.31 33.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.289 0.635 . . . . 0.0 110.673 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -108.58 128.55 54.93 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.02 -178.6 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.133 1.373 . . . . 0.0 109.227 -168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.76 169.28 8.91 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.003 -1.06 . . . . 0.0 110.845 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.0 -37.21 68.82 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.074 0.55 . . . . 0.0 111.043 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.97 -5.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 120.882 -1.136 . . . . 0.0 113.509 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -118.94 -12.83 9.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.381 1.073 . . . . 0.0 112.145 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.41 138.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 120.255 1.389 . . . . 0.0 110.588 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -147.37 176.69 9.82 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.71 0.804 . . . . 0.0 109.47 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.58 168.1 0.63 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.074 0.949 . . . . 0.0 110.714 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -28.04 69.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.247 170.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.2 m -64.39 116.52 6.16 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.698 0.799 . . . . 0.0 109.168 169.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -65.85 -24.73 66.94 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -84.14 -36.49 22.87 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -146.86 165.0 31.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.089 0.956 . . . . 0.0 110.624 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.08 169.19 14.17 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.3 mm -129.18 -13.75 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 124.819 1.248 . . . . 0.0 111.393 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.66 -36.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.54 1.518 . . . . 0.0 112.971 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.05 -30.24 77.2 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 119.605 1.093 . . . . 0.0 110.642 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -151.2 153.86 35.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.396 2.678 . . . . 0.0 104.28 169.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.65 12.23 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.98 1.264 . . . . 0.0 114.327 -169.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -82.44 -6.28 59.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.168 0.894 . . . . 0.0 112.266 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.4 -177.91 41.73 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 121.962 0.757 . . . . 0.0 114.04 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -148.21 165.88 29.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.326 1.451 . . . . 0.0 109.53 -169.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -72.28 135.32 45.95 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.511 -0.743 . . . . 0.0 110.571 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -152.15 -171.27 3.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.246 1.818 . . . . 0.0 107.465 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -154.76 -178.73 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.577 1.551 . . . . 0.0 108.762 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 77.6 p -143.2 175.91 9.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.359 1.064 . . . . 0.0 109.931 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.7 p -116.44 -0.6 12.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.615 1.166 . . . . 0.0 113.232 -169.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -80.98 44.58 0.77 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.592 1.087 . . . . 0.0 110.529 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 48.8 mt -72.31 144.83 48.19 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.7 m -62.92 -27.69 69.55 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.459 1.104 . . . . 0.0 113.276 -172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -63.89 -25.33 68.1 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.745 -0.597 . . . . 0.0 112.347 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 373' ' ' LYS . 10.9 mmpt? -68.96 -15.88 63.6 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.363 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.108 -174.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.32 0.105 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.4 m -63.63 151.47 41.61 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.817 0.847 . . . . 0.0 110.728 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -137.62 -15.72 1.38 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.603 1.561 . . . . 0.0 111.508 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 72.18 83.26 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.296 2.638 . . . . 0.0 113.06 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -139.23 -173.65 3.65 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.73 1.612 . . . . 0.0 109.512 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.1 mt -48.96 141.94 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.476 1.11 . . . . 0.0 109.467 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 60.49 22.25 11.93 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.091 1.756 . . . . 0.0 113.29 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -127.62 170.27 12.85 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.235 1.014 . . . . 0.0 108.805 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -74.03 149.65 41.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.778 1.231 . . . . 0.0 111.516 -171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.45 168.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 126.787 2.035 . . . . 0.0 108.059 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -101.69 130.92 48.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.61 140.2 44.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.997 0.919 . . . . 0.0 109.014 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.1 m -69.73 102.59 1.94 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.815 0.846 . . . . 0.0 110.711 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.91 153.39 41.88 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 m -58.19 -20.48 41.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.048 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -56.21 -48.03 77.24 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.09 0.956 . . . . 0.0 112.396 174.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.8 p -169.59 -72.75 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.586 0.354 . . . . 0.0 111.615 -173.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 -156.14 0.69 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.135 1.374 . . . . 0.0 110.012 -173.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -49.31 139.71 11.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.914 1.686 . . . . 0.0 115.047 -175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -146.33 156.51 49.84 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 130.12 3.368 . . . . 0.0 104.246 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.3 147.13 71.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.521 1.481 . . . . 0.0 110.968 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.34 164.69 36.95 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.182 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -95.24 132.63 40.01 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.526 1.53 . . . . 0.0 107.691 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.26 135.72 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.7 p -112.66 -33.57 6.08 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.849 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.19 164.67 36.87 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.739 1.154 . . . . 0.0 110.723 168.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.58 142.31 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -131.39 119.21 21.34 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -61.24 -19.76 62.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.409 0.684 . . . . 0.0 112.556 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.6 -30.76 44.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.852 0.861 . . . . 0.0 112.296 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.79 20.54 0.76 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.556 1.074 . . . . 0.0 112.967 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -129.3 169.82 14.38 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.72 1.26 . . . . 0.0 110.394 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -143.44 155.82 44.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.954 2.102 . . . . 0.0 107.728 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -133.0 131.81 41.16 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 m -140.04 157.32 25.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -122.09 122.83 40.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -78.24 150.24 33.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -64.18 -25.34 68.03 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.08 -26.83 68.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.629 0.772 . . . . 0.0 112.265 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.4 -16.83 5.93 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.102 1.334 . . . . 0.0 113.033 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.14 143.4 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.255 1.027 . . . . 0.0 109.356 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.67 144.41 38.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -152.05 155.9 38.87 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.269 0.628 . . . . 0.0 110.474 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.6 m -109.96 129.79 55.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 169.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.37 179.58 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.405 1.482 . . . . 0.0 109.677 -169.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.32 168.51 9.29 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.08 0.952 . . . . 0.0 110.758 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -55.43 -36.83 66.92 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.795 -0.566 . . . . 0.0 111.321 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.8 pt -64.23 -5.06 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -118.05 -11.04 10.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.315 1.046 . . . . 0.0 112.484 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.91 141.07 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 120.263 1.392 . . . . 0.0 110.991 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -150.47 172.33 15.62 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.305 1.042 . . . . 0.0 109.703 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.26 166.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.778 1.231 . . . . 0.0 111.59 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -68.1 -8.58 39.35 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.56 -0.713 . . . . 0.0 111.541 169.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -67.97 117.28 9.62 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.71 -44.27 90.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 112.121 -171.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -62.62 -67.02 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -151.23 163.36 39.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.741 1.216 . . . . 0.0 109.353 -170.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -84.54 164.18 18.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.075 0.55 . . . . 0.0 111.882 -170.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.7 15.01 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.759 0.824 . . . . 0.0 112.183 -173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.05 158.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 120.397 -1.44 . . . . 0.0 107.413 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.53 3.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.708 1.147 . . . . 0.0 111.992 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -143.72 65.86 1.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.926 2.09 . . . . 0.0 106.259 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.47 132.09 52.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.383 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.89 -2.33 0.93 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.149 0.979 . . . . 0.0 113.035 -171.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.38 -159.29 9.13 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 119.42 1.009 . . . . 0.0 112.794 -171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.8 m -139.4 164.69 29.18 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.06 1.744 . . . . 0.0 109.84 -169.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -60.7 145.3 49.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.2 -165.39 1.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.161 2.584 . . . . 0.0 107.1 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -144.94 169.94 17.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.269 1.028 . . . . 0.0 109.658 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 36.7 m -135.23 179.98 5.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.97 1.308 . . . . 0.0 111.056 -170.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.8 m -134.65 6.17 3.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.726 0.81 . . . . 0.0 113.039 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -75.88 24.82 0.12 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.408 1.483 . . . . 0.0 112.933 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 78.7 mt -59.71 145.82 43.57 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.68 1.192 . . . . 0.0 109.625 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 10.3 m -63.82 -31.34 72.49 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.431 0.692 . . . . 0.0 112.127 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -67.16 -22.28 65.77 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.711 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -68.44 -22.26 64.6 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.815 0.734 . . . . 0.0 111.995 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.229 0 N-CA-C 108.999 -1.641 . . . . 0.0 108.999 -179.528 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.38 0.133 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 m -61.76 152.4 31.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.967 0.907 . . . . 0.0 110.848 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.18 -12.09 1.66 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.742 1.617 . . . . 0.0 111.552 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 72.22 80.96 0.14 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.033 2.533 . . . . 0.0 113.279 169.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -134.57 -174.77 3.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.091 1.356 . . . . 0.0 109.523 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.0 mt -53.2 143.58 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.58 17.1 10.15 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.952 1.701 . . . . 0.0 113.258 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -123.27 173.24 8.06 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -84.37 156.45 21.84 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.408 -0.807 . . . . 0.0 111.302 -169.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.97 167.51 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.305 1.842 . . . . 0.0 109.05 170.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -95.97 127.35 41.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.36 144.14 38.07 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.455 0.702 . . . . 0.0 109.644 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -68.83 108.44 3.45 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.396 0.679 . . . . 0.0 109.883 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -73.29 162.56 29.22 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.987 0.915 . . . . 0.0 109.726 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 m -58.0 -19.64 32.51 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.568 1.147 . . . . 0.0 112.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.43 -23.15 56.65 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 113.334 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.2 m 110.7 8.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 130.151 3.38 . . . . 0.0 114.898 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -153.64 -176.93 6.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.555 1.07 . . . . 0.0 111.229 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -69.89 140.07 53.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -142.02 158.34 62.04 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 128.341 2.656 . . . . 0.0 106.074 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.23 145.61 73.04 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.612 1.541 . . . . 0.0 111.206 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.31 156.89 37.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.171 1.789 . . . . 0.0 109.044 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -83.54 133.51 34.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.907 1.283 . . . . 0.0 108.391 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.46 133.77 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 p -111.55 -32.56 6.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.031 171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 164.4 38.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.721 1.146 . . . . 0.0 110.676 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.13 141.42 33.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 169.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -129.57 128.0 41.84 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.73 -24.49 61.66 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.805 0.842 . . . . 0.0 112.47 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -56.29 -27.59 55.92 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 112.732 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.07 19.07 2.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.636 1.112 . . . . 0.0 112.705 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.2 p -123.54 168.98 11.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.502 1.151 . . . . 0.0 110.116 -173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.05 153.36 42.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.853 2.061 . . . . 0.0 106.965 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -133.26 135.7 45.08 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 170.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.94 159.69 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -123.96 120.63 33.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -77.03 150.04 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -64.89 -23.55 67.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -63.39 -24.44 67.84 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.392 0.677 . . . . 0.0 112.435 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.98 -14.56 7.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.02 1.295 . . . . 0.0 113.009 173.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.48 143.3 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.288 1.044 . . . . 0.0 108.992 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.76 143.61 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -151.18 155.47 38.94 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.056 0.543 . . . . 0.0 110.699 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -108.97 131.48 55.01 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.01 178.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.748 1.619 . . . . 0.0 108.902 -169.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.69 165.7 12.58 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.018 -1.051 . . . . 0.0 110.496 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.54 -37.07 64.97 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.856 0.862 . . . . 0.0 111.016 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.36 -11.54 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.005 -1.059 . . . . 0.0 113.547 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -106.6 -8.99 16.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 112.636 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.59 139.54 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.437 1.017 . . . . 0.0 110.99 -174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -152.12 175.03 13.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.944 0.498 . . . . 0.0 110.682 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.17 165.35 0.52 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.331 1.453 . . . . 0.0 111.728 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -64.25 -16.7 62.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.843 -0.536 . . . . 0.0 111.844 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.9 m -62.14 116.25 4.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.41 1.084 . . . . 0.0 108.983 170.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.26 -28.3 67.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.37 -76.76 0.09 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.153 0.581 . . . . 0.0 111.812 -171.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.18 165.36 29.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 0.0 109.537 -170.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -78.92 163.58 25.14 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.176 0.512 . . . . 0.0 112.329 -171.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 mt -129.7 28.29 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 124.958 1.303 . . . . 0.0 108.606 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.32 160.46 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.45 1.9 . . . . 0.0 106.207 175.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.66 -62.43 3.53 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.867 1.222 . . . . 0.0 111.716 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -142.0 72.22 1.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.28 130.47 46.36 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.447 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.47 -21.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -171.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.76 -171.17 47.44 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-O 121.955 0.753 . . . . 0.0 111.832 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.3 m -146.24 159.9 42.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.643 1.977 . . . . 0.0 108.03 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -56.38 127.93 33.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.767 0.427 . . . . 0.0 111.113 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -160.1 -164.52 1.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.44 1.896 . . . . 0.0 107.4 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -145.23 -180.0 7.01 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 109.748 176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 t -142.15 175.34 9.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.355 1.462 . . . . 0.0 108.889 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.2 m -133.0 -10.16 3.01 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -79.73 111.08 15.68 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.229 -1.396 . . . . 0.0 107.229 170.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 3.7 pp -153.75 -179.52 7.9 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 110.301 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.3 m -66.1 -23.93 66.6 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.603 1.161 . . . . 0.0 113.518 -170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -78.29 65.91 3.74 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 109.095 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.09 -15.16 63.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.121 0.969 . . . . 0.0 112.092 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.15 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.684 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.538 0.208 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -34.56 75.51 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 61.71 -8.89 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.675 1.99 . . . . 0.0 115.354 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 17.3 m-85 55.14 36.27 26.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.656 1.583 . . . . 0.0 114.155 169.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -82.24 -173.35 4.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.578 0.751 . . . . 0.0 110.402 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -50.94 142.99 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 61.87 21.49 12.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.384 1.873 . . . . 0.0 113.337 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.19 170.19 13.28 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.354 1.062 . . . . 0.0 109.192 171.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -65.19 149.07 50.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.006 2.122 . . . . 0.0 112.534 -174.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.31 164.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 127.932 2.493 . . . . 0.0 108.525 171.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.2 mt -95.48 130.21 42.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 168.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.66 145.12 38.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.517 0.727 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.1 m -69.02 116.09 9.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.906 0.482 . . . . 0.0 109.714 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -79.62 164.25 23.96 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.224 1.01 . . . . 0.0 110.597 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.9 m -57.23 -24.3 53.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.841 0.856 . . . . 0.0 112.33 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.77 -4.07 18.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.092 1.357 . . . . 0.0 113.459 172.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.4 m 75.28 156.86 0.18 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.633 2.773 . . . . 0.0 111.593 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.65 176.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 128.079 2.551 . . . . 0.0 115.425 -169.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -71.12 148.53 47.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -168.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -144.48 162.32 39.91 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 129.337 3.055 . . . . 0.0 106.01 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.33 145.89 61.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.892 1.728 . . . . 0.0 110.721 172.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.58 33.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.536 1.935 . . . . 0.0 108.748 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -101.58 133.78 45.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.244 1.417 . . . . 0.0 107.414 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.79 136.67 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.4 p -114.02 -32.9 5.9 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.86 -0.591 . . . . 0.0 110.278 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.21 35.28 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.263 0.938 . . . . 0.0 110.63 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.3 t -141.65 140.56 30.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -130.63 123.66 29.94 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -60.08 -22.97 63.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.722 0.809 . . . . 0.0 112.568 -175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.27 -28.62 59.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.877 . . . . 0.0 112.278 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 129.51 22.32 1.2 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.769 1.176 . . . . 0.0 112.782 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.6 p -127.12 169.42 13.44 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.786 1.293 . . . . 0.0 110.271 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -142.45 156.41 45.18 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.905 2.082 . . . . 0.0 108.022 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -133.92 134.83 43.09 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 169.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.56 157.57 24.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.85 131.33 53.99 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.442 1.497 . . . . 0.0 107.186 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.67 148.57 23.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.41 -24.28 66.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -169.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.56 -30.47 71.5 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.298 0.639 . . . . 0.0 112.386 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.23 -15.31 4.23 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.46 1.029 . . . . 0.0 113.545 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.58 143.88 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.69 1.245 . . . . 0.0 109.348 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 50.5 t -133.0 145.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.46 157.43 42.33 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.153 0.581 . . . . 0.0 110.719 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -108.74 131.92 54.47 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.15 178.6 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.307 1.443 . . . . 0.0 109.518 -169.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.71 167.11 11.32 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.141 -0.974 . . . . 0.0 110.502 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.28 -39.21 66.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.498 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.7 pt -61.51 -13.38 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -104.25 -8.69 19.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 118.112 -0.946 . . . . 0.0 112.637 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.8 140.5 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.818 1.19 . . . . 0.0 111.863 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -150.13 177.86 9.51 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 110.34 171.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -60.49 167.97 2.35 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.026 0.93 . . . . 0.0 111.096 176.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -69.29 -17.27 63.72 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.37 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.3 m -63.01 122.98 17.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -58.73 -37.86 77.1 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.354 0.662 . . . . 0.0 112.158 -173.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.6 -69.17 0.31 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -149.7 168.8 22.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.877 0.871 . . . . 0.0 111.204 -169.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.5 155.06 34.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.653 1.581 . . . . 0.0 110.83 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.32 21.27 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 123.987 0.915 . . . . 0.0 112.067 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.98 -46.36 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 120.192 -1.567 . . . . 0.0 112.078 169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.83 -32.49 82.99 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 171.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -145.84 162.9 36.63 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -121.28 56.24 1.04 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.39 1.45 . . . . 0.0 112.044 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -117.94 -19.14 9.29 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -83.95 -177.17 51.44 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 122.277 0.931 . . . . 0.0 112.676 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 47.7 m -148.67 165.17 32.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.246 2.218 . . . . 0.0 107.388 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -61.33 120.68 10.91 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.394 -0.816 . . . . 0.0 110.154 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -155.01 -170.91 3.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.185 2.194 . . . . 0.0 107.327 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.2 p80 -150.19 171.63 16.61 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.903 0.881 . . . . 0.0 110.179 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 22.7 m -138.1 178.09 7.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.567 1.547 . . . . 0.0 110.212 -174.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 12.5 m -127.92 8.77 6.27 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -169.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.88 31.73 0.37 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.404 1.081 . . . . 0.0 111.732 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.84 168.06 8.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.789 1.236 . . . . 0.0 110.589 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 8.8 m -62.99 -28.85 70.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.391 1.076 . . . . 0.0 112.422 -177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -64.04 -30.07 71.17 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.756 -0.59 . . . . 0.0 111.357 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -79.3 -6.59 57.06 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.567 0.747 . . . . 0.0 112.092 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.542 -1.144 . . . . 0.0 110.251 177.187 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.423 0.154 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.6 m -142.41 37.55 1.52 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.72 1.208 . . . . 0.0 110.348 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.94 115.2 17.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -107.55 127.83 53.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.47 1.108 . . . . 0.0 109.784 -169.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 2.7 mp0 -144.39 -173.79 4.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.664 1.586 . . . . 0.0 109.257 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.4 mt -51.51 143.71 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 169.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.68 22.11 12.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.27 1.828 . . . . 0.0 113.422 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.4 tp10 -130.13 169.57 15.16 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.345 1.058 . . . . 0.0 108.83 171.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.4 146.3 53.34 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.779 2.032 . . . . 0.0 112.689 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.29 171.88 5.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 0.0 107.915 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.7 mt -109.82 124.4 51.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.27 138.97 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.145 0.978 . . . . 0.0 108.649 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.9 m -69.09 134.87 49.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -109.73 156.95 19.64 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.282 1.433 . . . . 0.0 108.442 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -58.64 -19.78 41.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.503 1.121 . . . . 0.0 112.863 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.57 -50.19 70.74 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.103 0.961 . . . . 0.0 112.461 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -170.68 -67.5 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.94 0.496 . . . . 0.0 111.845 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -155.26 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.732 1.613 . . . . 0.0 109.675 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -51.81 139.08 22.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.897 2.079 . . . . 0.0 115.78 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -142.87 157.34 61.49 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 128.914 2.885 . . . . 0.0 105.582 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.73 145.73 64.22 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 120.985 1.124 . . . . 0.0 111.092 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.04 164.52 37.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.449 1.5 . . . . 0.0 109.356 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -97.63 132.16 43.54 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.381 1.473 . . . . 0.0 107.789 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.62 138.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 p -115.07 -32.34 5.75 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.249 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.37 164.86 36.63 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 119.572 1.078 . . . . 0.0 110.465 169.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.3 t -140.59 141.65 32.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -133.27 113.97 13.24 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -60.7 -19.67 59.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.322 0.649 . . . . 0.0 112.517 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.22 -30.47 38.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.064 0.946 . . . . 0.0 112.421 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.57 22.56 0.61 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.399 1.0 . . . . 0.0 112.743 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.4 p -131.85 169.64 15.97 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.059 1.429 . . . . 0.0 110.589 -171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -144.37 153.0 41.5 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.496 1.918 . . . . 0.0 107.215 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -130.8 134.07 46.53 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 170.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.5 m -140.12 155.26 23.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -118.48 125.93 50.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.668 1.587 . . . . 0.0 107.003 172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.76 151.69 27.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -65.83 -22.76 66.57 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.67 -27.49 68.96 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.141 0.577 . . . . 0.0 112.196 175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.7 -17.74 5.21 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.882 1.23 . . . . 0.0 113.09 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.13 146.07 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.232 1.013 . . . . 0.0 109.478 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.03 144.65 36.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.16 154.3 38.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.188 0.595 . . . . 0.0 110.851 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -108.37 130.23 55.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 169.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.79 175.84 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.377 1.471 . . . . 0.0 108.758 -169.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -97.53 168.39 10.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 121.008 -1.058 . . . . 0.0 110.543 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -54.53 -39.03 67.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.432 0.693 . . . . 0.0 111.086 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.3 pt -63.79 -6.61 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -114.3 -7.67 12.93 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 112.622 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.5 140.25 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 120.283 1.401 . . . . 0.0 111.71 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -149.42 174.24 12.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.088 0.955 . . . . 0.0 109.958 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.21 168.75 0.67 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.453 1.101 . . . . 0.0 111.265 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -63.13 -20.6 65.52 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.551 -0.718 . . . . 0.0 110.743 169.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.8 m -62.38 123.73 19.03 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.161 0.984 . . . . 0.0 110.561 170.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -60.68 -40.36 91.87 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.823 0.849 . . . . 0.0 112.128 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -62.96 -67.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -168.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -150.61 168.04 25.5 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.028 0.931 . . . . 0.0 111.049 -169.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -73.23 156.72 38.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.204 1.402 . . . . 0.0 110.782 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -139.75 24.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.958 0.903 . . . . 0.0 111.44 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 16.7 t -138.44 -60.66 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 120.603 -1.311 . . . . 0.0 109.93 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.33 -34.38 85.08 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -136.39 163.28 30.83 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.972 2.109 . . . . 0.0 105.779 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.73 18.11 9.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 114.137 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -79.57 -18.11 52.44 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.467 -0.777 . . . . 0.0 112.714 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -75.75 175.79 51.5 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 119.465 1.03 . . . . 0.0 113.114 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 40.8 m -149.98 163.77 37.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 107.761 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -61.45 132.04 52.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.477 -0.764 . . . . 0.0 111.279 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.21 -172.46 3.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.551 1.94 . . . . 0.0 108.355 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -146.42 168.72 20.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.538 1.135 . . . . 0.0 110.189 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 15.5 m -135.5 161.96 34.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.894 1.278 . . . . 0.0 109.171 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.7 p -106.39 -25.98 11.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -169.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -73.81 129.12 37.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 109.295 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 1.4 pp -156.65 174.37 15.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.088 1.355 . . . . 0.0 109.871 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . 0.465 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.0 m -66.26 -16.64 64.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 113.826 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -129.74 12.32 5.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.289 1.036 . . . . 0.0 113.075 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -63.73 144.73 56.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 173.914 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m 58.08 51.82 8.33 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.483 1.513 . . . . 0.0 112.373 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -98.02 13.13 31.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.822 1.249 . . . . 0.0 112.727 -170.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.429 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.9 m-85 72.79 71.49 0.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.212 1.805 . . . . 0.0 113.65 169.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -121.95 -174.29 2.85 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.742 1.617 . . . . 0.0 109.616 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.51 142.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 60.81 24.14 14.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.723 1.609 . . . . 0.0 113.185 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -127.27 169.78 13.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.676 1.191 . . . . 0.0 108.137 170.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.74 155.12 40.29 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.853 0.861 . . . . 0.0 112.603 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.32 164.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 127.275 2.23 . . . . 0.0 107.902 169.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.56 128.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.15 141.03 46.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 108.84 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.0 m -69.62 117.53 11.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.21 0.604 . . . . 0.0 109.684 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -84.21 162.56 20.14 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.722 1.209 . . . . 0.0 109.403 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.6 m -55.65 -20.12 12.9 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.071 1.348 . . . . 0.0 112.987 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.35 -51.88 18.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.356 1.463 . . . . 0.0 112.048 169.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.7 m 161.66 -46.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.74 2.816 . . . . 0.0 111.252 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.38 -168.0 2.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.056 0.844 . . . . 0.0 113.027 -169.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -54.31 141.77 28.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 127.083 2.153 . . . . 0.0 116.367 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -149.7 160.26 34.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 130.085 3.354 . . . . 0.0 105.168 168.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.16 147.3 66.44 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.489 1.459 . . . . 0.0 110.937 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.43 162.96 40.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.642 1.977 . . . . 0.0 108.952 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -91.47 133.66 35.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.174 1.39 . . . . 0.0 107.578 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.97 134.46 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -111.39 -31.94 6.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.698 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.57 160.74 43.19 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.592 1.087 . . . . 0.0 110.446 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.3 140.1 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 170.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -132.33 111.95 11.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -62.19 -16.35 52.54 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.728 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -53.47 -31.46 45.83 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.732 0.813 . . . . 0.0 112.071 169.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 136.19 18.18 0.75 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.837 1.208 . . . . 0.0 112.722 174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.1 p -129.41 172.16 11.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.735 1.267 . . . . 0.0 110.256 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -145.98 154.79 42.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.692 1.997 . . . . 0.0 107.178 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -133.0 133.65 43.41 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.87 157.78 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -122.98 124.67 43.68 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.225 1.41 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -80.09 149.64 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -65.54 -25.37 67.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -170.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.32 -25.65 66.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.318 0.647 . . . . 0.0 112.153 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -17.99 3.94 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.449 1.023 . . . . 0.0 113.766 171.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.61 144.99 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.204 1.002 . . . . 0.0 109.437 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.91 143.95 39.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -149.41 155.03 39.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.826 0.451 . . . . 0.0 110.826 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 128.84 55.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 m -147.44 178.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.133 1.373 . . . . 0.0 109.183 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.3 169.06 10.03 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.229 -0.919 . . . . 0.0 110.837 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -55.55 -38.58 69.49 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.043 0.537 . . . . 0.0 111.042 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.1 pt -63.37 -6.32 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.979 -1.076 . . . . 0.0 113.532 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -115.48 -8.5 12.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 112.453 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -142.5 139.63 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 120.377 1.444 . . . . 0.0 110.932 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -149.02 172.7 14.32 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.992 0.917 . . . . 0.0 110.012 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -54.65 166.39 0.47 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 111.18 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -67.11 -11.44 57.2 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.406 -0.809 . . . . 0.0 111.118 169.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.5 m -62.82 121.29 13.09 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 109.299 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.65 -44.5 90.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.547 0.739 . . . . 0.0 110.848 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -57.39 -61.29 2.59 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.263 1.425 . . . . 0.0 113.578 -169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -154.87 164.77 38.37 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.217 1.407 . . . . 0.0 108.373 -170.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -73.19 171.34 13.15 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.97 -69.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.159 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.644 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.33 -19.98 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 121.085 1.766 . . . . 0.0 114.356 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -109.02 19.56 29.91 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.404 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -152.84 -41.48 0.1 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.907 1.354 . . . . 0.0 113.381 -170.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 60.01 8.86 1.57 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.077 2.551 . . . . 0.0 116.651 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -108.09 -23.67 11.88 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.069 1.304 . . . . 0.0 111.12 173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.81 171.72 25.92 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 122.124 0.847 . . . . 0.0 113.055 174.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.5 m -146.38 159.67 43.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.876 1.671 . . . . 0.0 109.015 -169.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -61.95 130.42 45.54 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 -176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.07 -168.54 3.06 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.317 1.847 . . . . 0.0 107.415 170.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 -146.13 167.28 23.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.968 0.907 . . . . 0.0 109.875 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 20.4 m -136.8 -178.05 5.01 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.67 1.188 . . . . 0.0 111.047 -170.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 10.7 m -132.64 6.87 4.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -76.41 28.53 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.617 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 77.5 mt -62.32 149.54 41.85 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . 0.433 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 15.2 m 77.3 -26.79 0.18 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.72 2.808 . . . . 0.0 112.115 -169.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -63.13 -46.31 87.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -82.8 147.77 28.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.398 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -178.735 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 m -138.6 18.11 2.71 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.167 0.987 . . . . 0.0 111.234 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -137.14 109.86 7.55 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -109.46 126.53 53.59 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.623 1.169 . . . . 0.0 109.602 -169.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 3.4 mp0 -140.15 -174.03 3.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.686 1.594 . . . . 0.0 108.564 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -47.94 140.97 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.174 0.99 . . . . 0.0 108.504 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 59.5 25.66 14.5 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.5 1.92 . . . . 0.0 112.926 -175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.424 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -136.04 162.4 33.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.247 1.019 . . . . 0.0 108.976 172.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -65.41 146.21 55.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.588 2.355 . . . . 0.0 113.903 -169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -147.84 171.99 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 127.558 2.343 . . . . 0.0 108.487 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 mt -109.49 124.06 50.44 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.68 141.61 47.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.895 0.878 . . . . 0.0 109.069 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.8 m -69.05 103.77 1.95 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -69.42 155.15 40.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.2 m -58.22 -20.79 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 112.383 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -58.74 -48.91 79.56 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.296 1.038 . . . . 0.0 113.07 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.8 p -168.83 -71.61 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -161.62 1.38 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.388 1.875 . . . . 0.0 109.348 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -51.57 136.15 26.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -144.9 161.61 42.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 129.377 3.071 . . . . 0.0 104.654 168.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.18 147.22 59.69 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.955 1.77 . . . . 0.0 111.007 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.7 169.22 25.13 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.858 2.463 . . . . 0.0 107.132 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -115.07 146.35 41.4 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.55 1.068 . . . . 0.0 109.735 169.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.5 142.45 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.021 0.928 . . . . 0.0 108.555 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.1 p -119.11 -28.64 5.43 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.809 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.93 158.99 43.92 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 119.523 1.056 . . . . 0.0 110.087 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.5 143.05 38.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -134.08 116.74 15.81 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -61.35 -19.75 62.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.341 0.656 . . . . 0.0 112.409 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.84 -30.51 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.889 0.876 . . . . 0.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.96 23.54 0.77 Allowed Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.537 1.065 . . . . 0.0 112.691 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.4 p -131.66 169.34 16.3 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.442 1.621 . . . . 0.0 110.46 -171.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.41 150.99 37.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.387 1.875 . . . . 0.0 108.053 -169.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 m -130.59 134.41 46.97 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.05 156.84 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -119.98 127.04 52.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.28 146.4 26.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -60.91 -25.86 67.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -169.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.33 -29.34 70.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.979 0.512 . . . . 0.0 112.195 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.02 -19.07 3.49 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.47 1.033 . . . . 0.0 113.148 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.45 141.31 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.319 1.047 . . . . 0.0 109.643 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.92 142.3 43.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -154.01 157.85 39.69 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.895 0.478 . . . . 0.0 110.793 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 84.7 m -106.64 136.66 46.04 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.1 m -149.28 179.97 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.707 2.003 . . . . 0.0 108.375 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -98.06 168.13 10.46 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -54.51 -39.05 67.21 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.808 0.843 . . . . 0.0 111.272 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.48 -9.79 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -110.44 -7.24 14.79 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.05 0.94 . . . . 0.0 112.677 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.7 t -141.95 142.53 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.873 1.215 . . . . 0.0 111.081 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -148.61 179.03 8.13 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.034 0.934 . . . . 0.0 109.543 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.26 166.62 0.8 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.692 1.197 . . . . 0.0 110.833 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -62.29 -28.58 69.82 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.492 169.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.4 m -64.1 118.37 8.43 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.746 0.819 . . . . 0.0 109.154 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -63.21 -24.47 67.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.67 -62.42 1.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -154.39 167.07 31.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.92 1.288 . . . . 0.0 109.864 -173.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.13 165.96 24.39 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.806 0.842 . . . . 0.0 110.975 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.6 mt -129.11 -14.64 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 117.788 -1.101 . . . . 0.0 111.867 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.01 -28.88 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 121.413 1.915 . . . . 0.0 114.018 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.15 -44.64 97.88 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -159.06 121.44 3.54 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 169.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.9 104.62 5.57 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -169.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -137.27 -30.67 0.84 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -171.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -91.95 -174.56 42.52 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 118.953 0.797 . . . . 0.0 114.168 -171.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 80.4 p -153.31 170.99 19.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.659 1.984 . . . . 0.0 108.152 -169.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -58.04 124.7 20.23 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.381 0.992 . . . . 0.0 111.526 -171.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -158.53 -172.22 3.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.941 1.696 . . . . 0.0 109.001 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -155.19 -177.77 6.77 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.129 1.771 . . . . 0.0 109.254 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 90.0 p -144.43 -179.07 6.31 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.229 1.011 . . . . 0.0 110.094 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 m -110.67 4.2 19.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.849 0.86 . . . . 0.0 112.674 -170.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.84 40.62 0.47 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.509 1.123 . . . . 0.0 110.76 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.7 38.98 0.16 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.388 2.275 . . . . 0.0 112.764 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 20.2 m -118.87 27.34 8.94 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 109.066 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -141.74 -52.46 0.43 Allowed 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.854 1.261 . . . . 0.0 111.187 -170.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -69.21 -28.81 66.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.646 0.657 . . . . 0.0 110.286 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 172.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.462 0.172 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -59.81 149.7 30.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.534 1.133 . . . . 0.0 111.119 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -137.69 -7.53 1.67 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.302 1.441 . . . . 0.0 112.0 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 55.56 37.86 29.43 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.274 1.829 . . . . 0.0 112.521 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.69 -174.4 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.407 1.083 . . . . 0.0 109.921 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.9 143.12 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 61.84 19.01 10.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.127 1.771 . . . . 0.0 113.401 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -125.16 171.56 10.22 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -83.42 159.24 21.83 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.42 167.71 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 126.641 1.977 . . . . 0.0 108.12 169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.3 mt -94.97 133.57 38.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.72 142.92 34.78 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.802 0.841 . . . . 0.0 109.392 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.8 m -69.54 109.65 4.38 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.744 0.818 . . . . 0.0 109.549 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -79.25 159.51 27.26 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 m -57.86 -19.64 30.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.359 1.463 . . . . 0.0 113.05 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -49.62 -57.45 7.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.902 1.281 . . . . 0.0 112.101 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 m 171.27 -43.96 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 112.375 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.19 -167.62 2.66 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.871 0.76 . . . . 0.0 113.012 -169.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -64.9 141.78 58.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.584 1.154 . . . . 0.0 114.07 -169.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -145.45 157.83 51.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 128.776 2.83 . . . . 0.0 105.138 168.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.87 149.3 72.29 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 121.571 1.514 . . . . 0.0 111.046 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.03 158.46 40.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.886 2.074 . . . . 0.0 108.627 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -88.5 135.33 33.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.03 134.47 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 p -111.86 -30.33 7.33 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.423 0.689 . . . . 0.0 110.448 172.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.31 161.73 42.18 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.624 1.102 . . . . 0.0 110.612 169.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.42 141.29 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -127.86 132.87 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -58.68 -26.01 63.41 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.947 0.899 . . . . 0.0 112.174 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.94 -24.9 62.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.923 0.889 . . . . 0.0 112.743 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 119.95 19.13 4.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.75 1.166 . . . . 0.0 112.628 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -120.76 167.93 11.96 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.297 1.049 . . . . 0.0 110.253 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -140.8 152.79 45.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.815 2.046 . . . . 0.0 107.543 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.4 m -130.47 130.9 44.82 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 169.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.87 153.0 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -120.21 119.7 33.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.312 1.445 . . . . 0.0 107.299 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.43 146.88 38.32 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -64.86 -21.13 66.74 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 112.935 -173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.86 -18.63 64.35 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.812 0.845 . . . . 0.0 112.382 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.41 47.83 1.49 Allowed Glycine 0 C--N 1.342 0.877 0 C-N-CA 124.324 0.964 . . . . 0.0 110.784 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.9 t -134.63 142.73 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -132.51 144.71 36.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -150.1 158.46 44.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.418 0.687 . . . . 0.0 110.406 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.9 m -109.78 130.36 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.2 -178.54 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.401 1.48 . . . . 0.0 109.832 -169.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -105.69 169.54 8.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.796 1.238 . . . . 0.0 111.051 -172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -55.17 -38.07 67.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.215 0.606 . . . . 0.0 111.195 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.52 -5.05 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -117.85 -10.45 10.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.424 1.09 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.46 139.61 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.92 1.236 . . . . 0.0 111.216 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -149.94 169.69 20.58 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.604 0.762 . . . . 0.0 109.936 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.91 165.33 0.65 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.262 1.025 . . . . 0.0 111.588 172.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -65.93 -13.34 59.56 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.618 -0.676 . . . . 0.0 111.233 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.7 m -63.04 116.16 5.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.531 1.132 . . . . 0.0 109.332 169.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -58.29 -46.06 86.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.787 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.95 -52.14 46.61 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -151.31 160.84 43.58 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.985 0.914 . . . . 0.0 110.422 -171.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -76.1 171.15 14.97 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.692 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.9 mm -119.57 -16.67 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.446 1.099 . . . . 0.0 111.049 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 144' ' ' GLY . 9.9 p -150.88 -168.05 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 120.167 1.349 . . . . 0.0 108.808 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' H ' HG22 ' A' ' 143' ' ' VAL . . . 84.63 -37.57 2.93 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.448 -1.408 . . . . 0.0 112.777 169.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -148.02 -46.17 0.16 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.925 0.89 . . . . 0.0 110.145 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.27 25.22 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.25 0.547 . . . . 0.0 112.16 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.34 169.85 9.92 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.841 1.257 . . . . 0.0 109.095 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -161.44 -144.95 4.15 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.954 1.74 . . . . 0.0 109.088 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.7 t -139.4 149.16 43.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.179 0.992 . . . . 0.0 108.933 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -68.53 140.64 55.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.873 0.469 . . . . 0.0 110.423 -170.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -153.27 -165.28 2.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.169 1.787 . . . . 0.0 107.316 172.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -145.6 165.95 27.19 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.011 0.925 . . . . 0.0 109.729 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 27.8 m -133.84 -173.84 3.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.626 1.17 . . . . 0.0 110.408 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.1 m -132.79 6.47 4.0 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -75.8 22.56 0.14 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.279 1.432 . . . . 0.0 113.208 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.77 145.74 39.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.93 0.892 . . . . 0.0 109.456 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 5.7 p -65.58 -27.91 68.76 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.938 0.895 . . . . 0.0 112.311 174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -79.63 -4.67 52.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.491 1.117 . . . . 0.0 112.929 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -133.15 172.94 11.98 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.586 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.365 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.36 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.5 m -142.08 152.96 43.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.696 1.199 . . . . 0.0 109.366 -174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.45 -1.34 6.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.576 0.75 . . . . 0.0 112.365 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 19.7 m-85 57.03 55.0 6.4 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.286 1.834 . . . . 0.0 115.124 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.01 -173.75 4.89 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.534 0.683 . . . . 0.0 111.992 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.76 143.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 62.11 17.93 9.58 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.158 1.783 . . . . 0.0 113.291 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -116.66 173.72 6.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.233 1.013 . . . . 0.0 108.421 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -76.32 158.84 31.11 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 121.808 -0.557 . . . . 0.0 111.307 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.93 175.16 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 126.861 2.064 . . . . 0.0 108.226 171.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.5 mt -115.29 123.54 49.04 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.74 46.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.295 1.038 . . . . 0.0 108.934 -172.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.3 m -69.52 116.07 9.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -81.83 159.11 23.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.422 0.689 . . . . 0.0 109.314 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m -57.73 -20.82 37.21 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.887 1.275 . . . . 0.0 112.637 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.06 -49.76 75.79 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.178 0.591 . . . . 0.0 111.752 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.94 -65.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.084 0.554 . . . . 0.0 112.111 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 -160.86 1.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 110.909 -170.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -52.64 139.11 26.83 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -146.02 158.79 48.04 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.499 3.12 . . . . 0.0 105.175 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.88 148.37 64.17 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 121.627 1.551 . . . . 0.0 110.717 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.08 167.52 30.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.74 1.616 . . . . 0.0 109.49 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.5 135.56 41.74 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.351 1.461 . . . . 0.0 108.083 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.03 138.94 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -117.44 -32.83 4.8 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 118.609 -0.71 . . . . 0.0 110.211 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.63 162.08 41.72 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.887 1.222 . . . . 0.0 110.315 168.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.7 134.21 45.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -129.4 115.42 17.5 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -169.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -59.43 -21.42 59.97 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.733 0.813 . . . . 0.0 112.466 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.36 -29.89 36.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.246 1.018 . . . . 0.0 112.725 172.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.6 17.02 1.41 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.813 1.197 . . . . 0.0 112.756 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.1 p -127.19 169.03 13.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.861 1.33 . . . . 0.0 109.645 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.75 149.41 31.34 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -168.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 m -132.22 136.18 46.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.85 161.68 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -122.29 124.74 44.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -80.86 150.67 29.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 169.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.24 -23.61 66.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.152 0.581 . . . . 0.0 112.092 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.83 -15.18 5.96 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.234 1.397 . . . . 0.0 113.262 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.78 145.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 118.466 1.133 . . . . 0.0 109.266 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.21 144.21 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -149.75 156.44 41.86 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.913 0.485 . . . . 0.0 111.02 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.4 m -114.37 130.8 56.7 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.86 179.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.987 1.715 . . . . 0.0 108.346 -169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -85.89 164.73 17.3 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.793 -1.192 . . . . 0.0 110.054 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -54.44 -40.55 68.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.719 0.808 . . . . 0.0 110.827 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 39.2 pt -60.39 -16.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -97.55 -4.5 37.67 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.204 0.911 . . . . 0.0 112.684 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.1 146.91 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.758 1.163 . . . . 0.0 111.481 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -151.53 173.37 14.69 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.37 1.068 . . . . 0.0 108.68 171.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.28 169.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.879 1.272 . . . . 0.0 110.943 173.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -68.8 2.26 2.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.096 169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 m -63.21 142.41 58.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.831 -1.168 . . . . 0.0 109.838 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -66.47 -55.59 14.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.855 0.462 . . . . 0.0 110.647 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.58 -66.94 0.56 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -146.44 -178.94 6.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.015 0.926 . . . . 0.0 111.209 -169.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -73.17 171.26 13.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.444 1.498 . . . . 0.0 111.714 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -131.72 -19.73 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 125.455 1.502 . . . . 0.0 111.156 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.59 -38.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.803 -1.185 . . . . 0.0 111.996 -170.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.06 -49.14 42.73 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -161.24 117.12 2.16 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.31 128.2 35.39 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.467 0.576 . . . . 0.0 112.412 -169.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -146.9 -19.85 0.41 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.962 1.305 . . . . 0.0 113.149 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.65 165.6 36.6 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 119.745 1.157 . . . . 0.0 112.754 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 72.0 p -147.43 -17.39 0.38 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -168.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -152.53 146.43 25.23 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.814 1.188 . . . . 0.0 108.684 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.85 152.38 36.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.791 0.837 . . . . 0.0 111.18 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -78.27 172.95 12.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.776 0.831 . . . . 0.0 110.794 173.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 4.0 p -149.66 8.2 0.67 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.526 1.13 . . . . 0.0 112.455 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 m -141.21 -178.71 5.72 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.087 0.955 . . . . 0.0 110.387 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 24.5 m80 58.88 27.97 16.89 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.58 1.552 . . . . 0.0 113.511 172.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 70.7 mt -71.12 158.5 36.35 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . 0.436 ' SG ' HM1A ' A' ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 16.9 m 72.07 -28.05 0.18 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.483 2.713 . . . . 0.0 113.65 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -61.34 -23.96 66.12 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.035 -1.041 . . . . 0.0 111.571 170.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -66.34 -17.74 64.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 118.499 -0.763 . . . . 0.0 112.826 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.486 -1.175 . . . . 0.0 110.587 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 110.634 -0.135 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.0 m -134.4 33.09 3.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.453 0.701 . . . . 0.0 111.441 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 61.86 -40.85 0.14 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 129.837 3.255 . . . . 0.0 119.287 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.439 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 5.2 m-85 55.11 24.07 5.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -88.74 -173.02 3.95 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.151 0.98 . . . . 0.0 110.039 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 68.2 mt -50.81 141.18 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.312 -0.867 . . . . 0.0 109.326 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.77 25.18 15.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.277 1.831 . . . . 0.0 113.206 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.89 168.96 18.56 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.187 0.995 . . . . 0.0 110.067 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.23 145.6 55.71 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.849 2.059 . . . . 0.0 113.638 -171.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.63 160.4 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 128.113 2.565 . . . . 0.0 107.88 169.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.5 mt -97.49 122.83 41.0 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.99 143.19 42.65 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.566 0.746 . . . . 0.0 109.049 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.9 m -68.66 105.73 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -68.87 157.62 36.2 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 m -58.94 -16.35 17.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.403 1.081 . . . . 0.0 112.544 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.18 -57.48 9.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.795 169.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.6 p 170.02 -38.02 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.404 1.882 . . . . 0.0 113.991 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.45 -173.46 3.95 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.38 0.991 . . . . 0.0 112.807 -169.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.35 141.08 58.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 113.329 -170.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.6 161.39 49.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 128.732 2.813 . . . . 0.0 104.737 168.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.72 146.68 61.16 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 120.22 1.114 . . . . 0.0 110.186 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.76 165.86 34.69 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.809 2.044 . . . . 0.0 108.453 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -102.36 132.4 48.37 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.648 1.179 . . . . 0.0 107.878 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.74 139.8 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.4 p -114.45 -33.69 5.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.72 160.27 43.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.596 1.089 . . . . 0.0 110.344 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.6 t -133.0 145.56 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -131.96 120.22 22.18 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -59.48 -23.4 62.72 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.001 0.921 . . . . 0.0 112.804 -175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.69 -30.46 61.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.921 0.889 . . . . 0.0 112.386 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.91 24.67 0.79 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.465 1.031 . . . . 0.0 112.952 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.1 p -130.86 170.36 14.51 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.748 1.274 . . . . 0.0 110.331 -172.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -142.39 156.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.824 2.049 . . . . 0.0 108.246 -169.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.2 m -135.22 132.67 38.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.86 156.78 32.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -119.12 120.39 36.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -79.21 145.5 33.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -63.48 -24.98 68.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.21 -26.47 68.38 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.636 0.774 . . . . 0.0 112.125 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 130.46 -14.92 5.55 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.943 1.258 . . . . 0.0 113.327 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.89 143.9 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.574 1.187 . . . . 0.0 109.284 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.29 139.28 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -155.72 155.89 33.92 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.969 0.507 . . . . 0.0 111.684 176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -95.31 139.37 31.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.31 172.65 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.935 1.694 . . . . 0.0 108.684 -169.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -97.47 167.97 10.66 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.161 -0.962 . . . . 0.0 110.573 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -56.01 -36.79 68.32 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.29 0.636 . . . . 0.0 111.06 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 pt -64.17 -7.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.049 -1.032 . . . . 0.0 113.524 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -113.47 -9.2 13.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.316 1.046 . . . . 0.0 112.432 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.9 t -142.27 142.21 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 119.954 1.252 . . . . 0.0 111.644 -174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -147.09 172.2 14.13 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.188 1.395 . . . . 0.0 108.856 170.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -55.26 169.9 0.24 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.084 1.354 . . . . 0.0 110.842 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -65.8 -2.67 3.95 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.43 -0.794 . . . . 0.0 111.397 169.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.5 m -62.27 125.78 25.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.055 1.742 . . . . 0.0 108.997 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.25 -39.31 68.54 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.676 -0.64 . . . . 0.0 111.922 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.57 -60.95 1.96 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.813 0.278 . . . . 0.0 111.504 -169.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -152.64 172.75 16.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.766 1.626 . . . . 0.0 108.321 -171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -77.29 176.39 8.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.394 0.678 . . . . 0.0 112.373 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.7 mm -123.62 -62.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.615 1.566 . . . . 0.0 110.096 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.0 -32.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.482 1.037 . . . . 0.0 113.063 -169.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.87 -48.88 58.55 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -160.62 136.1 8.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.29 116.71 26.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.808 0.731 . . . . 0.0 112.596 -169.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -144.42 -18.47 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.306 169.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.96 161.81 43.43 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 120.113 1.324 . . . . 0.0 113.093 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 44.0 m -147.18 -21.33 0.4 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.89 139.92 31.0 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.631 1.559 . . . . 0.0 109.282 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.86 154.66 41.66 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.816 0.846 . . . . 0.0 110.845 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.73 165.7 21.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.414 0.686 . . . . 0.0 112.15 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 7.5 m -147.21 6.94 0.88 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.262 1.025 . . . . 0.0 113.279 -169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 6.2 m -135.68 174.89 10.11 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.536 1.062 . . . . 0.0 112.28 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 86.5 t60 55.06 -97.08 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.797 2.039 . . . . 0.0 111.114 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 24.5 mt 58.28 173.35 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.754 2.021 . . . . 0.0 111.977 -169.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 15.2 m 61.52 8.76 2.37 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.838 2.055 . . . . 0.0 114.151 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -144.0 13.21 1.65 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.305 1.442 . . . . 0.0 112.305 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -63.59 142.15 58.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 173.497 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.29 0.091 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 m -75.73 78.24 2.68 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.373 1.469 . . . . 0.0 110.967 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -148.57 137.48 21.59 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -120.76 134.94 55.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.065 1.746 . . . . 0.0 108.253 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 5.5 mp0 -139.17 -174.43 3.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.091 1.357 . . . . 0.0 109.871 -175.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -51.17 142.43 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 59.72 24.73 13.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.011 1.725 . . . . 0.0 112.864 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 9.5 tp10 -132.39 168.18 18.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.232 1.013 . . . . 0.0 108.749 170.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -73.25 147.99 44.08 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.311 1.845 . . . . 0.0 113.893 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.27 165.68 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 127.448 2.299 . . . . 0.0 108.101 171.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -96.26 131.13 43.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 168.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.75 141.44 43.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -69.49 113.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.227 0.611 . . . . 0.0 109.706 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -77.8 157.92 29.75 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.985 0.914 . . . . 0.0 109.32 174.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 m -58.07 -20.39 39.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.175 0.99 . . . . 0.0 112.748 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.06 -49.53 76.59 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.054 0.542 . . . . 0.0 112.086 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -173.89 -66.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 -161.79 1.41 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.736 1.215 . . . . 0.0 111.069 -170.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -53.73 141.09 27.61 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -147.23 158.3 44.51 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 129.564 3.145 . . . . 0.0 105.072 168.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.01 145.01 66.17 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.471 1.447 . . . . 0.0 110.607 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.49 166.0 32.45 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.511 1.925 . . . . 0.0 108.499 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -103.97 133.72 48.45 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.64 138.84 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 175.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -114.76 -32.01 5.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.306 0.642 . . . . 0.0 109.77 169.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.4 41.14 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.608 1.094 . . . . 0.0 110.385 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.2 t -136.43 139.31 45.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -132.04 110.36 10.67 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -61.61 -17.34 54.81 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.22 -31.82 45.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.942 0.897 . . . . 0.0 112.137 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 137.73 20.27 0.54 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.653 1.12 . . . . 0.0 112.928 173.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.3 p -131.65 171.57 13.3 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.122 1.461 . . . . 0.0 110.075 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 155.89 43.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.354 1.862 . . . . 0.0 107.759 -169.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 m -133.23 132.88 42.0 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.52 155.69 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -121.01 126.59 50.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.85 1.66 . . . . 0.0 107.356 172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -82.93 154.71 24.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -60.58 -30.54 69.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.446 0.698 . . . . 0.0 112.48 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.05 -25.85 68.57 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.639 0.776 . . . . 0.0 112.364 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.07 -14.96 7.4 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.997 1.284 . . . . 0.0 113.116 173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.55 144.43 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.494 1.147 . . . . 0.0 109.247 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.3 t -131.63 143.26 40.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.95 156.7 42.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.216 0.606 . . . . 0.0 110.84 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -109.35 129.15 55.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 169.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.24 177.91 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 125.197 1.399 . . . . 0.0 109.428 -169.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.66 169.15 9.47 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.245 -0.909 . . . . 0.0 110.677 -171.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -54.64 -38.46 66.88 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.517 0.727 . . . . 0.0 111.325 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.0 pt -63.98 -7.89 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -113.67 -6.98 13.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.172 0.989 . . . . 0.0 112.576 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.6 t -142.11 140.47 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 120.054 1.297 . . . . 0.0 110.872 -175.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -145.94 174.3 11.38 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.822 0.849 . . . . 0.0 109.841 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 137' ' ' SER . . . -59.12 166.94 1.89 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -81.52 47.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 168.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 135' ' ' ALA . 41.0 m -127.1 139.75 52.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 172.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -63.07 -41.77 99.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.001 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.82 -68.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -168.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -150.59 178.85 8.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.73 1.212 . . . . 0.0 111.022 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -75.89 159.1 31.29 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.11 1.764 . . . . 0.0 111.76 -173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -139.75 34.14 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.515 1.126 . . . . 0.0 110.976 175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.0 p -154.16 -49.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 120.479 -1.388 . . . . 0.0 110.874 169.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.33 -32.03 71.84 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 173.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -146.1 165.78 28.08 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -122.75 51.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.136 1.335 . . . . 0.0 112.632 -168.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -120.05 -5.49 10.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -65.03 162.79 38.85 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 122.18 0.878 . . . . 0.0 115.01 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 t -164.27 171.46 14.87 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 127.272 2.229 . . . . 0.0 106.73 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 52.65 76.28 0.2 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.192 1.397 . . . . 0.0 109.124 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.0 25.92 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -158.45 161.79 37.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.768 1.167 . . . . 0.0 109.953 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 3.2 m -142.86 147.96 36.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.608 0.763 . . . . 0.0 109.994 -169.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.9 m -82.45 -7.52 59.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.986 0.914 . . . . 0.0 113.265 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -72.57 27.0 0.05 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.703 2.001 . . . . 0.0 114.267 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.82 146.54 49.3 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.043 -1.036 . . . . 0.0 109.825 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 12.0 m -67.42 -31.65 72.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.292 0.637 . . . . 0.0 111.577 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -83.48 -12.27 56.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.959 0.904 . . . . 0.0 112.674 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -66.37 146.74 54.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.152 0.887 . . . . 0.0 108.86 -174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 172.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.0 m -139.22 32.53 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.255 1.022 . . . . 0.0 110.761 -169.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.64 64.69 0.77 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CD2' ' HB1' ' A' ' 135' ' ' ALA . 9.3 m-85 -53.3 111.47 0.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 127.38 2.272 . . . . 0.0 110.431 -173.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.518 ' H ' ' HB3' ' A' ' 91' ' ' GLU . 36.2 mt-30 -145.24 -175.35 4.67 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.356 2.262 . . . . 0.0 107.542 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.8 mt -53.69 142.85 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.5 22.59 12.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.547 1.539 . . . . 0.0 113.307 -175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.518 ' HB3' ' H ' ' A' ' 88' ' ' GLN . 8.2 tp10 -131.29 169.81 15.47 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -81.3 158.59 24.71 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.658 -0.651 . . . . 0.0 111.164 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -146.16 169.57 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 126.659 1.983 . . . . 0.0 107.969 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.7 mt -102.39 122.72 44.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.2 139.26 46.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.533 1.133 . . . . 0.0 108.58 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.8 m -68.96 135.12 50.46 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.806 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -112.18 154.79 24.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.926 1.691 . . . . 0.0 108.148 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.8 m -58.38 -20.71 46.23 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.647 1.179 . . . . 0.0 113.009 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -56.84 -47.92 79.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.251 1.02 . . . . 0.0 112.791 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.6 p -168.11 -68.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.886 0.475 . . . . 0.0 111.907 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -156.56 0.68 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.351 1.861 . . . . 0.0 109.253 -169.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -46.56 138.08 6.2 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.504 2.322 . . . . 0.0 115.854 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -145.49 157.08 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 129.202 3.001 . . . . 0.0 105.313 169.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.02 145.73 56.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.48 1.454 . . . . 0.0 110.75 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.77 155.7 37.68 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.575 1.55 . . . . 0.0 109.176 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -82.08 134.89 35.37 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.6 133.16 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.069 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -110.41 -31.46 7.27 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.276 172.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.12 163.91 38.39 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.52 1.054 . . . . 0.0 110.714 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.32 140.9 39.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -131.21 115.48 16.4 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -172.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.21 -21.02 61.27 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.584 0.753 . . . . 0.0 112.624 -175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.86 -31.39 39.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.083 0.953 . . . . 0.0 112.449 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 134.23 23.37 0.68 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.447 1.022 . . . . 0.0 112.697 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 78.4 p -131.75 169.88 15.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.988 1.394 . . . . 0.0 110.48 -172.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -143.16 152.62 41.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.5 1.92 . . . . 0.0 107.504 -169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.7 m -130.69 131.57 44.9 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 m -138.95 155.44 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -120.73 122.39 40.3 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.195 1.398 . . . . 0.0 107.453 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -77.93 148.34 34.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 169.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.6 -21.92 66.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.197 0.599 . . . . 0.0 112.525 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.77 -26.85 68.92 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.691 0.796 . . . . 0.0 112.305 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.2 5.91 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.052 1.311 . . . . 0.0 112.83 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.03 144.85 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.345 1.073 . . . . 0.0 109.16 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.11 144.41 38.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -149.2 155.21 40.27 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.128 0.571 . . . . 0.0 110.658 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -108.8 129.28 55.38 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.56 176.56 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.245 1.418 . . . . 0.0 109.087 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.3 168.43 9.55 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 -170.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -55.35 -37.13 67.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.561 0.744 . . . . 0.0 110.957 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.0 pt -64.88 -7.09 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -115.37 -7.52 12.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.188 0.995 . . . . 0.0 112.511 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.7 t -142.08 141.04 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 119.758 1.163 . . . . 0.0 110.847 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -150.17 176.96 10.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.702 0.801 . . . . 0.0 109.968 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 87' ' ' PHE . . . -59.52 168.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.635 1.174 . . . . 0.0 111.054 175.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -62.67 -21.6 65.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.055 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.2 m -62.45 120.51 11.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.926 0.891 . . . . 0.0 110.596 170.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.5 -40.59 79.02 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.154 0.982 . . . . 0.0 111.942 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.44 -64.52 0.84 Allowed 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -150.16 166.37 30.04 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.57 0.7 . . . . 0.0 112.628 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.84 153.25 36.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.271 1.829 . . . . 0.0 111.393 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -138.98 23.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.555 0.742 . . . . 0.0 112.08 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.72 -51.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.505 -1.372 . . . . 0.0 112.943 170.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.57 -33.49 60.83 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.415 1.007 . . . . 0.0 111.93 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -150.99 60.21 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.27 126.06 24.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.01 17.85 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.548 1.139 . . . . 0.0 112.962 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -147.5 -169.33 14.73 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.237 0.926 . . . . 0.0 112.773 -170.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.3 p -146.59 170.9 15.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.887 1.275 . . . . 0.0 110.751 -169.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -57.84 135.61 56.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.534 0.734 . . . . 0.0 111.598 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -161.72 -170.84 2.7 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.716 2.006 . . . . 0.0 108.23 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' HIS . . . . . . . . . . . . . 35.6 p80 -151.43 173.67 14.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.851 1.261 . . . . 0.0 110.115 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' SER . . . . . . . . . . . . . 35.2 p -152.1 167.91 26.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.234 1.014 . . . . 0.0 109.821 169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 7.4 m -79.61 -1.11 36.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.685 1.194 . . . . 0.0 113.409 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -72.97 89.68 1.44 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.979 0.912 . . . . 0.0 109.597 -178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.93 169.53 17.54 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.145 1.778 . . . . 0.0 108.535 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 7.0 m -62.79 -30.7 71.66 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.828 1.251 . . . . 0.0 113.757 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -81.52 60.79 4.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.723 0.809 . . . . 0.0 109.113 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -57.83 154.15 12.6 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 109.406 173.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 169.801 . . . . . . . . 0 0 . 1 stop_ save_